heart failure assessed (includes assessment of all the following components) (cad): blood pressure measured (2000f) level of activity assessed (1003f) clinical symptoms of volume overload (excess) assessed (1004f) weight, recorded (2001f) clinical signs of volume overload (excess) assessed (2002f)

osteoarthritis assessed (oa) includes assessment of all the following components: osteoarthritis symptoms and functional status assessed (1006f) use of anti-inflammatory or over-the-counter (otc) analgesic medications assessed (1007f) initial examination of the involved joint(s) (includes visual inspection, palpation, range of motion) (2004f)

anesthesia for reconstructive procedures of eyelid (eg, blepharoplasty, ptosis surgery)

anesthesia for procedures on external, middle, and inner ear including biopsy; not otherwise specified

anesthesia for procedures on external, middle, and inner ear including biopsy; otoscopy

anesthesia for procedures on external, middle, and inner ear including biopsy; tympanotomy

community-acquired bacterial pneumonia assessment (includes all of the following components) (cap): co-morbid conditions assessed (1026f) vital signs recorded (2010f) mental status assessed (2014f) hydration status assessed (2018f)

comprehensive preoperative assessment performed for cataract surgery with intraocular lens (iol) placement (includes assessment of all of the following components) (ec): dilated fundus evaluation performed within 12 months prior to cataract surgery (2020f) pre-surgical (cataract) axial length, corneal power measurement and method of intraocular lens power calculation documented (must be performed within 12 months prior to surgery) (3073f) preoperative assessment of functional or medical indication(s) for surgery prior to the cataract surgery with intraocular lens placement (must be performed within 12 months prior to cataract surgery) (3325f)

melanoma follow up completed (includes assessment of all of the following components) (ml): history obtained regarding new or changing moles (1050f) complete physical skin exam performed (2029f) patient counseled to perform a monthly self skin examination (5005f)

anesthesia for procedures on nose and accessory sinuses; not otherwise specified

anesthesia for procedures on nose and accessory sinuses; radical surgery

anesthesia for procedures on nose and accessory sinuses; biopsy, soft tissue

anesthesia for intraoral procedures, including biopsy; not otherwise specified

anesthesia for intraoral procedures, including biopsy; repair of cleft palate

anesthesia for intraoral procedures, including biopsy; excision of retropharyngeal tumor

anesthesia for intraoral procedures, including biopsy; radical surgery

anesthesia for procedures on facial bones or skull; not otherwise specified

anesthesia for procedures on facial bones or skull; radical surgery (including prognathism)

anesthesia for intracranial procedures; craniotomy or craniectomy for evacuation of hematoma

anesthesia for intracranial procedures; burr holes, including ventriculography

anesthesia for intracranial procedures; cranioplasty or elevation of depressed skull fracture, extradural (simple or compound)

anesthesia for intracranial procedures; procedures in sitting position

anesthesia for intracranial procedures; cerebrospinal fluid shunting procedures

anesthesia for intracranial procedures; electrocoagulation of intracranial nerve

anesthesia for all procedures on the integumentary system, muscles and nerves of head, neck, and posterior trunk, not otherwise specified

anesthesia for all procedures on esophagus, thyroid, larynx, trachea and lymphatic system of neck; not otherwise specified, age 1 year or older

anesthesia for all procedures on esophagus, thyroid, larynx, trachea and lymphatic system of neck; needle biopsy of thyroid

anesthesia for all procedures on the larynx and trachea in children younger than 1 year of age

anesthesia for procedures on major vessels of neck; not otherwise specified

anesthesia for procedures on major vessels of neck; simple ligation

anesthesia for procedures on the integumentary system on the extremities, anterior trunk and perineum; not otherwise specified

anesthesia for procedures on the integumentary system on the extremities, anterior trunk and perineum; reconstructive procedures on breast (eg, reduction or augmentation mammoplasty, muscle flaps)

anesthesia for procedures on the integumentary system on the extremities, anterior trunk and perineum; radical or modified radical procedures on breast

anesthesia for procedures on the integumentary system on the extremities, anterior trunk and perineum; radical or modified radical procedures on breast with internal mammary node dissection

anesthesia for procedures on the integumentary system on the extremities, anterior trunk and perineum; electrical conversion of arrhythmias

cerebral perfusion analysis using computed tomography with contrast administration, including post-processing of parametric maps with determination of cerebral blood flow, cerebral blood volume, and mean transit time

anesthesia for procedures on clavicle and scapula; not otherwise specified

anesthesia for procedures on clavicle and scapula; biopsy of clavicle

anesthesia for partial rib resection; radical procedures (eg, pectus excavatum)

anesthesia for closed chest procedures; (including bronchoscopy) not otherwise specified

anesthesia for closed chest procedures; mediastinoscopy and diagnostic thoracoscopy not utilizing 1 lung ventilation

anesthesia for closed chest procedures; mediastinoscopy and diagnostic thoracoscopy utilizing 1 lung ventilation

anesthesia for transvenous insertion or replacement of pacing cardioverter-defibrillator

anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation

anesthesia for thoracotomy procedures involving lungs, pleura, diaphragm, and mediastinum (including surgical thoracoscopy); not otherwise specified

anesthesia for thoracotomy procedures involving lungs, pleura, diaphragm, and mediastinum (including surgical thoracoscopy); utilizing 1 lung ventilation

anesthesia for thoracotomy procedures involving lungs, pleura, diaphragm, and mediastinum (including surgical thoracoscopy); decortication

anesthesia for thoracotomy procedures involving lungs, pleura, diaphragm, and mediastinum (including surgical thoracoscopy); pulmonary resection with thoracoplasty

anesthesia for thoracotomy procedures involving lungs, pleura, diaphragm, and mediastinum (including surgical thoracoscopy); intrathoracic procedures on the trachea and bronchi

computer-assisted musculoskeletal surgical navigational orthopedic procedure, with image-guidance based on fluoroscopic images (list separately in addition to code for primary procedure)

computer-assisted musculoskeletal surgical navigational orthopedic procedure, with image-guidance based on ct/mri images (list separately in addition to code for primary procedure)

anesthesia for procedures on heart, pericardial sac, and great vessels of chest; without pump oxygenator

anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, younger than 1 year of age

anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after original operation

anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator with hypothermic circulatory arrest

anesthesia for direct coronary artery bypass grafting; without pump oxygenator

anesthesia for direct coronary artery bypass grafting; with pump oxygenator

anesthesia for procedures on cervical spine and cord; not otherwise specified

anesthesia for procedures on cervical spine and cord; procedures with patient in the sitting position

anesthesia for procedures on thoracic spine and cord, not otherwise specified

anesthesia for procedures on the thoracic spine and cord, via an anterior transthoracic approach; not utilizing 1 lung ventilation

anesthesia for procedures on the thoracic spine and cord, via an anterior transthoracic approach; utilizing 1 lung ventilation

anesthesia for procedures in lumbar region; not otherwise specified

anesthesia for procedures in lumbar region; lumbar sympathectomy

anesthesia for procedures in lumbar region; diagnostic or therapeutic lumbar puncture

anesthesia for manipulation of the spine or for closed procedures on the cervical, thoracic or lumbar spine

anesthesia for extensive spine and spinal cord procedures (eg, spinal instrumentation or vascular procedures)

anesthesia for procedures on upper anterior abdominal wall; not otherwise specified

anesthesia for procedures on upper anterior abdominal wall; percutaneous liver biopsy

focused ultrasound ablation of uterine leiomyomata, including mr guidance; total leiomyomata volume less than 200 cc of tissue

focused ultrasound ablation of uterine leiomyomata, including mr guidance; total leiomyomata volume greater or equal to 200 cc of tissue

anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified

anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; endoscopic retrograde cholangiopancreatography (ercp)

anesthesia for hernia repairs in upper abdomen; not otherwise specified

anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence

anesthesia for hernia repairs in upper abdomen; transabdominal repair of diaphragmatic hernia

transcatheter placement of extracranial vertebral artery stent(s), including radiologic supervision and interpretation, open or percutaneous; initial vessel

transcatheter placement of extracranial vertebral artery stent(s), including radiologic supervision and interpretation, open or percutaneous; each additional vessel (list separately in addition to code for primary procedure)

anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified

anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; partial hepatectomy or management of liver hemorrhage (excluding liver biopsy)

anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; pancreatectomy, partial or total (eg, whipple procedure)

anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; liver transplant (recipient)

anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; gastric restrictive procedure for morbid obesity

anesthesia for procedures on lower anterior abdominal wall; not otherwise specified

anesthesia for procedures on lower anterior abdominal wall; panniculectomy

anesthesia for lower intestinal endoscopic procedures, endoscope introduced distal to duodenum; not otherwise specified

anesthesia for lower intestinal endoscopic procedures, endoscope introduced distal to duodenum; screening colonoscopy

anesthesia for combined upper and lower gastrointestinal endoscopic procedures, endoscope introduced both proximal to and distal to the duodenum

anesthesia for hernia repairs in lower abdomen; not otherwise specified

anesthesia for hernia repairs in lower abdomen; ventral and incisional hernias

anesthesia for hernia repairs in the lower abdomen not otherwise specified, younger than 1 year of age

anesthesia for hernia repairs in the lower abdomen not otherwise specified, infants younger than 37 weeks gestational age at birth and younger than 50 weeks gestational age at time of surgery

anesthesia for intraperitoneal procedures in lower abdomen including laparoscopy; not otherwise specified

anesthesia for intraperitoneal procedures in lower abdomen including laparoscopy; amniocentesis

anesthesia for intraperitoneal procedures in lower abdomen including laparoscopy; abdominoperineal resection

anesthesia for intraperitoneal procedures in lower abdomen including laparoscopy; radical hysterectomy

anesthesia for intraperitoneal procedures in lower abdomen including laparoscopy; pelvic exenteration

anesthesia for intraperitoneal procedures in lower abdomen including laparoscopy; tubal ligation/transection

anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; not otherwise specified

anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; renal procedures, including upper one-third of ureter, or donor nephrectomy

anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; total cystectomy

anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; radical prostatectomy (suprapubic, retropubic)

anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; adrenalectomy

anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; renal transplant (recipient)

anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; cystolithotomy

anesthesia for lithotripsy, extracorporeal shock wave; with water bath

anesthesia for lithotripsy, extracorporeal shock wave; without water bath

anesthesia for procedures on major lower abdominal vessels; not otherwise specified

anesthesia for procedures on major lower abdominal vessels; inferior vena cava ligation

anesthesia for transurethral procedures (including urethrocystoscopy); not otherwise specified

anesthesia for transurethral procedures (including urethrocystoscopy); transurethral resection of bladder tumor(s)

anesthesia for transurethral procedures (including urethrocystoscopy); transurethral resection of prostate

anesthesia for transurethral procedures (including urethrocystoscopy); post-transurethral resection bleeding

anesthesia for transurethral procedures (including urethrocystoscopy); with fragmentation, manipulation and/or removal of ureteral calculus

anesthesia for procedures on male genitalia (including open urethral procedures); not otherwise specified

anesthesia for procedures on male genitalia (including open urethral procedures); vasectomy, unilateral or bilateral

anesthesia for procedures on male genitalia (including open urethral procedures); seminal vesicles

anesthesia for procedures on male genitalia (including open urethral procedures); undescended testis, unilateral or bilateral

anesthesia for procedures on male genitalia (including open urethral procedures); radical orchiectomy, inguinal

anesthesia for procedures on male genitalia (including open urethral procedures); radical orchiectomy, abdominal

anesthesia for procedures on male genitalia (including open urethral procedures); orchiopexy, unilateral or bilateral

anesthesia for procedures on male genitalia (including open urethral procedures); complete amputation of penis

anesthesia for procedures on male genitalia (including open urethral procedures); radical amputation of penis with bilateral inguinal lymphadenectomy

anesthesia for procedures on male genitalia (including open urethral procedures); radical amputation of penis with bilateral inguinal and iliac lymphadenectomy

anesthesia for procedures on male genitalia (including open urethral procedures); insertion of penile prosthesis (perineal approach)

anesthesia for vaginal procedures (including biopsy of labia, vagina, cervix or endometrium); not otherwise specified

anesthesia for vaginal procedures (including biopsy of labia, vagina, cervix or endometrium); colpotomy, vaginectomy, colporrhaphy, and open urethral procedures

anesthesia for vaginal procedures (including biopsy of labia, vagina, cervix or endometrium); vaginal hysterectomy

anesthesia for vaginal procedures (including biopsy of labia, vagina, cervix or endometrium); cervical cerclage

anesthesia for vaginal procedures (including biopsy of labia, vagina, cervix or endometrium); culdoscopy

anesthesia for vaginal procedures (including biopsy of labia, vagina, cervix or endometrium); hysteroscopy and/or hysterosalpingography

removal of total disc arthroplasty (artificial disc), anterior approach, each additional interspace, cervical (list separately in addition to code for primary procedure)

revision including replacement of total disc arthroplasty (artificial disc), anterior approach, each additional interspace, cervical (list separately in addition to code for primary procedure)

placement of a subconjunctival retinal prosthesis receiver and pulse generator, and implantation of intraocular retinal electrode array, with vitrectomy

extracorporeal shock wave involving musculoskeletal system, not otherwise specified, high energy

extracorporeal shock wave, high energy, performed by a physician, requiring anesthesia other than local, involving lateral humeral epicondyle

quantitative sensory testing (qst), testing and interpretation per extremity; using touch pressure stimuli to assess large diameter sensation

quantitative sensory testing (qst), testing and interpretation per extremity; using vibration stimuli to assess large diameter fiber sensation

quantitative sensory testing (qst), testing and interpretation per extremity; using cooling stimuli to assess small nerve fiber sensation and hyperalgesia

quantitative sensory testing (qst), testing and interpretation per extremity; using heat-pain stimuli to assess small nerve fiber sensation and hyperalgesia

quantitative sensory testing (qst), testing and interpretation per extremity; using other stimuli to assess sensation

anesthesia for bone marrow aspiration and/or biopsy, anterior or posterior iliac crest

long-chain (c20-22) omega-3 fatty acids in red blood cell (rbc) membranes

anesthesia for radical procedures for tumor of pelvis, except hindquarter amputation

anesthesia for closed procedures involving symphysis pubis or sacroiliac joint

anesthesia for open procedures involving symphysis pubis or sacroiliac joint

anesthesia for open repair of fracture disruption of pelvis or column fracture involving acetabulum

anesthesia for open procedures involving hip joint; not otherwise specified

anesthesia for open procedures involving hip joint; hip disarticulation

anesthesia for open procedures involving hip joint; total hip arthroplasty

anesthesia for open procedures involving hip joint; revision of total hip arthroplasty

anesthesia for all closed procedures involving upper two-thirds of femur

anesthesia for open procedures involving upper two-thirds of femur; not otherwise specified

anesthesia for open procedures involving upper two-thirds of femur; amputation

anesthesia for open procedures involving upper two-thirds of femur; radical resection

anesthesia for all procedures on nerves, muscles, tendons, fascia, and bursae of upper leg

anesthesia for all procedures involving veins of upper leg, including exploration

common carotid intima-media thickness (imt) study for evaluation of atherosclerotic burden or coronary heart disease risk factor assessment

anesthesia for procedures involving arteries of upper leg, including bypass graft; not otherwise specified

anesthesia for procedures involving arteries of upper leg, including bypass graft; femoral artery ligation

anesthesia for procedures involving arteries of upper leg, including bypass graft; femoral artery embolectomy

anesthesia for all procedures on nerves, muscles, tendons, fascia, and bursae of knee and/or popliteal area

anesthesia for all closed procedures on lower one-third of femur

anesthesia for all closed procedures on upper ends of tibia, fibula, and/or patella

anesthesia for all open procedures on upper ends of tibia, fibula, and/or patella

anesthesia for open or surgical arthroscopic procedures on knee joint; not otherwise specified

anesthesia for open or surgical arthroscopic procedures on knee joint; total knee arthroplasty

anesthesia for open or surgical arthroscopic procedures on knee joint; disarticulation at knee

anesthesia for all cast applications, removal, or repair involving knee joint

anesthesia for procedures on veins of knee and popliteal area; not otherwise specified

anesthesia for procedures on veins of knee and popliteal area; arteriovenous fistula

anesthesia for procedures on arteries of knee and popliteal area; not otherwise specified

anesthesia for procedures on arteries of knee and popliteal area; popliteal thromboendarterectomy, with or without patch graft

anesthesia for procedures on arteries of knee and popliteal area; popliteal excision and graft or repair for occlusion or aneurysm

anesthesia for all closed procedures on lower leg, ankle, and foot

anesthesia for procedures on nerves, muscles, tendons, and fascia of lower leg, ankle, and foot; not otherwise specified

anesthesia for procedures on nerves, muscles, tendons, and fascia of lower leg, ankle, and foot; repair of ruptured achilles tendon, with or without graft

anesthesia for procedures on nerves, muscles, tendons, and fascia of lower leg, ankle, and foot; gastrocnemius recession (eg, strayer procedure)

anesthesia for open procedures on bones of lower leg, ankle, and foot; not otherwise specified

anesthesia for open procedures on bones of lower leg, ankle, and foot; radical resection (including below knee amputation)

anesthesia for open procedures on bones of lower leg, ankle, and foot; osteotomy or osteoplasty of tibia and/or fibula

anesthesia for open procedures on bones of lower leg, ankle, and foot; total ankle replacement

anesthesia for procedures on arteries of lower leg, including bypass graft; not otherwise specified

anesthesia for procedures on arteries of lower leg, including bypass graft; embolectomy, direct or with catheter

anesthesia for procedures on veins of lower leg; not otherwise specified

anesthesia for procedures on veins of lower leg; venous thrombectomy, direct or with catheter

computer-aided detection, including computer algorithm analysis of mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation, breast mri (list separately in addition to code for primary procedure)

anesthesia for all procedures on nerves, muscles, tendons, fascia, and bursae of shoulder and axilla

anesthesia for all closed procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint, and shoulder joint

anesthesia for diagnostic arthroscopic procedures of shoulder joint

anesthesia for open or surgical arthroscopic procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint, and shoulder joint; not otherwise specified

anesthesia for open or surgical arthroscopic procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint, and shoulder joint; shoulder disarticulation

anesthesia for open or surgical arthroscopic procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint, and shoulder joint; interthoracoscapular (forequarter) amputation

anesthesia for open or surgical arthroscopic procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint, and shoulder joint; total shoulder replacement

total disc arthroplasty (artificial disc), anterior approach, including discectomy to prepare interspace (other than for decompression), each additional interspace, lumbar (list separately in addition to code for primary procedure)

removal of total disc arthroplasty, (artificial disc), anterior approach, each additional interspace, lumbar (list separately in addition to code for primary procedure)

anesthesia for procedures on arteries of shoulder and axilla; not otherwise specified

anesthesia for procedures on arteries of shoulder and axilla; axillary-brachial aneurysm

anesthesia for procedures on arteries of shoulder and axilla; bypass graft

anesthesia for procedures on arteries of shoulder and axilla; axillary-femoral bypass graft

revision including replacement of total disc arthroplasty (artificial disc), anterior approach, each additional interspace, lumbar (list separately in addition to code for primary procedure)

anesthesia for shoulder cast application, removal or repair, not otherwise specified

anesthesia for procedures on nerves, muscles, tendons, fascia, and bursae of upper arm and elbow; not otherwise specified

anesthesia for procedures on nerves, muscles, tendons, fascia, and bursae of upper arm and elbow; tenotomy, elbow to shoulder, open

anesthesia for procedures on nerves, muscles, tendons, fascia, and bursae of upper arm and elbow; tenoplasty, elbow to shoulder

anesthesia for procedures on nerves, muscles, tendons, fascia, and bursae of upper arm and elbow; tenodesis, rupture of long tendon of biceps

anesthesia for diagnostic arthroscopic procedures of elbow joint

anesthesia for open or surgical arthroscopic procedures of the elbow; not otherwise specified

anesthesia for open or surgical arthroscopic procedures of the elbow; osteotomy of humerus

anesthesia for open or surgical arthroscopic procedures of the elbow; repair of nonunion or malunion of humerus

computer-aided detection (cad) (computer algorithm analysis of digital image data for lesion detection) with further physician review for interpretation and report, with or without digitization of film radiographic images, chest radiograph(s), performed concurrent with primary interpretation (list separately in addition to code for primary procedure)

anesthesia for open or surgical arthroscopic procedures of the elbow; radical procedures

anesthesia for open or surgical arthroscopic procedures of the elbow; excision of cyst or tumor of humerus

computer-aided detection (cad) (computer algorithm analysis of digital image data for lesion detection) with further physician review for interpretation and report, with or without digitization of film radiographic images, chest radiograph(s), performed remote from primary interpretation

anesthesia for open or surgical arthroscopic procedures of the elbow; total elbow replacement

anesthesia for procedures on arteries of upper arm and elbow; not otherwise specified

anesthesia for procedures on arteries of upper arm and elbow; embolectomy

anesthesia for procedures on veins of upper arm and elbow; not otherwise specified

anesthesia for procedures on veins of upper arm and elbow; phleborrhaphy

anesthesia for all procedures on nerves, muscles, tendons, fascia, and bursae of forearm, wrist, and hand

anesthesia for all closed procedures on radius, ulna, wrist, or hand bones

anesthesia for open or surgical arthroscopic/endoscopic procedures on distal radius, distal ulna, wrist, or hand joints; not otherwise specified

anesthesia for open or surgical arthroscopic/endoscopic procedures on distal radius, distal ulna, wrist, or hand joints; total wrist replacement

anesthesia for procedures on arteries of forearm, wrist, and hand; not otherwise specified

anesthesia for procedures on arteries of forearm, wrist, and hand; embolectomy

anesthesia for vascular shunt, or shunt revision, any type (eg, dialysis)

excision of rectal tumor, transanal endoscopic microsurgical approach (ie, tems), including muscularis propria (ie, full thickness)

anesthesia for procedures on veins of forearm, wrist, and hand; not otherwise specified

anesthesia for procedures on veins of forearm, wrist, and hand; phleborrhaphy

anesthesia for forearm, wrist, or hand cast application, removal, or repair

remote real-time interactive video-conferenced critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes

remote real-time interactive video-conferenced critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (list separately in addition to code for primary service)

placement of intraocular radiation source applicator (list separately in addition to primary procedure)

insertion of anterior segment aqueous drainage device, without extraocular reservoir, internal approach, into the trabecular meshwork; initial insertion

anesthesia for cardiac catheterization including coronary angiography and ventriculography (not to include swan-ganz catheter)

anesthesia for therapeutic interventional radiological procedures involving the arterial system; not otherwise specified

anesthesia for therapeutic interventional radiological procedures involving the arterial system; carotid or coronary

anesthesia for therapeutic interventional radiological procedures involving the arterial system; intracranial, intracardiac, or aortic

anesthesia for therapeutic interventional radiological procedures involving the venous/lymphatic system (not to include access to the central circulation); not otherwise specified

anesthesia for therapeutic interventional radiological procedures involving the venous/lymphatic system (not to include access to the central circulation); intrahepatic or portal circulation (eg, transvenous intrahepatic portosystemic shunt[s] [tips])

anesthesia for therapeutic interventional radiological procedures involving the venous/lymphatic system (not to include access to the central circulation); intrathoracic or jugular

anesthesia for therapeutic interventional radiological procedures involving the venous/lymphatic system (not to include access to the central circulation); intracranial

anesthesia for percutaneous image guided procedures on the spine and spinal cord; diagnostic

anesthesia for percutaneous image guided procedures on the spine and spinal cord; therapeutic

anesthesia for second- and third-degree burn excision or debridement with or without skin grafting, any site, for total body surface area (tbsa) treated during anesthesia and surgery; less than 4% total body surface area

anesthesia for second- and third-degree burn excision or debridement with or without skin grafting, any site, for total body surface area (tbsa) treated during anesthesia and surgery; between 4% and 9% of total body surface area

anesthesia for second- and third-degree burn excision or debridement with or without skin grafting, any site, for total body surface area (tbsa) treated during anesthesia and surgery; each additional 9% total body surface area or part thereof (list separately in addition to code for primary procedure)

arthrodesis, pre-sacral interbody technique, disc space preparation, discectomy, without instrumentation, with image guidance, includes bone graft when performed; l5-s1 interspace

anesthesia for cesarean hysterectomy without any labor analgesia/anesthesia care

neuraxial labor analgesia/anesthesia for planned vaginal delivery (this includes any repeat subarachnoid needle placement and drug injection and/or any necessary replacement of an epidural catheter during labor)

anesthesia for cesarean delivery following neuraxial labor analgesia/anesthesia (list separately in addition to code for primary procedure performed)

anesthesia for cesarean hysterectomy following neuraxial labor analgesia/anesthesia (list separately in addition to code for primary procedure performed)

arthrodesis, pre-sacral interbody technique, disc space preparation, discectomy, without instrumentation, with image guidance, includes bone graft when performed; l4-l5 interspace (list separately in addition to code for primary procedure)

measurement of ocular blood flow by repetitive intraocular pressure sampling, with interpretation and report

physiological support for harvesting of organ(s) from brain-dead patient

anesthesia for diagnostic or therapeutic nerve blocks and injections (when block or injection is performed by a different physician or other qualified health care professional); other than the prone position

anesthesia for diagnostic or therapeutic nerve blocks and injections (when block or injection is performed by a different physician or other qualified health care professional); prone position

daily hospital management of epidural or subarachnoid continuous drug administration

percutaneous sacral augmentation (sacroplasty), unilateral injection(s), including the use of a balloon or mechanical device, when used, 1 or more needles, includes imaging guidance and bone biopsy, when performed

percutaneous sacral augmentation (sacroplasty), bilateral injections, including the use of a balloon or mechanical device, when used, 2 or more needles, includes imaging guidance and bone biopsy, when performed

posterior vertebral joint(s) arthroplasty (eg, facet joint[s] replacement), including facetectomy, laminectomy, foraminotomy, and vertebral column fixation, injection of bone cement, when performed, including fluoroscopy, single level, lumbar spine

intravascular catheter-based coronary vessel or graft spectroscopy (eg, infrared) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation, and report, each vessel (list separately in addition to code for primary procedure)

computerized database analysis of multiple cycles of digitized cardiac electrical data from two or more ecg leads, including transmission to a remote center, application of multiple nonlinear mathematical transformations, with coronary artery obstruction severity assessment

evacuation of meibomian glands, automated, using heat and intermittent pressure, unilateral

comprehensive audiometry threshold evaluation and speech recognition (0209t, 0211t combined), automated

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; single level

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; second level (list separately in addition to code for primary procedure)

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; third and any additional level(s) (list separately in addition to code for primary procedure)

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; single level

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; second level (list separately in addition to code for primary procedure)

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; third and any additional level(s) (list separately in addition to code for primary procedure)

placement of a posterior intrafacet implant(s), unilateral or bilateral, including imaging and placement of bone graft(s) or synthetic device(s), single level; cervical

placement of a posterior intrafacet implant(s), unilateral or bilateral, including imaging and placement of bone graft(s) or synthetic device(s), single level; thoracic

placement of a posterior intrafacet implant(s), unilateral or bilateral, including imaging and placement of bone graft(s) or synthetic device(s), single level; lumbar

placement of a posterior intrafacet implant(s), unilateral or bilateral, including imaging and placement of bone graft(s) or synthetic device(s), single level; each additional vertebral segment (list separately in addition to code for primary procedure)

injection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, cervical or thoracic; single level

injection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, cervical or thoracic; each additional level (list separately in addition to code for primary procedure)

injection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, lumbar or sacral; single level

injection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, lumbar or sacral; each additional level (list separately in addition to code for primary procedure)

injection(s), platelet rich plasma, any site, including image guidance, harvesting and preparation when performed

transluminal peripheral atherectomy, open or percutaneous, including radiological supervision and interpretation; renal artery

transluminal peripheral atherectomy, open or percutaneous, including radiological supervision and interpretation; visceral artery (except renal), each vessel

transluminal peripheral atherectomy, open or percutaneous, including radiological supervision and interpretation; abdominal aorta

transluminal peripheral atherectomy, open or percutaneous, including radiological supervision and interpretation; brachiocephalic trunk and branches, each vessel

transluminal peripheral atherectomy, open or percutaneous, including radiological supervision and interpretation; iliac artery, each vessel

ligation, hemorrhoidal vascular bundle(s), including ultrasound guidance

insertion of anterior segment aqueous drainage device, without extraocular reservoir, internal approach, into the suprachoroidal space

endovascular repair of iliac artery bifurcation (eg, aneurysm, pseudoaneurysm, arteriovenous malformation, trauma, dissection) using bifurcated endograft from the common iliac artery into both the external and internal iliac artery, including all selective and/or nonselective catheterization(s) required for device placement and all associated radiological supervision and interpretation, unilateral

intramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one leg, including ultrasound guidance, if performed; complete procedure including unilateral or bilateral bone marrow harvest

intramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one leg, including ultrasound guidance, if performed; complete procedure excluding bone marrow harvest

intramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one leg, including ultrasound guidance, if performed; unilateral or bilateral bone marrow harvest only for intramuscular autologous bone marrow cell therapy

implantation or replacement of carotid sinus baroreflex activation device; total system (includes generator placement, unilateral or bilateral lead placement, intra-operative interrogation, programming, and repositioning, when performed)

implantation or replacement of carotid sinus baroreflex activation device; lead only, unilateral (includes intra-operative interrogation, programming, and repositioning, when performed)

implantation or replacement of carotid sinus baroreflex activation device; pulse generator only (includes intra-operative interrogation, programming, and repositioning, when performed)

revision or removal of carotid sinus baroreflex activation device; total system (includes generator placement, unilateral or bilateral lead placement, intra-operative interrogation, programming, and repositioning, when performed)

revision or removal of carotid sinus baroreflex activation device; lead only, unilateral (includes intra-operative interrogation, programming, and repositioning, when performed)

revision or removal of carotid sinus baroreflex activation device; pulse generator only (includes intra-operative interrogation, programming, and repositioning, when performed)

interrogation device evaluation (in person), carotid sinus baroreflex activation system, including telemetric iterative communication with the implantable device to monitor device diagnostics and programmed therapy values, with interpretation and report (eg, battery status, lead impedance, pulse amplitude, pulse width, therapy frequency, pathway mode, burst mode, therapy start/stop times each day)

interrogation device evaluation (in person), carotid sinus baroreflex activation system, including telemetric iterative communication with the implantable device to monitor device diagnostics and programmed therapy values, with interpretation and report (eg, battery status, lead impedance, pulse amplitude, pulse width, therapy frequency, pathway mode, burst mode, therapy start/stop times each day); with programming

percutaneous laminotomy/laminectomy (interlaminar approach) for decompression of neural elements, (with or without ligamentous resection, discectomy, facetectomy and/or foraminotomy), any method, under indirect image guidance (eg, fluoroscopic, ct), single or multiple levels, unilateral or bilateral; cervical or thoracic

percutaneous laminotomy/laminectomy (interlaminar approach) for decompression of neural elements, (with or without ligamentous resection, discectomy, facetectomy and/or foraminotomy), any method, under indirect image guidance (eg, fluoroscopic, ct), single or multiple levels, unilateral or bilateral; lumbar

transcutaneous electrical modulation pain reprocessing (eg, scrambler therapy), each treatment session (includes placement of electrodes)

corneal incisions in the recipient cornea created using a laser, in preparation for penetrating or lamellar keratoplasty (list separately in addition to code for primary procedure)

external electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; includes recording, scanning analysis with report, review and interpretation

external electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)

external electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; scanning analysis with report

external electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation

insertion of ocular telescope prosthesis including removal of crystalline lens or intraocular lens prosthesis

vagus nerve blocking therapy (morbid obesity); laparoscopic implantation of neurostimulator electrode array, anterior and posterior vagal trunks adjacent to esophagogastric junction (egj), with implantation of pulse generator, includes programming

vagus nerve blocking therapy (morbid obesity); laparoscopic revision or replacement of vagal trunk neurostimulator electrode array, including connection to existing pulse generator

vagus nerve blocking therapy (morbid obesity); laparoscopic removal of vagal trunk neurostimulator electrode array and pulse generator

vagus nerve blocking therapy (morbid obesity); removal of pulse generator

vagus nerve blocking therapy (morbid obesity); replacement of pulse generator

vagus nerve blocking therapy (morbid obesity); neurostimulator pulse generator electronic analysis, includes reprogramming when performed

monitoring of intraocular pressure for 24 hours or longer, unilateral or bilateral, with interpretation and report

tear film imaging, unilateral or bilateral, with interpretation and report

myocardial sympathetic innervation imaging, planar qualitative and quantitative assessment

myocardial sympathetic innervation imaging, planar qualitative and quantitative assessment; with tomographic spect

visual evoked potential, screening of visual acuity, automated, with report

extra-osseous subtalar joint implant for talotarsal stabilization

endothelial function assessment, using peripheral vascular response to reactive hyperemia, non-invasive (eg, brachial artery ultrasound, peripheral artery tonometry), unilateral or bilateral

transcatheter renal sympathetic denervation, percutaneous approach including arterial puncture, selective catheter placement(s) renal artery(ies), fluoroscopy, contrast injection(s), intraprocedural roadmapping and radiological supervision and interpretation, including pressure gradient measurements, flush aortogram and diagnostic renal angiography when performed; unilateral

transcatheter renal sympathetic denervation, percutaneous approach including arterial puncture, selective catheter placement(s) renal artery(ies), fluoroscopy, contrast injection(s), intraprocedural roadmapping and radiological supervision and interpretation, including pressure gradient measurements, flush aortogram and diagnostic renal angiography when performed; bilateral

quantitative pupillometry with interpretation and report, unilateral or bilateral

therapeutic apheresis with selective hdl delipidation and plasma reinfusion

transcatheter mitral valve repair percutaneous approach via the coronary sinus

ultrasound, elastography (list separately in addition to code for primary procedure)

placement of interstitial device(s) in bone for radiostereometric analysis (rsa)

radiologic examination, radiostereometric analysis (rsa); spine, (includes cervical, thoracic and lumbosacral, when performed)

radiologic examination, radiostereometric analysis (rsa); upper extremity(ies), (includes shoulder, elbow, and wrist, when performed)

radiologic examination, radiostereometric analysis (rsa); lower extremity(ies), (includes hip, proximal femur, knee, and ankle, when performed)

optical coherence tomography of breast or axillary lymph node, excised tissue, each specimen; real-time intraoperative

optical coherence tomography of breast or axillary lymph node, excised tissue, each specimen; interpretation and report, real-time or referred

optical coherence tomography of breast, surgical cavity; real-time intraoperative

optical coherence tomography of breast, surgical cavity; interpretation and report, real-time or referred

gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), colon, with interpretation and report

insertion of drug-eluting implant (including punctal dilation and implant removal when performed) into lacrimal canaliculus, each

bioelectrical impedance analysis whole body composition assessment, with interpretation and report

behavior identification assessment, by the physician or other qualified health care professional, face-to-face with patient and caregiver(s), includes administration of standardized and non-standardized tests, detailed behavioral history, patient observation and caregiver interview, interpretation of test results, discussion of findings and recommendations with the primary guardian(s)/caregiver(s), and preparation of report

observational behavioral follow-up assessment, includes physician or other qualified health care professional direction with interpretation and report, administered by one technician; first 30 minutes of technician time, face-to-face with the patient

observational behavioral follow-up assessment, includes physician or other qualified health care professional direction with interpretation and report, administered by one technician; each additional 30 minutes of technician time, face-to-face with the patient (list separately in addition to code for primary service)

exposure behavioral follow-up assessment, includes physician or other qualified health care professional direction with interpretation and report, administered by physician or other qualified health care professional with the assistance of one or more technicians; first 30 minutes of technician(s) time, face-to-face with the patient

exposure behavioral follow-up assessment, includes physician or other qualified health care professional direction with interpretation and report, administered by physician or other qualified health care professional with the assistance of one or more technicians; each additional 30 minutes of technician(s) time, face-to-face with the patient (list separately in addition to code for primary procedure)

adaptive behavior treatment by protocol, administered by technician, face-to-face with one patient; first 30 minutes of technician time

adaptive behavior treatment by protocol, administered by technician, face-to-face with one patient; each additional 30 minutes of technician time (list separately in addition to code for primary procedure)

group adaptive behavior treatment by protocol, administered by technician, face-to-face with two or more patients; first 30 minutes of technician time

group adaptive behavior treatment by protocol, administered by technician, face-to-face with two or more patients; each additional 30 minutes of technician time (list separately in addition to code for primary procedure)

adaptive behavior treatment with protocol modification administered by physician or other qualified health care professional with one patient; first 30 minutes of patient face-to-face time

adaptive behavior treatment with protocol modification administered by physician or other qualified health care professional with one patient; each additional 30 minutes of patient face-to-face time (list separately in addition to code for primary procedure)

family adaptive behavior treatment guidance, administered by physician or other qualified health care professional (without the patient present)

multiple-family group adaptive behavior treatment guidance, administered by physician or other qualified health care professional (without the patient present)

adaptive behavior treatment social skills group, administered by physician or other qualified health care professional face-to-face with multiple patients

exposure adaptive behavior treatment with protocol modification requiring two or more technicians for severe maladaptive behavior(s); first 60 minutes of technicians' time, face-to-face with patient

exposure adaptive behavior treatment with protocol modification requiring two or more technicians for severe maladaptive behavior(s); each additional 30 minutes of technicians' time face-to-face with patient (list separately in addition to code for primary procedure)

total disc arthroplasty (artificial disc), anterior approach, including discectomy with end plate preparation (includes osteophytectomy for nerve root or spinal cord decompression and microdissection), cervical, three or more levels

insertion of anterior segment aqueous drainage device, without extraocular reservoir, internal approach, into the trabecular meshwork; each additional device insertion (list separately in addition to code for primary procedure)

anoscopy with directed submucosal injection of bulking agent for fecal incontinence

visual field assessment, with concurrent real time data analysis and accessible data storage with patient initiated data transmitted to a remote surveillance center for up to 30 days; review and interpretation with report by a physician or other qualified health care professional

visual field assessment, with concurrent real time data analysis and accessible data storage with patient initiated data transmitted to a remote surveillance center for up to 30 days; technical support and patient instructions, surveillance, analysis, and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional

computer-aided animation and analysis of time series retinal images for the monitoring of disease progression, unilateral or bilateral, with interpretation and report

external heart rate and 3-axis accelerometer data recording up to 14 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; includes report, scanning analysis with report, review and interpretation by a physician or other qualified health care professional

external heart rate and 3-axis accelerometer data recording up to 14 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; review and interpretation only

external heart rate and 3-axis accelerometer data recording from 15 to 30 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; includes report, scanning analysis with report, review and interpretation by a physician or other qualified health care professional

external heart rate and 3-axis accelerometer data recording from 15 to 30 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; review and interpretation only

external heart rate and 3-axis accelerometer data recording more than 30 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; includes report, scanning analysis with report, review and interpretation by a physician or other qualified health care professional

external heart rate and 3-axis accelerometer data recording more than 30 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; review and interpretation only

transcatheter insertion or replacement of permanent leadless pacemaker, ventricular

transcatheter removal of permanent leadless pacemaker, ventricular

programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report, leadless pacemaker system

peri-procedural device evaluation (in person) and programming of device system parameters before or after a surgery, procedure or test with analysis, review and report, leadless pacemaker system

interrogation device evaluation (in person) with analysis, review and report, includes connection, recording and disconnection per patient encounter, leadless pacemaker system

high dose rate electronic brachytherapy, skin surface application, per fraction, includes basic dosimetry, when performed

high dose rate electronic brachytherapy, interstitial or intracavitary treatment, per fraction, includes basic dosimetry, when performed

intra-operative use of kinetic balance sensor for implant stability during knee replacement arthroplasty (list separately in addition to code for primary procedure)

endoscopic retrograde cholangiopancreatography (ercp), with optical endomicroscopy (list separately in addition to code for primary procedure)

magnetic resonance image guided high intensity focused ultrasound (mrgfus), stereotactic ablation lesion, intracranial for movement disorder including stereotactic navigation and frame placement when performed

myocardial strain imaging (quantitative assessment of myocardial mechanics using image-based analysis of local myocardial dynamics) (list separately in addition to code for primary procedure)

multi-spectral digital skin lesion analysis of clinically atypical cutaneous pigmented lesions for detection of melanomas and high risk melanocytic atypia; one to five lesions

multi-spectral digital skin lesion analysis of clinically atypical cutaneous pigmented lesions for detection of melanomas and high risk melanocytic atypia; six or more lesions

collagen cross-linking of cornea (including removal of the corneal epithelium and intraoperative pachymetry when performed)

preventive behavior change, intensive program of prevention of diabetes using a standardized diabetes prevention program curriculum, provided to individuals in a group setting, minimum 60 minutes, per day

transcervical uterine fibroid(s) ablation with ultrasound guidance, radiofrequency

oversight of the care of an extracorporeal liver assist system patient requiring review of status, review of laboratories and other studies, and revision of orders and liver assist care plan (as appropriate), within a calendar month, 30 minutes or more of non-face-to-face time

nasal endoscopy, surgical, ethmoid sinus, placement of drug eluting implant

nasal endoscopy, surgical, ethmoid sinus, placement of drug eluting implant; with biopsy, polypectomy or debridement

insertion or replacement of permanent cardiac contractility modulation system, including contractility evaluation when performed, and programming of sensing and therapeutic parameters; pulse generator with transvenous electrodes

insertion or replacement of permanent cardiac contractility modulation system, including contractility evaluation when performed, and programming of sensing and therapeutic parameters; pulse generator only

insertion or replacement of permanent cardiac contractility modulation system, including contractility evaluation when performed, and programming of sensing and therapeutic parameters; atrial electrode only

insertion or replacement of permanent cardiac contractility modulation system, including contractility evaluation when performed, and programming of sensing and therapeutic parameters; ventricular electrode only

removal of permanent cardiac contractility modulation system; pulse generator only

removal of permanent cardiac contractility modulation system; transvenous electrode (atrial or ventricular)

removal and replacement of permanent cardiac contractility modulation system pulse generator only

repositioning of previously implanted cardiac contractility modulation transvenous electrode (atrial or ventricular lead)

relocation of skin pocket for implanted cardiac contractility modulation pulse generator

programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, including review and report, implantable cardiac contractility modulation system

interrogation device evaluation (in person) with analysis, review and report, includes connection, recording and disconnection per patient encounter, implantable cardiac contractility modulation system

destruction of neurofibroma, extensive (cutaneous, dermal extending into subcutaneous); face, head and neck, greater than 50 neurofibromas

destruction of neurofibroma, extensive (cutaneous, dermal extending into subcutaneous); trunk and extremities, extensive, greater than 100 neurofibromas

transurethral waterjet ablation of prostate, including control of post-operative bleeding, including ultrasound guidance, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included when performed)

tactile breast imaging by computer-aided tactile sensors, unilateral or bilateral

insertion or replacement of neurostimulator system for treatment of central sleep apnea; complete system (transvenous placement of right or left stimulation lead, sensing lead, implantable pulse generator)

insertion or replacement of neurostimulator system for treatment of central sleep apnea; sensing lead only

insertion or replacement of neurostimulator system for treatment of central sleep apnea; stimulation lead only

insertion or replacement of neurostimulator system for treatment of central sleep apnea; pulse generator only

removal of neurostimulator system for treatment of central sleep apnea; pulse generator only

removal of neurostimulator system for treatment of central sleep apnea; sensing lead only

removal of neurostimulator system for treatment of central sleep apnea; stimulation lead only

removal and replacement of neurostimulator system for treatment of central sleep apnea, pulse generator only

repositioning of neurostimulator system for treatment of central sleep apnea; stimulation lead only

repositioning of neurostimulator system for treatment of central sleep apnea; sensing lead only

interrogation device evaluation implanted neurostimulator pulse generator system for central sleep apnea

programming device evaluation of implanted neurostimulator pulse generator system for central sleep apnea; single session

programming device evaluation of implanted neurostimulator pulse generator system for central sleep apnea; during sleep study

implantation of non-biologic or synthetic implant (eg, polypropylene) for fascial reinforcement of the abdominal wall (list separately in addition to code for primary procedure)

myocardial contrast perfusion echocardiography, at rest or with stress, for assessment of myocardial ischemia or viability (list separately in addition to code for primary procedure)

ablation, percutaneous, cryoablation, includes imaging guidance; upper extremity distal/peripheral nerve

ablation, percutaneous, cryoablation, includes imaging guidance; lower extremity distal/peripheral nerve

ablation, percutaneous, cryoablation, includes imaging guidance; nerve plexus or other truncal nerve (eg, brachial plexus, pudendal nerve)

real-time spectral analysis of prostate tissue by fluorescence spectroscopy, including imaging guidance (list separately in addition to code for primary procedure)

initial placement of a drug-eluting ocular insert under one or more eyelids, including fitting, training, and insertion, unilateral or bilateral

subsequent placement of a drug-eluting ocular insert under one or more eyelids, including re-training, and removal of existing insert, unilateral or bilateral

creation of subcutaneous pocket with insertion of implantable interstitial glucose sensor, including system activation and patient training

removal of implantable interstitial glucose sensor from subcutaneous pocket via incision

removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new implantable sensor, including system activation

insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; initial device

insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; each additional device (list separately in addition to code for primary procedure)

insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; complete system (counterpulsation device, vascular graft, implantable vascular hemostatic seal, mechano-electrical skin interface and subcutaneous electrodes)

insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; aortic counterpulsation device and vascular hemostatic seal

insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; mechano-electrical skin interface

insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; subcutaneous electrode

removal of permanently implantable aortic counterpulsation ventricular assist system; complete system (aortic counterpulsation device, vascular hemostatic seal, mechano-electrical skin interface and electrodes)

removal of permanently implantable aortic counterpulsation ventricular assist system; aortic counterpulsation device and vascular hemostatic seal

removal of permanently implantable aortic counterpulsation ventricular assist system; mechano-electrical skin interface

removal of permanently implantable aortic counterpulsation ventricular assist system; subcutaneous electrode

relocation of skin pocket with replacement of implanted aortic counterpulsation ventricular assist device, mechano-electrical skin interface and electrodes

repositioning of previously implanted aortic counterpulsation ventricular assist device; subcutaneous electrode

repositioning of previously implanted aortic counterpulsation ventricular assist device; aortic counterpulsation device

programming device evaluation (in person) with iterative adjustment of the implantable mechano-electrical skin interface and/or external driver to test the function of the device and select optimal permanent programmed values with analysis, including review and report, implantable aortic counterpulsation ventricular assist system, per day

interrogation device evaluation (in person) with analysis, review and report, includes connection, recording and disconnection per patient encounter, implantable aortic counterpulsation ventricular assist system, per day

visual evoked potential, testing for glaucoma, with interpretation and report

suprachoroidal injection of a pharmacologic agent (does not include supply of medication)

insertion of chest wall respiratory sensor electrode or electrode array, including connection to pulse generator (list separately in addition to code for primary procedure)

revision or replacement of chest wall respiratory sensor electrode or electrode array, including connection to existing pulse generator

removal of chest wall respiratory sensor electrode or electrode array

retinal polarization scan, ocular screening with on-site automated results, bilateral

optical coherence tomography (oct) for microstructural and morphological imaging of skin, image acquisition, interpretation, and report; first lesion

optical coherence tomography (oct) for microstructural and morphological imaging of skin, image acquisition, interpretation, and report; each additional lesion (list separately in addition to code for primary procedure)

device evaluation, interrogation, and initial programming of intraocular retinal electrode array (eg, retinal prosthesis), in person, with iterative adjustment of the implantable device to test functionality, select optimal permanent programmed values with analysis, including visual training, with review and report by a qualified health care professional

device evaluation and interrogation of intraocular retinal electrode array (eg, retinal prosthesis), in person, including reprogramming and visual training, when performed, with review and report by a qualified health care professional

insertion of anterior segment aqueous drainage device, with creation of intraocular reservoir, internal approach, into the supraciliary space

recording of fetal magnetic cardiac signal using at least 3 channels; patient recording and storage, data scanning with signal extraction, technical analysis and result, as well as supervision, review, and interpretation of report by a physician or other qualified health care professional

recording of fetal magnetic cardiac signal using at least 3 channels; patient recording, data scanning, with raw electronic signal transfer of data and storage

recording of fetal magnetic cardiac signal using at least 3 channels; signal extraction, technical analysis, and result

recording of fetal magnetic cardiac signal using at least 3 channels; review, interpretation, report by physician or other qualified health care professional

fractional ablative laser fenestration of burn and traumatic scars for functional improvement; first 100 cm2 or part thereof, or 1% of body surface area of infants and children

fractional ablative laser fenestration of burn and traumatic scars for functional improvement; each additional 100 cm2, or each additional 1% of body surface area of infants and children, or part thereof (list separately in addition to code for primary procedure)

injection(s), autologous white blood cell concentrate (autologous protein solution), any site, including image guidance, harvesting and preparation, when performed

absolute quantitation of myocardial blood flow, positron emission tomography (pet), rest and stress (list separately in addition to code for primary procedure)

transcatheter mitral valve implantation/replacement (tmvi) with prosthetic valve; percutaneous approach, including transseptal puncture, when performed

transcatheter mitral valve implantation/replacement (tmvi) with prosthetic valve; transthoracic exposure (eg, thoracotomy, transapical)

optical coherence tomography (oct) of middle ear, with interpretation and report; unilateral

optical coherence tomography (oct) of middle ear, with interpretation and report; bilateral

preventive behavior change, online/electronic structured intensive program for prevention of diabetes using a standardized diabetes prevention program curriculum, provided to an individual, per 30 days

autologous adipose-derived regenerative cell therapy for scleroderma in the hands; adipose tissue harvesting, isolation and preparation of harvested cells including incubation with cell dissociation enzymes, removal of non-viable cells and debris, determination of concentration and dilution of regenerative cells

autologous adipose-derived regenerative cell therapy for scleroderma in the hands; multiple injections in one or both hands

ablative laser treatment, non-contact, full field and fractional ablation, open wound, per day, total treatment surface area; first 20 sq cm or less

ablative laser treatment, non-contact, full field and fractional ablation, open wound, per day, total treatment surface area; each additional 20 sq cm, or part thereof (list separately in addition to code for primary procedure)

near-infrared spectroscopy studies of lower extremity wounds (eg, for oxyhemoglobin measurement)

surgical preparation and cannulation of marginal (extended) cadaver donor lung(s) to ex vivo organ perfusion system, including decannulation, separation from the perfusion system, and cold preservation of the allograft prior to implantation, when performed

initiation and monitoring marginal (extended) cadaver donor lung(s) organ perfusion system by physician or qualified health care professional, including physiological and laboratory assessment (eg, pulmonary artery flow, pulmonary artery pressure, left atrial pressure, pulmonary vascular resistance, mean/peak and plateau airway pressure, dynamic compliance and perfusate gas analysis), including bronchoscopy and x ray when performed; first two hours in sterile field

initiation and monitoring marginal (extended) cadaver donor lung(s) organ perfusion system by physician or qualified health care professional, including physiological and laboratory assessment (eg, pulmonary artery flow, pulmonary artery pressure, left atrial pressure, pulmonary vascular resistance, mean/peak and plateau airway pressure, dynamic compliance and perfusate gas analysis), including bronchoscopy and x ray when performed; each additional hour (list separately in addition to code for primary procedure)

external patient-activated, physician- or other qualified health care professional-prescribed, electrocardiographic rhythm derived event recorder without 24 hour attended monitoring; in-office connection

external patient-activated, physician- or other qualified health care professional-prescribed, electrocardiographic rhythm derived event recorder without 24 hour attended monitoring; review and interpretation by a physician or other qualified health care professional per 30 days with at least one patient-generated triggered event

cystourethroscopy, with mechanical dilation and urethral therapeutic drug delivery for urethral stricture or stenosis, including fluoroscopy, when performed

initial prenatal care visit (report at first prenatal encounter with health care professional providing obstetrical care. report also date of visit and, in a separate field, the date of the last menstrual period [lmp]) (prenatal)

infectious agent detection by nucleic acid (dna or rna), human papillomavirus (hpv) for five or more separately reported high-risk hpv types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) (ie, genotyping)

prenatal flow sheet documented in medical record by first prenatal visit (documentation includes at minimum blood pressure, weight, urine protein, uterine size, fetal heart tones, and estimated date of delivery). report also: date of visit and, in a separate field, the date of the last menstrual period [lmp] (note: if reporting 0501f prenatal flow sheet, it is not necessary to report 0500f initial prenatal care visit) (prenatal)

noninvasive estimated coronary fractional flow reserve (ffr) derived from coronary computed tomography angiography data using computation fluid dynamics physiologic simulation software analysis of functional data to assess the severity of coronary artery disease; data preparation and transmission, analysis of fluid dynamics and simulated maximal coronary hyperemia, generation of estimated ffr model, with anatomical data review in comparison with estimated ffr model to reconcile discordant data, interpretation and report

subsequent prenatal care visit (prenatal) [excludes: patients who are seen for a condition unrelated to pregnancy or prenatal care (eg, an upper respiratory infection; patients seen for consultation only, not for continuing care)]

noninvasive estimated coronary fractional flow reserve (ffr) derived from coronary computed tomography angiography data using computation fluid dynamics physiologic simulation software analysis of functional data to assess the severity of coronary artery disease; data preparation and transmission

noninvasive estimated coronary fractional flow reserve (ffr) derived from coronary computed tomography angiography data using computation fluid dynamics physiologic simulation software analysis of functional data to assess the severity of coronary artery disease; analysis of fluid dynamics and simulated maximal coronary hyperemia, and generation of estimated ffr model

noninvasive estimated coronary fractional flow reserve (ffr) derived from coronary computed tomography angiography data using computation fluid dynamics physiologic simulation software analysis of functional data to assess the severity of coronary artery disease; anatomical data review in comparison with estimated ffr model to reconcile discordant data, interpretation and report

plan of care for elevated hemoglobin level documented for patient receiving erythropoiesis-stimulating agent therapy (esa) (ckd)

planned chemotherapy regimen, including at a minimum: drug(s) prescribed, dose, and duration, documented prior to initiation of a new treatment regimen (onc)

radiation dose limits to normal tissues established prior to the initiation of a course of 3d conformal radiation for a minimum of 2 tissue/organ (onc)

recommended follow-up interval for repeat colonoscopy of at least 10 years documented in colonoscopy report (end/polyp)

interval of 3 or more years since patient's last colonoscopy, documented (end/polyp)

plan for follow-up care for major depressive disorder, documented (mdd adol)

cytopathology report on routine nongynecologic specimen finalized within two working days of accession date (path)

cytopathology report on nongynecologic specimen with documentation that the specimen was non-routine (path)

patient transferred directly from anesthetizing location to critical care unit (peri2)

patient not transferred directly from anesthetizing location to critical care unit (peri2)

anginal symptoms and level of activity assessed (nma-no measure associated)

image-guided fluid collection drainage by catheter (eg, abscess, hematoma, seroma, lymphocele, cyst), soft tissue (eg, extremity, abdominal wall, neck), percutaneous

placement of soft tissue localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous, including imaging guidance; first lesion

placement of soft tissue localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous, including imaging guidance; each additional lesion (list separately in addition to code for primary procedure)

acne surgery (eg, marsupialization, opening or removal of multiple milia, comedones, cysts, pustules)

clinical symptoms of volume overload (excess) assessed (nma-no measure associated)

asthma symptoms evaluated (includes documentation of numeric frequency of symptoms or patient completion of an asthma assessment tool/survey/questionnaire) (nma-no measure associated)

incision and drainage of abscess (eg, carbuncle, suppurative hidradenitis, cutaneous or subcutaneous abscess, cyst, furuncle, or paronychia); simple or single

incision and drainage of abscess (eg, carbuncle, suppurative hidradenitis, cutaneous or subcutaneous abscess, cyst, furuncle, or paronychia); complicated or multiple

osteoarthritis symptoms and functional status assessed (may include the use of a standardized scale or the completion of an assessment questionnaire, such as the sf-36, aaos hip & knee questionnaire) (oa) [instructions: report when osteoarthritis is addressed during the patient encounter]

use of anti-inflammatory or analgesic over-the-counter (otc) medications for symptom relief assessed (oa)

gastrointestinal and renal risk factors assessed for patients on prescribed or otc non-steroidal anti-inflammatory drug (nsaid) (oa)

incision and removal of foreign body, subcutaneous tissues; simple

incision and removal of foreign body, subcutaneous tissues; complicated

chronic obstructive pulmonary disease (copd) symptoms assessed (includes assessment of at least 1 of the following: dyspnea, cough/sputum, wheezing), or respiratory symptom assessment tool completed (copd)

co-morbid conditions assessed (eg, includes assessment for presence or absence of: malignancy, liver disease, congestive heart failure, cerebrovascular disease, renal disease, chronic obstructive pulmonary disease, asthma, diabetes, other co-morbid conditions) (cap)

smoking status and exposure to second hand smoke in the home assessed (asthma)

current tobacco smoker or currently exposed to secondhand smoke (asthma)

current tobacco non-smoker and not currently exposed to secondhand smoke (asthma)

dsm-5 criteria for major depressive disorder documented at the initial evaluation (mdd, mdd adol)

documentation of permanent or persistent or paroxysmal atrial fibrillation (str)

documentation of absence of permanent and persistent and paroxysmal atrial fibrillation (str)

ischemic stroke symptom onset of less than 3 hours prior to arrival (str)

ischemic stroke symptom onset greater than or equal to 3 hours prior to arrival (str)

alarm symptoms (involuntary weight loss, dysphagia, or gastrointestinal bleeding) assessed; none present (gerd)

alarm symptoms (involuntary weight loss, dysphagia, or gastrointestinal bleeding) assessed; 1 or more present (gerd)

urinary incontinence characterized (eg, frequency, volume, timing, type of symptoms, how bothersome) (ger)

debridement of extensive eczematous or infected skin; up to 10% of body surface

debridement of extensive eczematous or infected skin; each additional 10% of the body surface, or part thereof (list separately in addition to code for primary procedure)

debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing soft tissue infection; external genitalia and perineum

debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing soft tissue infection; abdominal wall, with or without fascial closure

debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing soft tissue infection; external genitalia, perineum and abdominal wall, with or without fascial closure

removal of prosthetic material or mesh, abdominal wall for infection (eg, for chronic or recurrent mesh infection or necrotizing soft tissue infection) (list separately in addition to code for primary procedure)

patient screened for future fall risk; documentation of 2 or more falls in the past year or any fall with injury in the past year (ger)

debridement including removal of foreign material at the site of an open fracture and/or an open dislocation (eg, excisional debridement); skin and subcutaneous tissues

debridement including removal of foreign material at the site of an open fracture and/or an open dislocation (eg, excisional debridement); skin, subcutaneous tissue, muscle fascia, and muscle

debridement including removal of foreign material at the site of an open fracture and/or an open dislocation (eg, excisional debridement); skin, subcutaneous tissue, muscle fascia, muscle, and bone

patient screened for future fall risk; documentation of no falls in the past year or only 1 fall without injury in the past year (ger)

debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less

debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less

debridement, bone (includes epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed); first 20 sq cm or less

debridement, subcutaneous tissue (includes epidermis and dermis, if performed); each additional 20 sq cm, or part thereof (list separately in addition to code for primary procedure)

debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); each additional 20 sq cm, or part thereof (list separately in addition to code for primary procedure)

debridement, bone (includes epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed); each additional 20 sq cm, or part thereof (list separately in addition to code for primary procedure)

paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion

paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions

paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); more than 4 lesions

biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion

biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (list separately in addition to code for primary procedure)

patient discharged from an inpatient facility (eg, hospital, skilled nursing facility, or rehabilitation facility) within the last 60 days (ger)

discharge medications reconciled with the current medication list in outpatient medical record (coa) (ger)

removal of skin tags, multiple fibrocutaneous tags, any area; up to and including 15 lesions

removal of skin tags, multiple fibrocutaneous tags, any area; each additional 10 lesions, or part thereof (list separately in addition to code for primary procedure)

advance care planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (dem) (ger, pall cr)

advance care planning discussed and documented in the medical record, patient did not wish or was not able to name a surrogate decision maker or provide an advance care plan (dem) (ger, pall cr)

shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 0.5 cm or less

shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 0.6 to 1.0 cm

shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 1.1 to 2.0 cm

shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter over 2.0 cm

shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, feet, genitalia; lesion diameter 0.5 cm or less

shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, feet, genitalia; lesion diameter 0.6 to 1.0 cm

shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, feet, genitalia; lesion diameter 1.1 to 2.0 cm

shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, feet, genitalia; lesion diameter over 2.0 cm

back pain and function assessed, including all of the following: pain assessment and functional status and patient history, including notation of presence or absence of "red flags" (warning signs) and assessment of prior treatment and response, and employment status (bkp)

shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, nose, lips, mucous membrane; lesion diameter 0.5 cm or less

shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, nose, lips, mucous membrane; lesion diameter 0.6 to 1.0 cm

shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, nose, lips, mucous membrane; lesion diameter 1.1 to 2.0 cm

shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, nose, lips, mucous membrane; lesion diameter over 2.0 cm

excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 0.5 cm or less

excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 0.6 to 1.0 cm

excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 1.1 to 2.0 cm

excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 2.1 to 3.0 cm

excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 3.1 to 4.0 cm

excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter over 4.0 cm

excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 0.5 cm or less

excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 0.6 to 1.0 cm

excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 1.1 to 2.0 cm

excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 2.1 to 3.0 cm

excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 3.1 to 4.0 cm

excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter over 4.0 cm

excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 0.5 cm or less

excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 0.6 to 1.0 cm

excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 1.1 to 2.0 cm

excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 2.1 to 3.0 cm

excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 3.1 to 4.0 cm

excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter over 4.0 cm

excision of skin and subcutaneous tissue for hidradenitis, axillary; with simple or intermediate repair

excision of skin and subcutaneous tissue for hidradenitis, axillary; with complex repair

excision of skin and subcutaneous tissue for hidradenitis, inguinal; with simple or intermediate repair

excision of skin and subcutaneous tissue for hidradenitis, inguinal; with complex repair

excision of skin and subcutaneous tissue for hidradenitis, perianal, perineal, or umbilical; with simple or intermediate repair

excision of skin and subcutaneous tissue for hidradenitis, perianal, perineal, or umbilical; with complex repair

documentation that a patient has a substantial risk of death within 1 year (pall cr)

documentation that a patient does not have a substantial risk of death within one year (pall cr)

documentation of advanced disease diagnosis, goals of care prioritize comfort (pall cr)

documentation of advanced disease diagnosis, goals of care do not prioritize comfort (pall cr)

advance care plan or similar legal document present in the medical record (coa)

advance care planning discussion documented in the medical record (coa)

excision, malignant lesion including margins, trunk, arms, or legs; excised diameter 0.5 cm or less

excision, malignant lesion including margins, trunk, arms, or legs; excised diameter 0.6 to 1.0 cm

excision, malignant lesion including margins, trunk, arms, or legs; excised diameter 1.1 to 2.0 cm

excision, malignant lesion including margins, trunk, arms, or legs; excised diameter 2.1 to 3.0 cm

excision, malignant lesion including margins, trunk, arms, or legs; excised diameter 3.1 to 4.0 cm

excision, malignant lesion including margins, trunk, arms, or legs; excised diameter over 4.0 cm

review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, otcs, herbal therapies and supplements) documented in the medical record (coa)

excision, malignant lesion including margins, scalp, neck, hands, feet, genitalia; excised diameter 0.5 cm or less

excision, malignant lesion including margins, scalp, neck, hands, feet, genitalia; excised diameter 0.6 to 1.0 cm

excision, malignant lesion including margins, scalp, neck, hands, feet, genitalia; excised diameter 1.1 to 2.0 cm

excision, malignant lesion including margins, scalp, neck, hands, feet, genitalia; excised diameter 2.1 to 3.0 cm

excision, malignant lesion including margins, scalp, neck, hands, feet, genitalia; excised diameter 3.1 to 4.0 cm

excision, malignant lesion including margins, scalp, neck, hands, feet, genitalia; excised diameter over 4.0 cm

excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter 0.5 cm or less

excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter 0.6 to 1.0 cm

excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter 1.1 to 2.0 cm

excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter 2.1 to 3.0 cm

excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter 3.1 to 4.0 cm

excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter over 4.0 cm

avulsion of nail plate, partial or complete, simple; each additional nail plate (list separately in addition to code for primary procedure)

excision of nail and nail matrix, partial or complete (eg, ingrown or deformed nail), for permanent removal

biopsy of nail unit (eg, plate, bed, matrix, hyponychium, proximal and lateral nail folds) (separate procedure)

functional status for dementia assessed and results reviewed (dem)

tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.0 sq cm or less

tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.1 to 20.0 sq cm

tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; each additional 20.0 sq cm, or part thereof (list separately in addition to code for primary procedure)

subcutaneous injection of filling material (eg, collagen); 1 cc or less

subcutaneous injection of filling material (eg, collagen); 1.1 to 5.0 cc

subcutaneous injection of filling material (eg, collagen); 5.1 to 10.0 cc

subcutaneous injection of filling material (eg, collagen); over 10.0 cc

insertion of tissue expander(s) for other than breast, including subsequent expansion

subcutaneous hormone pellet implantation (implantation of estradiol and/or testosterone pellets beneath the skin)

removal with reinsertion, non-biodegradable drug delivery implant

simple repair of superficial wounds of scalp, neck, axillae, external genitalia, trunk and/or extremities (including hands and feet); 2.5 cm or less

simple repair of superficial wounds of scalp, neck, axillae, external genitalia, trunk and/or extremities (including hands and feet); 2.6 cm to 7.5 cm

simple repair of superficial wounds of scalp, neck, axillae, external genitalia, trunk and/or extremities (including hands and feet); 7.6 cm to 12.5 cm

simple repair of superficial wounds of scalp, neck, axillae, external genitalia, trunk and/or extremities (including hands and feet); 12.6 cm to 20.0 cm

simple repair of superficial wounds of scalp, neck, axillae, external genitalia, trunk and/or extremities (including hands and feet); 20.1 cm to 30.0 cm

simple repair of superficial wounds of scalp, neck, axillae, external genitalia, trunk and/or extremities (including hands and feet); over 30.0 cm

seizure type(s) and current seizure frequency(ies) documented (epi)

simple repair of superficial wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 2.5 cm or less

simple repair of superficial wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 2.6 cm to 5.0 cm

simple repair of superficial wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 5.1 cm to 7.5 cm

simple repair of superficial wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 7.6 cm to 12.5 cm

simple repair of superficial wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 12.6 cm to 20.0 cm

simple repair of superficial wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 20.1 cm to 30.0 cm

simple repair of superficial wounds of face, ears, eyelids, nose, lips and/or mucous membranes; over 30.0 cm

repair, intermediate, wounds of scalp, axillae, trunk and/or extremities (excluding hands and feet); 2.5 cm or less

repair, intermediate, wounds of scalp, axillae, trunk and/or extremities (excluding hands and feet); 2.6 cm to 7.5 cm

repair, intermediate, wounds of scalp, axillae, trunk and/or extremities (excluding hands and feet); 7.6 cm to 12.5 cm

repair, intermediate, wounds of scalp, axillae, trunk and/or extremities (excluding hands and feet); 12.6 cm to 20.0 cm

repair, intermediate, wounds of scalp, axillae, trunk and/or extremities (excluding hands and feet); 20.1 cm to 30.0 cm

repair, intermediate, wounds of scalp, axillae, trunk and/or extremities (excluding hands and feet); over 30.0 cm

repair, intermediate, wounds of neck, hands, feet and/or external genitalia; 2.5 cm or less

repair, intermediate, wounds of neck, hands, feet and/or external genitalia; 2.6 cm to 7.5 cm

repair, intermediate, wounds of neck, hands, feet and/or external genitalia; 7.6 cm to 12.5 cm

repair, intermediate, wounds of neck, hands, feet and/or external genitalia; 12.6 cm to 20.0 cm

repair, intermediate, wounds of neck, hands, feet and/or external genitalia; 20.1 cm to 30.0 cm

repair, intermediate, wounds of neck, hands, feet and/or external genitalia; over 30.0 cm

repair, intermediate, wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 2.5 cm or less

repair, intermediate, wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 2.6 cm to 5.0 cm

repair, intermediate, wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 5.1 cm to 7.5 cm

repair, intermediate, wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 7.6 cm to 12.5 cm

repair, intermediate, wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 12.6 cm to 20.0 cm

repair, intermediate, wounds of face, ears, eyelids, nose, lips and/or mucous membranes; 20.1 cm to 30.0 cm

repair, intermediate, wounds of face, ears, eyelids, nose, lips and/or mucous membranes; over 30.0 cm

etiology of epilepsy or epilepsy syndrome(s) reviewed and documented (epi)

repair, complex, trunk; each additional 5 cm or less (list separately in addition to code for primary procedure)

repair, complex, scalp, arms, and/or legs; each additional 5 cm or less (list separately in addition to code for primary procedure)

repair, complex, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; 1.1 cm to 2.5 cm

repair, complex, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; 2.6 cm to 7.5 cm

repair, complex, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; each additional 5 cm or less (list separately in addition to code for primary procedure)

repair, complex, eyelids, nose, ears and/or lips; 1.1 cm to 2.5 cm

repair, complex, eyelids, nose, ears and/or lips; 2.6 cm to 7.5 cm

repair, complex, eyelids, nose, ears and/or lips; each additional 5 cm or less (list separately in addition to code for primary procedure)

secondary closure of surgical wound or dehiscence, extensive or complicated

adjacent tissue transfer or rearrangement, trunk; defect 10 sq cm or less

adjacent tissue transfer or rearrangement, trunk; defect 10.1 sq cm to 30.0 sq cm

adjacent tissue transfer or rearrangement, scalp, arms and/or legs; defect 10 sq cm or less

adjacent tissue transfer or rearrangement, scalp, arms and/or legs; defect 10.1 sq cm to 30.0 sq cm

adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10 sq cm or less

adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10.1 sq cm to 30.0 sq cm

adjacent tissue transfer or rearrangement, eyelids, nose, ears and/or lips; defect 10 sq cm or less

adjacent tissue transfer or rearrangement, eyelids, nose, ears and/or lips; defect 10.1 sq cm to 30.0 sq cm

adjacent tissue transfer or rearrangement, any area; defect 30.1 sq cm to 60.0 sq cm

adjacent tissue transfer or rearrangement, any area; each additional 30.0 sq cm, or part thereof (list separately in addition to code for primary procedure)

filleted finger or toe flap, including preparation of recipient site

symptoms improved or remained consistent with treatment goals since last assessment (hf)

symptoms demonstrated clinically important deterioration since last assessment (hf)

no qualifying cardiac event/diagnosis in previous 12 months (cad)

surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar (including subcutaneous tissues), or incisional release of scar contracture, trunk, arms, legs; first 100 sq cm or 1% of body area of infants and children

surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar (including subcutaneous tissues), or incisional release of scar contracture, trunk, arms, legs; each additional 100 sq cm, or part thereof, or each additional 1% of body area of infants and children (list separately in addition to code for primary procedure)

surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar (including subcutaneous tissues), or incisional release of scar contracture, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet and/or multiple digits; first 100 sq cm or 1% of body area of infants and children

surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar (including subcutaneous tissues), or incisional release of scar contracture, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet and/or multiple digits; each additional 100 sq cm, or part thereof, or each additional 1% of body area of infants and children (list separately in addition to code for primary procedure)

symptoms and signs of distal symmetric polyneuropathy reviewed and documented (dsp)

patient queried about pain and pain interference with function using a valid and reliable instrument (dsp)

patient queried about symptoms of respiratory insufficiency (als)

harvest of skin for tissue cultured skin autograft, 100 sq cm or less

pinch graft, single or multiple, to cover small ulcer, tip of digit, or other minimal open area (except on face), up to defect size 2 cm diameter

split-thickness autograft, trunk, arms, legs; first 100 sq cm or less, or 1% of body area of infants and children (except 15050)

split-thickness autograft, trunk, arms, legs; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

epidermal autograft, trunk, arms, legs; first 100 sq cm or less, or 1% of body area of infants and children

epidermal autograft, trunk, arms, legs; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

epidermal autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 100 sq cm or less, or 1% of body area of infants and children

epidermal autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

split-thickness autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 100 sq cm or less, or 1% of body area of infants and children (except 15050)

split-thickness autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

dermal autograft, trunk, arms, legs; first 100 sq cm or less, or 1% of body area of infants and children

dermal autograft, trunk, arms, legs; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

dermal autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 100 sq cm or less, or 1% of body area of infants and children

dermal autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

tissue cultured skin autograft, trunk, arms, legs; first 25 sq cm or less

tissue cultured skin autograft, trunk, arms, legs; additional 1 sq cm to 75 sq cm (list separately in addition to code for primary procedure)

tissue cultured skin autograft, trunk, arms, legs; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

tissue cultured skin autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 25 sq cm or less

tissue cultured skin autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; additional 1 sq cm to 75 sq cm (list separately in addition to code for primary procedure)

tissue cultured skin autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

full thickness graft, free, including direct closure of donor site, trunk; 20 sq cm or less

full thickness graft, free, including direct closure of donor site, trunk; each additional 20 sq cm, or part thereof (list separately in addition to code for primary procedure)

full thickness graft, free, including direct closure of donor site, scalp, arms, and/or legs; 20 sq cm or less

full thickness graft, free, including direct closure of donor site, scalp, arms, and/or legs; each additional 20 sq cm, or part thereof (list separately in addition to code for primary procedure)

full thickness graft, free, including direct closure of donor site, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands, and/or feet; 20 sq cm or less

full thickness graft, free, including direct closure of donor site, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands, and/or feet; each additional 20 sq cm, or part thereof (list separately in addition to code for primary procedure)

full thickness graft, free, including direct closure of donor site, nose, ears, eyelids, and/or lips; 20 sq cm or less

full thickness graft, free, including direct closure of donor site, nose, ears, eyelids, and/or lips; each additional 20 sq cm, or part thereof (list separately in addition to code for primary procedure)

application of skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area

application of skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)

application of skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children

application of skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area

application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)

application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children

application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

formation of direct or tubed pedicle, with or without transfer; trunk

formation of direct or tubed pedicle, with or without transfer; scalp, arms, or legs

formation of direct or tubed pedicle, with or without transfer; forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands or feet

formation of direct or tubed pedicle, with or without transfer; eyelids, nose, ears, lips, or intraoral

delay of flap or sectioning of flap (division and inset); at trunk

delay of flap or sectioning of flap (division and inset); at scalp, arms, or legs

delay of flap or sectioning of flap (division and inset); at forehead, cheeks, chin, neck, axillae, genitalia, hands, or feet

delay of flap or sectioning of flap (division and inset); at eyelids, nose, ears, or lips

transfer, intermediate, of any pedicle flap (eg, abdomen to wrist, walking tube), any location

midface flap (ie, zygomaticofacial flap) with preservation of vascular pedicle(s)

forehead flap with preservation of vascular pedicle (eg, axial pattern flap, paramedian forehead flap)

muscle, myocutaneous, or fasciocutaneous flap; head and neck with named vascular pedicle (ie, buccinators, genioglossus, temporalis, masseter, sternocleidomastoid, levator scapulae)

flap; island pedicle requiring identification and dissection of an anatomically named axial vessel

graft; composite (eg, full thickness of external ear or nasal ala), including primary closure, donor area

implantation of biologic implant (eg, acellular dermal matrix) for soft tissue reinforcement (ie, breast, trunk) (list separately in addition to code for primary procedure)

dermabrasion; total face (eg, for acne scarring, fine wrinkling, rhytids, general keratosis)

abrasion; each additional 4 lesions or less (list separately in addition to code for primary procedure)

blepharoplasty, upper eyelid; with excessive skin weighting down lid

rhytidectomy; neck with platysmal tightening (platysmal flap, p-flap)

excision, excessive skin and subcutaneous tissue (includes lipectomy); abdomen, infraumbilical panniculectomy

excision, excessive skin and subcutaneous tissue (includes lipectomy); thigh

excision, excessive skin and subcutaneous tissue (includes lipectomy); leg

excision, excessive skin and subcutaneous tissue (includes lipectomy); hip

excision, excessive skin and subcutaneous tissue (includes lipectomy); buttock

excision, excessive skin and subcutaneous tissue (includes lipectomy); arm

excision, excessive skin and subcutaneous tissue (includes lipectomy); forearm or hand

excision, excessive skin and subcutaneous tissue (includes lipectomy); submental fat pad

excision, excessive skin and subcutaneous tissue (includes lipectomy); other area

graft for facial nerve paralysis; free fascia graft (including obtaining fascia)

graft for facial nerve paralysis; free muscle graft (including obtaining graft)

graft for facial nerve paralysis; free muscle flap by microsurgical technique

excision, excessive skin and subcutaneous tissue (includes lipectomy), abdomen (eg, abdominoplasty) (includes umbilical transposition and fascial plication) (list separately in addition to code for primary procedure)

removal of sutures under anesthesia (other than local), same surgeon

removal of sutures under anesthesia (other than local), other surgeon

dressing change (for other than burns) under anesthesia (other than local)

intravenous injection of agent (eg, fluorescein) to test vascular flow in flap or graft

excision, coccygeal pressure ulcer, with coccygectomy; with primary suture

excision, coccygeal pressure ulcer, with coccygectomy; with flap closure

excision, sacral pressure ulcer, with primary suture; with ostectomy

excision, sacral pressure ulcer, with skin flap closure; with ostectomy

excision, sacral pressure ulcer, in preparation for muscle or myocutaneous flap or skin graft closure

excision, sacral pressure ulcer, in preparation for muscle or myocutaneous flap or skin graft closure; with ostectomy

excision, ischial pressure ulcer, with primary suture; with ostectomy (ischiectomy)

excision, ischial pressure ulcer, with skin flap closure; with ostectomy

excision, ischial pressure ulcer, with ostectomy, in preparation for muscle or myocutaneous flap or skin graft closure

excision, trochanteric pressure ulcer, with primary suture; with ostectomy

excision, trochanteric pressure ulcer, with skin flap closure; with ostectomy

excision, trochanteric pressure ulcer, in preparation for muscle or myocutaneous flap or skin graft closure

excision, trochanteric pressure ulcer, in preparation for muscle or myocutaneous flap or skin graft closure; with ostectomy

initial treatment, first degree burn, when no more than local treatment is required

dressings and/or debridement of partial-thickness burns, initial or subsequent; small (less than 5% total body surface area)

dressings and/or debridement of partial-thickness burns, initial or subsequent; medium (eg, whole face or whole extremity, or 5% to 10% total body surface area)

dressings and/or debridement of partial-thickness burns, initial or subsequent; large (eg, more than 1 extremity, or greater than 10% total body surface area)

escharotomy; each additional incision (list separately in addition to code for primary procedure)

destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion

destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (list separately in addition to code for first lesion)

destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses), 15 or more lesions

destruction of cutaneous vascular proliferative lesions (eg, laser technique); less than 10 sq cm

destruction of cutaneous vascular proliferative lesions (eg, laser technique); 10.0 to 50.0 sq cm

destruction of cutaneous vascular proliferative lesions (eg, laser technique); over 50.0 sq cm

destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions

destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), trunk, arms or legs; lesion diameter 0.5 cm or less

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), trunk, arms or legs; lesion diameter 0.6 to 1.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), trunk, arms or legs; lesion diameter 1.1 to 2.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), trunk, arms or legs; lesion diameter 2.1 to 3.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), trunk, arms or legs; lesion diameter 3.1 to 4.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), trunk, arms or legs; lesion diameter over 4.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), scalp, neck, hands, feet, genitalia; lesion diameter 0.5 cm or less

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), scalp, neck, hands, feet, genitalia; lesion diameter 0.6 to 1.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), scalp, neck, hands, feet, genitalia; lesion diameter 1.1 to 2.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), scalp, neck, hands, feet, genitalia; lesion diameter 2.1 to 3.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), scalp, neck, hands, feet, genitalia; lesion diameter 3.1 to 4.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), scalp, neck, hands, feet, genitalia; lesion diameter over 4.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), face, ears, eyelids, nose, lips, mucous membrane; lesion diameter 0.5 cm or less

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), face, ears, eyelids, nose, lips, mucous membrane; lesion diameter 0.6 to 1.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), face, ears, eyelids, nose, lips, mucous membrane; lesion diameter 1.1 to 2.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), face, ears, eyelids, nose, lips, mucous membrane; lesion diameter 2.1 to 3.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), face, ears, eyelids, nose, lips, mucous membrane; lesion diameter 3.1 to 4.0 cm

destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), face, ears, eyelids, nose, lips, mucous membrane; lesion diameter over 4.0 cm

mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), head, neck, hands, feet, genitalia, or any location with surgery directly involving muscle, cartilage, bone, tendon, major nerves, or vessels; first stage, up to 5 tissue blocks

mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), head, neck, hands, feet, genitalia, or any location with surgery directly involving muscle, cartilage, bone, tendon, major nerves, or vessels; each additional stage after the first stage, up to 5 tissue blocks (list separately in addition to code for primary procedure)

mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), of the trunk, arms, or legs; first stage, up to 5 tissue blocks

mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), of the trunk, arms, or legs; each additional stage after the first stage, up to 5 tissue blocks (list separately in addition to code for primary procedure)

mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), each additional block after the first 5 tissue blocks, any stage (list separately in addition to code for primary procedure)

unlisted procedure, skin, mucous membrane and subcutaneous tissue

puncture aspiration of cyst of breast; each additional cyst (list separately in addition to code for primary procedure)

biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including stereotactic guidance

biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; each additional lesion, including stereotactic guidance (list separately in addition to code for primary procedure)

biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including ultrasound guidance

biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; each additional lesion, including ultrasound guidance (list separately in addition to code for primary procedure)

biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including magnetic resonance guidance

biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; each additional lesion, including magnetic resonance guidance (list separately in addition to code for primary procedure)

biopsy of breast; percutaneous, needle core, not using imaging guidance (separate procedure)

ablation, cryosurgical, of fibroadenoma, including ultrasound guidance, each fibroadenoma

nipple exploration, with or without excision of a solitary lactiferous duct or a papilloma lactiferous duct

excision of cyst, fibroadenoma, or other benign or malignant tumor, aberrant breast tissue, duct lesion, nipple or areolar lesion (except 19300), open, male or female, 1 or more lesions

excision of breast lesion identified by preoperative placement of radiological marker, open; single lesion

excision of breast lesion identified by preoperative placement of radiological marker, open; each additional lesion separately identified by a preoperative radiological marker (list separately in addition to code for primary procedure)

excision of chest wall tumor involving ribs, with plastic reconstruction; without mediastinal lymphadenectomy

excision of chest wall tumor involving ribs, with plastic reconstruction; with mediastinal lymphadenectomy

placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; first lesion, including mammographic guidance

placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; each additional lesion, including mammographic guidance (list separately in addition to code for primary procedure)

placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; first lesion, including stereotactic guidance

placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; each additional lesion, including stereotactic guidance (list separately in addition to code for primary procedure)

placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; first lesion, including ultrasound guidance

placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; each additional lesion, including ultrasound guidance (list separately in addition to code for primary procedure)

placement of breast localization device(s) (eg clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; first lesion, including magnetic resonance guidance

placement of breast localization device(s) (eg clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; each additional lesion, including magnetic resonance guidance (list separately in addition to code for primary procedure)

preparation of tumor cavity, with placement of a radiation therapy applicator for intraoperative radiation therapy (iort) concurrent with partial mastectomy (list separately in addition to code for primary procedure)

placement of radiotherapy afterloading expandable catheter (single or multichannel) into the breast for interstitial radioelement application following partial mastectomy, includes imaging guidance; on date separate from partial mastectomy

placement of radiotherapy afterloading expandable catheter (single or multichannel) into the breast for interstitial radioelement application following partial mastectomy, includes imaging guidance; concurrent with partial mastectomy (list separately in addition to code for primary procedure)

placement of radiotherapy after loading brachytherapy catheters (multiple tube and button type) into the breast for interstitial radioelement application following (at the time of or subsequent to) partial mastectomy, includes imaging guidance

mastectomy, partial (eg, lumpectomy, tylectomy, quadrantectomy, segmentectomy)

mastectomy, partial (eg, lumpectomy, tylectomy, quadrantectomy, segmentectomy); with axillary lymphadenectomy

mastectomy, radical, including pectoral muscles, axillary lymph nodes

mastectomy, radical, including pectoral muscles, axillary and internal mammary lymph nodes (urban type operation)

mastectomy, modified radical, including axillary lymph nodes, with or without pectoralis minor muscle, but excluding pectoralis major muscle

immediate insertion of breast prosthesis following mastopexy, mastectomy or in reconstruction

delayed insertion of breast prosthesis following mastopexy, mastectomy or in reconstruction

breast reconstruction, immediate or delayed, with tissue expander, including subsequent expansion

breast reconstruction with latissimus dorsi flap, without prosthetic implant

breast reconstruction with transverse rectus abdominis myocutaneous flap (tram), single pedicle, including closure of donor site

breast reconstruction with transverse rectus abdominis myocutaneous flap (tram), single pedicle, including closure of donor site; with microvascular anastomosis (supercharging)

breast reconstruction with transverse rectus abdominis myocutaneous flap (tram), double pedicle, including closure of donor site

incision and drainage of soft tissue abscess, subfascial (ie, involves the soft tissue below the deep fascia)

clinical signs of volume overload (excess) assessed (nma-no measure associated)

initial examination of the involved joint(s) (includes visual inspection, palpation, range of motion) (oa) [instructions: report only for initial osteoarthritis visit or for visits for new joint involvement]

exploration of penetrating wound (separate procedure); abdomen/flank/back

exploration of penetrating wound (separate procedure); extremity

vital signs (temperature, pulse, respiratory rate, and blood pressure) documented and reviewed (cap) (em)

excision of epiphyseal bar, with or without autogenous soft tissue graft obtained through same fascial incision

hydration status assessed (normal/mildly dehydrated/severely dehydrated) (cap)

dilated macular exam performed, including documentation of the presence or absence of macular thickening or hemorrhage and the level of macular degeneration severity (ec)

dilated fundus evaluation performed within 12 months prior to cataract surgery (ec)

dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy (ec)

biopsy, bone, trocar, or needle; superficial (eg, ilium, sternum, spinous process, ribs)

biopsy, bone, trocar, or needle; deep (eg, vertebral body, femur)

dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed (dm)

biopsy, bone, open; superficial (eg, sternum, spinous process, rib, patella, olecranon process, calcaneus, tarsal, metatarsal, carpal, metacarpal, phalanx)

biopsy, bone, open; deep (eg, humeral shaft, ischium, femoral shaft)

7 standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed (dm)

eye imaging validated to match diagnosis from 7 standard field stereoscopic photos results documented and reviewed (dm)

foot examination performed (includes examination through visual inspection, sensory exam with monofilament, and pulse exam - report when any of the 3 components are completed) (dm)

tympanic membrane mobility assessed with pneumatic otoscopy or tympanometry (ome)

physical examination on the date of the initial visit for low back pain performed, in accordance with specifications (bkp)

documentation of mental health assessment prior to intervention (back surgery or epidural steroid injection) or for back pain episode lasting longer than 6 weeks (bkp)

wound characteristics including size and nature of wound base tissue and amount of drainage prior to debridement documented (cwc)

removal of foreign body in muscle or tendon sheath; deep or complicated

injection, therapeutic (eg, local anesthetic, corticosteroid), carpal tunnel

injection, enzyme (eg, collagenase), palmar fascial cord (ie, dupuytren's contracture)

injection(s); single tendon sheath, or ligament, aponeurosis (eg, plantar "fascia")

injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)

injection(s); single or multiple trigger point(s), 3 or more muscles

placement of needles or catheters into muscle and/or soft tissue for subsequent interstitial radioelement application (at the time of or subsequent to the procedure)

arthrocentesis, aspiration and/or injection, small joint or bursa (eg, fingers, toes); without ultrasound guidance

arthrocentesis, aspiration and/or injection, small joint or bursa (eg, fingers, toes); with ultrasound guidance, with permanent recording and reporting

arthrocentesis, aspiration and/or injection, intermediate joint or bursa (eg, temporomandibular, acromioclavicular, wrist, elbow or ankle, olecranon bursa); without ultrasound guidance

arthrocentesis, aspiration and/or injection, intermediate joint or bursa (eg, temporomandibular, acromioclavicular, wrist, elbow or ankle, olecranon bursa); with ultrasound guidance, with permanent recording and reporting

patient interviewed directly on or before date of diagnosis of major depressive disorder (mdd adol)

arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance

arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); with ultrasound guidance, with permanent recording and reporting

insertion of wire or pin with application of skeletal traction, including removal (separate procedure)

application of cranial tongs, caliper, or stereotactic frame, including removal (separate procedure)

application of halo, including removal, cranial, 6 or more pins placed, for thin skull osteology (eg, pediatric patients, hydrocephalus, osteogenesis imperfecta)

removal of implant; superficial (eg, buried wire, pin or rod) (separate procedure)

removal of implant; deep (eg, buried wire, pin, screw, metal band, nail, rod or plate)

application of a uniplane (pins or wires in 1 plane), unilateral, external fixation system

application of a multiplane (pins or wires in more than 1 plane), unilateral, external fixation system (eg, ilizarov, monticelli type)

adjustment or revision of external fixation system requiring anesthesia (eg, new pin[s] or wire[s] and/or new ring[s] or bar[s])

application of multiplane (pins or wires in more than 1 plane), unilateral, external fixation with stereotactic computer-assisted adjustment (eg, spatial frame), including imaging; initial and subsequent alignment(s), assessment(s), and computation(s) of adjustment schedule(s)

application of multiplane (pins or wires in more than 1 plane), unilateral, external fixation with stereotactic computer-assisted adjustment (eg, spatial frame), including imaging; exchange (ie, removal and replacement) of strut, each

replantation, arm (includes surgical neck of humerus through elbow joint), complete amputation

replantation, forearm (includes radius and ulna to radial carpal joint), complete amputation

replantation, hand (includes hand through metacarpophalangeal joints), complete amputation

replantation, digit, excluding thumb (includes metacarpophalangeal joint to insertion of flexor sublimis tendon), complete amputation

replantation, digit, excluding thumb (includes distal tip to sublimis tendon insertion), complete amputation

replantation, thumb (includes carpometacarpal joint to mp joint), complete amputation

replantation, thumb (includes distal tip to mp joint), complete amputation

bone graft, any donor area; minor or small (eg, dowel or button)

fascia lata graft; by incision and area exposure, complex or sheet

tendon graft, from a distance (eg, palmaris, toe extensor, plantaris)

allograft, morselized, or placement of osteopromotive material, for spine surgery only (list separately in addition to code for primary procedure)

allograft, structural, for spine surgery only (list separately in addition to code for primary procedure)

autograft for spine surgery only (includes harvesting the graft); local (eg, ribs, spinous process, or laminar fragments) obtained from same incision (list separately in addition to code for primary procedure)

autograft for spine surgery only (includes harvesting the graft); morselized (through separate skin or fascial incision) (list separately in addition to code for primary procedure)

autograft for spine surgery only (includes harvesting the graft); structural, bicortical or tricortical (through separate skin or fascial incision) (list separately in addition to code for primary procedure)

bone marrow aspiration for bone grafting, spine surgery only, through separate skin or fascial incision (list separately in addition to code for primary procedure)

monitoring of interstitial fluid pressure (includes insertion of device, eg, wick catheter technique, needle manometer technique) in detection of muscle compartment syndrome

bone graft with microvascular anastomosis; other than fibula, iliac crest, or metatarsal

free osteocutaneous flap with microvascular anastomosis; other than iliac crest, metatarsal, or great toe

free osteocutaneous flap with microvascular anastomosis; iliac crest

free osteocutaneous flap with microvascular anastomosis; metatarsal

free osteocutaneous flap with microvascular anastomosis; great toe with web space

electrical stimulation to aid bone healing; noninvasive (nonoperative)

electrical stimulation to aid bone healing; invasive (operative)

low intensity ultrasound stimulation to aid bone healing, noninvasive (nonoperative)

ablation therapy for reduction or eradication of 1 or more bone tumors (eg, metastasis) including adjacent soft tissue when involved by tumor extension, percutaneous, including imaging guidance when performed; radiofrequency

ablation therapy for reduction or eradication of 1 or more bone tumors (eg, metastasis) including adjacent soft tissue when involved by tumor extension, percutaneous, including imaging guidance when performed; cryoablation

computer-assisted surgical navigational procedure for musculoskeletal procedures, image-less (list separately in addition to code for primary procedure)

excision, tumor, soft tissue of face or scalp, subcutaneous; less than 2 cm

excision, tumor, soft tissue of face or scalp, subcutaneous; 2 cm or greater

excision, tumor, soft tissue of face and scalp, subfascial (eg, subgaleal, intramuscular); less than 2 cm

excision, tumor, soft tissue of face and scalp, subfascial (eg, subgaleal, intramuscular); 2 cm or greater

radical resection of tumor (eg, sarcoma), soft tissue of face or scalp; less than 2 cm

radical resection of tumor (eg, sarcoma), soft tissue of face or scalp; 2 cm or greater

excision of bone (eg, for osteomyelitis or bone abscess); mandible

excision of bone (eg, for osteomyelitis or bone abscess); facial bone(s)

removal by contouring of benign tumor of facial bone (eg, fibrous dysplasia)

excision of benign tumor or cyst of maxilla or zygoma by enucleation and curettage

excision of benign tumor or cyst of mandible, by enucleation and/or curettage

excision of benign tumor or cyst of mandible; requiring intra-oral osteotomy (eg, locally aggressive or destructive lesion[s])

excision of benign tumor or cyst of mandible; requiring extra-oral osteotomy and partial mandibulectomy (eg, locally aggressive or destructive lesion[s])

excision of benign tumor or cyst of maxilla; requiring intra-oral osteotomy (eg, locally aggressive or destructive lesion[s])

excision of benign tumor or cyst of maxilla; requiring extra-oral osteotomy and partial maxillectomy (eg, locally aggressive or destructive lesion[s])

meniscectomy, partial or complete, temporomandibular joint (separate procedure)

manipulation of temporomandibular joint(s) (tmj), therapeutic, requiring an anesthesia service (ie, general or monitored anesthesia care)

impression and custom preparation; surgical obturator prosthesis

impression and custom preparation; definitive obturator prosthesis

impression and custom preparation; mandibular resection prosthesis

impression and custom preparation; palatal augmentation prosthesis

application of halo type appliance for maxillofacial fixation, includes removal (separate procedure)

application of interdental fixation device for conditions other than fracture or dislocation, includes removal

genioplasty; augmentation (autograft, allograft, prosthetic material)

genioplasty; sliding osteotomies, 2 or more osteotomies (eg, wedge excision or bone wedge reversal for asymmetrical chin)

genioplasty; sliding, augmentation with interpositional bone grafts (includes obtaining autografts)

augmentation, mandibular body or angle; with bone graft, onlay or interpositional (includes obtaining autograft)

reduction forehead; contouring and application of prosthetic material or bone graft (includes obtaining autograft)

reduction forehead; contouring and setback of anterior frontal sinus wall

reconstruction midface, lefort i; single piece, segment movement in any direction (eg, for long face syndrome), without bone graft

reconstruction midface, lefort i; 2 pieces, segment movement in any direction, without bone graft

reconstruction midface, lefort i; 3 or more pieces, segment movement in any direction, without bone graft

reconstruction midface, lefort i; single piece, segment movement in any direction, requiring bone grafts (includes obtaining autografts)

reconstruction midface, lefort i; 2 pieces, segment movement in any direction, requiring bone grafts (includes obtaining autografts) (eg, ungrafted unilateral alveolar cleft)

reconstruction midface, lefort i; 3 or more pieces, segment movement in any direction, requiring bone grafts (includes obtaining autografts) (eg, ungrafted bilateral alveolar cleft or multiple osteotomies)

reconstruction midface, lefort ii; anterior intrusion (eg, treacher-collins syndrome)

reconstruction midface, lefort ii; any direction, requiring bone grafts (includes obtaining autografts)

reconstruction midface, lefort iii (extracranial), any type, requiring bone grafts (includes obtaining autografts); without lefort i

reconstruction midface, lefort iii (extracranial), any type, requiring bone grafts (includes obtaining autografts); with lefort i

reconstruction midface, lefort iii (extra and intracranial) with forehead advancement (eg, mono bloc), requiring bone grafts (includes obtaining autografts); without lefort i

reconstruction midface, lefort iii (extra and intracranial) with forehead advancement (eg, mono bloc), requiring bone grafts (includes obtaining autografts); with lefort i

reconstruction superior-lateral orbital rim and lower forehead, advancement or alteration, with or without grafts (includes obtaining autografts)

reconstruction, bifrontal, superior-lateral orbital rims and lower forehead, advancement or alteration (eg, plagiocephaly, trigonocephaly, brachycephaly), with or without grafts (includes obtaining autografts)

reconstruction, entire or majority of forehead and/or supraorbital rims; with grafts (allograft or prosthetic material)

reconstruction, entire or majority of forehead and/or supraorbital rims; with autograft (includes obtaining grafts)

reconstruction by contouring of benign tumor of cranial bones (eg, fibrous dysplasia), extracranial

reconstruction of orbital walls, rims, forehead, nasoethmoid complex following intra- and extracranial excision of benign tumor of cranial bone (eg, fibrous dysplasia), with multiple autografts (includes obtaining grafts); total area of bone grafting less than 40 sq cm

reconstruction of orbital walls, rims, forehead, nasoethmoid complex following intra- and extracranial excision of benign tumor of cranial bone (eg, fibrous dysplasia), with multiple autografts (includes obtaining grafts); total area of bone grafting greater than 40 sq cm but less than 80 sq cm

reconstruction of orbital walls, rims, forehead, nasoethmoid complex following intra- and extracranial excision of benign tumor of cranial bone (eg, fibrous dysplasia), with multiple autografts (includes obtaining grafts); total area of bone grafting greater than 80 sq cm

reconstruction midface, osteotomies (other than lefort type) and bone grafts (includes obtaining autografts)

reconstruction of mandibular rami, horizontal, vertical, c, or l osteotomy; without bone graft

reconstruction of mandibular rami, horizontal, vertical, c, or l osteotomy; with bone graft (includes obtaining graft)

reconstruction of mandibular rami and/or body, sagittal split; without internal rigid fixation

reconstruction of mandibular rami and/or body, sagittal split; with internal rigid fixation

osteoplasty, facial bones; augmentation (autograft, allograft, or prosthetic implant)

graft, bone; nasal, maxillary or malar areas (includes obtaining graft)

graft; rib cartilage, autogenous, to face, chin, nose or ear (includes obtaining graft)

graft; ear cartilage, autogenous, to nose or ear (includes obtaining graft)

arthroplasty, temporomandibular joint, with or without autograft (includes obtaining graft)

arthroplasty, temporomandibular joint, with prosthetic joint replacement

reconstruction of mandible, extraoral, with transosteal bone plate (eg, mandibular staple bone plate)

reconstruction of mandible or maxilla, subperiosteal implant; partial

reconstruction of mandible or maxilla, subperiosteal implant; complete

reconstruction of mandibular condyle with bone and cartilage autografts (includes obtaining grafts) (eg, for hemifacial microsomia)

reconstruction of mandible or maxilla, endosteal implant (eg, blade, cylinder); partial

reconstruction of mandible or maxilla, endosteal implant (eg, blade, cylinder); complete

reconstruction of zygomatic arch and glenoid fossa with bone and cartilage (includes obtaining autografts)

reconstruction of orbit with osteotomies (extracranial) and with bone grafts (includes obtaining autografts) (eg, micro-ophthalmia)

periorbital osteotomies for orbital hypertelorism, with bone grafts; extracranial approach

periorbital osteotomies for orbital hypertelorism, with bone grafts; combined intra- and extracranial approach

periorbital osteotomies for orbital hypertelorism, with bone grafts; with forehead advancement

orbital repositioning, periorbital osteotomies, unilateral, with bone grafts; extracranial approach

orbital repositioning, periorbital osteotomies, unilateral, with bone grafts; combined intra- and extracranial approach

reduction of masseter muscle and bone (eg, for treatment of benign masseteric hypertrophy); extraoral approach

reduction of masseter muscle and bone (eg, for treatment of benign masseteric hypertrophy); intraoral approach

open treatment of nasal fracture; complicated, with internal and/or external skeletal fixation

open treatment of nasal fracture; with concomitant open treatment of fractured septum

open treatment of nasal septal fracture, with or without stabilization

closed treatment of nasal septal fracture, with or without stabilization

open treatment of nasoethmoid fracture; without external fixation

percutaneous treatment of nasoethmoid complex fracture, with splint, wire or headcap fixation, including repair of canthal ligaments and/or the nasolacrimal apparatus

open treatment of complicated (eg, comminuted or involving posterior wall) frontal sinus fracture, via coronal or multiple approaches

closed treatment of nasomaxillary complex fracture (lefort ii type), with interdental wire fixation or fixation of denture or splint

open treatment of nasomaxillary complex fracture (lefort ii type); with wiring and/or local fixation

open treatment of nasomaxillary complex fracture (lefort ii type); requiring multiple open approaches

open treatment of nasomaxillary complex fracture (lefort ii type); with bone grafting (includes obtaining graft)

percutaneous treatment of fracture of malar area, including zygomatic arch and malar tripod, with manipulation

open treatment of depressed zygomatic arch fracture (eg, gillies approach)

open treatment of depressed malar fracture, including zygomatic arch and malar tripod

open treatment of complicated (eg, comminuted or involving cranial nerve foramina) fracture(s) of malar area, including zygomatic arch and malar tripod; with internal fixation and multiple surgical approaches

open treatment of complicated (eg, comminuted or involving cranial nerve foramina) fracture(s) of malar area, including zygomatic arch and malar tripod; with bone grafting (includes obtaining graft)

open treatment of orbital floor blowout fracture; transantral approach (caldwell-luc type operation)

open treatment of orbital floor blowout fracture; periorbital approach

open treatment of orbital floor blowout fracture; combined approach

open treatment of orbital floor blowout fracture; periorbital approach, with alloplastic or other implant

open treatment of orbital floor blowout fracture; periorbital approach with bone graft (includes obtaining graft)

closed treatment of fracture of orbit, except blowout; without manipulation

closed treatment of fracture of orbit, except blowout; with manipulation

open treatment of fracture of orbit, except blowout; without implant

open treatment of fracture of orbit, except blowout; with implant

open treatment of fracture of orbit, except blowout; with bone grafting (includes obtaining graft)

closed treatment of palatal or maxillary fracture (lefort i type), with interdental wire fixation or fixation of denture or splint

open treatment of palatal or maxillary fracture (lefort i type); complicated (comminuted or involving cranial nerve foramina), multiple approaches

closed treatment of craniofacial separation (lefort iii type) using interdental wire fixation of denture or splint

open treatment of craniofacial separation (lefort iii type); with wiring and/or internal fixation

open treatment of craniofacial separation (lefort iii type); complicated (eg, comminuted or involving cranial nerve foramina), multiple surgical approaches

open treatment of craniofacial separation (lefort iii type); complicated, utilizing internal and/or external fixation techniques (eg, head cap, halo device, and/or intermaxillary fixation)

open treatment of craniofacial separation (lefort iii type); complicated, multiple surgical approaches, internal fixation, with bone grafting (includes obtaining graft)

closed treatment of mandibular or maxillary alveolar ridge fracture (separate procedure)

open treatment of mandibular or maxillary alveolar ridge fracture (separate procedure)

percutaneous treatment of mandibular fracture, with external fixation

closed treatment of mandibular fracture with interdental fixation

open treatment of mandibular fracture; without interdental fixation

open treatment of mandibular fracture; with interdental fixation

open treatment of complicated mandibular fracture by multiple surgical approaches including internal fixation, interdental fixation, and/or wiring of dentures or splints

closed treatment of temporomandibular dislocation; initial or subsequent

closed treatment of temporomandibular dislocation; complicated (eg, recurrent requiring intermaxillary fixation or splinting), initial or subsequent

incision and drainage, deep abscess or hematoma, soft tissues of neck or thorax

incision and drainage, deep abscess or hematoma, soft tissues of neck or thorax; with partial rib ostectomy

incision, deep, with opening of bone cortex (eg, for osteomyelitis or bone abscess), thorax

excision, tumor, soft tissue of neck or anterior thorax, subcutaneous; 3 cm or greater

excision, tumor, soft tissue of neck or anterior thorax, subfascial (eg, intramuscular); 5 cm or greater

excision, tumor, soft tissue of neck or anterior thorax, subcutaneous; less than 3 cm

excision, tumor, soft tissue of neck or anterior thorax, subfascial (eg, intramuscular); less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of neck or anterior thorax; less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of neck or anterior thorax; 5 cm or greater

division of sternocleidomastoid for torticollis, open operation; without cast application

division of sternocleidomastoid for torticollis, open operation; with cast application

reconstructive repair of pectus excavatum or carinatum; minimally invasive approach (nuss procedure), without thoracoscopy

reconstructive repair of pectus excavatum or carinatum; minimally invasive approach (nuss procedure), with thoracoscopy

closure of median sternotomy separation with or without debridement (separate procedure)

open treatment of rib fracture(s) with internal fixation, includes thoracoscopic visualization when performed, unilateral; 1-3 ribs

open treatment of rib fracture(s) with internal fixation, includes thoracoscopic visualization when performed, unilateral; 4-6 ribs

open treatment of rib fracture(s) with internal fixation, includes thoracoscopic visualization when performed, unilateral; 7 or more ribs

open treatment of sternum fracture with or without skeletal fixation

excision, tumor, soft tissue of back or flank, subcutaneous; less than 3 cm

excision, tumor, soft tissue of back or flank, subcutaneous; 3 cm or greater

excision, tumor, soft tissue of back or flank, subfascial (eg, intramuscular); less than 5 cm

excision, tumor, soft tissue of back or flank, subfascial (eg, intramuscular); 5 cm or greater

radical resection of tumor (eg, sarcoma), soft tissue of back or flank; less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of back or flank; 5 cm or greater

incision and drainage, open, of deep abscess (subfascial), posterior spine; cervical, thoracic, or cervicothoracic

incision and drainage, open, of deep abscess (subfascial), posterior spine; lumbar, sacral, or lumbosacral

partial excision of posterior vertebral component (eg, spinous process, lamina or facet) for intrinsic bony lesion, single vertebral segment; cervical

partial excision of posterior vertebral component (eg, spinous process, lamina or facet) for intrinsic bony lesion, single vertebral segment; thoracic

partial excision of posterior vertebral component (eg, spinous process, lamina or facet) for intrinsic bony lesion, single vertebral segment; lumbar

partial excision of posterior vertebral component (eg, spinous process, lamina or facet) for intrinsic bony lesion, single vertebral segment; each additional segment (list separately in addition to code for primary procedure)

partial excision of vertebral body, for intrinsic bony lesion, without decompression of spinal cord or nerve root(s), single vertebral segment; cervical

partial excision of vertebral body, for intrinsic bony lesion, without decompression of spinal cord or nerve root(s), single vertebral segment; thoracic

partial excision of vertebral body, for intrinsic bony lesion, without decompression of spinal cord or nerve root(s), single vertebral segment; lumbar

partial excision of vertebral body, for intrinsic bony lesion, without decompression of spinal cord or nerve root(s), single vertebral segment; each additional vertebral segment (list separately in addition to code for primary procedure)

osteotomy of spine, posterior or posterolateral approach, 3 columns, 1 vertebral segment (eg, pedicle/vertebral body subtraction); thoracic

osteotomy of spine, posterior or posterolateral approach, 3 columns, 1 vertebral segment (eg, pedicle/vertebral body subtraction); lumbar

osteotomy of spine, posterior or posterolateral approach, 3 columns, 1 vertebral segment (eg, pedicle/vertebral body subtraction); each additional vertebral segment (list separately in addition to code for primary procedure)

osteotomy of spine, posterior or posterolateral approach, 1 vertebral segment; cervical

osteotomy of spine, posterior or posterolateral approach, 1 vertebral segment; thoracic

osteotomy of spine, posterior or posterolateral approach, 1 vertebral segment; lumbar

osteotomy of spine, posterior or posterolateral approach, 1 vertebral segment; each additional vertebral segment (list separately in addition to primary procedure)

osteotomy of spine, including discectomy, anterior approach, single vertebral segment; cervical

osteotomy of spine, including discectomy, anterior approach, single vertebral segment; thoracic

osteotomy of spine, including discectomy, anterior approach, single vertebral segment; lumbar

osteotomy of spine, including discectomy, anterior approach, single vertebral segment; each additional vertebral segment (list separately in addition to code for primary procedure)

closed treatment of vertebral body fracture(s), without manipulation, requiring and including casting or bracing

closed treatment of vertebral fracture(s) and/or dislocation(s) requiring casting or bracing, with and including casting and/or bracing by manipulation or traction

open treatment and/or reduction of odontoid fracture(s) and or dislocation(s) (including os odontoideum), anterior approach, including placement of internal fixation; without grafting

open treatment and/or reduction of odontoid fracture(s) and or dislocation(s) (including os odontoideum), anterior approach, including placement of internal fixation; with grafting

open treatment and/or reduction of vertebral fracture(s) and/or dislocation(s), posterior approach, 1 fractured vertebra or dislocated segment; lumbar

open treatment and/or reduction of vertebral fracture(s) and/or dislocation(s), posterior approach, 1 fractured vertebra or dislocated segment; cervical

open treatment and/or reduction of vertebral fracture(s) and/or dislocation(s), posterior approach, 1 fractured vertebra or dislocated segment; thoracic

open treatment and/or reduction of vertebral fracture(s) and/or dislocation(s), posterior approach, 1 fractured vertebra or dislocated segment; each additional fractured vertebra or dislocated segment (list separately in addition to code for primary procedure)

percutaneous vertebroplasty (bone biopsy included when performed), 1 vertebral body, unilateral or bilateral injection, inclusive of all imaging guidance; cervicothoracic

percutaneous vertebroplasty (bone biopsy included when performed), 1 vertebral body, unilateral or bilateral injection, inclusive of all imaging guidance; lumbosacral

percutaneous vertebroplasty (bone biopsy included when performed), 1 vertebral body, unilateral or bilateral injection, inclusive of all imaging guidance; each additional cervicothoracic or lumbosacral vertebral body (list separately in addition to code for primary procedure)

percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device (eg, kyphoplasty), 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance; thoracic

percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device (eg, kyphoplasty), 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance; lumbar

percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device (eg, kyphoplasty), 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance; each additional thoracic or lumbar vertebral body (list separately in addition to code for primary procedure)

percutaneous intradiscal electrothermal annuloplasty, unilateral or bilateral including fluoroscopic guidance; single level

percutaneous intradiscal electrothermal annuloplasty, unilateral or bilateral including fluoroscopic guidance; 1 or more additional levels (list separately in addition to code for primary procedure)

arthrodesis, lateral extracavitary technique, including minimal discectomy to prepare interspace (other than for decompression); thoracic

arthrodesis, lateral extracavitary technique, including minimal discectomy to prepare interspace (other than for decompression); lumbar

arthrodesis, lateral extracavitary technique, including minimal discectomy to prepare interspace (other than for decompression); thoracic or lumbar, each additional vertebral segment (list separately in addition to code for primary procedure)

arthrodesis, anterior transoral or extraoral technique, clivus-c1-c2 (atlas-axis), with or without excision of odontoid process

arthrodesis, anterior interbody, including disc space preparation, discectomy, osteophytectomy and decompression of spinal cord and/or nerve roots; cervical below c2

arthrodesis, anterior interbody, including disc space preparation, discectomy, osteophytectomy and decompression of spinal cord and/or nerve roots; cervical below c2, each additional interspace (list separately in addition to code for separate procedure)

arthrodesis, anterior interbody technique, including minimal discectomy to prepare interspace (other than for decompression); cervical below c2

arthrodesis, anterior interbody technique, including minimal discectomy to prepare interspace (other than for decompression); thoracic

arthrodesis, anterior interbody technique, including minimal discectomy to prepare interspace (other than for decompression); lumbar

arthrodesis, anterior interbody technique, including minimal discectomy to prepare interspace (other than for decompression); each additional interspace (list separately in addition to code for primary procedure)

arthrodesis, pre-sacral interbody technique, including disc space preparation, discectomy, with posterior instrumentation, with image guidance, includes bone graft when performed, l5-s1 interspace

arthrodesis, posterior or posterolateral technique, single level; cervical below c2 segment

arthrodesis, posterior or posterolateral technique, single level; thoracic (with lateral transverse technique, when performed)

arthrodesis, posterior or posterolateral technique, single level; lumbar (with lateral transverse technique, when performed)

arthrodesis, posterior or posterolateral technique, single level; each additional vertebral segment (list separately in addition to code for primary procedure)

arthrodesis, posterior interbody technique, including laminectomy and/or discectomy to prepare interspace (other than for decompression), single interspace; lumbar

arthrodesis, posterior interbody technique, including laminectomy and/or discectomy to prepare interspace (other than for decompression), single interspace; each additional interspace (list separately in addition to code for primary procedure)

arthrodesis, combined posterior or posterolateral technique with posterior interbody technique including laminectomy and/or discectomy sufficient to prepare interspace (other than for decompression), single interspace and segment; lumbar

arthrodesis, combined posterior or posterolateral technique with posterior interbody technique including laminectomy and/or discectomy sufficient to prepare interspace (other than for decompression), single interspace and segment; each additional interspace and segment (list separately in addition to code for primary procedure)

arthrodesis, posterior, for spinal deformity, with or without cast; up to 6 vertebral segments

arthrodesis, posterior, for spinal deformity, with or without cast; 7 to 12 vertebral segments

arthrodesis, posterior, for spinal deformity, with or without cast; 13 or more vertebral segments

arthrodesis, anterior, for spinal deformity, with or without cast; 2 to 3 vertebral segments

arthrodesis, anterior, for spinal deformity, with or without cast; 4 to 7 vertebral segments

arthrodesis, anterior, for spinal deformity, with or without cast; 8 or more vertebral segments

kyphectomy, circumferential exposure of spine and resection of vertebral segment(s) (including body and posterior elements); single or 2 segments

kyphectomy, circumferential exposure of spine and resection of vertebral segment(s) (including body and posterior elements); 3 or more segments

posterior non-segmental instrumentation (eg, harrington rod technique, pedicle fixation across 1 interspace, atlantoaxial transarticular screw fixation, sublaminar wiring at c1, facet screw fixation) (list separately in addition to code for primary procedure)

internal spinal fixation by wiring of spinous processes (list separately in addition to code for primary procedure)

posterior segmental instrumentation (eg, pedicle fixation, dual rods with multiple hooks and sublaminar wires); 3 to 6 vertebral segments (list separately in addition to code for primary procedure)

posterior segmental instrumentation (eg, pedicle fixation, dual rods with multiple hooks and sublaminar wires); 7 to 12 vertebral segments (list separately in addition to code for primary procedure)

posterior segmental instrumentation (eg, pedicle fixation, dual rods with multiple hooks and sublaminar wires); 13 or more vertebral segments (list separately in addition to code for primary procedure)

anterior instrumentation; 2 to 3 vertebral segments (list separately in addition to code for primary procedure)

anterior instrumentation; 4 to 7 vertebral segments (list separately in addition to code for primary procedure)

anterior instrumentation; 8 or more vertebral segments (list separately in addition to code for primary procedure)

pelvic fixation (attachment of caudal end of instrumentation to pelvic bony structures) other than sacrum (list separately in addition to code for primary procedure)

removal of posterior nonsegmental instrumentation (eg, harrington rod)

insertion of interbody biomechanical device(s) (eg, synthetic cage, mesh) with integral anterior instrumentation for device anchoring (eg, screws, flanges), when performed, to intervertebral disc space in conjunction with interbody arthrodesis, each interspace (list separately in addition to code for primary procedure)

insertion of intervertebral biomechanical device(s) (eg, synthetic cage, mesh) with integral anterior instrumentation for device anchoring (eg, screws, flanges), when performed, to vertebral corpectomy(ies) (vertebral body resection, partial or complete) defect, in conjunction with interbody arthrodesis, each contiguous defect (list separately in addition to code for primary procedure)

total disc arthroplasty (artificial disc), anterior approach, including discectomy with end plate preparation (includes osteophytectomy for nerve root or spinal cord decompression and microdissection); single interspace, cervical

total disc arthroplasty (artificial disc), anterior approach, including discectomy to prepare interspace (other than for decompression), single interspace, lumbar

total disc arthroplasty (artificial disc), anterior approach, including discectomy with end plate preparation (includes osteophytectomy for nerve root or spinal cord decompression and microdissection); second level, cervical (list separately in addition to code for primary procedure)

insertion of intervertebral biomechanical device(s) (eg, synthetic cage, mesh, methylmethacrylate) to intervertebral disc space or vertebral body defect without interbody arthrodesis, each contiguous defect (list separately in addition to code for primary procedure)

revision including replacement of total disc arthroplasty (artificial disc), anterior approach, single interspace; cervical

revision including replacement of total disc arthroplasty (artificial disc), anterior approach, single interspace; lumbar

removal of total disc arthroplasty (artificial disc), anterior approach, single interspace; cervical

removal of total disc arthroplasty (artificial disc), anterior approach, single interspace; lumbar

insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar; single level

insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar; second level (list separately in addition to code for primary procedure)

insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar; single level

insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar; second level (list separately in addition to code for primary procedure)

excision, tumor, soft tissue of abdominal wall, subfascial (eg, intramuscular); less than 5 cm

excision, tumor, soft tissue of abdominal wall, subfascial (eg, intramuscular); 5 cm or greater

excision, tumor, soft tissue of abdominal wall, subcutaneous; less than 3 cm

excision, tumor, soft tissue of abdominal wall, subcutaneous; 3 cm or greater

radical resection of tumor (eg, sarcoma), soft tissue of abdominal wall; less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of abdominal wall; 5 cm or greater

incision, bone cortex (eg, osteomyelitis or bone abscess), shoulder area

arthrotomy, glenohumeral joint, including exploration, drainage, or removal of foreign body

arthrotomy, acromioclavicular, sternoclavicular joint, including exploration, drainage, or removal of foreign body

excision, tumor, soft tissue of shoulder area, subcutaneous; 3 cm or greater

excision, tumor, soft tissue of shoulder area, subfascial (eg, intramuscular); 5 cm or greater

excision, tumor, soft tissue of shoulder area, subcutaneous; less than 3 cm

excision, tumor, soft tissue of shoulder area, subfascial (eg, intramuscular); less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of shoulder area; less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of shoulder area; 5 cm or greater

arthrotomy, acromioclavicular joint or sternoclavicular joint, including biopsy and/or excision of torn cartilage

arthrotomy; glenohumeral joint, with synovectomy, with or without biopsy

arthrotomy; sternoclavicular joint, with synovectomy, with or without biopsy

arthrotomy, glenohumeral joint, with joint exploration, with or without removal of loose or foreign body

acromioplasty or acromionectomy, partial, with or without coracoacromial ligament release

excision or curettage of bone cyst or benign tumor of clavicle or scapula

excision or curettage of bone cyst or benign tumor of clavicle or scapula; with autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor of clavicle or scapula; with allograft

excision or curettage of bone cyst or benign tumor of proximal humerus

excision or curettage of bone cyst or benign tumor of proximal humerus; with autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor of proximal humerus; with allograft

sequestrectomy (eg, for osteomyelitis or bone abscess), clavicle

sequestrectomy (eg, for osteomyelitis or bone abscess), humeral head to surgical neck

partial excision (craterization, saucerization, or diaphysectomy) bone (eg, osteomyelitis), clavicle

partial excision (craterization, saucerization, or diaphysectomy) bone (eg, osteomyelitis), scapula

partial excision (craterization, saucerization, or diaphysectomy) bone (eg, osteomyelitis), proximal humerus

removal of foreign body, shoulder; deep (subfascial or intramuscular)

removal of prosthesis, includes debridement and synovectomy when performed; humeral or glenoid component

removal of prosthesis, includes debridement and synovectomy when performed; humeral and glenoid components (eg, total shoulder)

injection procedure for shoulder arthrography or enhanced ct/mri shoulder arthrography

repair of ruptured musculotendinous cuff (eg, rotator cuff) open; acute

repair of ruptured musculotendinous cuff (eg, rotator cuff) open; chronic

reconstruction of complete shoulder (rotator) cuff avulsion, chronic (includes acromioplasty)

capsulorrhaphy, anterior; putti-platt procedure or magnuson type operation

capsulorrhaphy, anterior; with labral repair (eg, bankart procedure)

capsulorrhaphy, anterior, any type; with coracoid process transfer

capsulorrhaphy, glenohumeral joint, posterior, with or without bone block

capsulorrhaphy, glenohumeral joint, any type multi-directional instability

arthroplasty, glenohumeral joint; total shoulder (glenoid and proximal humeral replacement (eg, total shoulder))

revision of total shoulder arthroplasty, including allograft when performed; humeral or glenoid component

revision of total shoulder arthroplasty, including allograft when performed; humeral and glenoid component

osteotomy, clavicle, with or without internal fixation; with bone graft for nonunion or malunion (includes obtaining graft and/or necessary fixation)

prophylactic treatment (nailing, pinning, plating or wiring) with or without methylmethacrylate; clavicle

prophylactic treatment (nailing, pinning, plating or wiring) with or without methylmethacrylate; proximal humerus

open treatment of clavicular fracture, includes internal fixation, when performed

closed treatment of sternoclavicular dislocation; without manipulation

closed treatment of sternoclavicular dislocation; with manipulation

open treatment of sternoclavicular dislocation, acute or chronic

open treatment of sternoclavicular dislocation, acute or chronic; with fascial graft (includes obtaining graft)

closed treatment of acromioclavicular dislocation; without manipulation

closed treatment of acromioclavicular dislocation; with manipulation

open treatment of acromioclavicular dislocation, acute or chronic

open treatment of acromioclavicular dislocation, acute or chronic; with fascial graft (includes obtaining graft)

closed treatment of scapular fracture; with manipulation, with or without skeletal traction (with or without shoulder joint involvement)

open treatment of scapular fracture (body, glenoid or acromion) includes internal fixation, when performed

closed treatment of proximal humeral (surgical or anatomical neck) fracture; without manipulation

closed treatment of proximal humeral (surgical or anatomical neck) fracture; with manipulation, with or without skeletal traction

open treatment of proximal humeral (surgical or anatomical neck) fracture, includes internal fixation, when performed, includes repair of tuberosity(s), when performed

open treatment of proximal humeral (surgical or anatomical neck) fracture, includes internal fixation, when performed, includes repair of tuberosity(s), when performed; with proximal humeral prosthetic replacement

closed treatment of greater humeral tuberosity fracture; without manipulation

closed treatment of greater humeral tuberosity fracture; with manipulation

open treatment of greater humeral tuberosity fracture, includes internal fixation, when performed

closed treatment of shoulder dislocation, with manipulation; without anesthesia

closed treatment of shoulder dislocation, with manipulation; requiring anesthesia

closed treatment of shoulder dislocation, with fracture of greater humeral tuberosity, with manipulation

open treatment of shoulder dislocation, with fracture of greater humeral tuberosity, includes internal fixation, when performed

closed treatment of shoulder dislocation, with surgical or anatomical neck fracture, with manipulation

open treatment of shoulder dislocation, with surgical or anatomical neck fracture, includes internal fixation, when performed

manipulation under anesthesia, shoulder joint, including application of fixation apparatus (dislocation excluded)

arthrodesis, glenohumeral joint; with autogenous graft (includes obtaining graft)

incision and drainage, upper arm or elbow area; deep abscess or hematoma

incision, deep, with opening of bone cortex (eg, for osteomyelitis or bone abscess), humerus or elbow

arthrotomy, elbow, including exploration, drainage, or removal of foreign body

arthrotomy of the elbow, with capsular excision for capsular release (separate procedure)

biopsy, soft tissue of upper arm or elbow area; deep (subfascial or intramuscular)

excision, tumor, soft tissue of upper arm or elbow area, subcutaneous; 3 cm or greater

excision, tumor, soft tissue of upper arm or elbow area, subfascial (eg, intramuscular); 5 cm or greater

excision, tumor, soft tissue of upper arm or elbow area, subcutaneous; less than 3 cm

excision, tumor, soft tissue of upper arm or elbow area, subfascial (eg, intramuscular); less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of upper arm or elbow area; less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of upper arm or elbow area; 5 cm or greater

arthrotomy, elbow; with joint exploration, with or without biopsy, with or without removal of loose or foreign body

excision or curettage of bone cyst or benign tumor, humerus; with autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor, humerus; with allograft

excision or curettage of bone cyst or benign tumor of head or neck of radius or olecranon process

excision or curettage of bone cyst or benign tumor of head or neck of radius or olecranon process; with autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor of head or neck of radius or olecranon process; with allograft

sequestrectomy (eg, for osteomyelitis or bone abscess), shaft or distal humerus

sequestrectomy (eg, for osteomyelitis or bone abscess), radial head or neck

sequestrectomy (eg, for osteomyelitis or bone abscess), olecranon process

partial excision (craterization, saucerization, or diaphysectomy) bone (eg, osteomyelitis), humerus

partial excision (craterization, saucerization, or diaphysectomy) bone (eg, osteomyelitis), radial head or neck

partial excision (craterization, saucerization, or diaphysectomy) bone (eg, osteomyelitis), olecranon process

radical resection of capsule, soft tissue, and heterotopic bone, elbow, with contracture release (separate procedure)

removal of prosthesis, includes debridement and synovectomy when performed; humeral and ulnar components

removal of prosthesis, includes debridement and synovectomy when performed; radial head

removal of foreign body, upper arm or elbow area; deep (subfascial or intramuscular)

muscle or tendon transfer, any type, upper arm or elbow, single (excluding 24320-24331)

tenoplasty, with muscle transfer, with or without free graft, elbow to shoulder, single (seddon-brookes type procedure)

flexor-plasty, elbow (eg, steindler type advancement); with extensor advancement

repair, tendon or muscle, upper arm or elbow, each tendon or muscle, primary or secondary (excludes rotator cuff)

reinsertion of ruptured biceps or triceps tendon, distal, with or without tendon graft

reconstruction lateral collateral ligament, elbow, with tendon graft (includes harvesting of graft)

reconstruction medial collateral ligament, elbow, with tendon graft (includes harvesting of graft)

tenotomy, elbow, lateral or medial (eg, epicondylitis, tennis elbow, golfer's elbow); percutaneous

tenotomy, elbow, lateral or medial (eg, epicondylitis, tennis elbow, golfer's elbow); debridement, soft tissue and/or bone, open

tenotomy, elbow, lateral or medial (eg, epicondylitis, tennis elbow, golfer's elbow); debridement, soft tissue and/or bone, open with tendon repair or reattachment

arthroplasty, elbow; with implant and fascia lata ligament reconstruction

arthroplasty, elbow; with distal humerus and proximal ulnar prosthetic replacement (eg, total elbow)

revision of total elbow arthroplasty, including allograft when performed; humeral or ulnar component

revision of total elbow arthroplasty, including allograft when performed; humeral and ulnar component

multiple osteotomies with realignment on intramedullary rod, humeral shaft (sofield type procedure)

osteoplasty, humerus (eg, shortening or lengthening) (excluding 64876)

repair of nonunion or malunion, humerus; without graft (eg, compression technique)

repair of nonunion or malunion, humerus; with iliac or other autograft (includes obtaining graft)

hemiepiphyseal arrest (eg, cubitus varus or valgus, distal humerus)

decompression fasciotomy, forearm, with brachial artery exploration

prophylactic treatment (nailing, pinning, plating or wiring), with or without methylmethacrylate, humeral shaft

closed treatment of humeral shaft fracture; without manipulation

closed treatment of humeral shaft fracture; with manipulation, with or without skeletal traction

open treatment of humeral shaft fracture with plate/screws, with or without cerclage

treatment of humeral shaft fracture, with insertion of intramedullary implant, with or without cerclage and/or locking screws

closed treatment of supracondylar or transcondylar humeral fracture, with or without intercondylar extension; without manipulation

closed treatment of supracondylar or transcondylar humeral fracture, with or without intercondylar extension; with manipulation, with or without skin or skeletal traction

percutaneous skeletal fixation of supracondylar or transcondylar humeral fracture, with or without intercondylar extension

open treatment of humeral supracondylar or transcondylar fracture, includes internal fixation, when performed; without intercondylar extension

open treatment of humeral supracondylar or transcondylar fracture, includes internal fixation, when performed; with intercondylar extension

closed treatment of humeral epicondylar fracture, medial or lateral; without manipulation

closed treatment of humeral epicondylar fracture, medial or lateral; with manipulation

percutaneous skeletal fixation of humeral epicondylar fracture, medial or lateral, with manipulation

open treatment of humeral epicondylar fracture, medial or lateral, includes internal fixation, when performed

closed treatment of humeral condylar fracture, medial or lateral; without manipulation

closed treatment of humeral condylar fracture, medial or lateral; with manipulation

open treatment of humeral condylar fracture, medial or lateral, includes internal fixation, when performed

percutaneous skeletal fixation of humeral condylar fracture, medial or lateral, with manipulation

open treatment of periarticular fracture and/or dislocation of the elbow (fracture distal humerus and proximal ulna and/or proximal radius)

open treatment of periarticular fracture and/or dislocation of the elbow (fracture distal humerus and proximal ulna and/or proximal radius); with implant arthroplasty

closed treatment of monteggia type of fracture dislocation at elbow (fracture proximal end of ulna with dislocation of radial head), with manipulation

open treatment of monteggia type of fracture dislocation at elbow (fracture proximal end of ulna with dislocation of radial head), includes internal fixation, when performed

closed treatment of radial head subluxation in child, nursemaid elbow, with manipulation

closed treatment of radial head or neck fracture; without manipulation

closed treatment of radial head or neck fracture; with manipulation

open treatment of radial head or neck fracture, includes internal fixation or radial head excision, when performed

open treatment of radial head or neck fracture, includes internal fixation or radial head excision, when performed; with radial head prosthetic replacement

closed treatment of ulnar fracture, proximal end (eg, olecranon or coronoid process[es]); without manipulation

closed treatment of ulnar fracture, proximal end (eg, olecranon or coronoid process[es]); with manipulation

open treatment of ulnar fracture, proximal end (eg, olecranon or coronoid process[es]), includes internal fixation, when performed

arthrodesis, elbow joint; with autogenous graft (includes obtaining graft)

amputation, arm through humerus; secondary closure or scar revision

incision, extensor tendon sheath, wrist (eg, de quervains disease)

incision, flexor tendon sheath, wrist (eg, flexor carpi radialis)

decompression fasciotomy, forearm and/or wrist, flexor or extensor compartment; without debridement of nonviable muscle and/or nerve

decompression fasciotomy, forearm and/or wrist, flexor or extensor compartment; with debridement of nonviable muscle and/or nerve

decompression fasciotomy, forearm and/or wrist, flexor and extensor compartment; without debridement of nonviable muscle and/or nerve

decompression fasciotomy, forearm and/or wrist, flexor and extensor compartment; with debridement of nonviable muscle and/or nerve

incision and drainage, forearm and/or wrist; deep abscess or hematoma

incision, deep, bone cortex, forearm and/or wrist (eg, osteomyelitis or bone abscess)

arthrotomy, radiocarpal or midcarpal joint, with exploration, drainage, or removal of foreign body

biopsy, soft tissue of forearm and/or wrist; deep (subfascial or intramuscular)

excision, tumor, soft tissue of forearm and/or wrist area, subcutaneous; 3 cm or greater

excision, tumor, soft tissue of forearm and/or wrist area, subfascial (eg, intramuscular); 3 cm or greater

excision, tumor, soft tissue of forearm and/or wrist area, subcutaneous; less than 3 cm

excision, tumor, soft tissue of forearm and/or wrist area, subfascial (eg, intramuscular); less than 3 cm

radical resection of tumor (eg, sarcoma), soft tissue of forearm and/or wrist area; less than 3 cm

radical resection of tumor (eg, sarcoma), soft tissue of forearm and/or wrist area; 3 cm or greater

arthrotomy, wrist joint; with joint exploration, with or without biopsy, with or without removal of loose or foreign body

arthrotomy, distal radioulnar joint including repair of triangular cartilage, complex

excision of tendon, forearm and/or wrist, flexor or extensor, each

radical excision of bursa, synovia of wrist, or forearm tendon sheaths (eg, tenosynovitis, fungus, tbc, or other granulomas, rheumatoid arthritis); flexors

radical excision of bursa, synovia of wrist, or forearm tendon sheaths (eg, tenosynovitis, fungus, tbc, or other granulomas, rheumatoid arthritis); extensors, with or without transposition of dorsal retinaculum

synovectomy, extensor tendon sheath, wrist, single compartment; with resection of distal ulna

excision or curettage of bone cyst or benign tumor of radius or ulna (excluding head or neck of radius and olecranon process)

excision or curettage of bone cyst or benign tumor of radius or ulna (excluding head or neck of radius and olecranon process); with autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor of radius or ulna (excluding head or neck of radius and olecranon process); with allograft

excision or curettage of bone cyst or benign tumor of carpal bones

excision or curettage of bone cyst or benign tumor of carpal bones; with autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor of carpal bones; with allograft

sequestrectomy (eg, for osteomyelitis or bone abscess), forearm and/or wrist

partial excision (craterization, saucerization, or diaphysectomy) of bone (eg, for osteomyelitis); ulna

partial excision (craterization, saucerization, or diaphysectomy) of bone (eg, for osteomyelitis); radius

excision distal ulna partial or complete (eg, darrach type or matched resection)

repair, tendon or muscle, flexor, forearm and/or wrist; primary, single, each tendon or muscle

repair, tendon or muscle, flexor, forearm and/or wrist; secondary, single, each tendon or muscle

repair, tendon or muscle, flexor, forearm and/or wrist; secondary, with free graft (includes obtaining graft), each tendon or muscle

repair, tendon or muscle, extensor, forearm and/or wrist; primary, single, each tendon or muscle

repair, tendon or muscle, extensor, forearm and/or wrist; secondary, single, each tendon or muscle

repair, tendon or muscle, extensor, forearm and/or wrist; secondary, with free graft (includes obtaining graft), each tendon or muscle

repair, tendon sheath, extensor, forearm and/or wrist, with free graft (includes obtaining graft) (eg, for extensor carpi ulnaris subluxation)

lengthening or shortening of flexor or extensor tendon, forearm and/or wrist, single, each tendon

tenotomy, open, flexor or extensor tendon, forearm and/or wrist, single, each tendon

tenolysis, flexor or extensor tendon, forearm and/or wrist, single, each tendon

tendon transplantation or transfer, flexor or extensor, forearm and/or wrist, single; each tendon

tendon transplantation or transfer, flexor or extensor, forearm and/or wrist, single; with tendon graft(s) (includes obtaining graft), each tendon

flexor origin slide (eg, for cerebral palsy, volkmann contracture), forearm and/or wrist

flexor origin slide (eg, for cerebral palsy, volkmann contracture), forearm and/or wrist; with tendon(s) transfer

capsulorrhaphy or reconstruction, wrist, open (eg, capsulodesis, ligament repair, tendon transfer or graft) (includes synovectomy, capsulotomy and open reduction) for carpal instability

arthroplasty, wrist, with or without interposition, with or without external or internal fixation

reconstruction for stabilization of unstable distal ulna or distal radioulnar joint, secondary by soft tissue stabilization (eg, tendon transfer, tendon graft or weave, or tenodesis) with or without open reduction of distal radioulnar joint

multiple osteotomies, with realignment on intramedullary rod (sofield type procedure); radius or ulna

multiple osteotomies, with realignment on intramedullary rod (sofield type procedure); radius and ulna

repair of nonunion or malunion, radius or ulna; without graft (eg, compression technique)

repair of nonunion or malunion, radius or ulna; with autograft (includes obtaining graft)

repair of nonunion or malunion, radius and ulna; without graft (eg, compression technique)

repair of nonunion or malunion, radius and ulna; with autograft (includes obtaining graft)

insertion of vascular pedicle into carpal bone (eg, hori procedure)

repair of nonunion of carpal bone (excluding carpal scaphoid (navicular)) (includes obtaining graft and necessary fixation), each bone

repair of nonunion, scaphoid carpal (navicular) bone, with or without radial styloidectomy (includes obtaining graft and necessary fixation)

arthroplasty with prosthetic replacement; scaphoid carpal (navicular)

arthroplasty with prosthetic replacement; distal radius and partial or entire carpus (total wrist)

arthroplasty, interposition, intercarpal or carpometacarpal joints

revision of arthroplasty, including removal of implant, wrist joint

epiphyseal arrest by epiphysiodesis or stapling; distal radius or ulna

epiphyseal arrest by epiphysiodesis or stapling; distal radius and ulna

prophylactic treatment (nailing, pinning, plating or wiring) with or without methylmethacrylate; radius

prophylactic treatment (nailing, pinning, plating or wiring) with or without methylmethacrylate; ulna

prophylactic treatment (nailing, pinning, plating or wiring) with or without methylmethacrylate; radius and ulna

open treatment of radial shaft fracture, includes internal fixation, when performed

closed treatment of radial shaft fracture and closed treatment of dislocation of distal radioulnar joint (galeazzi fracture/dislocation)

open treatment of radial shaft fracture, includes internal fixation, when performed, and closed treatment of distal radioulnar joint dislocation (galeazzi fracture/ dislocation), includes percutaneous skeletal fixation, when performed

open treatment of radial shaft fracture, includes internal fixation, when performed, and open treatment of distal radioulnar joint dislocation (galeazzi fracture/ dislocation), includes internal fixation, when performed, includes repair of triangular fibrocartilage complex

open treatment of ulnar shaft fracture, includes internal fixation, when performed

closed treatment of radial and ulnar shaft fractures; without manipulation

closed treatment of radial and ulnar shaft fractures; with manipulation

open treatment of radial and ulnar shaft fractures, with internal fixation, when performed; of radius or ulna

open treatment of radial and ulnar shaft fractures, with internal fixation, when performed; of radius and ulna

closed treatment of distal radial fracture (eg, colles or smith type) or epiphyseal separation, includes closed treatment of fracture of ulnar styloid, when performed; without manipulation

closed treatment of distal radial fracture (eg, colles or smith type) or epiphyseal separation, includes closed treatment of fracture of ulnar styloid, when performed; with manipulation

percutaneous skeletal fixation of distal radial fracture or epiphyseal separation

open treatment of distal radial extra-articular fracture or epiphyseal separation, with internal fixation

open treatment of distal radial intra-articular fracture or epiphyseal separation; with internal fixation of 2 fragments

open treatment of distal radial intra-articular fracture or epiphyseal separation; with internal fixation of 3 or more fragments

closed treatment of carpal scaphoid (navicular) fracture; without manipulation

closed treatment of carpal scaphoid (navicular) fracture; with manipulation

open treatment of carpal scaphoid (navicular) fracture, includes internal fixation, when performed

closed treatment of carpal bone fracture (excluding carpal scaphoid [navicular]); without manipulation, each bone

closed treatment of carpal bone fracture (excluding carpal scaphoid [navicular]); with manipulation, each bone

open treatment of carpal bone fracture (other than carpal scaphoid [navicular]), each bone

closed treatment of radiocarpal or intercarpal dislocation, 1 or more bones, with manipulation

open treatment of radiocarpal or intercarpal dislocation, 1 or more bones

closed treatment of distal radioulnar dislocation with manipulation

open treatment of distal radioulnar dislocation, acute or chronic

closed treatment of trans-scaphoperilunar type of fracture dislocation, with manipulation

open treatment of trans-scaphoperilunar type of fracture dislocation

arthrodesis, wrist; complete, without bone graft (includes radiocarpal and/or intercarpal and/or carpometacarpal joints)

arthrodesis, wrist; with iliac or other autograft (includes obtaining graft)

arthrodesis, wrist; limited, without bone graft (eg, intercarpal or radiocarpal)

arthrodesis, distal radioulnar joint with segmental resection of ulna, with or without bone graft (eg, sauve-kapandji procedure)

amputation, forearm, through radius and ulna; open, circular (guillotine)

amputation, forearm, through radius and ulna; secondary closure or scar revision

disarticulation through wrist; secondary closure or scar revision

incision, bone cortex, hand or finger (eg, osteomyelitis or bone abscess)

decompression fingers and/or hand, injection injury (eg, grease gun)

arthrotomy, with exploration, drainage, or removal of loose or foreign body; carpometacarpal joint

arthrotomy, with exploration, drainage, or removal of loose or foreign body; metacarpophalangeal joint, each

arthrotomy, with exploration, drainage, or removal of loose or foreign body; interphalangeal joint, each

excision, tumor or vascular malformation, soft tissue of hand or finger, subcutaneous; 1.5 cm or greater

excision, tumor, soft tissue, or vascular malformation, of hand or finger, subfascial (eg, intramuscular); 1.5 cm or greater

excision, tumor or vascular malformation, soft tissue of hand or finger, subcutaneous; less than 1.5 cm

excision, tumor, soft tissue, or vascular malformation, of hand or finger, subfascial (eg, intramuscular); less than 1.5 cm

radical resection of tumor (eg, sarcoma), soft tissue of hand or finger; less than 3 cm

radical resection of tumor (eg, sarcoma), soft tissue of hand or finger; 3 cm or greater

fasciectomy, palm only, with or without z-plasty, other local tissue rearrangement, or skin grafting (includes obtaining graft)

fasciectomy, partial palmar with release of single digit including proximal interphalangeal joint, with or without z-plasty, other local tissue rearrangement, or skin grafting (includes obtaining graft)

fasciectomy, partial palmar with release of single digit including proximal interphalangeal joint, with or without z-plasty, other local tissue rearrangement, or skin grafting (includes obtaining graft); each additional digit (list separately in addition to code for primary procedure)

synovectomy, metacarpophalangeal joint including intrinsic release and extensor hood reconstruction, each digit

synovectomy, proximal interphalangeal joint, including extensor reconstruction, each interphalangeal joint

synovectomy, tendon sheath, radical (tenosynovectomy), flexor tendon, palm and/or finger, each tendon

excision of lesion of tendon sheath or joint capsule (eg, cyst, mucous cyst, or ganglion), hand or finger

excision of tendon, palm, flexor or extensor, single, each tendon

excision or curettage of bone cyst or benign tumor of metacarpal

excision or curettage of bone cyst or benign tumor of metacarpal; with autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor of proximal, middle, or distal phalanx of finger

excision or curettage of bone cyst or benign tumor of proximal, middle, or distal phalanx of finger; with autograft (includes obtaining graft)

partial excision (craterization, saucerization, or diaphysectomy) bone (eg, osteomyelitis); metacarpal

partial excision (craterization, saucerization, or diaphysectomy) bone (eg, osteomyelitis); proximal or middle phalanx of finger

partial excision (craterization, saucerization, or diaphysectomy) bone (eg, osteomyelitis); distal phalanx of finger

radical resection of tumor, proximal or middle phalanx of finger

manipulation, palmar fascial cord (ie, dupuytren's cord), post enzyme injection (eg, collagenase), single cord

repair or advancement, flexor tendon, not in zone 2 digital flexor tendon sheath (eg, no man's land); primary or secondary without free graft, each tendon

repair or advancement, flexor tendon, not in zone 2 digital flexor tendon sheath (eg, no man's land); secondary with free graft (includes obtaining graft), each tendon

repair or advancement, flexor tendon, in zone 2 digital flexor tendon sheath (eg, no man's land); primary, without free graft, each tendon

repair or advancement, flexor tendon, in zone 2 digital flexor tendon sheath (eg, no man's land); secondary, without free graft, each tendon

repair or advancement, flexor tendon, in zone 2 digital flexor tendon sheath (eg, no man's land); secondary, with free graft (includes obtaining graft), each tendon

repair or advancement of profundus tendon, with intact superficialis tendon; primary, each tendon

repair or advancement of profundus tendon, with intact superficialis tendon; secondary with free graft (includes obtaining graft), each tendon

repair or advancement of profundus tendon, with intact superficialis tendon; secondary without free graft, each tendon

excision flexor tendon, with implantation of synthetic rod for delayed tendon graft, hand or finger, each rod

removal of synthetic rod and insertion of flexor tendon graft, hand or finger (includes obtaining graft), each rod

repair, extensor tendon, hand, primary or secondary; without free graft, each tendon

repair, extensor tendon, hand, primary or secondary; with free graft (includes obtaining graft), each tendon

excision of extensor tendon, with implantation of synthetic rod for delayed tendon graft, hand or finger, each rod

removal of synthetic rod and insertion of extensor tendon graft (includes obtaining graft), hand or finger, each rod

repair, extensor tendon, finger, primary or secondary; without free graft, each tendon

repair, extensor tendon, finger, primary or secondary; with free graft (includes obtaining graft) each tendon

repair of extensor tendon, central slip, secondary (eg, boutonniere deformity); using local tissue(s), including lateral band(s), each finger

repair of extensor tendon, central slip, secondary (eg, boutonniere deformity); with free graft (includes obtaining graft), each finger

closed treatment of distal extensor tendon insertion, with or without percutaneous pinning (eg, mallet finger)

repair of extensor tendon, distal insertion, primary or secondary; without graft (eg, mallet finger)

repair of extensor tendon, distal insertion, primary or secondary; with free graft (includes obtaining graft)

tenolysis, complex, extensor tendon, finger, including forearm, each tendon

transfer or transplant of tendon, carpometacarpal area or dorsum of hand; without free graft, each tendon

transfer or transplant of tendon, carpometacarpal area or dorsum of hand; with free tendon graft (includes obtaining graft), each tendon

transfer or transplant of tendon, palmar; without free tendon graft, each tendon

transfer or transplant of tendon, palmar; with free tendon graft (includes obtaining graft), each tendon

opponensplasty; tendon transfer with graft (includes obtaining graft), each tendon

transfer of tendon to restore intrinsic function; ring and small finger

reconstruction of tendon pulley, each tendon; with local tissues (separate procedure)

reconstruction of tendon pulley, each tendon; with tendon or fascial graft (includes obtaining graft) (separate procedure)

capsulectomy or capsulotomy; metacarpophalangeal joint, each joint

arthroplasty, metacarpophalangeal joint; with prosthetic implant, each joint

arthroplasty, interphalangeal joint; with prosthetic implant, each joint

repair of collateral ligament, metacarpophalangeal or interphalangeal joint

reconstruction, collateral ligament, metacarpophalangeal joint, single; with tendon or fascial graft (includes obtaining graft)

reconstruction, collateral ligament, metacarpophalangeal joint, single; with local tissue (eg, adductor advancement)

reconstruction, collateral ligament, interphalangeal joint, single, including graft, each joint

repair non-union, metacarpal or phalanx (includes obtaining bone graft with or without external or internal fixation)

repair and reconstruction, finger, volar plate, interphalangeal joint

transfer, toe-to-hand with microvascular anastomosis; great toe wrap-around with bone graft

transfer, toe-to-hand with microvascular anastomosis; other than great toe, single

transfer, toe-to-hand with microvascular anastomosis; other than great toe, double

transfer, finger to another position without microvascular anastomosis

repair of syndactyly (web finger) each web space; with skin flaps

repair of syndactyly (web finger) each web space; with skin flaps and grafts

repair of syndactyly (web finger) each web space; complex (eg, involving bone, nails)

excision of constricting ring of finger, with multiple z-plasties

closed treatment of metacarpal fracture, single; without manipulation, each bone

closed treatment of metacarpal fracture, single; with manipulation, each bone

closed treatment of metacarpal fracture, with manipulation, with external fixation, each bone

percutaneous skeletal fixation of metacarpal fracture, each bone

open treatment of metacarpal fracture, single, includes internal fixation, when performed, each bone

closed treatment of carpometacarpal dislocation, thumb, with manipulation

closed treatment of carpometacarpal fracture dislocation, thumb (bennett fracture), with manipulation

percutaneous skeletal fixation of carpometacarpal fracture dislocation, thumb (bennett fracture), with manipulation

open treatment of carpometacarpal fracture dislocation, thumb (bennett fracture), includes internal fixation, when performed

closed treatment of carpometacarpal dislocation, other than thumb, with manipulation, each joint; without anesthesia

closed treatment of carpometacarpal dislocation, other than thumb, with manipulation, each joint; requiring anesthesia

percutaneous skeletal fixation of carpometacarpal dislocation, other than thumb, with manipulation, each joint

open treatment of carpometacarpal dislocation, other than thumb; includes internal fixation, when performed, each joint

open treatment of carpometacarpal dislocation, other than thumb; complex, multiple, or delayed reduction

closed treatment of metacarpophalangeal dislocation, single, with manipulation; without anesthesia

closed treatment of metacarpophalangeal dislocation, single, with manipulation; requiring anesthesia

percutaneous skeletal fixation of metacarpophalangeal dislocation, single, with manipulation

open treatment of metacarpophalangeal dislocation, single, includes internal fixation, when performed

closed treatment of phalangeal shaft fracture, proximal or middle phalanx, finger or thumb; without manipulation, each

closed treatment of phalangeal shaft fracture, proximal or middle phalanx, finger or thumb; with manipulation, with or without skin or skeletal traction, each

percutaneous skeletal fixation of unstable phalangeal shaft fracture, proximal or middle phalanx, finger or thumb, with manipulation, each

open treatment of phalangeal shaft fracture, proximal or middle phalanx, finger or thumb, includes internal fixation, when performed, each

closed treatment of articular fracture, involving metacarpophalangeal or interphalangeal joint; without manipulation, each

closed treatment of articular fracture, involving metacarpophalangeal or interphalangeal joint; with manipulation, each

open treatment of articular fracture, involving metacarpophalangeal or interphalangeal joint, includes internal fixation, when performed, each

closed treatment of distal phalangeal fracture, finger or thumb; without manipulation, each

closed treatment of distal phalangeal fracture, finger or thumb; with manipulation, each

percutaneous skeletal fixation of distal phalangeal fracture, finger or thumb, each

open treatment of distal phalangeal fracture, finger or thumb, includes internal fixation, when performed, each

closed treatment of interphalangeal joint dislocation, single, with manipulation; without anesthesia

closed treatment of interphalangeal joint dislocation, single, with manipulation; requiring anesthesia

percutaneous skeletal fixation of interphalangeal joint dislocation, single, with manipulation

open treatment of interphalangeal joint dislocation, includes internal fixation, when performed, single

fusion in opposition, thumb, with autogenous graft (includes obtaining graft)

arthrodesis, carpometacarpal joint, thumb, with or without internal fixation

arthrodesis, carpometacarpal joint, thumb, with or without internal fixation; with autograft (includes obtaining graft)

arthrodesis, carpometacarpal joint, digit, other than thumb, each

arthrodesis, carpometacarpal joint, digit, other than thumb, each; with autograft (includes obtaining graft)

arthrodesis, metacarpophalangeal joint, with or without internal fixation

arthrodesis, metacarpophalangeal joint, with or without internal fixation; with autograft (includes obtaining graft)

arthrodesis, interphalangeal joint, with or without internal fixation

arthrodesis, interphalangeal joint, with or without internal fixation; each additional interphalangeal joint (list separately in addition to code for primary procedure)

arthrodesis, interphalangeal joint, with or without internal fixation; with autograft (includes obtaining graft)

arthrodesis, interphalangeal joint, with or without internal fixation; with autograft (includes obtaining graft), each additional joint (list separately in addition to code for primary procedure)

amputation, metacarpal, with finger or thumb (ray amputation), single, with or without interosseous transfer

amputation, finger or thumb, primary or secondary, any joint or phalanx, single, including neurectomies; with direct closure

amputation, finger or thumb, primary or secondary, any joint or phalanx, single, including neurectomies; with local advancement flaps (v-y, hood)

incision and drainage, pelvis or hip joint area; deep abscess or hematoma

incision, bone cortex, pelvis and/or hip joint (eg, osteomyelitis or bone abscess)

tenotomy, adductor, subcutaneous, open, with obturator neurectomy

tenotomy, abductors and/or extensor(s) of hip, open (separate procedure)

decompression fasciotomy(ies), pelvic (buttock) compartment(s) (eg, gluteus medius-minimus, gluteus maximus, iliopsoas, and/or tensor fascia lata muscle), unilateral

arthrotomy, hip, including exploration or removal of loose or foreign body

denervation, hip joint, intrapelvic or extrapelvic intra-articular branches of sciatic, femoral, or obturator nerves

capsulectomy or capsulotomy, hip, with or without excision of heterotopic bone, with release of hip flexor muscles (ie, gluteus medius, gluteus minimus, tensor fascia latae, rectus femoris, sartorius, iliopsoas)

biopsy, soft tissue of pelvis and hip area; deep, subfascial or intramuscular

excision, tumor, soft tissue of pelvis and hip area, subcutaneous; 3 cm or greater

excision, tumor, soft tissue of pelvis and hip area, subfascial (eg, intramuscular); 5 cm or greater

excision, tumor, soft tissue of pelvis and hip area, subcutaneous; less than 3 cm

excision, tumor, soft tissue of pelvis and hip area, subfascial (eg, intramuscular); less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of pelvis and hip area; less than 5 cm

decompression fasciotomy(ies), pelvic (buttock) compartment(s) (eg, gluteus medius-minimus, gluteus maximus, iliopsoas, and/or tensor fascia lata muscle) with debridement of nonviable muscle, unilateral

radical resection of tumor (eg, sarcoma), soft tissue of pelvis and hip area; 5 cm or greater

excision of bone cyst or benign tumor, wing of ilium, symphysis pubis, or greater trochanter of femur; superficial, includes autograft, when performed

excision of bone cyst or benign tumor, wing of ilium, symphysis pubis, or greater trochanter of femur; deep (subfascial), includes autograft, when performed

excision of bone cyst or benign tumor, wing of ilium, symphysis pubis, or greater trochanter of femur; with autograft requiring separate incision

partial excision, wing of ilium, symphysis pubis, or greater trochanter of femur, (craterization, saucerization) (eg, osteomyelitis or bone abscess); superficial

partial excision, wing of ilium, symphysis pubis, or greater trochanter of femur, (craterization, saucerization) (eg, osteomyelitis or bone abscess); deep (subfascial or intramuscular)

radical resection of tumor; wing of ilium, 1 pubic or ischial ramus or symphysis pubis

radical resection of tumor; ilium, including acetabulum, both pubic rami, or ischium and acetabulum

radical resection of tumor; ischial tuberosity and greater trochanter of femur

removal of foreign body, pelvis or hip; deep (subfascial or intramuscular)

removal of hip prosthesis; complicated, including total hip prosthesis, methylmethacrylate with or without insertion of spacer

injection procedure for sacroiliac joint, anesthetic/steroid, with image guidance (fluoroscopy or ct) including arthrography when performed

transfer external oblique muscle to greater trochanter including fascial or tendon extension (graft)

transfer paraspinal muscle to hip (includes fascial or tendon extension graft)

acetabuloplasty; resection, femoral head (eg, girdlestone procedure)

hemiarthroplasty, hip, partial (eg, femoral stem prosthesis, bipolar arthroplasty)

arthroplasty, acetabular and proximal femoral prosthetic replacement (total hip arthroplasty), with or without autograft or allograft

conversion of previous hip surgery to total hip arthroplasty, with or without autograft or allograft

revision of total hip arthroplasty; both components, with or without autograft or allograft

revision of total hip arthroplasty; acetabular component only, with or without autograft or allograft

revision of total hip arthroplasty; femoral component only, with or without allograft

osteotomy and transfer of greater trochanter of femur (separate procedure)

osteotomy, iliac, acetabular or innominate bone; with open reduction of hip

osteotomy, iliac, acetabular or innominate bone; with femoral osteotomy

osteotomy, iliac, acetabular or innominate bone; with femoral osteotomy and with open reduction of hip

osteotomy, intertrochanteric or subtrochanteric including internal or external fixation and/or cast

bone graft, femoral head, neck, intertrochanteric or subtrochanteric area (includes obtaining bone graft)

treatment of slipped femoral epiphysis; by traction, without reduction

treatment of slipped femoral epiphysis; by single or multiple pinning, in situ

open treatment of slipped femoral epiphysis; single or multiple pinning or bone graft (includes obtaining graft)

open treatment of slipped femoral epiphysis; closed manipulation with single or multiple pinning

open treatment of slipped femoral epiphysis; osteoplasty of femoral neck (heyman type procedure)

open treatment of slipped femoral epiphysis; osteotomy and internal fixation

epiphyseal arrest by epiphysiodesis or stapling, greater trochanter of femur

prophylactic treatment (nailing, pinning, plating or wiring) with or without methylmethacrylate, femoral neck and proximal femur

closed treatment of posterior pelvic ring fracture(s), dislocation(s), diastasis or subluxation of the ilium, sacroiliac joint, and/or sacrum, with or without anterior pelvic ring fracture(s) and/or dislocation(s) of the pubic symphysis and/or superior/inferior rami, unilateral or bilateral; without manipulation

closed treatment of posterior pelvic ring fracture(s), dislocation(s), diastasis or subluxation of the ilium, sacroiliac joint, and/or sacrum, with or without anterior pelvic ring fracture(s) and/or dislocation(s) of the pubic symphysis and/or superior/inferior rami, unilateral or bilateral; with manipulation, requiring more than local anesthesia (ie, general anesthesia, moderate sedation, spinal/epidural)

open treatment of iliac spine(s), tuberosity avulsion, or iliac wing fracture(s), unilateral, for pelvic bone fracture patterns that do not disrupt the pelvic ring, includes internal fixation, when performed

percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns that disrupt the pelvic ring, unilateral (includes ipsilateral ilium, sacroiliac joint and/or sacrum)

open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns that disrupt the pelvic ring, unilateral, includes internal fixation, when performed (includes pubic symphysis and/or ipsilateral superior/inferior rami)

open treatment of posterior pelvic bone fracture and/or dislocation, for fracture patterns that disrupt the pelvic ring, unilateral, includes internal fixation, when performed (includes ipsilateral ilium, sacroiliac joint and/or sacrum)

closed treatment of acetabulum (hip socket) fracture(s); without manipulation

closed treatment of acetabulum (hip socket) fracture(s); with manipulation, with or without skeletal traction

open treatment of posterior or anterior acetabular wall fracture, with internal fixation

open treatment of acetabular fracture(s) involving anterior or posterior (one) column, or a fracture running transversely across the acetabulum, with internal fixation

open treatment of acetabular fracture(s) involving anterior and posterior (two) columns, includes t-fracture and both column fracture with complete articular detachment, or single column or transverse fracture with associated acetabular wall fracture, with internal fixation

closed treatment of femoral fracture, proximal end, neck; without manipulation

closed treatment of femoral fracture, proximal end, neck; with manipulation, with or without skeletal traction

percutaneous skeletal fixation of femoral fracture, proximal end, neck

open treatment of femoral fracture, proximal end, neck, internal fixation or prosthetic replacement

closed treatment of intertrochanteric, peritrochanteric, or subtrochanteric femoral fracture; without manipulation

closed treatment of intertrochanteric, peritrochanteric, or subtrochanteric femoral fracture; with manipulation, with or without skin or skeletal traction

treatment of intertrochanteric, peritrochanteric, or subtrochanteric femoral fracture; with plate/screw type implant, with or without cerclage

treatment of intertrochanteric, peritrochanteric, or subtrochanteric femoral fracture; with intramedullary implant, with or without interlocking screws and/or cerclage

closed treatment of greater trochanteric fracture, without manipulation

open treatment of greater trochanteric fracture, includes internal fixation, when performed

closed treatment of hip dislocation, traumatic; without anesthesia

closed treatment of hip dislocation, traumatic; requiring anesthesia

open treatment of hip dislocation, traumatic, without internal fixation

open treatment of hip dislocation, traumatic, with acetabular wall and femoral head fracture, with or without internal or external fixation

treatment of spontaneous hip dislocation (developmental, including congenital or pathological), by abduction, splint or traction; without anesthesia, without manipulation

treatment of spontaneous hip dislocation (developmental, including congenital or pathological), by abduction, splint or traction; with manipulation, requiring anesthesia

open treatment of spontaneous hip dislocation (developmental, including congenital or pathological), replacement of femoral head in acetabulum (including tenotomy, etc)

open treatment of spontaneous hip dislocation (developmental, including congenital or pathological), replacement of femoral head in acetabulum (including tenotomy, etc); with femoral shaft shortening

closed treatment of post hip arthroplasty dislocation; without anesthesia

closed treatment of post hip arthroplasty dislocation; requiring regional or general anesthesia

closed treatment of femoral fracture, proximal end, head; without manipulation

closed treatment of femoral fracture, proximal end, head; with manipulation

open treatment of femoral fracture, proximal end, head, includes internal fixation, when performed

arthrodesis, sacroiliac joint, percutaneous or minimally invasive (indirect visualization), with image guidance, includes obtaining bone graft when performed, and placement of transfixing device

arthrodesis, open, sacroiliac joint, including obtaining bone graft, including instrumentation, when performed

arthrodesis, hip joint (including obtaining graft); with subtrochanteric osteotomy

incision and drainage, deep abscess, bursa, or hematoma, thigh or knee region

incision, deep, with opening of bone cortex, femur or knee (eg, osteomyelitis or bone abscess)

tenotomy, percutaneous, adductor or hamstring; single tendon (separate procedure)

arthrotomy, knee, with exploration, drainage, or removal of foreign body (eg, infection)

biopsy, soft tissue of thigh or knee area; deep (subfascial or intramuscular)

excision, tumor, soft tissue of thigh or knee area, subcutaneous; less than 3 cm

excision, tumor, soft tissue of thigh or knee area, subfascial (eg, intramuscular); less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of thigh or knee area; less than 5 cm

arthrotomy, knee; including joint exploration, biopsy, or removal of loose or foreign bodies

arthrotomy, with excision of semilunar cartilage (meniscectomy) knee; medial or lateral

arthrotomy, with excision of semilunar cartilage (meniscectomy) knee; medial and lateral

arthrotomy, with synovectomy, knee; anterior and posterior including popliteal area

excision, tumor, soft tissue of thigh or knee area, subcutaneous; 3 cm or greater

excision, tumor, soft tissue of thigh or knee area, subfascial (eg, intramuscular); 5 cm or greater

excision of lesion of meniscus or capsule (eg, cyst, ganglion), knee

excision or curettage of bone cyst or benign tumor of femur; with allograft

excision or curettage of bone cyst or benign tumor of femur; with autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor of femur; with internal fixation (list in addition to code for primary procedure)

partial excision (craterization, saucerization, or diaphysectomy) bone, femur, proximal tibia and/or fibula (eg, osteomyelitis or bone abscess)

radical resection of tumor (eg, sarcoma), soft tissue of thigh or knee area; 5 cm or greater

suture of infrapatellar tendon; secondary reconstruction, including fascial or tendon graft

suture of quadriceps or hamstring muscle rupture; secondary reconstruction, including fascial or tendon graft

tenotomy, open, hamstring, knee to hip; multiple tendons, bilateral

transplant or transfer (with muscle redirection or rerouting), thigh (eg, extensor to flexor); single tendon

transplant or transfer (with muscle redirection or rerouting), thigh (eg, extensor to flexor); multiple tendons

transfer, tendon or muscle, hamstrings to femur (eg, egger's type procedure)

repair, primary, torn ligament and/or capsule, knee; collateral and cruciate ligaments

osteochondral autograft(s), knee, open (eg, mosaicplasty) (includes harvesting of autograft[s])

reconstruction of dislocating patella; (eg, hauser type procedure)

reconstruction of dislocating patella; with extensor realignment and/or muscle advancement or release (eg, campbell, goldwaite type procedure)

ligamentous reconstruction (augmentation), knee; extra-articular

ligamentous reconstruction (augmentation), knee; intra-articular (open)

ligamentous reconstruction (augmentation), knee; intra-articular (open) and extra-articular

arthroplasty, knee, tibial plateau; with debridement and partial synovectomy

arthroplasty, femoral condyles or tibial plateau(s), knee; with debridement and partial synovectomy

arthroplasty, knee, condyle and plateau; medial or lateral compartment

arthroplasty, knee, condyle and plateau; medial and lateral compartments with or without patella resurfacing (total knee arthroplasty)

osteotomy, multiple, with realignment on intramedullary rod, femoral shaft (eg, sofield type procedure)

osteotomy, proximal tibia, including fibular excision or osteotomy (includes correction of genu varus [bowleg] or genu valgus [knock-knee]); before epiphyseal closure

osteotomy, proximal tibia, including fibular excision or osteotomy (includes correction of genu varus [bowleg] or genu valgus [knock-knee]); after epiphyseal closure

osteoplasty, femur; combined, lengthening and shortening with femoral segment transfer

repair, nonunion or malunion, femur, distal to head and neck; without graft (eg, compression technique)

repair, nonunion or malunion, femur, distal to head and neck; with iliac or other autogenous bone graft (includes obtaining graft)

arrest, epiphyseal, any method (eg, epiphysiodesis); distal femur

arrest, epiphyseal, any method (eg, epiphysiodesis); tibia and fibula, proximal

arrest, epiphyseal, any method (eg, epiphysiodesis); combined distal femur, proximal tibia and fibula

arrest, hemiepiphyseal, distal femur or proximal tibia or fibula (eg, genu varus or valgus)

revision of total knee arthroplasty, with or without allograft; 1 component

revision of total knee arthroplasty, with or without allograft; femoral and entire tibial component

removal of prosthesis, including total knee prosthesis, methylmethacrylate with or without insertion of spacer, knee

prophylactic treatment (nailing, pinning, plating, or wiring) with or without methylmethacrylate, femur

decompression fasciotomy, thigh and/or knee, 1 compartment (flexor or extensor or adductor)

decompression fasciotomy, thigh and/or knee, 1 compartment (flexor or extensor or adductor); with debridement of nonviable muscle and/or nerve

decompression fasciotomy, thigh and/or knee, multiple compartments

decompression fasciotomy, thigh and/or knee, multiple compartments; with debridement of nonviable muscle and/or nerve

closed treatment of femoral shaft fracture, without manipulation

closed treatment of supracondylar or transcondylar femoral fracture with or without intercondylar extension, without manipulation

closed treatment of femoral shaft fracture, with manipulation, with or without skin or skeletal traction

closed treatment of supracondylar or transcondylar femoral fracture with or without intercondylar extension, with manipulation, with or without skin or skeletal traction

open treatment of femoral shaft fracture, with or without external fixation, with insertion of intramedullary implant, with or without cerclage and/or locking screws

open treatment of femoral shaft fracture with plate/screws, with or without cerclage

closed treatment of femoral fracture, distal end, medial or lateral condyle, without manipulation

percutaneous skeletal fixation of femoral fracture, distal end, medial or lateral condyle, or supracondylar or transcondylar, with or without intercondylar extension, or distal femoral epiphyseal separation

closed treatment of femoral fracture, distal end, medial or lateral condyle, with manipulation

open treatment of femoral supracondylar or transcondylar fracture without intercondylar extension, includes internal fixation, when performed

open treatment of femoral supracondylar or transcondylar fracture with intercondylar extension, includes internal fixation, when performed

open treatment of femoral fracture, distal end, medial or lateral condyle, includes internal fixation, when performed

closed treatment of distal femoral epiphyseal separation; without manipulation

closed treatment of distal femoral epiphyseal separation; with manipulation, with or without skin or skeletal traction

open treatment of distal femoral epiphyseal separation, includes internal fixation, when performed

open treatment of patellar fracture, with internal fixation and/or partial or complete patellectomy and soft tissue repair

closed treatment of tibial fracture, proximal (plateau); without manipulation

closed treatment of tibial fracture, proximal (plateau); with or without manipulation, with skeletal traction

open treatment of tibial fracture, proximal (plateau); unicondylar, includes internal fixation, when performed

open treatment of tibial fracture, proximal (plateau); bicondylar, with or without internal fixation

closed treatment of intercondylar spine(s) and/or tuberosity fracture(s) of knee, with or without manipulation

open treatment of intercondylar spine(s) and/or tuberosity fracture(s) of the knee, includes internal fixation, when performed

open treatment of knee dislocation, includes internal fixation, when performed; without primary ligamentous repair or augmentation/reconstruction

open treatment of knee dislocation, includes internal fixation, when performed; with primary ligamentous repair

open treatment of knee dislocation, includes internal fixation, when performed; with primary ligamentous repair, with augmentation/reconstruction

open treatment of patellar dislocation, with or without partial or total patellectomy

manipulation of knee joint under general anesthesia (includes application of traction or other fixation devices)

amputation, thigh, through femur, any level; immediate fitting technique including first cast

amputation, thigh, through femur, any level; open, circular (guillotine)

amputation, thigh, through femur, any level; secondary closure or scar revision

decompression fasciotomy, leg; anterior and/or lateral compartments only

decompression fasciotomy, leg; anterior and/or lateral, and posterior compartment(s)

tenotomy, percutaneous, achilles tendon (separate procedure); local anesthesia

tenotomy, percutaneous, achilles tendon (separate procedure); general anesthesia

arthrotomy, ankle, including exploration, drainage, or removal of foreign body

arthrotomy, posterior capsular release, ankle, with or without achilles tendon lengthening

biopsy, soft tissue of leg or ankle area; deep (subfascial or intramuscular)

radical resection of tumor (eg, sarcoma), soft tissue of leg or ankle area; less than 5 cm

radical resection of tumor (eg, sarcoma), soft tissue of leg or ankle area; 5 cm or greater

excision, tumor, soft tissue of leg or ankle area, subcutaneous; less than 3 cm

excision, tumor, soft tissue of leg or ankle area, subfascial (eg, intramuscular); less than 5 cm

arthrotomy, ankle, with joint exploration, with or without biopsy, with or without removal of loose or foreign body

excision of lesion of tendon sheath or capsule (eg, cyst or ganglion), leg and/or ankle

excision, tumor, soft tissue of leg or ankle area, subcutaneous; 3 cm or greater

excision, tumor, soft tissue of leg or ankle area, subfascial (eg, intramuscular); 5 cm or greater

excision or curettage of bone cyst or benign tumor, tibia or fibula

excision or curettage of bone cyst or benign tumor, tibia or fibula; with autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor, tibia or fibula; with allograft

partial excision (craterization, saucerization, or diaphysectomy), bone (eg, osteomyelitis); tibia

partial excision (craterization, saucerization, or diaphysectomy), bone (eg, osteomyelitis); fibula

repair, primary, open or percutaneous, ruptured achilles tendon; with graft (includes obtaining graft)

repair, flexor tendon, leg; secondary, with or without graft, each tendon

repair, extensor tendon, leg; primary, without graft, each tendon

repair, extensor tendon, leg; secondary, with or without graft, each tendon

tenolysis, flexor or extensor tendon, leg and/or ankle; single, each tendon

tenolysis, flexor or extensor tendon, leg and/or ankle; multiple tendons (through separate incision[s])

lengthening or shortening of tendon, leg or ankle; single tendon (separate procedure)

lengthening or shortening of tendon, leg or ankle; multiple tendons (through same incision), each

transfer or transplant of single tendon (with muscle redirection or rerouting); superficial (eg, anterior tibial extensors into midfoot)

transfer or transplant of single tendon (with muscle redirection or rerouting); deep (eg, anterior tibial or posterior tibial through interosseous space, flexor digitorum longus, flexor hallucis longus, or peroneal tendon to midfoot or hindfoot)

transfer or transplant of single tendon (with muscle redirection or rerouting); each additional tendon (list separately in addition to code for primary procedure)

repair, primary, disrupted ligament, ankle; both collateral ligaments

repair, secondary, disrupted ligament, ankle, collateral (eg, watson-jones procedure)

osteotomy; multiple, with realignment on intramedullary rod (eg, sofield type procedure)

repair of nonunion or malunion, tibia; without graft, (eg, compression technique)

repair of nonunion or malunion, tibia; with iliac or other autograft (includes obtaining graft)

repair of nonunion or malunion, tibia; by synostosis, with fibula, any method

repair of fibula nonunion and/or malunion with internal fixation

arrest, epiphyseal (epiphysiodesis), open; distal tibia and fibula

arrest, epiphyseal (epiphysiodesis), any method, combined, proximal and distal tibia and fibula

arrest, epiphyseal (epiphysiodesis), any method, combined, proximal and distal tibia and fibula; and distal femur

prophylactic treatment (nailing, pinning, plating or wiring) with or without methylmethacrylate, tibia

closed treatment of tibial shaft fracture (with or without fibular fracture); without manipulation

closed treatment of tibial shaft fracture (with or without fibular fracture); with manipulation, with or without skeletal traction

percutaneous skeletal fixation of tibial shaft fracture (with or without fibular fracture) (eg, pins or screws)

open treatment of tibial shaft fracture (with or without fibular fracture), with plate/screws, with or without cerclage

treatment of tibial shaft fracture (with or without fibular fracture) by intramedullary implant, with or without interlocking screws and/or cerclage

closed treatment of medial malleolus fracture; without manipulation

closed treatment of medial malleolus fracture; with manipulation, with or without skin or skeletal traction

open treatment of medial malleolus fracture, includes internal fixation, when performed

closed treatment of posterior malleolus fracture; without manipulation

closed treatment of posterior malleolus fracture; with manipulation

open treatment of posterior malleolus fracture, includes internal fixation, when performed

closed treatment of proximal fibula or shaft fracture; without manipulation

closed treatment of proximal fibula or shaft fracture; with manipulation

open treatment of proximal fibula or shaft fracture, includes internal fixation, when performed

closed treatment of distal fibular fracture (lateral malleolus); without manipulation

closed treatment of distal fibular fracture (lateral malleolus); with manipulation

open treatment of distal fibular fracture (lateral malleolus), includes internal fixation, when performed

closed treatment of bimalleolar ankle fracture (eg, lateral and medial malleoli, or lateral and posterior malleoli or medial and posterior malleoli); without manipulation

closed treatment of bimalleolar ankle fracture (eg, lateral and medial malleoli, or lateral and posterior malleoli or medial and posterior malleoli); with manipulation

open treatment of bimalleolar ankle fracture (eg, lateral and medial malleoli, or lateral and posterior malleoli, or medial and posterior malleoli), includes internal fixation, when performed

closed treatment of trimalleolar ankle fracture; without manipulation

closed treatment of trimalleolar ankle fracture; with manipulation

open treatment of trimalleolar ankle fracture, includes internal fixation, when performed, medial and/or lateral malleolus; without fixation of posterior lip

open treatment of trimalleolar ankle fracture, includes internal fixation, when performed, medial and/or lateral malleolus; with fixation of posterior lip

closed treatment of fracture of weight bearing articular portion of distal tibia (eg, pilon or tibial plafond), with or without anesthesia; without manipulation

closed treatment of fracture of weight bearing articular portion of distal tibia (eg, pilon or tibial plafond), with or without anesthesia; with skeletal traction and/or requiring manipulation

open treatment of fracture of weight bearing articular surface/portion of distal tibia (eg, pilon or tibial plafond), with internal fixation, when performed; of fibula only

open treatment of fracture of weight bearing articular surface/portion of distal tibia (eg, pilon or tibial plafond), with internal fixation, when performed; of tibia only

open treatment of fracture of weight bearing articular surface/portion of distal tibia (eg, pilon or tibial plafond), with internal fixation, when performed; of both tibia and fibula

open treatment of distal tibiofibular joint (syndesmosis) disruption, includes internal fixation, when performed

closed treatment of proximal tibiofibular joint dislocation; without anesthesia

closed treatment of proximal tibiofibular joint dislocation; requiring anesthesia

open treatment of proximal tibiofibular joint dislocation, includes internal fixation, when performed, or with excision of proximal fibula

closed treatment of ankle dislocation; requiring anesthesia, with or without percutaneous skeletal fixation

open treatment of ankle dislocation, with or without percutaneous skeletal fixation; without repair or internal fixation

open treatment of ankle dislocation, with or without percutaneous skeletal fixation; with repair or internal or external fixation

manipulation of ankle under general anesthesia (includes application of traction or other fixation apparatus)

amputation, leg, through tibia and fibula; with immediate fitting technique including application of first cast

amputation, leg, through tibia and fibula; open, circular (guillotine)

amputation, leg, through tibia and fibula; secondary closure or scar revision

amputation, ankle, through malleoli of tibia and fibula (eg, syme, pirogoff type procedures), with plastic closure and resection of nerves

decompression fasciotomy, leg; anterior and/or lateral compartments only, with debridement of nonviable muscle and/or nerve

decompression fasciotomy, leg; posterior compartment(s) only, with debridement of nonviable muscle and/or nerve

decompression fasciotomy, leg; anterior and/or lateral, and posterior compartment(s), with debridement of nonviable muscle and/or nerve

incision and drainage below fascia, with or without tendon sheath involvement, foot; single bursal space

incision and drainage below fascia, with or without tendon sheath involvement, foot; multiple areas

arthrotomy, including exploration, drainage, or removal of loose or foreign body; intertarsal or tarsometatarsal joint

arthrotomy, including exploration, drainage, or removal of loose or foreign body; metatarsophalangeal joint

arthrotomy, including exploration, drainage, or removal of loose or foreign body; interphalangeal joint

excision, tumor, soft tissue of foot or toe, subcutaneous; 1.5 cm or greater

excision, tumor, soft tissue of foot or toe, subfascial (eg, intramuscular); 1.5 cm or greater

excision, tumor, soft tissue of foot or toe, subcutaneous; less than 1.5 cm

excision, tumor, soft tissue of foot or toe, subfascial (eg, intramuscular); less than 1.5 cm

radical resection of tumor (eg, sarcoma), soft tissue of foot or toe; less than 3 cm

radical resection of tumor (eg, sarcoma), soft tissue of foot or toe; 3 cm or greater

excision of lesion, tendon, tendon sheath, or capsule (including synovectomy) (eg, cyst or ganglion); foot

excision of lesion, tendon, tendon sheath, or capsule (including synovectomy) (eg, cyst or ganglion); toe(s), each

excision or curettage of bone cyst or benign tumor, talus or calcaneus

excision or curettage of bone cyst or benign tumor, talus or calcaneus; with iliac or other autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor, talus or calcaneus; with allograft

excision or curettage of bone cyst or benign tumor, tarsal or metatarsal, except talus or calcaneus

excision or curettage of bone cyst or benign tumor, tarsal or metatarsal, except talus or calcaneus; with iliac or other autograft (includes obtaining graft)

excision or curettage of bone cyst or benign tumor, tarsal or metatarsal, except talus or calcaneus; with allograft

excision or curettage of bone cyst or benign tumor, phalanges of foot

ostectomy, partial excision, fifth metatarsal head (bunionette) (separate procedure)

ostectomy, complete excision; other metatarsal head (second, third or fourth)

ostectomy, complete excision; all metatarsal heads, with partial proximal phalangectomy, excluding first metatarsal (eg, clayton type procedure)

ostectomy, calcaneus; for spur, with or without plantar fascial release

partial excision (craterization, saucerization, sequestrectomy, or diaphysectomy) bone (eg, osteomyelitis or bossing); talus or calcaneus

partial excision (craterization, saucerization, sequestrectomy, or diaphysectomy) bone (eg, osteomyelitis or bossing); tarsal or metatarsal bone, except talus or calcaneus

partial excision (craterization, saucerization, sequestrectomy, or diaphysectomy) bone (eg, osteomyelitis or bossing); phalanx of toe

hemiphalangectomy or interphalangeal joint excision, toe, proximal end of phalanx, each

repair, tendon, flexor, foot; primary or secondary, without free graft, each tendon

repair, tendon, flexor, foot; secondary with free graft, each tendon (includes obtaining graft)

repair, tendon, extensor, foot; primary or secondary, each tendon

repair, tendon, extensor, foot; secondary with free graft, each tendon (includes obtaining graft)

tenotomy, open, tendon flexor; foot, single or multiple tendon(s) (separate procedure)

tenotomy, open, tendon flexor; toe, single tendon (separate procedure)

reconstruction (advancement), posterior tibial tendon with excision of accessory tarsal navicular bone (eg, kidner type procedure)

division of plantar fascia and muscle (eg, steindler stripping) (separate procedure)

capsulotomy, midfoot; extensive, including posterior talotibial capsulotomy and tendon(s) lengthening (eg, resistant clubfoot deformity)

capsulotomy; metatarsophalangeal joint, with or without tenorrhaphy, each joint (separate procedure)

capsulotomy; interphalangeal joint, each joint (separate procedure)

correction, hammertoe (eg, interphalangeal fusion, partial or total phalangectomy)

correction, cock-up fifth toe, with plastic skin closure (eg, ruiz-mora type procedure)

ostectomy, partial, exostectomy or condylectomy, metatarsal head, each metatarsal head

hallux rigidus correction with cheilectomy, debridement and capsular release of the first metatarsophalangeal joint; without implant

hallux rigidus correction with cheilectomy, debridement and capsular release of the first metatarsophalangeal joint; with implant

correction, hallux valgus (bunionectomy), with sesamoidectomy, when performed; with resection of proximal phalanx base, when performed, any method

correction, hallux valgus (bunionectomy), with sesamoidectomy, when performed; with proximal metatarsal osteotomy, any method

correction, hallux valgus (bunionectomy), with sesamoidectomy, when performed; with distal metatarsal osteotomy, any method

correction, hallux valgus (bunionectomy), with sesamoidectomy, when performed; with first metatarsal and medial cuneiform joint arthrodesis, any method

correction, hallux valgus (bunionectomy), with sesamoidectomy, when performed; with proximal phalanx osteotomy, any method

correction, hallux valgus (bunionectomy), with sesamoidectomy, when performed; with double osteotomy, any method

osteotomy; calcaneus (eg, dwyer or chambers type procedure), with or without internal fixation

osteotomy, tarsal bones, other than calcaneus or talus; with autograft (includes obtaining graft) (eg, fowler type)

osteotomy, with or without lengthening, shortening or angular correction, metatarsal; first metatarsal

osteotomy, with or without lengthening, shortening or angular correction, metatarsal; first metatarsal with autograft (other than first toe)

osteotomy, with or without lengthening, shortening or angular correction, metatarsal; other than first metatarsal, each

osteotomy, with or without lengthening, shortening or angular correction, metatarsal; multiple (eg, swanson type cavus foot procedure)

osteotomy, shortening, angular or rotational correction; proximal phalanx, first toe (separate procedure)

osteotomy, shortening, angular or rotational correction; other phalanges, any toe

reconstruction, angular deformity of toe, soft tissue procedures only (eg, overlapping second toe, fifth toe, curly toes)

repair, nonunion or malunion; metatarsal, with or without bone graft (includes obtaining graft)

reconstruction, toe(s); syndactyly, with or without skin graft(s), each web

percutaneous skeletal fixation of calcaneal fracture, with manipulation

open treatment of calcaneal fracture, includes internal fixation, when performed

open treatment of calcaneal fracture, includes internal fixation, when performed; with primary iliac or other autogenous bone graft (includes obtaining graft)

percutaneous skeletal fixation of talus fracture, with manipulation

open treatment of talus fracture, includes internal fixation, when performed

open osteochondral autograft, talus (includes obtaining graft[s])

treatment of tarsal bone fracture (except talus and calcaneus); without manipulation, each

treatment of tarsal bone fracture (except talus and calcaneus); with manipulation, each

percutaneous skeletal fixation of tarsal bone fracture (except talus and calcaneus), with manipulation, each

open treatment of tarsal bone fracture (except talus and calcaneus), includes internal fixation, when performed, each

closed treatment of metatarsal fracture; without manipulation, each

closed treatment of metatarsal fracture; with manipulation, each

percutaneous skeletal fixation of metatarsal fracture, with manipulation, each

open treatment of metatarsal fracture, includes internal fixation, when performed, each

closed treatment of fracture great toe, phalanx or phalanges; without manipulation

closed treatment of fracture great toe, phalanx or phalanges; with manipulation

percutaneous skeletal fixation of fracture great toe, phalanx or phalanges, with manipulation

open treatment of fracture, great toe, phalanx or phalanges, includes internal fixation, when performed

closed treatment of fracture, phalanx or phalanges, other than great toe; without manipulation, each

closed treatment of fracture, phalanx or phalanges, other than great toe; with manipulation, each

open treatment of fracture, phalanx or phalanges, other than great toe, includes internal fixation, when performed, each

open treatment of sesamoid fracture, with or without internal fixation

closed treatment of tarsal bone dislocation, other than talotarsal; without anesthesia

closed treatment of tarsal bone dislocation, other than talotarsal; requiring anesthesia

percutaneous skeletal fixation of tarsal bone dislocation, other than talotarsal, with manipulation

open treatment of tarsal bone dislocation, includes internal fixation, when performed

closed treatment of talotarsal joint dislocation; without anesthesia

closed treatment of talotarsal joint dislocation; requiring anesthesia

percutaneous skeletal fixation of talotarsal joint dislocation, with manipulation

open treatment of talotarsal joint dislocation, includes internal fixation, when performed

closed treatment of tarsometatarsal joint dislocation; without anesthesia

closed treatment of tarsometatarsal joint dislocation; requiring anesthesia

percutaneous skeletal fixation of tarsometatarsal joint dislocation, with manipulation

open treatment of tarsometatarsal joint dislocation, includes internal fixation, when performed

closed treatment of metatarsophalangeal joint dislocation; without anesthesia

closed treatment of metatarsophalangeal joint dislocation; requiring anesthesia

percutaneous skeletal fixation of metatarsophalangeal joint dislocation, with manipulation

open treatment of metatarsophalangeal joint dislocation, includes internal fixation, when performed

closed treatment of interphalangeal joint dislocation; without anesthesia

closed treatment of interphalangeal joint dislocation; requiring anesthesia

percutaneous skeletal fixation of interphalangeal joint dislocation, with manipulation

open treatment of interphalangeal joint dislocation, includes internal fixation, when performed

arthrodesis, midtarsal or tarsometatarsal, multiple or transverse

arthrodesis, midtarsal or tarsometatarsal, multiple or transverse; with osteotomy (eg, flatfoot correction)

arthrodesis, with tendon lengthening and advancement, midtarsal, tarsal navicular-cuneiform (eg, miller type procedure)

arthrodesis, with extensor hallucis longus transfer to first metatarsal neck, great toe, interphalangeal joint (eg, jones type procedure)

extracorporeal shock wave, high energy, performed by a physician or other qualified health care professional, requiring anesthesia other than local, including ultrasound guidance, involving the plantar fascia

application of halo type body cast (see 20661-20663 for insertion)

application of body cast, shoulder to hips; including head, minerva type

application of body cast, shoulder to hips; including both thighs

application of hip spica cast; 1 and one-half spica or both legs

application of long leg cast (thigh to toes); walker or ambulatory type

application of short leg cast (below knee to toes); walking or ambulatory type

application of clubfoot cast with molding or manipulation, long or short leg

application of multi-layer compression system; leg (below knee), including ankle and foot

application of multi-layer compression system; upper arm, forearm, hand, and fingers

removal or bivalving; shoulder or hip spica, minerva, or risser jacket, etc.

arthroscopy, temporomandibular joint, diagnostic, with or without synovial biopsy (separate procedure)

arthroscopy, shoulder, diagnostic, with or without synovial biopsy (separate procedure)

arthroscopy, shoulder, surgical; with removal of loose body or foreign body

arthroscopy, shoulder, surgical; distal claviculectomy including distal articular surface (mumford procedure)

arthroscopy, shoulder, surgical; with lysis and resection of adhesions, with or without manipulation

arthroscopy, shoulder, surgical; decompression of subacromial space with partial acromioplasty, with coracoacromial ligament (ie, arch) release, when performed (list separately in addition to code for primary procedure)

arthroscopy, elbow, diagnostic, with or without synovial biopsy (separate procedure)

arthroscopy, elbow, surgical; with removal of loose body or foreign body

arthroscopy, wrist, diagnostic, with or without synovial biopsy (separate procedure)

arthroscopy, wrist, surgical; for infection, lavage and drainage

arthroscopy, wrist, surgical; excision and/or repair of triangular fibrocartilage and/or joint debridement

arthroscopy, wrist, surgical; internal fixation for fracture or instability

endoscopy, wrist, surgical, with release of transverse carpal ligament

arthroscopically aided treatment of intercondylar spine(s) and/or tuberosity fracture(s) of the knee, with or without manipulation; without internal or external fixation (includes arthroscopy)

arthroscopically aided treatment of intercondylar spine(s) and/or tuberosity fracture(s) of the knee, with or without manipulation; with internal or external fixation (includes arthroscopy)

arthroscopically aided treatment of tibial fracture, proximal (plateau); unicondylar, includes internal fixation, when performed (includes arthroscopy)

arthroscopically aided treatment of tibial fracture, proximal (plateau); bicondylar, includes internal fixation, when performed (includes arthroscopy)

arthroscopy, hip, diagnostic with or without synovial biopsy (separate procedure)

arthroscopy, hip, surgical; with removal of loose body or foreign body

arthroscopy, hip, surgical; with debridement/shaving of articular cartilage (chondroplasty), abrasion arthroplasty, and/or resection of labrum

arthroscopy, knee, surgical; osteochondral autograft(s) (eg, mosaicplasty) (includes harvesting of the autograft[s])

arthroscopy, knee, surgical; osteochondral allograft (eg, mosaicplasty)

arthroscopy, knee, surgical; meniscal transplantation (includes arthrotomy for meniscal insertion), medial or lateral

arthroscopy, knee, diagnostic, with or without synovial biopsy (separate procedure)

arthroscopy, knee, surgical; for removal of loose body or foreign body (eg, osteochondritis dissecans fragmentation, chondral fragmentation)

arthroscopy, knee, surgical; synovectomy, limited (eg, plica or shelf resection) (separate procedure)

arthroscopy, knee, surgical; synovectomy, major, 2 or more compartments (eg, medial or lateral)

arthroscopy, knee, surgical; debridement/shaving of articular cartilage (chondroplasty)

arthroscopy, knee, surgical; abrasion arthroplasty (includes chondroplasty where necessary) or multiple drilling or microfracture

arthroscopy, knee, surgical; with meniscectomy (medial and lateral, including any meniscal shaving) including debridement/shaving of articular cartilage (chondroplasty), same or separate compartment(s), when performed

arthroscopy, knee, surgical; with meniscectomy (medial or lateral, including any meniscal shaving) including debridement/shaving of articular cartilage (chondroplasty), same or separate compartment(s), when performed

arthroscopy, knee, surgical; with meniscus repair (medial or lateral)

arthroscopy, knee, surgical; with meniscus repair (medial and lateral)

arthroscopy, knee, surgical; with lysis of adhesions, with or without manipulation (separate procedure)

arthroscopy, knee, surgical; drilling for osteochondritis dissecans with bone grafting, with or without internal fixation (including debridement of base of lesion)

arthroscopy, knee, surgical; drilling for intact osteochondritis dissecans lesion

arthroscopy, knee, surgical; drilling for intact osteochondritis dissecans lesion with internal fixation

arthroscopically aided anterior cruciate ligament repair/augmentation or reconstruction

arthroscopically aided posterior cruciate ligament repair/augmentation or reconstruction

arthroscopy, ankle, surgical, excision of osteochondral defect of talus and/or tibia, including drilling of the defect

arthroscopically aided repair of large osteochondritis dissecans lesion, talar dome fracture, or tibial plafond fracture, with or without internal fixation (includes arthroscopy)

arthroscopy, ankle (tibiotalar and fibulotalar joints), surgical; with removal of loose body or foreign body

arthroscopy, ankle (tibiotalar and fibulotalar joints), surgical; synovectomy, partial

arthroscopy, ankle (tibiotalar and fibulotalar joints), surgical; debridement, limited

arthroscopy, ankle (tibiotalar and fibulotalar joints), surgical; debridement, extensive

arthroscopy, ankle (tibiotalar and fibulotalar joints), surgical; with ankle arthrodesis

arthroscopy, metacarpophalangeal joint, diagnostic, includes synovial biopsy

arthroscopy, metacarpophalangeal joint, surgical; with debridement

arthroscopy, metacarpophalangeal joint, surgical; with reduction of displaced ulnar collateral ligament (eg, stener lesion)

arthroscopy, subtalar joint, surgical; with removal of loose body or foreign body

arthroscopy, subtalar joint, surgical; with subtalar arthrodesis

arthroscopy, hip, surgical; with femoroplasty (ie, treatment of cam lesion)

arthroscopy, hip, surgical; with acetabuloplasty (ie, treatment of pincer lesion)

excision or destruction (eg, laser), intranasal lesion; internal approach

excision or destruction (eg, laser), intranasal lesion; external approach (lateral rhinotomy)

lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) (cad)

submucous resection inferior turbinate, partial or complete, any method

patient screened for unhealthy alcohol use using a systematic screening method (pv) (dsp)

colorectal cancer screening results documented and reviewed (pv)

pre-procedure risk assessment and depth of insertion and quality of the bowel prep and complete description of polyp(s) found, including location of each polyp, size, number and gross morphology and recommendations for follow-up in final colonoscopy report documented (end/polyp)

left ventricular ejection fraction (lvef) assessment planned post discharge (hf)

left ventricular function (lvf) assessment (eg, echocardiography, nuclear test, or ventriculography) documented in the medical record (includes quantitative or qualitative assessment results) (nma-no measure associated)

left ventricular ejection fraction (lvef) less than 40% or documentation of moderately or severely depressed left ventricular systolic function (cad, hf)

left ventricular ejection fraction (lvef) greater than or equal to 40% or documentation as normal or mildly depressed left ventricular systolic function (cad, hf)

spirometry test results demonstrate fev1/fvc less than 70% with copd symptoms (eg, dyspnea, cough/sputum, wheezing) (cap, copd)

spirometry test results demonstrate fev1/fvc greater than or equal to 70% or patient does not have copd symptoms (copd)

oxygen saturation results documented and reviewed (includes assessment through pulse oximetry or arterial blood gas measurement) (cap, copd) (em)

oxygen saturation less than or equal to 88% or a pao2 less than or equal to 55 mm hg (copd)

oxygen saturation greater than 88% or pao2 greater than 55 mm hg (copd)

pulmonary function test performed within 12 months prior to surgery (lung/esop cx)

rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip

functional expiratory volume (fev1) less than 40% of predicted value (copd)

rhinoplasty, primary; complete, external parts including bony pyramid, lateral and alar cartilages, and/or elevation of nasal tip

functional expiratory volume (fev1) greater than or equal to 40% of predicted value (copd)

rhinoplasty, secondary; minor revision (small amount of nasal tip work)

rhinoplasty, secondary; intermediate revision (bony work with osteotomies)

rhinoplasty, secondary; major revision (nasal tip work and osteotomies)

rhinoplasty for nasal deformity secondary to congenital cleft lip and/or palate, including columellar lengthening; tip only

rhinoplasty for nasal deformity secondary to congenital cleft lip and/or palate, including columellar lengthening; tip, septum, osteotomies

repair of nasal vestibular stenosis (eg, spreader grafting, lateral nasal wall reconstruction)

septoplasty or submucous resection, with or without cartilage scoring, contouring or replacement with graft

left ventricular ejection fraction (lvef) less than or equal to 35% (hf)

left ventricular ejection fraction (lvef) greater than 35% or no lvef result available (hf)

repair fistula; oromaxillary (combine with 31030 if antrotomy is included)

positive microalbuminuria test result documented and reviewed (dm)

negative microalbuminuria test result documented and reviewed (dm)

septal or other intranasal dermatoplasty (does not include obtaining graft)

positive macroalbuminuria test result documented and reviewed (dm)

documentation of treatment for nephropathy (eg, patient receiving dialysis, patient being treated for esrd, crf, arf, or renal insufficiency, any visit to a nephrologist) (dm)

low risk for retinopathy (no evidence of retinopathy in the prior year) (dm)

pre-surgical (cataract) axial length, corneal power measurement and method of intraocular lens power calculation documented within 12 months prior to surgery (ec)

most recent systolic blood pressure less than 130 mm hg (dm), (htn, ckd, cad)

most recent systolic blood pressure 130-139 mm hg (dm),(htn, ckd, cad)

most recent systolic blood pressure greater than or equal to 140 mm hg (htn, ckd, cad) (dm)

most recent diastolic blood pressure less than 80 mm hg (htn, ckd, cad) (dm)

most recent diastolic blood pressure 80-89 mm hg (htn, ckd, cad) (dm)

ablation, soft tissue of inferior turbinates, unilateral or bilateral, any method (eg, electrocautery, radiofrequency ablation, or tissue volume reduction); superficial

ablation, soft tissue of inferior turbinates, unilateral or bilateral, any method (eg, electrocautery, radiofrequency ablation, or tissue volume reduction); intramural (ie, submucosal)

most recent diastolic blood pressure greater than or equal to 90 mm hg (htn, ckd, cad) (dm)

kt/v less than 1.2 (clearance of urea [kt]/volume [v]) (esrd, p-esrd)

kt/v equal to or greater than 1.2 and less than 1.7 (clearance of urea [kt]/volume [v]) (esrd, p-esrd)

kt/v greater than or equal to 1.7 (clearance of urea [kt]/volume [v]) (esrd, p-esrd)

control nasal hemorrhage, anterior, simple (limited cautery and/or packing) any method

control nasal hemorrhage, anterior, complex (extensive cautery and/or packing) any method

control nasal hemorrhage, posterior, with posterior nasal packs and/or cautery, any method; initial

control nasal hemorrhage, posterior, with posterior nasal packs and/or cautery, any method; subsequent

major depressive disorder, severe without psychotic features (mdd)

documentation of new diagnosis of initial or recurrent episode of major depressive disorder (mdd)

central dual-energy x-ray absorptiometry (dxa) results documented (op)(ibd)

central dual-energy x-ray absorptiometry (dxa) ordered (op)(ibd)

lavage by cannulation; maxillary sinus (antrum puncture or natural ostium)

carotid imaging study report (includes direct or indirect reference to measurements of distal internal carotid diameter as the denominator for stenosis measurement) (str, rad)

sinusotomy, maxillary (antrotomy); radical (caldwell-luc) without removal of antrochoanal polyps

sinusotomy, maxillary (antrotomy); radical (caldwell-luc) with removal of antrochoanal polyps

sinusotomy, sphenoid, with or without biopsy; with mucosal stripping or removal of polyp(s)

sinusotomy frontal; transorbital, unilateral (for mucocele or osteoma, lynch type)

sinusotomy frontal; obliterative without osteoplastic flap, brow incision (includes ablation)

sinusotomy frontal; obliterative, without osteoplastic flap, coronal incision (includes ablation)

sinusotomy frontal; obliterative, with osteoplastic flap, brow incision

sinusotomy frontal; obliterative, with osteoplastic flap, coronal incision

sinusotomy frontal; nonobliterative, with osteoplastic flap, brow incision

sinusotomy frontal; nonobliterative, with osteoplastic flap, coronal incision

sinusotomy, unilateral, 3 or more paranasal sinuses (frontal, maxillary, ethmoid, sphenoid)

documentation in final ct or mri report of presence or absence of hemorrhage and mass lesion and acute infarction (str)

ct or mri of the brain performed in the hospital within 24 hours of arrival or performed in an outpatient imaging center, to confirm initial diagnosis of stroke, tia or intracranial hemorrhage (str)

ct or mri of the brain performed greater than 24 hours after arrival to the hospital or performed in an outpatient imaging center for purpose other than confirmation of initial diagnosis of stroke, tia, or intracranial hemorrhage (str)

quantitative results of an evaluation of current level of activity and clinical symptoms (hf)

heart failure disease specific structured assessment tool completed (hf)

nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)

nasal/sinus endoscopy, diagnostic with maxillary sinusoscopy (via inferior meatus or canine fossa puncture)

nasal/sinus endoscopy, diagnostic with sphenoid sinusoscopy (via puncture of sphenoidal face or cannulation of ostium)

nasal/sinus endoscopy, surgical; with biopsy, polypectomy or debridement (separate procedure)

nasal/sinus endoscopy, surgical; with control of nasal hemorrhage

nasal/sinus endoscopy, surgical; with ligation of sphenopalatine artery

nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior), including frontal sinus exploration, with removal of tissue from frontal sinus, when performed

nasal/sinus endoscopy, surgical with ethmoidectomy; partial (anterior)

nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior)

nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior), including sphenoidotomy

nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior), including sphenoidotomy, with removal of tissue from the sphenoid sinus

nasal/sinus endoscopy, surgical, with maxillary antrostomy; with removal of tissue from maxillary sinus

esophageal biopsy report with a statement about dysplasia (present, absent, or indefinite, and if present, contains appropriate grading) (path)

nasal/sinus endoscopy, surgical, with frontal sinus exploration, including removal of tissue from frontal sinus, when performed

nasal/sinus endoscopy, surgical, with sphenoidotomy; with removal of tissue from the sphenoid sinus

nasal/sinus endoscopy, surgical, with repair of cerebrospinal fluid leak; ethmoid region

nasal/sinus endoscopy, surgical, with repair of cerebrospinal fluid leak; sphenoid region

nasal/sinus endoscopy, surgical; with medial or inferior orbital wall decompression

nasal/sinus endoscopy, surgical; with medial orbital wall and inferior orbital wall decompression

nasal/sinus endoscopy, surgical; with dilation of maxillary sinus ostium (eg, balloon dilation), transnasal or via canine fossa

nasal/sinus endoscopy, surgical; with dilation of frontal sinus ostium (eg, balloon dilation)

nasal/sinus endoscopy, surgical; with dilation of sphenoid sinus ostium (eg, balloon dilation)

nasal/sinus endoscopy, surgical; with dilation of frontal and sphenoid sinus ostia (eg, balloon dilation)

laryngotomy (thyrotomy, laryngofissure), with removal of tumor or laryngocele, cordectomy

documentation of referral for upper gastrointestinal endoscopy (gerd)

laryngectomy; subtotal supraglottic, without radical neck dissection

laryngectomy; subtotal supraglottic, with radical neck dissection

pharyngolaryngectomy, with radical neck dissection; without reconstruction

pharyngolaryngectomy, with radical neck dissection; with reconstruction

upper gastrointestinal endoscopy report indicates suspicion of barrett's esophagus (gerd)

upper gastrointestinal endoscopy report indicates no suspicion of barrett's esophagus (gerd)

laryngoscopy direct, with or without tracheoscopy; for aspiration

laryngoscopy direct, with or without tracheoscopy; diagnostic, newborn

laryngoscopy direct, with or without tracheoscopy; diagnostic, except newborn

laryngoscopy direct, with or without tracheoscopy; diagnostic, with operating microscope or telescope

laryngoscopy direct, with or without tracheoscopy; with insertion of obturator

laryngoscopy direct, with or without tracheoscopy; with dilation, initial

laryngoscopy direct, with or without tracheoscopy; with dilation, subsequent

laryngoscopy, direct, operative, with foreign body removal; with operating microscope or telescope

laryngoscopy, direct, operative, with biopsy; with operating microscope or telescope

laryngoscopy, direct, operative, with excision of tumor and/or stripping of vocal cords or epiglottis

laryngoscopy, direct, operative, with excision of tumor and/or stripping of vocal cords or epiglottis; with operating microscope or telescope

laryngoscopy, direct, operative, with operating microscope or telescope, with submucosal removal of non-neoplastic lesion(s) of vocal cord; reconstruction with local tissue flap(s)

laryngoscopy, direct, operative, with operating microscope or telescope, with submucosal removal of non-neoplastic lesion(s) of vocal cord; reconstruction with graft(s) (includes obtaining autograft)

laryngoplasty; for laryngeal stenosis, with graft, without indwelling stent placement, younger than 12 years of age

laryngoplasty; for laryngeal stenosis, with graft, without indwelling stent placement, age 12 years or older

laryngoplasty; for laryngeal stenosis, with graft, with indwelling stent placement, younger than 12 years of age

laryngoplasty; for laryngeal stenosis, with graft, with indwelling stent placement, age 12 years or older

cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (hem)

laryngoscopy, direct, operative, with arytenoidectomy; with operating microscope or telescope

laryngoscopy, direct, with injection into vocal cord(s), therapeutic

laryngoscopy, direct, with injection into vocal cord(s), therapeutic; with operating microscope or telescope

laryngoscopy, flexible; with ablation or destruction of lesion(s) with laser, unilateral

laryngoscopy, flexible; with therapeutic injection(s) (eg, chemodenervation agent or corticosteroid, injected percutaneous, transoral, or via endoscope channel), unilateral

laryngoscopy, flexible; with injection(s) for augmentation (eg, percutaneous, transoral), unilateral

laryngoplasty; for laryngeal web, with indwelling keel or stent insertion

laryngoplasty; with open reduction and fixation of (eg, plating) fracture, includes tracheostomy, if performed

section recurrent laryngeal nerve, therapeutic (separate procedure), unilateral

tracheostomy, planned (separate procedure); younger than 2 years

documentation of iron stores prior to initiating erythropoietin therapy (hem)

construction of tracheoesophageal fistula and subsequent insertion of an alaryngeal speech prosthesis (eg, voice button, blom-singer prosthesis)

tracheal puncture, percutaneous with transtracheal aspiration and/or injection

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; diagnostic, with cell washing, when performed (separate procedure)

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with brushing or protected brushings

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial or endobronchial biopsy(s), single or multiple sites

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with placement of fiducial markers, single or multiple

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with computer-assisted, image-guided navigation (list separately in addition to code for primary procedure[s])

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial needle aspiration biopsy(s), trachea, main stem and/or lobar bronchus(i)

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with tracheal/bronchial dilation or closed reduction of fracture

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with placement of tracheal stent(s) (includes tracheal/bronchial dilation as required)

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), each additional lobe (list separately in addition to code for primary procedure)

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial needle aspiration biopsy(s), each additional lobe (list separately in addition to code for primary procedure)

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with balloon occlusion, with assessment of air leak, with administration of occlusive substance (eg, fibrin glue), if performed

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with removal of foreign body

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with placement of bronchial stent(s) (includes tracheal/bronchial dilation as required), initial bronchus

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; each additional major bronchus stented (list separately in addition to code for primary procedure)

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with revision of tracheal or bronchial stent inserted at previous session (includes tracheal/bronchial dilation as required)

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with excision of tumor

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with destruction of tumor or relief of stenosis by any method other than excision (eg, laser therapy, cryotherapy)

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with placement of catheter(s) for intracavitary radioelement application

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with therapeutic aspiration of tracheobronchial tree, initial

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with therapeutic aspiration of tracheobronchial tree, subsequent, same hospital stay

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with balloon occlusion, when performed, assessment of air leak, airway sizing, and insertion of bronchial valve(s), initial lobe

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with removal of bronchial valve(s), initial lobe

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with removal of bronchial valve(s), each additional lobe (list separately in addition to code for primary procedure)

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with balloon occlusion, when performed, assessment of air leak, airway sizing, and insertion of bronchial valve(s), each additional lobe (list separately in addition to code for primary procedure[s])

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (eg, aspiration[s]/biopsy[ies]), one or two mediastinal and/or hilar lymph node stations or structures

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (eg, aspiration[s]/biopsy[ies]), 3 or more mediastinal and/or hilar lymph node stations or structures

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s) (list separately in addition to code for primary procedure[s])

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial thermoplasty, 1 lobe

bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial thermoplasty, 2 or more lobes

flow cytometry studies performed at time of diagnosis or prior to initiating treatment (hem)

catheter aspiration (separate procedure); tracheobronchial with fiberscope, bedside

transtracheal (percutaneous) introduction of needle wire dilator/stent or indwelling tube for oxygen therapy

surgical closure tracheostomy or fistula; without plastic repair

thoracotomy, with diagnostic biopsy(ies) of lung infiltrate(s) (eg, wedge, incisional), unilateral

thoracotomy, with diagnostic biopsy(ies) of lung nodule(s) or mass(es) (eg, wedge, incisional), unilateral

thoracotomy; with control of traumatic hemorrhage and/or repair of lung tear

thoracotomy; with cyst(s) removal, includes pleural procedure when performed

thoracotomy; with resection-plication of bullae, includes any pleural procedure when performed

thoracotomy; with removal of intrapleural foreign body or fibrin deposit

rna testing for hepatitis c documented as performed within 6 months prior to initiation of antiviral treatment for hepatitis c (hep-c)

hepatitis c quantitative rna testing documented as performed at 12 weeks from initiation of antiviral treatment (hep-c)

documentation that hearing test was performed within 6 months prior to tympanostomy tube insertion (ome)

removal of lung, pneumonectomy; with resection of segment of trachea followed by broncho-tracheal anastomosis (sleeve pneumonectomy)

removal of lung, other than pneumonectomy; single lobe (lobectomy)

removal of lung, other than pneumonectomy; 2 lobes (bilobectomy)

removal of lung, other than pneumonectomy; single segment (segmentectomy)

removal of lung, other than pneumonectomy; with circumferential resection of segment of bronchus followed by broncho-bronchial anastomosis (sleeve lobectomy)

removal of lung, other than pneumonectomy; with all remaining lung following previous removal of a portion of lung (completion pneumonectomy)

removal of lung, other than pneumonectomy; with resection-plication of emphysematous lung(s) (bullous or non-bullous) for lung volume reduction, sternal split or transthoracic approach, includes any pleural procedure, when performed

resection and repair of portion of bronchus (bronchoplasty) when performed at time of lobectomy or segmentectomy (list separately in addition to code for primary procedure)

resection of apical lung tumor (eg, pancoast tumor), including chest wall resection, rib(s) resection(s), neurovascular dissection, when performed; without chest wall reconstruction(s)

resection of apical lung tumor (eg, pancoast tumor), including chest wall resection, rib(s) resection(s), neurovascular dissection, when performed; with chest wall reconstruction

thoracotomy; with therapeutic wedge resection (eg, mass, nodule), initial

thoracotomy; with therapeutic wedge resection (eg, mass or nodule), each additional resection, ipsilateral (list separately in addition to code for primary procedure)

thoracotomy; with diagnostic wedge resection followed by anatomic lung resection (list separately in addition to code for primary procedure)

specimen site other than anatomic location of primary tumor (path)

tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure)

placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), percutaneous, intra-thoracic, single or multiple

thoracentesis, needle or catheter, aspiration of the pleural space; without imaging guidance

thoracentesis, needle or catheter, aspiration of the pleural space; with imaging guidance

pleural drainage, percutaneous, with insertion of indwelling catheter; without imaging guidance

pleural drainage, percutaneous, with insertion of indwelling catheter; with imaging guidance

instillation, via chest tube/catheter, agent for pleurodesis (eg, talc for recurrent or persistent pneumothorax)

instillation(s), via chest tube/catheter, agent for fibrinolysis (eg, fibrinolytic agent for break up of multiloculated effusion); initial day

instillation(s), via chest tube/catheter, agent for fibrinolysis (eg, fibrinolytic agent for break up of multiloculated effusion); subsequent day

thoracoscopy, diagnostic (separate procedure); lungs, pericardial sac, mediastinal or pleural space, without biopsy

thoracoscopy, diagnostic (separate procedure); pericardial sac, with biopsy

thoracoscopy, diagnostic (separate procedure); mediastinal space, with biopsy

thoracoscopy; with diagnostic biopsy(ies) of lung infiltrate(s) (eg, wedge, incisional), unilateral

thoracoscopy; with diagnostic biopsy(ies) of lung nodule(s) or mass(es) (eg, wedge, incisional), unilateral

pt category (primary tumor), pn category (regional lymph nodes), and histologic grade documented in pathology report (path)

thoracoscopy, surgical; with pleurodesis (eg, mechanical or chemical)

thoracoscopy, surgical; with total pulmonary decortication, including intrapleural pneumonolysis

thoracoscopy, surgical; with removal of intrapleural foreign body or fibrin deposit

thoracoscopy, surgical; with resection-plication of bullae, includes any pleural procedure when performed

thoracoscopy, surgical; with removal of clot or foreign body from pericardial sac

thoracoscopy, surgical; with creation of pericardial window or partial resection of pericardial sac for drainage

ribonucleic acid (rna) testing for hepatitis c viremia ordered or results documented (hep c)

thoracoscopy, surgical; with excision of pericardial cyst, tumor, or mass

thoracoscopy, surgical; with excision of mediastinal cyst, tumor, or mass

thoracoscopy, surgical; with therapeutic wedge resection (eg, mass, nodule), initial unilateral

thoracoscopy, surgical; with therapeutic wedge resection (eg, mass or nodule), each additional resection, ipsilateral (list separately in addition to code for primary procedure)

thoracoscopy, surgical; with diagnostic wedge resection followed by anatomic lung resection (list separately in addition to code for primary procedure)

thoracoscopy, surgical; with removal of a single lung segment (segmentectomy)

hepatitis c genotype testing documented as performed prior to initiation of antiviral treatment for hepatitis c (hep c)

thoracoscopy, surgical; with resection-plication for emphysematous lung (bullous or non-bullous) for lung volume reduction (lvrs), unilateral includes any pleural procedure, when performed

thoracoscopy, surgical; with resection of thymus, unilateral or bilateral

thoracoscopy, surgical; with mediastinal and regional lymphadenectomy (list separately in addition to code for primary procedure)

pathology report includes pt category, pn category, gleason score, and statement about margin status (path)

prostate-specific antigen (psa), and primary tumor (t) stage, and gleason score documented prior to initiation of treatment (prca)

bone scan performed prior to initiation of treatment or at any time since diagnosis of prostate cancer (prca)

thoracic target(s) delineation for stereotactic body radiation therapy (srs/sbrt), (photon or particle beam), entire course of treatment

bone scan not performed prior to initiation of treatment nor at any time since diagnosis of prostate cancer (prca)

prostate cancer risk of recurrence not determined or neither low, intermediate nor high (prca)

serum levels of calcium, phosphorus, intact parathyroid hormone (pth) and lipid profile ordered (ckd)

closure of chest wall following open flap drainage for empyema (clagett type procedure)

intraocular pressure (iop) reduced by a value of greater than or equal to 15% from the pre-intervention level (ec)

donor pneumonectomy(s) (including cold preservation), from cadaver donor

lung transplant, double (bilateral sequential or en bloc); without cardiopulmonary bypass

lung transplant, double (bilateral sequential or en bloc); with cardiopulmonary bypass

backbench standard preparation of cadaver donor lung allograft prior to transplantation, including dissection of allograft from surrounding soft tissues to prepare pulmonary venous/atrial cuff, pulmonary artery, and bronchus; unilateral

backbench standard preparation of cadaver donor lung allograft prior to transplantation, including dissection of allograft from surrounding soft tissues to prepare pulmonary venous/atrial cuff, pulmonary artery, and bronchus; bilateral

intraocular pressure (iop) reduced by a value less than 15% from the pre-intervention level (ec)

thoracoplasty, schede type or extrapleural (all stages); with closure of bronchopleural fistula

hiv testing ordered or documented and reviewed during the first or second prenatal visit (pre-cr)

pneumonolysis, extraperiosteal, including filling or packing procedures

group b streptococcus (gbs) screening documented as performed during week 35-37 gestation (pre-cr)

ablation therapy for reduction or eradication of 1 or more pulmonary tumor(s) including pleura or chest wall when involved by tumor extension, percutaneous, including imaging guidance when performed, unilateral; cryoablation

ablation therapy for reduction or eradication of 1 or more pulmonary tumor(s) including pleura or chest wall when involved by tumor extension, percutaneous, including imaging guidance when performed, unilateral; radiofrequency

american joint committee on cancer (ajcc) stage documented and reviewed (onc)

cancer stage documented in medical record as metastatic and reviewed (onc)

pericardiotomy for removal of clot or foreign body (primary procedure)

creation of pericardial window or partial resection for drainage

pericardiectomy, subtotal or complete; without cardiopulmonary bypass

pericardiectomy, subtotal or complete; with cardiopulmonary bypass

excision of intracardiac tumor, resection with cardiopulmonary bypass

transmyocardial laser revascularization, by thoracotomy; (separate procedure)

transmyocardial laser revascularization, by thoracotomy; performed at the time of other open cardiac procedure(s) (list separately in addition to code for primary procedure)

estrogen receptor (er) or progesterone receptor (pr) positive breast cancer (onc)

estrogen receptor (er) and progesterone receptor (pr) negative breast cancer (onc)

pathology report confirming malignancy documented in the medical record and reviewed prior to the initiation of chemotherapy (onc)

pathology report confirming malignancy documented in the medical record and reviewed prior to the initiation of radiation therapy (onc)

1 of the following diagnostic imaging studies ordered: chest x-ray, ct, ultrasound, mri, pet, or nuclear medicine scans (ml)

insertion of epicardial electrode(s); open incision (eg, thoracotomy, median sternotomy, subxiphoid approach)

insertion of epicardial electrode(s); endoscopic approach (eg, thoracoscopy, pericardioscopy)

insertion of new or replacement of permanent pacemaker with transvenous electrode(s); atrial

insertion of new or replacement of permanent pacemaker with transvenous electrode(s); ventricular

insertion of new or replacement of permanent pacemaker with transvenous electrode(s); atrial and ventricular

none of the following diagnostic imaging studies ordered: chest x-ray, ct, ultrasound, mri, pet, or nuclear medicine scans (ml)

insertion or replacement of temporary transvenous single chamber cardiac electrode or pacemaker catheter (separate procedure)

insertion or replacement of temporary transvenous dual chamber pacing electrodes (separate procedure)

insertion of pacemaker pulse generator only; with existing single lead

insertion of pacemaker pulse generator only; with existing dual leads

upgrade of implanted pacemaker system, conversion of single chamber system to dual chamber system (includes removal of previously placed pulse generator, testing of existing lead, insertion of new lead, insertion of new pulse generator)

repositioning of previously implanted transvenous pacemaker or implantable defibrillator (right atrial or right ventricular) electrode

insertion of a single transvenous electrode, permanent pacemaker or implantable defibrillator

insertion of 2 transvenous electrodes, permanent pacemaker or implantable defibrillator

repair of single transvenous electrode, permanent pacemaker or implantable defibrillator

repair of 2 transvenous electrodes for permanent pacemaker or implantable defibrillator

insertion of pacemaker pulse generator only; with existing multiple leads

insertion of pacing electrode, cardiac venous system, for left ventricular pacing, with attachment to previously placed pacemaker or implantable defibrillator pulse generator (including revision of pocket, removal, insertion, and/or replacement of existing generator)

insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system) (list separately in addition to code for primary procedure)

repositioning of previously implanted cardiac venous system (left ventricular) electrode (including removal, insertion and/or replacement of existing generator)

removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator; single lead system

removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator; dual lead system

removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator; multiple lead system

insertion of implantable defibrillator pulse generator only; with existing dual leads

insertion of implantable defibrillator pulse generator only; with existing multiple leads

removal of transvenous pacemaker electrode(s); single lead system, atrial or ventricular

removal of permanent epicardial pacemaker and electrodes by thoracotomy; single lead system, atrial or ventricular

removal of permanent epicardial pacemaker and electrodes by thoracotomy; dual lead system

clinical tumor, node and metastases (tnm) staging documented and reviewed prior to surgery (lung/esop cx)

insertion of implantable defibrillator pulse generator only; with existing single lead

removal of single or dual chamber implantable defibrillator electrode(s); by thoracotomy

removal of single or dual chamber implantable defibrillator electrode(s); by transvenous extraction

insertion or replacement of permanent implantable defibrillator system, with transvenous lead(s), single or dual chamber

operative ablation of supraventricular arrhythmogenic focus or pathway (eg, wolff-parkinson-white, atrioventricular node re-entry), tract(s) and/or focus (foci); without cardiopulmonary bypass

operative ablation of supraventricular arrhythmogenic focus or pathway (eg, wolff-parkinson-white, atrioventricular node re-entry), tract(s) and/or focus (foci); with cardiopulmonary bypass

operative tissue ablation and reconstruction of atria, limited (eg, modified maze procedure)

operative tissue ablation and reconstruction of atria, extensive (eg, maze procedure); without cardiopulmonary bypass

operative tissue ablation and reconstruction of atria, extensive (eg, maze procedure); with cardiopulmonary bypass

operative tissue ablation and reconstruction of atria, performed at the time of other cardiac procedure(s), limited (eg, modified maze procedure) (list separately in addition to code for primary procedure)

operative tissue ablation and reconstruction of atria, performed at the time of other cardiac procedure(s), extensive (eg, maze procedure), without cardiopulmonary bypass (list separately in addition to code for primary procedure)

operative tissue ablation and reconstruction of atria, performed at the time of other cardiac procedure(s), extensive (eg, maze procedure), with cardiopulmonary bypass (list separately in addition to code for primary procedure)

preoperative assessment of functional or medical indication(s) for surgery prior to the cataract surgery with intraocular lens placement (must be performed within 12 months prior to cataract surgery) (ec)

operative ablation of ventricular arrhythmogenic focus with cardiopulmonary bypass

removal of implantable defibrillator pulse generator with replacement of implantable defibrillator pulse generator; single lead system

removal of implantable defibrillator pulse generator with replacement of implantable defibrillator pulse generator; dual lead system

removal of implantable defibrillator pulse generator with replacement of implantable defibrillator pulse generator; multiple lead system

endoscopy, surgical; operative tissue ablation and reconstruction of atria, limited (eg, modified maze procedure), without cardiopulmonary bypass

endoscopy, surgical; operative tissue ablation and reconstruction of atria, extensive (eg, maze procedure), without cardiopulmonary bypass

insertion or replacement of permanent subcutaneous implantable defibrillator system, with subcutaneous electrode, including defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters, when performed

repositioning of previously implanted subcutaneous implantable defibrillator electrode

removal of an implantable, patient-activated cardiac event recorder

performance status documented and reviewed within 2 weeks prior to surgery (lung/esop cx)

cardiotomy, exploratory (includes removal of foreign body, atrial or ventricular thrombus); without bypass

cardiotomy, exploratory (includes removal of foreign body, atrial or ventricular thrombus); with cardiopulmonary bypass

suture repair of aorta or great vessels; without shunt or cardiopulmonary bypass

suture repair of aorta or great vessels; with cardiopulmonary bypass

insertion of graft, aorta or great vessels; without shunt, or cardiopulmonary bypass

insertion of graft, aorta or great vessels; with cardiopulmonary bypass

percutaneous transcatheter closure of the left atrial appendage with endocardial implant, including fluoroscopy, transseptal puncture, catheter placement(s), left atrial angiography, left atrial appendage angiography, when performed, and radiological supervision and interpretation

transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; percutaneous femoral artery approach

transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; open femoral artery approach

transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; open axillary artery approach

transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; open iliac artery approach

transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; transaortic approach (eg, median sternotomy, mediastinotomy)

transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; transapical exposure (eg, left thoracotomy)

transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; cardiopulmonary bypass support with percutaneous peripheral arterial and venous cannulation (eg, femoral vessels) (list separately in addition to code for primary procedure)

transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; cardiopulmonary bypass support with open peripheral arterial and venous cannulation (eg, femoral, iliac, axillary vessels) (list separately in addition to code for primary procedure)

transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; cardiopulmonary bypass support with central arterial and venous cannulation (eg, aorta, right atrium, pulmonary artery) (list separately in addition to code for primary procedure)

valvuloplasty, aortic valve, open, with cardiopulmonary bypass; simple (ie, valvotomy, debridement, debulking, and/or simple commissural resuspension)

valvuloplasty, aortic valve, open, with cardiopulmonary bypass; complex (eg, leaflet extension, leaflet resection, leaflet reconstruction, or annuloplasty)

replacement, aortic valve, open, with cardiopulmonary bypass; with prosthetic valve other than homograft or stentless valve

replacement, aortic valve, open, with cardiopulmonary bypass; with allograft valve (freehand)

mammogram assessment category of "incomplete: need additional imaging evaluation" documented (rad)

replacement, aortic valve, open, with cardiopulmonary bypass; with stentless tissue valve

replacement, aortic valve; with aortic annulus enlargement, noncoronary sinus

replacement, aortic valve; with transventricular aortic annulus enlargement (konno procedure)

replacement, aortic valve; by translocation of autologous pulmonary valve with allograft replacement of pulmonary valve (ross procedure)

repair of left ventricular outflow tract obstruction by patch enlargement of the outflow tract

resection or incision of subvalvular tissue for discrete subvalvular aortic stenosis

ventriculomyotomy (-myectomy) for idiopathic hypertrophic subaortic stenosis (eg, asymmetric septal hypertrophy)

transcatheter mitral valve repair, percutaneous approach, including transseptal puncture when performed; initial prosthesis

transcatheter mitral valve repair, percutaneous approach, including transseptal puncture when performed; additional prosthesis(es) during same session (list separately in addition to code for primary procedure)

valvotomy, mitral valve; open heart, with cardiopulmonary bypass

valvuloplasty, mitral valve, with cardiopulmonary bypass; with prosthetic ring

valvuloplasty, mitral valve, with cardiopulmonary bypass; radical reconstruction, with or without ring

mammogram assessment category of "probably benign," documented (rad)

mammogram assessment category of "highly suggestive of malignancy," documented (rad)

valvotomy, pulmonary valve, open heart, with cardiopulmonary bypass

right ventricular resection for infundibular stenosis, with or without commissurotomy

transcatheter pulmonary valve implantation, percutaneous approach, including pre-stenting of the valve delivery site, when performed

outflow tract augmentation (gusset), with or without commissurotomy or infundibular resection

repair of non-structural prosthetic valve dysfunction with cardiopulmonary bypass (separate procedure)

repair of coronary arteriovenous or arteriocardiac chamber fistula; with cardiopulmonary bypass

repair of coronary arteriovenous or arteriocardiac chamber fistula; without cardiopulmonary bypass

repair of anomalous coronary artery from pulmonary artery origin; by ligation

repair of anomalous coronary artery from pulmonary artery origin; by graft, without cardiopulmonary bypass

repair of anomalous coronary artery from pulmonary artery origin; by graft, with cardiopulmonary bypass

repair of anomalous coronary artery from pulmonary artery origin; with construction of intrapulmonary artery tunnel (takeuchi procedure)

repair of anomalous coronary artery from pulmonary artery origin; by translocation from pulmonary artery to aorta

repair of anomalous (eg, intramural) aortic origin of coronary artery by unroofing or translocation

endoscopy, surgical, including video-assisted harvest of vein(s) for coronary artery bypass procedure (list separately in addition to code for primary procedure)

mammogram assessment category of "known biopsy proven malignancy," documented (rad)

coronary artery bypass, vein only; 6 or more coronary venous grafts

coronary artery bypass, using venous graft(s) and arterial graft(s); single vein graft (list separately in addition to code for primary procedure)

coronary artery bypass, using venous graft(s) and arterial graft(s); 2 venous grafts (list separately in addition to code for primary procedure)

coronary artery bypass, using venous graft(s) and arterial graft(s); 3 venous grafts (list separately in addition to code for primary procedure)

negative screen for depressive symptoms as categorized by using a standardized depression screening/assessment tool (mdd)

coronary artery bypass, using venous graft(s) and arterial graft(s); 4 venous grafts (list separately in addition to code for primary procedure)

coronary artery bypass, using venous graft(s) and arterial graft(s); 5 venous grafts (list separately in addition to code for primary procedure)

coronary artery bypass, using venous graft(s) and arterial graft(s); 6 or more venous grafts (list separately in addition to code for primary procedure)

no significant depressive symptoms as categorized by using a standardized depression assessment tool (mdd)

reoperation, coronary artery bypass procedure or valve procedure, more than 1 month after original operation (list separately in addition to code for primary procedure)

coronary artery bypass, using arterial graft(s); single arterial graft

coronary artery bypass, using arterial graft(s); 2 coronary arterial grafts

coronary artery bypass, using arterial graft(s); 3 coronary arterial grafts

coronary artery bypass, using arterial graft(s); 4 or more coronary arterial grafts

mild to moderate depressive symptoms as categorized by using a standardized depression screening/assessment tool (mdd)

repair of postinfarction ventricular septal defect, with or without myocardial resection

surgical ventricular restoration procedure, includes prosthetic patch, when performed (eg, ventricular remodeling, svr, saver, dor procedures)

clinically significant depressive symptoms as categorized by using a standardized depression screening/assessment tool (mdd)

coronary endarterectomy, open, any method, of left anterior descending, circumflex, or right coronary artery performed in conjunction with coronary artery bypass graft procedure, each vessel (list separately in addition to primary procedure)

closure of atrioventricular valve (mitral or tricuspid) by suture or patch

closure of semilunar valve (aortic or pulmonary) by suture or patch

anastomosis of pulmonary artery to aorta (damus-kaye-stansel procedure)

repair of complex cardiac anomaly other than pulmonary atresia with ventricular septal defect by construction or replacement of conduit from right or left ventricle to pulmonary artery

repair of complex cardiac anomalies (eg, single ventricle with subaortic obstruction) by surgical enlargement of ventricular septal defect

repair of double outlet right ventricle with intraventricular tunnel repair

repair of double outlet right ventricle with intraventricular tunnel repair; with repair of right ventricular outflow tract obstruction

repair of complex cardiac anomalies (eg, tricuspid atresia) by closure of atrial septal defect and anastomosis of atria or vena cava to pulmonary artery (simple fontan procedure)

repair of complex cardiac anomalies (eg, single ventricle) by modified fontan procedure

repair of single ventricle with aortic outflow obstruction and aortic arch hypoplasia (hypoplastic left heart syndrome) (eg, norwood procedure)

application of right and left pulmonary artery bands (eg, hybrid approach stage 1)

transthoracic insertion of catheter for stent placement with catheter removal and closure (eg, hybrid approach stage 1)

reconstruction of complex cardiac anomaly (eg, single ventricle or hypoplastic left heart) with palliation of single ventricle with aortic outflow obstruction and aortic arch hypoplasia, creation of cavopulmonary anastomosis, and removal of right and left pulmonary bands (eg, hybrid approach stage 2, norwood, bidirectional glenn, pulmonary artery debanding)

repair atrial septal defect, secundum, with cardiopulmonary bypass, with or without patch

direct or patch closure, sinus venosus, with or without anomalous pulmonary venous drainage

repair of atrial septal defect and ventricular septal defect, with direct or patch closure

repair of incomplete or partial atrioventricular canal (ostium primum atrial septal defect), with or without atrioventricular valve repair

repair of intermediate or transitional atrioventricular canal, with or without atrioventricular valve repair

repair of complete atrioventricular canal, with or without prosthetic valve

closure of multiple ventricular septal defects; with pulmonary valvotomy or infundibular resection (acyanotic)

closure of multiple ventricular septal defects; with removal of pulmonary artery band, with or without gusset

closure of single ventricular septal defect, with or without patch

closure of single ventricular septal defect, with or without patch; with pulmonary valvotomy or infundibular resection (acyanotic)

closure of single ventricular septal defect, with or without patch; with removal of pulmonary artery band, with or without gusset

complete repair tetralogy of fallot without pulmonary atresia; with transannular patch

complete repair tetralogy of fallot with pulmonary atresia including construction of conduit from right ventricle to pulmonary artery and closure of ventricular septal defect

repair sinus of valsalva fistula, with cardiopulmonary bypass; with repair of ventricular septal defect

repair of isolated partial anomalous pulmonary venous return (eg, scimitar syndrome)

ajcc breast cancer stage i: t1mic, t1a or t1b (tumor size <= 1 cm) documented (onc)

complete repair of anomalous pulmonary venous return (supracardiac, intracardiac, or infracardiac types)

repair of cor triatriatum or supravalvular mitral ring by resection of left atrial membrane

atrial septectomy or septostomy; closed heart (blalock-hanlon type operation)

atrial septectomy or septostomy; open heart with cardiopulmonary bypass

atrial septectomy or septostomy; open heart, with inflow occlusion

ajcc breast cancer stage i: t1c (tumor size > 1 cm to 2 cm) documented (onc)

shunt; subclavian to pulmonary artery (blalock-taussig type operation)

shunt; ascending aorta to pulmonary artery (waterston type operation)

shunt; descending aorta to pulmonary artery (potts-smith type operation)

shunt; superior vena cava to pulmonary artery for flow to 1 lung (classical glenn procedure)

shunt; superior vena cava to pulmonary artery for flow to both lungs (bidirectional glenn procedure)

anastomosis, cavopulmonary, second superior vena cava (list separately in addition to primary procedure)

repair of transposition of the great arteries with ventricular septal defect and subpulmonary stenosis; without surgical enlargement of ventricular septal defect

repair of transposition of the great arteries with ventricular septal defect and subpulmonary stenosis; with surgical enlargement of ventricular septal defect

repair of transposition of the great arteries, atrial baffle procedure (eg, mustard or senning type) with cardiopulmonary bypass

repair of transposition of the great arteries, atrial baffle procedure (eg, mustard or senning type) with cardiopulmonary bypass; with removal of pulmonary band

repair of transposition of the great arteries, atrial baffle procedure (eg, mustard or senning type) with cardiopulmonary bypass; with closure of ventricular septal defect

repair of transposition of the great arteries, atrial baffle procedure (eg, mustard or senning type) with cardiopulmonary bypass; with repair of subpulmonic obstruction

repair of transposition of the great arteries, aortic pulmonary artery reconstruction (eg, jatene type)

repair of transposition of the great arteries, aortic pulmonary artery reconstruction (eg, jatene type); with removal of pulmonary band

repair of transposition of the great arteries, aortic pulmonary artery reconstruction (eg, jatene type); with closure of ventricular septal defect

repair of transposition of the great arteries, aortic pulmonary artery reconstruction (eg, jatene type); with repair of subpulmonic obstruction

aortic root translocation with ventricular septal defect and pulmonary stenosis repair (ie, nikaidoh procedure); without coronary ostium reimplantation

aortic root translocation with ventricular septal defect and pulmonary stenosis repair (ie, nikaidoh procedure); with reimplantation of 1 or both coronary ostia

aortic suspension (aortopexy) for tracheal decompression (eg, for tracheomalacia) (separate procedure)

obliteration of aortopulmonary septal defect; without cardiopulmonary bypass

obliteration of aortopulmonary septal defect; with cardiopulmonary bypass

repair of patent ductus arteriosus; by division, younger than 18 years

repair of patent ductus arteriosus; by division, 18 years and older

excision of coarctation of aorta, with or without associated patent ductus arteriosus; with direct anastomosis

excision of coarctation of aorta, with or without associated patent ductus arteriosus; with graft

excision of coarctation of aorta, with or without associated patent ductus arteriosus; repair using either left subclavian artery or prosthetic material as gusset for enlargement

repair of hypoplastic or interrupted aortic arch using autogenous or prosthetic material; without cardiopulmonary bypass

repair of hypoplastic or interrupted aortic arch using autogenous or prosthetic material; with cardiopulmonary bypass

ascending aorta graft, with cardiopulmonary bypass, includes valve suspension, when performed

ascending aorta graft, with cardiopulmonary bypass, with aortic root replacement using valved conduit and coronary reconstruction (eg, bentall)

ascending aorta graft, with cardiopulmonary bypass with valve suspension, with coronary reconstruction and valve-sparing aortic root remodeling (eg, david procedure, yacoub procedure)

repair of thoracoabdominal aortic aneurysm with graft, with or without cardiopulmonary bypass

endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); involving coverage of left subclavian artery origin, initial endoprosthesis plus descending thoracic aortic extension(s), if required, to level of celiac artery origin

endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); not involving coverage of left subclavian artery origin, initial endoprosthesis plus descending thoracic aortic extension(s), if required, to level of celiac artery origin

placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); initial extension

placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); each additional proximal extension (list separately in addition to code for primary procedure)

placement of distal extension prosthesis(s) delayed after endovascular repair of descending thoracic aorta

open subclavian to carotid artery transposition performed in conjunction with endovascular repair of descending thoracic aorta, by neck incision, unilateral

bypass graft, with other than vein, transcervical retropharyngeal carotid-carotid, performed in conjunction with endovascular repair of descending thoracic aorta, by neck incision

pulmonary endarterectomy, with or without embolectomy, with cardiopulmonary bypass

repair of pulmonary artery stenosis by reconstruction with patch or graft

repair of pulmonary atresia with ventricular septal defect, by construction or replacement of conduit from right or left ventricle to pulmonary artery

ligation and takedown of a systemic-to-pulmonary artery shunt, performed in conjunction with a congenital heart procedure (list separately in addition to code for primary procedure)

repair of pulmonary artery arborization anomalies by unifocalization; without cardiopulmonary bypass

repair of pulmonary artery arborization anomalies by unifocalization; with cardiopulmonary bypass

implantation of a total replacement heart system (artificial heart) with recipient cardiectomy

removal and replacement of total replacement heart system (artificial heart)

removal of a total replacement heart system (artificial heart) for heart transplantation (list separately in addition to code for primary procedure)

backbench standard preparation of cadaver donor heart/lung allograft prior to transplantation, including dissection of allograft from surrounding soft tissues to prepare aorta, superior vena cava, inferior vena cava, and trachea for implantation

backbench standard preparation of cadaver donor heart allograft prior to transplantation, including dissection of allograft from surrounding soft tissues to prepare aorta, superior vena cava, inferior vena cava, pulmonary artery, and left atrium for implantation

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; initiation, veno-venous

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; initiation, veno-arterial

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; daily management, each day, veno-venous

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; daily management, each day, veno-arterial

quantitative her2 immunohistochemistry (ihc) evaluation of breast cancer consistent with the scoring system defined in the asco/cap guidelines (path)

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; insertion of peripheral (arterial and/or venous) cannula(e), percutaneous, birth through 5 years of age (includes fluoroscopic guidance, when performed)

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; insertion of peripheral (arterial and/or venous) cannula(e), percutaneous, 6 years and older (includes fluoroscopic guidance, when performed)

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; insertion of peripheral (arterial and/or venous) cannula(e), open, birth through 5 years of age

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; insertion of peripheral (arterial and/or venous) cannula(e), open, 6 years and older

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; insertion of central cannula(e) by sternotomy or thoracotomy, birth through 5 years of age

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; insertion of central cannula(e) by sternotomy or thoracotomy, 6 years and older

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; reposition peripheral (arterial and/or venous) cannula(e), percutaneous, birth through 5 years of age (includes fluoroscopic guidance, when performed)

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; reposition peripheral (arterial and/or venous) cannula(e), percutaneous, 6 years and older (includes fluoroscopic guidance, when performed)

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; reposition peripheral (arterial and/or venous) cannula(e), open, birth through 5 years of age (includes fluoroscopic guidance, when performed)

quantitative non-her2 immunohistochemistry (ihc) evaluation of breast cancer (eg, testing for estrogen or progesterone receptors [er/pr]) performed (path)

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; reposition peripheral (arterial and/or venous) cannula(e), open, 6 years and older (includes fluoroscopic guidance, when performed)

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; reposition of central cannula(e) by sternotomy or thoracotomy, birth through 5 years of age (includes fluoroscopic guidance, when performed)

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; reposition central cannula(e) by sternotomy or thoracotomy, 6 years and older (includes fluoroscopic guidance, when performed)

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; removal of peripheral (arterial and/or venous) cannula(e), percutaneous, birth through 5 years of age

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; removal of peripheral (arterial and/or venous) cannula(e), percutaneous, 6 years and older

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; removal of peripheral (arterial and/or venous) cannula(e), open, birth through 5 years of age

insertion of intra-aortic balloon assist device through the femoral artery, open approach

removal of intra-aortic balloon assist device including repair of femoral artery, with or without graft

insertion of intra-aortic balloon assist device through the ascending aorta

removal of intra-aortic balloon assist device from the ascending aorta, including repair of the ascending aorta, with or without graft

insertion of ventricular assist device; extracorporeal, single ventricle

insertion of ventricular assist device; extracorporeal, biventricular

removal of ventricular assist device; extracorporeal, single ventricle

removal of ventricular assist device; extracorporeal, biventricular

insertion of ventricular assist device, implantable intracorporeal, single ventricle

removal of ventricular assist device, implantable intracorporeal, single ventricle

replacement of extracorporeal ventricular assist device, single or biventricular, pump(s), single or each pump

replacement of ventricular assist device pump(s); implantable intracorporeal, single ventricle, without cardiopulmonary bypass

replacement of ventricular assist device pump(s); implantable intracorporeal, single ventricle, with cardiopulmonary bypass

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; removal of peripheral (arterial and/or venous) cannula(e), open, 6 years and older

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; removal of central cannula(e) by sternotomy or thoracotomy, birth through 5 years of age

extracorporeal membrane oxygenation (ecmo)/extracorporeal life support (ecls) provided by physician; removal of central cannula(e) by sternotomy or thoracotomy, 6 years and older

arterial exposure with creation of graft conduit (eg, chimney graft) to facilitate arterial perfusion for ecmo/ecls (list separately in addition to code for primary procedure)

insertion of left heart vent by thoracic incision (eg, sternotomy, thoracotomy) for ecmo/ecls

removal of left heart vent by thoracic incision (eg, sternotomy, thoracotomy) for ecmo/ecls

insertion of ventricular assist device, percutaneous including radiological supervision and interpretation; arterial access only

insertion of ventricular assist device, percutaneous including radiological supervision and interpretation; both arterial and venous access, with transseptal puncture

removal of percutaneous ventricular assist device at separate and distinct session from insertion

repositioning of percutaneous ventricular assist device with imaging guidance at separate and distinct session from insertion

embolectomy or thrombectomy, with or without catheter; carotid, subclavian or innominate artery, by neck incision

embolectomy or thrombectomy, with or without catheter; innominate, subclavian artery, by thoracic incision

embolectomy or thrombectomy, with or without catheter; axillary, brachial, innominate, subclavian artery, by arm incision

embolectomy or thrombectomy, with or without catheter; radial or ulnar artery, by arm incision

embolectomy or thrombectomy, with or without catheter; renal, celiac, mesentery, aortoiliac artery, by abdominal incision

embolectomy or thrombectomy, with or without catheter; femoropopliteal, aortoiliac artery, by leg incision

embolectomy or thrombectomy, with or without catheter; popliteal-tibio-peroneal artery, by leg incision

thrombectomy, direct or with catheter; vena cava, iliac vein, by abdominal incision

thrombectomy, direct or with catheter; vena cava, iliac, femoropopliteal vein, by leg incision

thrombectomy, direct or with catheter; vena cava, iliac, femoropopliteal vein, by abdominal and leg incision

thrombectomy, direct or with catheter; subclavian vein, by neck incision

thrombectomy, direct or with catheter; axillary and subclavian vein, by arm incision

tb screening performed and results interpreted within six months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy for ra (ra)

endovascular repair of infrarenal aorta by deployment of an aorto-aortic tube endograft including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, all endograft extension(s) placed in the aorta from the level of the renal arteries to the aortic bifurcation, and all angioplasty/stenting performed from the level of the renal arteries to the aortic bifurcation; for other than rupture (eg, for aneurysm, pseudoaneurysm, dissection, penetrating ulcer)

endovascular repair of infrarenal aorta by deployment of an aorto-aortic tube endograft including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, all endograft extension(s) placed in the aorta from the level of the renal arteries to the aortic bifurcation, and all angioplasty/stenting performed from the level of the renal arteries to the aortic bifurcation; for rupture including temporary aortic and/or iliac balloon occlusion, when performed (eg, for aneurysm, pseudoaneurysm, dissection, penetrating ulcer, traumatic disruption)

endovascular repair of infrarenal aorta and/or iliac artery(ies) by deployment of an aorto-uni-iliac endograft including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, all endograft extension(s) placed in the aorta from the level of the renal arteries to the iliac bifurcation, and all angioplasty/stenting performed from the level of the renal arteries to the iliac bifurcation; for other than rupture (eg, for aneurysm, pseudoaneurysm, dissection, penetrating ulcer)

endovascular repair of infrarenal aorta and/or iliac artery(ies) by deployment of an aorto-uni-iliac endograft including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, all endograft extension(s) placed in the aorta from the level of the renal arteries to the iliac bifurcation, and all angioplasty/stenting performed from the level of the renal arteries to the iliac bifurcation; for rupture including temporary aortic and/or iliac balloon occlusion, when performed (eg, for aneurysm, pseudoaneurysm, dissection, penetrating ulcer, traumatic disruption)

endovascular repair of infrarenal aorta and/or iliac artery(ies) by deployment of an aorto-bi-iliac endograft including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, all endograft extension(s) placed in the aorta from the level of the renal arteries to the iliac bifurcation, and all angioplasty/stenting performed from the level of the renal arteries to the iliac bifurcation; for other than rupture (eg, for aneurysm, pseudoaneurysm, dissection, penetrating ulcer)

endovascular repair of infrarenal aorta and/or iliac artery(ies) by deployment of an aorto-bi-iliac endograft including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, all endograft extension(s) placed in the aorta from the level of the renal arteries to the iliac bifurcation, and all angioplasty/stenting performed from the level of the renal arteries to the iliac bifurcation; for rupture including temporary aortic and/or iliac balloon occlusion, when performed (eg, for aneurysm, pseudoaneurysm, dissection, penetrating ulcer, traumatic disruption)

endovascular repair of iliac artery by deployment of an ilio-iliac tube endograft including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, and all endograft extension(s) proximally to the aortic bifurcation and distally to the iliac bifurcation, and treatment zone angioplasty/stenting, when performed, unilateral; for other than rupture (eg, for aneurysm, pseudoaneurysm, dissection, arteriovenous malformation)

endovascular repair of iliac artery by deployment of an ilio-iliac tube endograft including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, and all endograft extension(s) proximally to the aortic bifurcation and distally to the iliac bifurcation, and treatment zone angioplasty/stenting, when performed, unilateral; for rupture including temporary aortic and/or iliac balloon occlusion, when performed (eg, for aneurysm, pseudoaneurysm, dissection, arteriovenous malformation, traumatic disruption)

placement of extension prosthesis(es) distal to the common iliac artery(ies) or proximal to the renal artery(ies) for endovascular repair of infrarenal abdominal aortic or iliac aneurysm, false aneurysm, dissection, penetrating ulcer, including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, and treatment zone angioplasty/stenting, when performed, per vessel treated (list separately in addition to code for primary procedure)

delayed placement of distal or proximal extension prosthesis for endovascular repair of infrarenal abdominal aortic or iliac aneurysm, false aneurysm, dissection, endoleak, or endograft migration, including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, and treatment zone angioplasty/stenting, when performed; initial vessel treated

delayed placement of distal or proximal extension prosthesis for endovascular repair of infrarenal abdominal aortic or iliac aneurysm, false aneurysm, dissection, endoleak, or endograft migration, including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation, and treatment zone angioplasty/stenting, when performed; each additional vessel treated (list separately in addition to code for primary procedure)

transcatheter delivery of enhanced fixation device(s) to the endograft (eg, anchor, screw, tack) and all associated radiological supervision and interpretation

percutaneous access and closure of femoral artery for delivery of endograft through a large sheath (12 french or larger), including ultrasound guidance, when performed, unilateral (list separately in addition to code for primary procedure)

open femoral artery exposure with creation of conduit for delivery of endovascular prosthesis or for establishment of cardiopulmonary bypass, by groin incision, unilateral (list separately in addition to code for primary procedure)

open axillary/subclavian artery exposure for delivery of endovascular prosthesis by infraclavicular or supraclavicular incision, unilateral (list separately in addition to code for primary procedure)

open axillary/subclavian artery exposure with creation of conduit for delivery of endovascular prosthesis or for establishment of cardiopulmonary bypass, by infraclavicular or supraclavicular incision, unilateral (list separately in addition to code for primary procedure)

disease prognosis for rheumatoid arthritis assessed, poor prognosis documented (ra)

disease prognosis for rheumatoid arthritis assessed, good prognosis documented (ra)

endovascular placement of iliac artery occlusion device (list separately in addition to code for primary procedure)

open femoral artery exposure for delivery of endovascular prosthesis, by groin incision, unilateral (list separately in addition to code for primary procedure)

placement of femoral-femoral prosthetic graft during endovascular aortic aneurysm repair (list separately in addition to code for primary procedure)

open iliac artery exposure for delivery of endovascular prosthesis or iliac occlusion during endovascular therapy, by abdominal or retroperitoneal incision, unilateral (list separately in addition to code for primary procedure)

open repair of infrarenal aortic aneurysm or dissection, plus repair of associated arterial trauma, following unsuccessful endovascular repair; tube prosthesis

open repair of infrarenal aortic aneurysm or dissection, plus repair of associated arterial trauma, following unsuccessful endovascular repair; aorto-bi-iliac prosthesis

open repair of infrarenal aortic aneurysm or dissection, plus repair of associated arterial trauma, following unsuccessful endovascular repair; aorto-bifemoral prosthesis

open iliac artery exposure with creation of conduit for delivery of endovascular prosthesis or for establishment of cardiopulmonary bypass, by abdominal or retroperitoneal incision, unilateral (list separately in addition to code for primary procedure)

open brachial artery exposure for delivery of endovascular prosthesis, unilateral (list separately in addition to code for primary procedure)

physician planning of a patient-specific fenestrated visceral aortic endograft requiring a minimum of 90 minutes of physician time

endovascular repair of visceral aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption) by deployment of a fenestrated visceral aortic endograft and all associated radiological supervision and interpretation, including target zone angioplasty, when performed; including one visceral artery endoprosthesis (superior mesenteric, celiac or renal artery)

endovascular repair of visceral aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption) by deployment of a fenestrated visceral aortic endograft and all associated radiological supervision and interpretation, including target zone angioplasty, when performed; including two visceral artery endoprostheses (superior mesenteric, celiac and/or renal artery[s])

endovascular repair of visceral aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption) by deployment of a fenestrated visceral aortic endograft and all associated radiological supervision and interpretation, including target zone angioplasty, when performed; including three visceral artery endoprostheses (superior mesenteric, celiac and/or renal artery[s])

endovascular repair of visceral aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption) by deployment of a fenestrated visceral aortic endograft and all associated radiological supervision and interpretation, including target zone angioplasty, when performed; including four or more visceral artery endoprostheses (superior mesenteric, celiac and/or renal artery[s])

endovascular repair of visceral aorta and infrarenal abdominal aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption) with a fenestrated visceral aortic endograft and concomitant unibody or modular infrarenal aortic endograft and all associated radiological supervision and interpretation, including target zone angioplasty, when performed; including one visceral artery endoprosthesis (superior mesenteric, celiac or renal artery)

endovascular repair of visceral aorta and infrarenal abdominal aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption) with a fenestrated visceral aortic endograft and concomitant unibody or modular infrarenal aortic endograft and all associated radiological supervision and interpretation, including target zone angioplasty, when performed; including two visceral artery endoprostheses (superior mesenteric, celiac and/or renal artery[s])

endovascular repair of visceral aorta and infrarenal abdominal aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption) with a fenestrated visceral aortic endograft and concomitant unibody or modular infrarenal aortic endograft and all associated radiological supervision and interpretation, including target zone angioplasty, when performed; including three visceral artery endoprostheses (superior mesenteric, celiac and/or renal artery[s])

endovascular repair of visceral aorta and infrarenal abdominal aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption) with a fenestrated visceral aortic endograft and concomitant unibody or modular infrarenal aortic endograft and all associated radiological supervision and interpretation, including target zone angioplasty, when performed; including four or more visceral artery endoprostheses (superior mesenteric, celiac and/or renal artery[s])

hiv indeterminate (infants of undetermined hiv status born of hiv-infected mothers) (hiv)

no history of nadir cd4+ cell count <350 cells/mm3 and no history of aids-defining condition (hiv)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm and associated occlusive disease, carotid, subclavian artery, by neck incision

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, carotid, subclavian artery, by neck incision

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, vertebral artery

cd4+ cell count or cd4+ cell percentage documented as performed (hiv)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm and associated occlusive disease, axillary-brachial artery, by arm incision

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, axillary-brachial artery, by arm incision

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, innominate, subclavian artery, by thoracic incision

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, innominate, subclavian artery, by thoracic incision

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, radial or ulnar artery

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, abdominal aorta

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, abdominal aorta

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, abdominal aorta involving visceral vessels (mesenteric, celiac, renal)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, abdominal aorta involving visceral vessels (mesenteric, celiac, renal)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, abdominal aorta involving iliac vessels (common, hypogastric, external)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, abdominal aorta involving iliac vessels (common, hypogastric, external)

documentation that tuberculosis (tb) screening test performed and results interpreted (hiv) (ibd)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, splenic artery

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, splenic artery

chlamydia and gonorrhea screenings documented as performed (hiv)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, hepatic, celiac, renal, or mesenteric artery

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, hepatic, celiac, renal, or mesenteric artery

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, iliac artery (common, hypogastric, external)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, iliac artery (common, hypogastric, external)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, common femoral artery (profunda femoris, superficial femoral)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, common femoral artery (profunda femoris, superficial femoral)

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, popliteal artery

direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, popliteal artery

hepatitis b virus (hbv) status assessed and results interpreted within one year prior to receiving a first course of anti-tnf (tumor necrosis factor) therapy (ibd)

repair, acquired or traumatic arteriovenous fistula; head and neck

repair, acquired or traumatic arteriovenous fistula; thorax and abdomen

repair, acquired or traumatic arteriovenous fistula; extremities

repair blood vessel with vein graft; intrathoracic, without bypass

repair blood vessel with graft other than vein; intrathoracic, with bypass

repair blood vessel with graft other than vein; intrathoracic, without bypass

thromboendarterectomy, including patch graft, if performed; carotid, vertebral, subclavian, by neck incision

thromboendarterectomy, including patch graft, if performed; superficial femoral artery

thromboendarterectomy, including patch graft, if performed; popliteal artery

thromboendarterectomy, including patch graft, if performed; tibioperoneal trunk artery

thromboendarterectomy, including patch graft, if performed; tibial or peroneal artery, initial vessel

thromboendarterectomy, including patch graft, if performed; each additional tibial or peroneal artery (list separately in addition to code for primary procedure)

thromboendarterectomy, including patch graft, if performed; subclavian, innominate, by thoracic incision

thromboendarterectomy, including patch graft, if performed; axillary-brachial

thromboendarterectomy, including patch graft, if performed; abdominal aorta

thromboendarterectomy, including patch graft, if performed; mesenteric, celiac, or renal

thromboendarterectomy, including patch graft, if performed; iliac

thromboendarterectomy, including patch graft, if performed; iliofemoral

thromboendarterectomy, including patch graft, if performed; combined aortoiliac

thromboendarterectomy, including patch graft, if performed; combined aortoiliofemoral

thromboendarterectomy, including patch graft, if performed; common femoral

thromboendarterectomy, including patch graft, if performed; deep (profunda) femoral

reoperation, carotid, thromboendarterectomy, more than 1 month after original operation (list separately in addition to code for primary procedure)

angioscopy (noncoronary vessels or grafts) during therapeutic intervention (list separately in addition to code for primary procedure)

harvest of upper extremity vein, 1 segment, for lower extremity or coronary artery bypass procedure (list separately in addition to code for primary procedure)

bypass graft, with vein; common carotid-ipsilateral internal carotid

bypass graft, with vein; carotid-subclavian or subclavian-carotid

bypass graft, with vein; aortosubclavian, aortoinnominate, or aortocarotid

patient had international normalized ratio (inr) measurement performed (afib)

bypass graft, with vein; femoral-anterior tibial, posterior tibial, peroneal artery or other distal vessels

bypass graft, with vein; tibial-tibial, peroneal-tibial, or tibial/peroneal trunk-tibial

bypass graft, with vein; popliteal-tibial, -peroneal artery or other distal vessels

harvest of femoropopliteal vein, 1 segment, for vascular reconstruction procedure (eg, aortic, vena caval, coronary, peripheral artery) (list separately in addition to code for primary procedure)

in-situ vein bypass; femoral-anterior tibial, posterior tibial, or peroneal artery

harvest of upper extremity artery, 1 segment, for coronary artery bypass procedure (list separately in addition to code for primary procedure)

bypass graft, with other than vein; common carotid-ipsilateral internal carotid

bypass graft, with other than vein; axillary-popliteal or -tibial

bypass graft, with other than vein; aortosubclavian, aortoinnominate, or aortocarotid

bypass graft, with other than vein; aortoceliac, aortomesenteric, aortorenal

bypass graft, with other than vein; splenorenal (splenic to renal arterial anastomosis)

bypass graft, with other than vein; femoral-anterior tibial, posterior tibial, or peroneal artery

bypass graft, with other than vein; popliteal-tibial or -peroneal artery

bypass graft; composite, prosthetic and vein (list separately in addition to code for primary procedure)

bypass graft; autogenous composite, 2 segments of veins from 2 locations (list separately in addition to code for primary procedure)

bypass graft; autogenous composite, 3 or more segments of vein from 2 or more locations (list separately in addition to code for primary procedure)

placement of vein patch or cuff at distal anastomosis of bypass graft, synthetic conduit (list separately in addition to code for primary procedure)

creation of distal arteriovenous fistula during lower extremity bypass surgery (non-hemodialysis) (list separately in addition to code for primary procedure)

transposition and/or reimplantation; vertebral to carotid artery

transposition and/or reimplantation; vertebral to subclavian artery

transposition and/or reimplantation; subclavian to carotid artery

transposition and/or reimplantation; carotid to subclavian artery

reimplantation, visceral artery to infrarenal aortic prosthesis, each artery (list separately in addition to code for primary procedure)

reoperation, femoral-popliteal or femoral (popliteal)-anterior tibial, posterior tibial, peroneal artery, or other distal vessels, more than 1 month after original operation (list separately in addition to code for primary procedure)

exploration (not followed by surgical repair), with or without lysis of artery; carotid artery

final report for bone scintigraphy study includes correlation with existing relevant imaging studies (eg, x ray, mri, ct) corresponding to the same anatomical region in question (nuc_med)

exploration (not followed by surgical repair), with or without lysis of artery; femoral artery

patient considered to be potentially at risk for fracture in a weight-bearing site (nuc_med)

patient not considered to be potentially at risk for fracture in a weight-bearing site (nuc_med)

exploration (not followed by surgical repair), with or without lysis of artery; popliteal artery

exploration (not followed by surgical repair), with or without lysis of artery; other vessels

exploration for postoperative hemorrhage, thrombosis or infection; neck

exploration for postoperative hemorrhage, thrombosis or infection; chest

exploration for postoperative hemorrhage, thrombosis or infection; abdomen

exploration for postoperative hemorrhage, thrombosis or infection; extremity

thrombectomy of arterial or venous graft (other than hemodialysis graft or fistula)

thrombectomy of arterial or venous graft (other than hemodialysis graft or fistula); with revision of arterial or venous graft

revision, lower extremity arterial bypass, without thrombectomy, open; with vein patch angioplasty

revision, lower extremity arterial bypass, without thrombectomy, open; with segmental vein interposition

revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with nonautogenous patch graft (eg, dacron, eptfe, bovine pericardium)

revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with autogenous vein patch graft

injection procedures (eg, thrombin) for percutaneous treatment of extremity pseudoaneurysm

injection procedure for extremity venography (including introduction of needle or intracatheter)

selective catheter placement, venous system; first order branch (eg, renal vein, jugular vein)

selective catheter placement, venous system; second order, or more selective, branch (eg, left adrenal vein, petrosal sinus)

selective catheter placement, segmental or subsegmental pulmonary artery

introduction of needle or intracatheter, carotid or vertebral artery

introduction of needle or intracatheter, upper or lower extremity artery

selective catheter placement, arterial system; each first order thoracic or brachiocephalic branch, within a vascular family

selective catheter placement, arterial system; initial second order thoracic or brachiocephalic branch, within a vascular family

selective catheter placement, arterial system; initial third order or more selective thoracic or brachiocephalic branch, within a vascular family

selective catheter placement, arterial system; additional second order, third order, and beyond, thoracic or brachiocephalic branch, within a vascular family (list in addition to code for initial second or third order vessel as appropriate)

non-selective catheter placement, thoracic aorta, with angiography of the extracranial carotid, vertebral, and/or intracranial vessels, unilateral or bilateral, and all associated radiological supervision and interpretation, includes angiography of the cervicocerebral arch, when performed

selective catheter placement, common carotid or innominate artery, unilateral, any approach, with angiography of the ipsilateral extracranial carotid circulation and all associated radiological supervision and interpretation, includes angiography of the cervicocerebral arch, when performed

selective catheter placement, common carotid or innominate artery, unilateral, any approach, with angiography of the ipsilateral intracranial carotid circulation and all associated radiological supervision and interpretation, includes angiography of the extracranial carotid and cervicocerebral arch, when performed

selective catheter placement, internal carotid artery, unilateral, with angiography of the ipsilateral intracranial carotid circulation and all associated radiological supervision and interpretation, includes angiography of the extracranial carotid and cervicocerebral arch, when performed

selective catheter placement, subclavian or innominate artery, unilateral, with angiography of the ipsilateral vertebral circulation and all associated radiological supervision and interpretation, includes angiography of the cervicocerebral arch, when performed

selective catheter placement, vertebral artery, unilateral, with angiography of the ipsilateral vertebral circulation and all associated radiological supervision and interpretation, includes angiography of the cervicocerebral arch, when performed

selective catheter placement, external carotid artery, unilateral, with angiography of the ipsilateral external carotid circulation and all associated radiological supervision and interpretation (list separately in addition to code for primary procedure)

selective catheter placement, each intracranial branch of the internal carotid or vertebral arteries, unilateral, with angiography of the selected vessel circulation and all associated radiological supervision and interpretation (eg, middle cerebral artery, posterior inferior cerebellar artery) (list separately in addition to code for primary procedure)

selective catheter placement, arterial system; each first order abdominal, pelvic, or lower extremity artery branch, within a vascular family

selective catheter placement, arterial system; initial second order abdominal, pelvic, or lower extremity artery branch, within a vascular family

selective catheter placement, arterial system; initial third order or more selective abdominal, pelvic, or lower extremity artery branch, within a vascular family

selective catheter placement, arterial system; additional second order, third order, and beyond, abdominal, pelvic, or lower extremity artery branch, within a vascular family (list in addition to code for initial second or third order vessel as appropriate)

selective catheter placement (first-order), main renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture and catheter placement(s), fluoroscopy, contrast injection(s), image postprocessing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; unilateral

selective catheter placement (first-order), main renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture and catheter placement(s), fluoroscopy, contrast injection(s), image postprocessing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; bilateral

superselective catheter placement (one or more second order or higher renal artery branches) renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture, catheterization, fluoroscopy, contrast injection(s), image postprocessing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; unilateral

superselective catheter placement (one or more second order or higher renal artery branches) renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture, catheterization, fluoroscopy, contrast injection(s), image postprocessing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; bilateral

insertion of implantable intra-arterial infusion pump (eg, for chemotherapy of liver)

venipuncture, younger than age 3 years, necessitating the skill of a physician or other qualified health care professional, not to be used for routine venipuncture; femoral or jugular vein

venipuncture, younger than age 3 years, necessitating the skill of a physician or other qualified health care professional, not to be used for routine venipuncture; scalp vein

venipuncture, younger than age 3 years, necessitating the skill of a physician or other qualified health care professional, not to be used for routine venipuncture; other vein

venipuncture, age 3 years or older, necessitating the skill of a physician or other qualified health care professional (separate procedure), for diagnostic or therapeutic purposes (not to be used for routine venipuncture)

collection of capillary blood specimen (eg, finger, heel, ear stick)

partial exchange transfusion, blood, plasma or crystalloid necessitating the skill of a physician or other qualified health care professional, newborn

injection of non-compounded foam sclerosant with ultrasound compression maneuvers to guide dispersion of the injectate, inclusive of all imaging guidance and monitoring; single incompetent extremity truncal vein (eg, great saphenous vein, accessory saphenous vein)

injection of non-compounded foam sclerosant with ultrasound compression maneuvers to guide dispersion of the injectate, inclusive of all imaging guidance and monitoring; multiple incompetent truncal veins (eg, great saphenous vein, accessory saphenous vein), same leg

injection(s) of sclerosant for spider veins (telangiectasia), limb or trunk

injection of sclerosant; single incompetent vein (other than telangiectasia)

injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg

endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; first vein treated

endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; subsequent vein(s) treated in a single extremity, each through separate access sites (list separately in addition to code for primary procedure)

endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; first vein treated

endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; subsequent vein(s) treated in a single extremity, each through separate access sites (list separately in addition to code for primary procedure)

endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, laser; first vein treated

endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, laser; subsequent vein(s) treated in a single extremity, each through separate access sites (list separately in addition to code for primary procedure)

endovenous ablation therapy of incompetent vein, extremity, by transcatheter delivery of a chemical adhesive (eg, cyanoacrylate) remote from the access site, inclusive of all imaging guidance and monitoring, percutaneous; first vein treated

endovenous ablation therapy of incompetent vein, extremity, by transcatheter delivery of a chemical adhesive (eg, cyanoacrylate) remote from the access site, inclusive of all imaging guidance and monitoring, percutaneous; subsequent vein(s) treated in a single extremity, each through separate access sites (list separately in addition to code for primary procedure)

catheterization of umbilical vein for diagnosis or therapy, newborn

therapeutic apheresis; with extracorporeal immunoadsorption, selective adsorption or selective filtration and plasma reinfusion

insertion of non-tunneled centrally inserted central venous catheter; younger than 5 years of age

insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older

insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; younger than 5 years of age

insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older

insertion of tunneled centrally inserted central venous access device, with subcutaneous port; younger than 5 years of age

insertion of tunneled centrally inserted central venous access device, with subcutaneous port; age 5 years or older

insertion of tunneled centrally inserted central venous access device with subcutaneous pump

insertion of tunneled centrally inserted central venous access device, requiring 2 catheters via 2 separate venous access sites; without subcutaneous port or pump (eg, tesio type catheter)

insertion of tunneled centrally inserted central venous access device, requiring 2 catheters via 2 separate venous access sites; with subcutaneous port(s)

insertion of peripherally inserted central venous catheter (picc), without subcutaneous port or pump; younger than 5 years of age

insertion of peripherally inserted central venous catheter (picc), without subcutaneous port or pump; age 5 years or older

insertion of peripherally inserted central venous access device, with subcutaneous port; younger than 5 years of age

insertion of peripherally inserted central venous access device, with subcutaneous port; age 5 years or older

repair of tunneled or non-tunneled central venous access catheter, without subcutaneous port or pump, central or peripheral insertion site

repair of central venous access device, with subcutaneous port or pump, central or peripheral insertion site

replacement, catheter only, of central venous access device, with subcutaneous port or pump, central or peripheral insertion site

replacement, complete, of a non-tunneled centrally inserted central venous catheter, without subcutaneous port or pump, through same venous access

replacement, complete, of a tunneled centrally inserted central venous catheter, without subcutaneous port or pump, through same venous access

replacement, complete, of a tunneled centrally inserted central venous access device, with subcutaneous port, through same venous access

replacement, complete, of a tunneled centrally inserted central venous access device, with subcutaneous pump, through same venous access

replacement, complete, of a peripherally inserted central venous catheter (picc), without subcutaneous port or pump, through same venous access

replacement, complete, of a peripherally inserted central venous access device, with subcutaneous port, through same venous access

removal of tunneled central venous catheter, without subcutaneous port or pump

removal of tunneled central venous access device, with subcutaneous port or pump, central or peripheral insertion

collection of blood specimen from a completely implantable venous access device

collection of blood specimen using established central or peripheral catheter, venous, not otherwise specified

declotting by thrombolytic agent of implanted vascular access device or catheter

mechanical removal of pericatheter obstructive material (eg, fibrin sheath) from central venous device via separate venous access

mechanical removal of intraluminal (intracatheter) obstructive material from central venous device through device lumen

repositioning of previously placed central venous catheter under fluoroscopic guidance

contrast injection(s) for radiologic evaluation of existing central venous access device, including fluoroscopy, image documentation and report

arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous

arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); cutdown

arterial catheterization for prolonged infusion therapy (chemotherapy), cutdown

catheterization, umbilical artery, newborn, for diagnosis or therapy

insertion of cannula for hemodialysis, other purpose (separate procedure); vein to vein

insertion of cannula for hemodialysis, other purpose (separate procedure); arteriovenous, external (scribner type)

insertion of cannula for hemodialysis, other purpose (separate procedure); arteriovenous, external revision, or closure

arteriovenous anastomosis, open; by upper arm cephalic vein transposition

arteriovenous anastomosis, open; by upper arm basilic vein transposition

arteriovenous anastomosis, open; direct, any site (eg, cimino type) (separate procedure)

insertion of arterial and venous cannula(s) for isolated extracorporeal circulation including regional chemotherapy perfusion to an extremity, with or without hyperthermia, with removal of cannula(s) and repair of arteriotomy and venotomy sites

creation of arteriovenous fistula by other than direct arteriovenous anastomosis (separate procedure); autogenous graft

creation of arteriovenous fistula by other than direct arteriovenous anastomosis (separate procedure); nonautogenous graft (eg, biological collagen, thermoplastic graft)

thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure)

revision, open, arteriovenous fistula; without thrombectomy, autogenous or nonautogenous dialysis graft (separate procedure)

revision, open, arteriovenous fistula; with thrombectomy, autogenous or nonautogenous dialysis graft (separate procedure)

distal revascularization and interval ligation (dril), upper extremity hemodialysis access (steal syndrome)

external cannula declotting (separate procedure); without balloon catheter

external cannula declotting (separate procedure); with balloon catheter

introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, radiological supervision and interpretation and image documentation and report

introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, radiological supervision and interpretation and image documentation and report; with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty

introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, radiological supervision and interpretation and image documentation and report; with transcatheter placement of intravascular stent(s), peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the stenting, and all angioplasty within the peripheral dialysis segment

percutaneous transluminal mechanical thrombectomy and/or infusion for thrombolysis, dialysis circuit, any method, including all imaging and radiological supervision and interpretation, diagnostic angiography, fluoroscopic guidance, catheter placement(s), and intraprocedural pharmacological thrombolytic injection(s)

percutaneous transluminal mechanical thrombectomy and/or infusion for thrombolysis, dialysis circuit, any method, including all imaging and radiological supervision and interpretation, diagnostic angiography, fluoroscopic guidance, catheter placement(s), and intraprocedural pharmacological thrombolytic injection(s); with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty

percutaneous transluminal mechanical thrombectomy and/or infusion for thrombolysis, dialysis circuit, any method, including all imaging and radiological supervision and interpretation, diagnostic angiography, fluoroscopic guidance, catheter placement(s), and intraprocedural pharmacological thrombolytic injection(s); with transcatheter placement of intravascular stent(s), peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the stenting, and all angioplasty within the peripheral dialysis circuit

transluminal balloon angioplasty, central dialysis segment, performed through dialysis circuit, including all imaging and radiological supervision and interpretation required to perform the angioplasty (list separately in addition to code for primary procedure)

transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging and radiological supervision and interpretation required to perform the stenting, and all angioplasty in the central dialysis segment (list separately in addition to code for primary procedure)

dialysis circuit permanent vascular embolization or occlusion (including main circuit or any accessory veins), endovascular, including all imaging and radiological supervision and interpretation necessary to complete the intervention (list separately in addition to code for primary procedure)

venous anastomosis, open; splenorenal, distal (selective decompression of esophagogastric varices, any technique)

insertion of transvenous intrahepatic portosystemic shunt(s) (tips) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract formation/dilatation, stent placement and all associated imaging guidance and documentation)

revision of transvenous intrahepatic portosystemic shunt(s) (tips) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract recanulization/dilatation, stent placement and all associated imaging guidance and documentation)

primary percutaneous transluminal mechanical thrombectomy, noncoronary, non-intracranial, arterial or arterial bypass graft, including fluoroscopic guidance and intraprocedural pharmacological thrombolytic injection(s); initial vessel

primary percutaneous transluminal mechanical thrombectomy, noncoronary, non-intracranial, arterial or arterial bypass graft, including fluoroscopic guidance and intraprocedural pharmacological thrombolytic injection(s); second and all subsequent vessel(s) within the same vascular family (list separately in addition to code for primary mechanical thrombectomy procedure)

secondary percutaneous transluminal thrombectomy (eg, nonprimary mechanical, snare basket, suction technique), noncoronary, non-intracranial, arterial or arterial bypass graft, including fluoroscopic guidance and intraprocedural pharmacological thrombolytic injections, provided in conjunction with another percutaneous intervention other than primary mechanical thrombectomy (list separately in addition to code for primary procedure)

percutaneous transluminal mechanical thrombectomy, vein(s), including intraprocedural pharmacological thrombolytic injections and fluoroscopic guidance

percutaneous transluminal mechanical thrombectomy, vein(s), including intraprocedural pharmacological thrombolytic injections and fluoroscopic guidance, repeat treatment on subsequent day during course of thrombolytic therapy

insertion of intravascular vena cava filter, endovascular approach including vascular access, vessel selection, and radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance (ultrasound and fluoroscopy), when performed

repositioning of intravascular vena cava filter, endovascular approach including vascular access, vessel selection, and radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance (ultrasound and fluoroscopy), when performed

retrieval (removal) of intravascular vena cava filter, endovascular approach including vascular access, vessel selection, and radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance (ultrasound and fluoroscopy), when performed

transcatheter retrieval, percutaneous, of intravascular foreign body (eg, fractured venous or arterial catheter), includes radiological supervision and interpretation, and imaging guidance (ultrasound or fluoroscopy), when performed

transcatheter therapy, arterial infusion for thrombolysis other than coronary or intracranial, any method, including radiological supervision and interpretation, initial treatment day

transcatheter therapy, venous infusion for thrombolysis, any method, including radiological supervision and interpretation, initial treatment day

transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up catheter contrast injection, position change, or exchange, when performed

transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up catheter contrast injection, position change, or exchange, when performed; cessation of thrombolysis including removal of catheter and vessel closure by any method

transcatheter placement of intravascular stent(s), cervical carotid artery, open or percutaneous, including angioplasty, when performed, and radiological supervision and interpretation; with distal embolic protection

transcatheter placement of intravascular stent(s), cervical carotid artery, open or percutaneous, including angioplasty, when performed, and radiological supervision and interpretation; without distal embolic protection

transcatheter placement of intravascular stent(s), intrathoracic common carotid artery or innominate artery by retrograde treatment, open ipsilateral cervical carotid artery exposure, including angioplasty, when performed, and radiological supervision and interpretation

transcatheter placement of intravascular stent(s), intrathoracic common carotid artery or innominate artery, open or percutaneous antegrade approach, including angioplasty, when performed, and radiological supervision and interpretation

revascularization, endovascular, open or percutaneous, iliac artery, unilateral, initial vessel; with transluminal angioplasty

revascularization, endovascular, open or percutaneous, iliac artery, unilateral, initial vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed

revascularization, endovascular, open or percutaneous, iliac artery, each additional ipsilateral iliac vessel; with transluminal angioplasty (list separately in addition to code for primary procedure)

revascularization, endovascular, open or percutaneous, iliac artery, each additional ipsilateral iliac vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed (list separately in addition to code for primary procedure)

revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with transluminal angioplasty

revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with atherectomy, includes angioplasty within the same vessel, when performed

revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed

revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with transluminal stent placement(s) and atherectomy, includes angioplasty within the same vessel, when performed

revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal angioplasty

revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with atherectomy, includes angioplasty within the same vessel, when performed

revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed

revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal stent placement(s) and atherectomy, includes angioplasty within the same vessel, when performed

revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with transluminal angioplasty (list separately in addition to code for primary procedure)

revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with atherectomy, includes angioplasty within the same vessel, when performed (list separately in addition to code for primary procedure)

revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed (list separately in addition to code for primary procedure)

revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with transluminal stent placement(s) and atherectomy, includes angioplasty within the same vessel, when performed (list separately in addition to code for primary procedure)

transcatheter placement of an intravascular stent(s) (except lower extremity artery(s) for occlusive disease, cervical carotid, extracranial vertebral or intrathoracic carotid, intracranial, or coronary), open or percutaneous, including radiological supervision and interpretation and including all angioplasty within the same vessel, when performed; initial artery

transcatheter placement of an intravascular stent(s) (except lower extremity artery(s) for occlusive disease, cervical carotid, extracranial vertebral or intrathoracic carotid, intracranial, or coronary), open or percutaneous, including radiological supervision and interpretation and including all angioplasty within the same vessel, when performed; each additional artery (list separately in addition to code for primary procedure)

transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; initial vein

transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; each additional vein (list separately in addition to code for primary procedure)

vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; venous, other than hemorrhage (eg, congenital or acquired venous malformations, venous and capillary hemangiomas, varices, varicoceles)

vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; arterial, other than hemorrhage or tumor (eg, congenital or acquired arterial malformations, arteriovenous malformations, arteriovenous fistulas, aneurysms, pseudoaneurysms)

vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction

vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for arterial or venous hemorrhage or lymphatic extravasation

transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery; initial artery

transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery; each additional artery (list separately in addition to code for primary procedure)

transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein; initial vein

transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein; each additional vein (list separately in addition to code for primary procedure)

intravascular ultrasound (noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation; initial noncoronary vessel (list separately in addition to code for primary procedure)

intravascular ultrasound (noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation; each additional noncoronary vessel (list separately in addition to code for primary procedure)

vascular endoscopy, surgical, with ligation of perforator veins, subfascial (seps)

patient not receiving dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days (ibd)

electrodiagnostic studies for distal symmetric polyneuropathy conducted (or requested), documented, and reviewed within 6 months of initial evaluation for condition (dsp)

electrodiagnostic studies for distal symmetric polyneuropathy not conducted (or requested), documented, or reviewed within 6 months of initial evaluation for condition (dsp)

patient has clear clinical symptoms and signs that are highly suggestive of neuropathy and cannot be attributed to another condition, and has an obvious cause for the neuropathy (dsp)

screening tests for diabetes mellitus reviewed, requested, or ordered (dsp)

patient has pseudobulbar affect, sialorrhea, or als-related symptoms (als)

patient does not have pseudobulbar affect, sialorrhea, or als-related symptoms (als)

patient referred for pulmonary function testing or peak cough expiratory flow (als)

patient screened for dysphagia, weight loss, and impaired nutrition, and results documented (als)

ligation; internal or common carotid artery, with gradual occlusion, as with selverstone or crutchfield clamp

patient exhibits dysphagia, weight loss, or impaired nutrition (als)

patient does not exhibit dysphagia, weight loss, or impaired nutrition (als)

ligation and division of long saphenous vein at saphenofemoral junction, or distal interruptions

ligation, division, and stripping, long (greater) saphenous veins from saphenofemoral junction to knee or below

ligation and division and complete stripping of long or short saphenous veins with radical excision of ulcer and skin graft and/or interruption of communicating veins of lower leg, with excision of deep fascia

adenoma(s) or other neoplasm detected during screening colonoscopy (scadr)

ligation of perforator veins, subfascial, radical (linton type), including skin graft, when performed, open,1 leg

ligation of perforator vein(s), subfascial, open, including ultrasound guidance, when performed, 1 leg

stab phlebectomy of varicose veins, 1 extremity; 10-20 stab incisions

stab phlebectomy of varicose veins, 1 extremity; more than 20 incisions

adenoma(s) or other neoplasm not detected during screening colonoscopy (scadr)

ligation and division of short saphenous vein at saphenopopliteal junction (separate procedure)

ligation, division, and/or excision of varicose vein cluster(s), 1 leg

splenectomy; total, en bloc for extensive disease, in conjunction with other procedure (list in addition to code for primary procedure)

repair of ruptured spleen (splenorrhaphy) with or without partial splenectomy

management of recipient hematopoietic progenitor cell donor search and cell acquisition

blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; allogeneic

blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous

transplant preparation of hematopoietic progenitor cells; cryopreservation and storage

transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washing, per donor

transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, with washing, per donor

transplant preparation of hematopoietic progenitor cells; specific cell depletion within harvest, t-cell depletion

transplant preparation of hematopoietic progenitor cells; tumor cell depletion

transplant preparation of hematopoietic progenitor cells; red blood cell removal

transplant preparation of hematopoietic progenitor cells; platelet depletion

transplant preparation of hematopoietic progenitor cells; plasma (volume) depletion

transplant preparation of hematopoietic progenitor cells; cell concentration in plasma, mononuclear, or buffy coat layer

hematopoietic progenitor cell (hpc); allogeneic transplantation per donor

biopsy or excision of lymph node(s); by needle, superficial (eg, cervical, inguinal, axillary)

biopsy or excision of lymph node(s); open, deep cervical node(s)

biopsy or excision of lymph node(s); open, deep cervical node(s) with excision scalene fat pad

biopsy or excision of lymph node(s); open, deep axillary node(s)

biopsy or excision of lymph node(s); open, internal mammary node(s)

excision of cystic hygroma, axillary or cervical; without deep neurovascular dissection

excision of cystic hygroma, axillary or cervical; with deep neurovascular dissection

limited lymphadenectomy for staging (separate procedure); pelvic and para-aortic

limited lymphadenectomy for staging (separate procedure); retroperitoneal (aortic and/or splenic)

laparoscopy, surgical; with retroperitoneal lymph node sampling (biopsy), single or multiple

laparoscopy, surgical; with bilateral total pelvic lymphadenectomy

laparoscopy, surgical; with bilateral total pelvic lymphadenectomy and peri-aortic lymph node sampling (biopsy), single or multiple

laparoscopy, surgical; with bilateral total pelvic lymphadenectomy and peri-aortic lymph node sampling, peritoneal washings, peritoneal biopsy(ies), omentectomy, and diaphragmatic washings, including diaphragmatic and other serosal biopsy(ies), when performed

thoracic lymphadenectomy by thoracotomy, mediastinal and regional lymphadenectomy (list separately in addition to code for primary procedure)

abdominal lymphadenectomy, regional, including celiac, gastric, portal, peripancreatic, with or without para-aortic and vena caval nodes (list separately in addition to code for primary procedure)

inguinofemoral lymphadenectomy, superficial, including cloquet's node (separate procedure)

inguinofemoral lymphadenectomy, superficial, in continuity with pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes (separate procedure)

pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes (separate procedure)

retroperitoneal transabdominal lymphadenectomy, extensive, including pelvic, aortic, and renal nodes (separate procedure)

injection procedure; radioactive tracer for identification of sentinel node

intraoperative identification (eg, mapping) of sentinel lymph node(s) includes injection of non-radioactive dye, when performed (list separately in addition to code for primary procedure)

mediastinotomy with exploration, drainage, removal of foreign body, or biopsy; cervical approach

mediastinotomy with exploration, drainage, removal of foreign body, or biopsy; transthoracic approach, including either transthoracic or median sternotomy

mediastinoscopy; includes biopsy(ies) of mediastinal mass (eg, lymphoma), when performed

mediastinoscopy; with lymph node biopsy(ies) (eg, lung cancer staging)

repair, neonatal diaphragmatic hernia, with or without chest tube insertion and with or without creation of ventral hernia

repair, diaphragmatic hernia (other than neonatal), traumatic; acute

repair, diaphragmatic hernia (other than neonatal), traumatic; chronic

imbrication of diaphragm for eventration, transthoracic or transabdominal, paralytic or nonparalytic

resection, diaphragm; with complex repair (eg, prosthetic material, local muscle flap)

tobacco use cessation intervention, counseling (copd, cap, cad, asthma) (dm) (pv)

tobacco use cessation intervention, pharmacologic therapy (copd, cad, cap, pv, asthma) (dm) (pv)

patient education, written/oral, appropriate for patients with heart failure, performed (nma-no measure associated)

patient screened for tobacco use and received tobacco cessation intervention (counseling, pharmacotherapy, or both), if identified as a tobacco user (pv, cad)

pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed (op) (ibd)

beta-blocker therapy prescribed or currently being taken (cad,hf)

angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed or currently being taken (cad, ckd, hf) (dm)

written discharge instructions provided to heart failure patients discharged home (instructions include all of the following components: activity level, diet, discharge medications, follow-up appointment, weight monitoring, what to do if symptoms worsen) (nma-no measure associated)

persistent asthma, preferred long term control medication or an acceptable alternative treatment, prescribed (nma-no measure associated)

anti-inflammatory/analgesic agent prescribed (oa) (use for prescribed or continued medication[s], including over-the-counter medication[s])

therapeutic exercise for the involved joint(s) instructed or physical or occupational therapy prescribed (oa)

documentation of receipt of counseling on exercise and either both calcium and vitamin d use or counseling regarding both calcium and vitamin d use (op)

long-term oxygen therapy prescribed (more than 15 hours per day) (copd)

influenza immunization ordered or administered (copd, pv, ckd, esrd)(ibd)

pneumococcal vaccine administered or previously received (copd) (pv), (ibd)

documentation of order for cefazolin or cefuroxime for antimicrobial prophylaxis (peri 2)

documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor given intraoperatively (peri 2)

documentation that an order was given to discontinue prophylactic antibiotics within 48 hours of surgical end time, cardiac procedures (peri 2)

documentation that an order was given for venous thromboembolism (vte) prophylaxis to be given within 24 hours prior to incision time or 24 hours after surgery end time (peri 2)

documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or given intraoperatively (peri 2)

documentation of order for prophylactic parenteral antibiotics to be given within 1 hour (if fluoroquinolone or vancomycin, 2 hours) prior to surgical incision (or start of procedure when no incision is required) (peri 2)

documentation that administration of prophylactic parenteral antibiotic was initiated within 1 hour (if fluoroquinolone or vancomycin, 2 hours) prior to surgical incision (or start of procedure when no incision is required) as ordered (peri 2)

documentation that order was given to discontinue prophylactic antibiotics within 24 hours of surgical end time, non-cardiac procedure (peri 2)

hypertension plan of care documented as appropriate (nma-no measure associated)

excision of lip; full thickness, reconstruction with local flap (eg, estlander or fan)

excision of lip; full thickness, reconstruction with cross lip flap (abbe-estlander)

antidepressant pharmacotherapy considered and not prescribed (mdd adol)

repair lip, full thickness; over one-half vertical height, or complex

patient referral for electroconvulsive therapy (ect) documented (mdd)

plastic repair of cleft lip/nasal deformity; primary, partial or complete, unilateral

plastic repair of cleft lip/nasal deformity; primary bilateral, 1-stage procedure

plastic repair of cleft lip/nasal deformity; primary bilateral, 1 of 2 stages

deep vein thrombosis (dvt) prophylaxis received by end of hospital day 2 (str)

plastic repair of cleft lip/nasal deformity; secondary, by recreation of defect and reclosure

plastic repair of cleft lip/nasal deformity; with cross lip pedicle flap (abbe-estlander type), including sectioning and inserting of pedicle

documentation that tissue plasminogen activator (t-pa) administration was considered (str)

documentation that rehabilitation services were considered (str)

drainage of abscess, cyst, hematoma, vestibule of mouth; complicated

removal of embedded foreign body, vestibule of mouth; complicated

excision of lesion of mucosa and submucosa, vestibule of mouth; without repair

excision of lesion of mucosa and submucosa, vestibule of mouth; with simple repair

excision of lesion of mucosa and submucosa, vestibule of mouth; with complex repair

excision of lesion of mucosa and submucosa, vestibule of mouth; complex, with excision of underlying muscle

excision of frenum, labial or buccal (frenumectomy, frenulectomy, frenectomy)

destruction of lesion or scar of vestibule of mouth by physical methods (eg, laser, thermal, cryo, chemical)

closure of laceration, vestibule of mouth; over 2.5 cm or complex

vestibuloplasty; complex (including ridge extension, muscle repositioning)

aspirin received within 24 hours before emergency department arrival or during emergency department stay (em)

aspirin or clopidogrel prescribed or currently being taken (cad)

intraoral incision and drainage of abscess, cyst, or hematoma of tongue or floor of mouth; lingual

intraoral incision and drainage of abscess, cyst, or hematoma of tongue or floor of mouth; sublingual, superficial

intraoral incision and drainage of abscess, cyst, or hematoma of tongue or floor of mouth; sublingual, deep, supramylohyoid

intraoral incision and drainage of abscess, cyst, or hematoma of tongue or floor of mouth; submental space

intraoral incision and drainage of abscess, cyst, or hematoma of tongue or floor of mouth; submandibular space

intraoral incision and drainage of abscess, cyst, or hematoma of tongue or floor of mouth; masticator space

extraoral incision and drainage of abscess, cyst, or hematoma of floor of mouth; sublingual

extraoral incision and drainage of abscess, cyst, or hematoma of floor of mouth; submental

extraoral incision and drainage of abscess, cyst, or hematoma of floor of mouth; submandibular

extraoral incision and drainage of abscess, cyst, or hematoma of floor of mouth; masticator space

placement of needles, catheters, or other device(s) into the head and/or neck region (percutaneous, transoral, or transnasal) for subsequent interstitial radioelement application

internal mammary artery graft performed for primary, isolated coronary artery bypass graft procedure (cabg)

excision of lesion of tongue with closure; with local tongue flap

glossectomy; complete or total, with or without tracheostomy, without radical neck dissection

glossectomy; complete or total, with or without tracheostomy, with unilateral radical neck dissection

glossectomy; composite procedure with resection floor of mouth and mandibular resection, without radical neck dissection

glossectomy; composite procedure with resection floor of mouth, with suprahyoid neck dissection

glossectomy; composite procedure with resection floor of mouth, mandibular resection, and radical neck dissection (commando type)

beta blocker administered within 24 hours prior to surgical incision (cabg)

antibiotic neither prescribed nor dispensed (uri, phar), (a-bronch)

repair of laceration 2.5 cm or less; floor of mouth and/or anterior two-thirds of tongue

repair of laceration 2.5 cm or less; posterior one-third of tongue

repair of laceration of tongue, floor of mouth, over 2.6 cm or complex

topical preparations (including otc) prescribed for acute otitis externa (aoe)

antihistamines or decongestants neither prescribed nor recommended (ome)

two or more anti-hypertensive agents prescribed or currently being taken (cad, htn)

hepatitis a vaccine injection administered or previously received (hep-c)

hepatitis b vaccine injection administered or previously received (hep-c, hiv) (ibd)

suture of tongue to lip for micrognathia (douglas type procedure)

patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period (hep-c)

submucosal ablation of the tongue base, radiofrequency, 1 or more sites, per session

combination peginterferon and ribavirin therapy prescribed (hep-c)

counseling regarding contraception received prior to initiation of antiviral treatment (hep-c)

patient counseling at a minimum on all of the following treatment options for clinically localized prostate cancer: active surveillance, and interstitial prostate brachytherapy, and external beam radiotherapy, and radical prostatectomy, provided prior to initiation of treatment (prca)

adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [gnrh] agonist or antagonist) prescribed/administered (prca)

3-dimensional conformal radiotherapy (3d-crt) or intensity modulated radiation therapy (imrt) received (prca)

head of bed elevation (30-45 degrees) on first ventilator day ordered (crit)

patient receiving care in the intensive care unit (icu) and receiving mechanical ventilation, 24 hours or less (crit)

patient either not receiving care in the intensive care unit (icu) or not receiving mechanical ventilation or receiving mechanical ventilation greater than 24 hours (crit)

patient receiving erythropoiesis-stimulating agents (esa) therapy (ckd)

patient not receiving erythropoiesis-stimulating agents (esa) therapy (ckd)

counseling about the potential impact of glaucoma on visual functioning and quality of life, and importance of treatment adherence provided to patient and/or caregiver(s) (ec)

best-corrected visual acuity of 20/40 or better (distance or near) achieved within the 90 days following cataract surgery (ec)

counseling about value of protection from uv light and lack of proven efficacy of nutritional supplements in prevention or progression of cataract development provided to patient and/or caregiver(s) (nma-no measure associated)

counseling about the benefits and/or risks of the age-related eye disease study (areds) formulation for preventing progression of age-related macular degeneration (amd) provided to patient and/or caregiver(s) (ec)

anti-d immune globulin received between 26 and 30 weeks gestation (pre-cr)

drainage of abscess, cyst, hematoma from dentoalveolar structures

removal of embedded foreign body from dentoalveolar structures; soft tissues

removal of embedded foreign body from dentoalveolar structures; bone

adjuvant chemotherapy referred, prescribed, or previously received for stage iii colon cancer (onc)

conformal radiation therapy received (nma-no measure associated)

excision of lesion or tumor (except listed above), dentoalveolar structures; without repair

excision of lesion or tumor (except listed above), dentoalveolar structures; with simple repair

excision of lesion or tumor (except listed above), dentoalveolar structures; with complex repair

excision of hyperplastic alveolar mucosa, each quadrant (specify)

conformal radiation therapy not received (nma-no measure associated)

destruction of lesion (except excision), dentoalveolar structures

continuous (12-months) therapy with proton pump inhibitor (ppi) or histamine h2 receptor antagonist (h2ra) received (gerd)

no continuous (12-months) therapy with either proton pump inhibitor (ppi) or histamine h2 receptor antagonist (h2ra) received (gerd)

disease modifying anti-rheumatic drug therapy prescribed or dispensed (ra)

appropriate angiotensin converting enzyme (ace)/angiotensin receptor blockers (arb) therapeutic monitoring test ordered or performed (am)

appropriate digoxin therapeutic monitoring test ordered or performed (am)

appropriate diuretic therapeutic monitoring test ordered or performed (am)

appropriate anticonvulsant therapeutic monitoring test ordered or performed (am)

patient receiving <10 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months (ra)

patient receiving >=10 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity (ra)

patient receiving first-time biologic disease modifying anti-rheumatic drug therapy for rheumatoid arthritis (ra)

patient not receiving first-time biologic disease modifying anti-rheumatic drug therapy for rheumatoid arthritis (ra)

external beam radiotherapy as primary therapy to prostate with or without nodal irradiation (prca)

external beam radiotherapy with or without nodal irradiation as adjuvant or salvage therapy for prostate cancer patient (prca)

angiotensin converting enzyme (ace) or angiotensin receptor blockers (arb) medication therapy for 6 months or more (mm)

palatopharyngoplasty (eg, uvulopalatopharyngoplasty, uvulopharyngoplasty)

destruction of lesion, palate or uvula (thermal, cryo or chemical)

palatoplasty for cleft palate, with closure of alveolar ridge; soft tissue only

palatoplasty for cleft palate, with closure of alveolar ridge; with bone graft to alveolar ridge (includes obtaining graft)

sialolithotomy; submandibular (submaxillary), sublingual or parotid, uncomplicated, intraoral

sialolithotomy; submandibular (submaxillary), complicated, intraoral

instruction in therapeutic exercise with follow-up provided to patients during episode of back pain lasting longer than 12 weeks (bkp)

excision of parotid tumor or parotid gland; lateral lobe, without nerve dissection

excision of parotid tumor or parotid gland; lateral lobe, with dissection and preservation of facial nerve

excision of parotid tumor or parotid gland; total, with dissection and preservation of facial nerve

excision of parotid tumor or parotid gland; total, en bloc removal with sacrifice of facial nerve

excision of parotid tumor or parotid gland; total, with unilateral radical neck dissection

counseling for supervised exercise program provided to patients during episode of back pain lasting longer than 12 weeks (bkp)

patient counseled during the initial visit to maintain or resume normal activities (bkp)

patient counseled during the initial visit for an episode of back pain against bed rest lasting 4 days or longer (bkp)

plastic repair of salivary duct, sialodochoplasty; primary or simple

plastic repair of salivary duct, sialodochoplasty; secondary or complicated

parotid duct diversion, bilateral (wilke type procedure); with excision of both submandibular glands

active warming used intraoperatively for the purpose of maintaining normothermia, or at least 1 body temperature equal to or greater than 36 degrees centigrade (or 96.8 degrees fahrenheit) recorded within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time (crit)

parotid duct diversion, bilateral (wilke type procedure); with ligation of both submandibular (wharton's) ducts

duration of general or neuraxial anesthesia 60 minutes or longer, as documented in the anesthesia record (crit) (peri2)

duration of general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record (crit) (peri2)

technique other than surface culture of the wound exudate used (eg, levine/deep swab technique, semi-quantitative or quantitative swab technique) or wound surface culture technique not used (cwc)

dilation and catheterization of salivary duct, with or without injection

use of wet to dry dressings neither prescribed nor recommended (cwc)

patient education regarding the need for long term compression therapy including interval replacement of compression stockings received (cwc)

appropriate method of offloading (pressure relief) prescribed (cwc)

patient receiving potent antiretroviral therapy for 6 months or longer (hiv)

patient receiving potent antiretroviral therapy for less than 6 months or not receiving potent antiretroviral therapy (hiv)

incision and drainage abscess; retropharyngeal or parapharyngeal, intraoral approach

incision and drainage abscess; retropharyngeal or parapharyngeal, external approach

influenza immunization administered or previously received (hiv) (p-esrd)

pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count or percentage (hiv)

excision branchial cleft cyst or vestige, confined to skin and subcutaneous tissues

excision branchial cleft cyst, vestige, or fistula, extending beneath subcutaneous tissues and/or into pharynx

radical resection of tonsil, tonsillar pillars, and/or retromolar trigone; without closure

radical resection of tonsil, tonsillar pillars, and/or retromolar trigone; closure with local flap (eg, tongue, buccal)

radical resection of tonsil, tonsillar pillars, and/or retromolar trigone; closure with other flap

excision or destruction lingual tonsil, any method (separate procedure)

resection of lateral pharyngeal wall or pyriform sinus, direct closure by advancement of lateral and posterior pharyngeal walls

resection of pharyngeal wall requiring closure with myocutaneous or fasciocutaneous flap or free muscle, skin, or fascial flap with microvascular anastomosis

control oropharyngeal hemorrhage, primary or secondary (eg, post-tonsillectomy); simple

control oropharyngeal hemorrhage, primary or secondary (eg, post-tonsillectomy); complicated, requiring hospitalization

control oropharyngeal hemorrhage, primary or secondary (eg, post-tonsillectomy); with secondary surgical intervention

control of nasopharyngeal hemorrhage, primary or secondary (eg, postadenoidectomy); simple, with posterior nasal packs, with or without anterior packs and/or cautery

control of nasopharyngeal hemorrhage, primary or secondary (eg, postadenoidectomy); complicated, requiring hospitalization

control of nasopharyngeal hemorrhage, primary or secondary (eg, postadenoidectomy); with secondary surgical intervention

patient receiving warfarin therapy for nonvalvular atrial fibrillation or atrial flutter (afib)

patient not receiving warfarin therapy for nonvalvular atrial fibrillation or atrial flutter (afib)

patient education regarding appropriate foot care and daily inspection of the feet received (cwc)

patient counseled regarding psychosocial and pharmacologic treatment options for opioid addiction (sud)

excision of lesion, esophagus, with primary repair; cervical approach

excision of lesion, esophagus, with primary repair; thoracic or abdominal approach

total or near total esophagectomy, without thoracotomy; with pharyngogastrostomy or cervical esophagogastrostomy, with or without pyloroplasty (transhiatal)

total or near total esophagectomy, without thoracotomy; with colon interposition or small intestine reconstruction, including intestine mobilization, preparation and anastomosis(es)

total or near total esophagectomy, with thoracotomy; with pharyngogastrostomy or cervical esophagogastrostomy, with or without pyloroplasty (ie, mckeown esophagectomy or tri-incisional esophagectomy)

total or near total esophagectomy, with thoracotomy; with colon interposition or small intestine reconstruction, including intestine mobilization, preparation, and anastomosis(es)

partial esophagectomy, cervical, with free intestinal graft, including microvascular anastomosis, obtaining the graft and intestinal reconstruction

partial esophagectomy, distal two-thirds, with thoracotomy and separate abdominal incision, with or without proximal gastrectomy; with thoracic esophagogastrostomy, with or without pyloroplasty (ivor lewis)

partial esophagectomy, distal two-thirds, with thoracotomy and separate abdominal incision, with or without proximal gastrectomy; with colon interposition or small intestine reconstruction, including intestine mobilization, preparation, and anastomosis(es)

partial esophagectomy, distal two-thirds, with thoracotomy only, with or without proximal gastrectomy, with thoracic esophagogastrostomy, with or without pyloroplasty

partial esophagectomy, thoracoabdominal or abdominal approach, with or without proximal gastrectomy; with esophagogastrostomy, with or without pyloroplasty

partial esophagectomy, thoracoabdominal or abdominal approach, with or without proximal gastrectomy; with colon interposition or small intestine reconstruction, including intestine mobilization, preparation, and anastomosis(es)

total or partial esophagectomy, without reconstruction (any approach), with cervical esophagostomy

diverticulectomy of hypopharynx or esophagus, with or without myotomy; cervical approach

diverticulectomy of hypopharynx or esophagus, with or without myotomy; thoracic approach

esophagoscopy, rigid, transoral with diverticulectomy of hypopharynx or cervical esophagus (eg, zenker's diverticulum), with cricopharyngeal myotomy, includes use of telescope or operating microscope and repair, when performed

esophagoscopy, rigid, transoral; diagnostic, including collection of specimen(s) by brushing or washing when performed (separate procedure)

esophagoscopy, rigid, transoral; with directed submucosal injection(s), any substance

esophagoscopy, rigid, transoral; with biopsy, single or multiple

esophagoscopy, rigid, transoral; with removal of foreign body(s)

esophagoscopy, rigid, transoral; with balloon dilation (less than 30 mm diameter)

esophagoscopy, rigid, transoral; with insertion of guide wire followed by dilation over guide wire

esophagoscopy, flexible, transnasal; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

esophagoscopy, flexible, transnasal; with biopsy, single or multiple

esophagoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

esophagoscopy, flexible, transoral; with directed submucosal injection(s), any substance

esophagoscopy, flexible, transoral; with biopsy, single or multiple

esophagoscopy, flexible, transoral; with injection sclerosis of esophageal varices

esophagoscopy, flexible, transoral; with band ligation of esophageal varices

patient counseled regarding psychosocial and pharmacologic treatment options for alcohol dependence (sud)

esophagogastroduodenoscopy, flexible, transoral; with esophagogastric fundoplasty, partial or complete, includes duodenoscopy when performed

esophagoscopy, flexible, transoral; with endoscopic mucosal resection

esophagoscopy, flexible, transoral; with placement of endoscopic stent (includes pre- and post-dilation and guide wire passage, when performed)

esophagoscopy, flexible, transoral; with dilation of esophagus, by balloon or dilator, retrograde (includes fluoroscopic guidance, when performed)

esophagoscopy, flexible, transoral; with dilation of esophagus with balloon (30 mm diameter or larger) (includes fluoroscopic guidance, when performed)

esophagoscopy, flexible, transoral; with removal of foreign body(s)

esophagoscopy, flexible, transoral; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps

esophagoscopy, flexible, transoral; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique

esophagoscopy, flexible, transoral; with transendoscopic balloon dilation (less than 30 mm diameter)

esophagoscopy, flexible, transoral; with insertion of guide wire followed by passage of dilator(s) over guide wire

esophagoscopy, flexible, transoral; with control of bleeding, any method

esophagoscopy, flexible, transoral; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed)

caregiver provided with education and referred to additional resources for support (dem)

esophagoscopy, flexible, transoral; with endoscopic ultrasound examination

esophagoscopy, flexible, transoral; with transendoscopic ultrasound-guided intramural or transmural fine needle aspiration/biopsy(s)

esophagogastroduodenoscopy, flexible, transoral; with dilation of esophagus with balloon (30 mm diameter or larger) (includes fluoroscopic guidance, when performed)

esophagogastroduodenoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

esophagogastroduodenoscopy, flexible, transoral; with directed submucosal injection(s), any substance

esophagogastroduodenoscopy, flexible, transoral; with endoscopic ultrasound examination limited to the esophagus, stomach or duodenum, and adjacent structures

esophagogastroduodenoscopy, flexible, transoral; with transendoscopic ultrasound-guided intramural or transmural fine needle aspiration/biopsy(s), (includes endoscopic ultrasound examination limited to the esophagus, stomach or duodenum, and adjacent structures)

esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple

esophagogastroduodenoscopy, flexible, transoral; with transmural drainage of pseudocyst (includes placement of transmural drainage catheter[s]/stent[s], when performed, and endoscopic ultrasound, when performed)

esophagogastroduodenoscopy, flexible, transoral; with insertion of intraluminal tube or catheter

esophagogastroduodenoscopy, flexible, transoral; with transendoscopic ultrasound-guided intramural or transmural fine needle aspiration/biopsy(s) (includes endoscopic ultrasound examination of the esophagus, stomach, and either the duodenum or a surgically altered stomach where the jejunum is examined distal to the anastomosis)

esophagogastroduodenoscopy, flexible, transoral; with injection sclerosis of esophageal/gastric varices

esophagogastroduodenoscopy, flexible, transoral; with band ligation of esophageal/gastric varices

esophagogastroduodenoscopy, flexible, transoral; with dilation of gastric/duodenal stricture(s) (eg, balloon, bougie)

esophagogastroduodenoscopy, flexible, transoral; with directed placement of percutaneous gastrostomy tube

esophagogastroduodenoscopy, flexible, transoral; with removal of foreign body(s)

esophagogastroduodenoscopy, flexible, transoral; with insertion of guide wire followed by passage of dilator(s) through esophagus over guide wire

esophagogastroduodenoscopy, flexible, transoral; with transendoscopic balloon dilation of esophagus (less than 30 mm diameter)

patient (or caregiver) queried about parkinson's disease medication related motor complications (prkns)

esophagogastroduodenoscopy, flexible, transoral; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps

esophagogastroduodenoscopy, flexible, transoral; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique

esophagogastroduodenoscopy, flexible, transoral; with optical endomicroscopy

esophagogastroduodenoscopy, flexible, transoral; with transendoscopic ultrasound-guided transmural injection of diagnostic or therapeutic substance(s) (eg, anesthetic, neurolytic agent) or fiducial marker(s) (includes endoscopic ultrasound examination of the esophagus, stomach, and either the duodenum or a surgically altered stomach where the jejunum is examined distal to the anastomosis)

esophagogastroduodenoscopy, flexible, transoral; with endoscopic mucosal resection

esophagogastroduodenoscopy, flexible, transoral; with control of bleeding, any method

esophagogastroduodenoscopy, flexible, transoral; with delivery of thermal energy to the muscle of lower esophageal sphincter and/or gastric cardia, for treatment of gastroesophageal reflux disease

esophagogastroduodenoscopy, flexible, transoral; with endoscopic ultrasound examination, including the esophagus, stomach, and either the duodenum or a surgically altered stomach where the jejunum is examined distal to the anastomosis

medical and surgical treatment options reviewed with patient (or caregiver) (prkns)

endoscopic retrograde cholangiopancreatography (ercp); diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

endoscopic retrograde cholangiopancreatography (ercp); with biopsy, single or multiple

endoscopic retrograde cholangiopancreatography (ercp); with sphincterotomy/papillotomy

endoscopic retrograde cholangiopancreatography (ercp); with pressure measurement of sphincter of oddi

endoscopic retrograde cholangiopancreatography (ercp); with removal of calculi/debris from biliary/pancreatic duct(s)

endoscopic retrograde cholangiopancreatography (ercp); with destruction of calculi, any method (eg, mechanical, electrohydraulic, lithotripsy)

esophagogastroduodenoscopy, flexible, transoral; with placement of endoscopic stent (includes pre- and post-dilation and guide wire passage, when performed)

patient (or caregiver) queried about symptoms of autonomic dysfunction (prkns)

esophagogastroduodenoscopy, flexible, transoral; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed)

endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s) (list separately in addition to code(s) for primary procedure)

endoscopic retrograde cholangiopancreatography (ercp); with placement of endoscopic stent into biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent

endoscopic retrograde cholangiopancreatography (ercp); with removal of foreign body(s) or stent(s) from biliary/pancreatic duct(s)

endoscopic retrograde cholangiopancreatography (ercp); with removal and exchange of stent(s), biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent exchanged

endoscopic retrograde cholangiopancreatography (ercp); with trans-endoscopic balloon dilation of biliary/pancreatic duct(s) or of ampulla (sphincteroplasty), including sphincterotomy, when performed, each duct

endoscopic retrograde cholangiopancreatography (ercp); with ablation of tumor(s), polyp(s), or other lesion(s), including pre- and post-dilation and guide wire passage, when performed

laparoscopy, surgical, esophagomyotomy (heller type), with fundoplasty, when performed

laparoscopy, surgical, esophagogastric fundoplasty (eg, nissen, toupet procedures)

laparoscopy, surgical, repair of paraesophageal hernia, includes fundoplasty, when performed; without implantation of mesh

laparoscopy, surgical, repair of paraesophageal hernia, includes fundoplasty, when performed; with implantation of mesh

laparoscopy, surgical, esophageal lengthening procedure (eg, collis gastroplasty or wedge gastroplasty) (list separately in addition to code for primary procedure)

laparoscopy, surgical, esophageal sphincter augmentation procedure, placement of sphincter augmentation device (ie, magnetic band), including cruroplasty when performed

esophagectomy, total or near total, with laparoscopic mobilization of the abdominal and mediastinal esophagus and proximal gastrectomy, with laparoscopic pyloric drainage procedure if performed, with open cervical pharyngogastrostomy or esophagogastrostomy (ie, laparoscopic transhiatal esophagectomy)

esophagectomy, distal two-thirds, with laparoscopic mobilization of the abdominal and lower mediastinal esophagus and proximal gastrectomy, with laparoscopic pyloric drainage procedure if performed, with separate thoracoscopic mobilization of the middle and upper mediastinal esophagus and thoracic esophagogastrostomy (ie, laparoscopic thoracoscopic esophagectomy, ivor lewis esophagectomy)

esophagectomy, total or near total, with thoracoscopic mobilization of the upper, middle, and lower mediastinal esophagus, with separate laparoscopic proximal gastrectomy, with laparoscopic pyloric drainage procedure if performed, with open cervical pharyngogastrostomy or esophagogastrostomy (ie, thoracoscopic, laparoscopic and cervical incision esophagectomy, mckeown esophagectomy, tri-incisional esophagectomy)

esophagoplasty (plastic repair or reconstruction), cervical approach; without repair of tracheoesophageal fistula

esophagoplasty (plastic repair or reconstruction), cervical approach; with repair of tracheoesophageal fistula

counseling about epilepsy specific safety issues provided to patient (or caregiver(s)) (epi)

esophagoplasty (plastic repair or reconstruction), thoracic approach; without repair of tracheoesophageal fistula

esophagoplasty (plastic repair or reconstruction), thoracic approach; with repair of tracheoesophageal fistula

esophagoplasty for congenital defect (plastic repair or reconstruction), thoracic approach; without repair of congenital tracheoesophageal fistula

esophagoplasty for congenital defect (plastic repair or reconstruction), thoracic approach; with repair of congenital tracheoesophageal fistula

esophagogastrostomy (cardioplasty), with or without vagotomy and pyloroplasty, transabdominal or transthoracic approach

esophagogastric fundoplasty, with fundic patch (thal-nissen procedure)

repair, paraesophageal hiatal hernia (including fundoplication), via laparotomy, except neonatal; without implantation of mesh or other prosthesis

repair, paraesophageal hiatal hernia (including fundoplication), via laparotomy, except neonatal; with implantation of mesh or other prosthesis

repair, paraesophageal hiatal hernia (including fundoplication), via thoracotomy, except neonatal; without implantation of mesh or other prosthesis

repair, paraesophageal hiatal hernia (including fundoplication), via thoracotomy, except neonatal; with implantation of mesh or other prosthesis

repair, paraesophageal hiatal hernia, (including fundoplication), via thoracoabdominal incision, except neonatal; without implantation of mesh or other prosthesis

repair, paraesophageal hiatal hernia, (including fundoplication), via thoracoabdominal incision, except neonatal; with implantation of mesh or other prosthesis

esophageal lengthening procedure (eg, collis gastroplasty or wedge gastroplasty) (list separately in addition to code for primary procedure)

esophagojejunostomy (without total gastrectomy); abdominal approach

esophagojejunostomy (without total gastrectomy); thoracic approach

esophagostomy, fistulization of esophagus, external; thoracic approach

esophagostomy, fistulization of esophagus, external; cervical approach

gastrointestinal reconstruction for previous esophagectomy, for obstructing esophageal lesion or fistula, or for previous esophageal exclusion; with stomach, with or without pyloroplasty

gastrointestinal reconstruction for previous esophagectomy, for obstructing esophageal lesion or fistula, or for previous esophageal exclusion; with colon interposition or small intestine reconstruction, including intestine mobilization, preparation, and anastomosis(es)

ligation or stapling at gastroesophageal junction for pre-existing esophageal perforation

counseling for women of childbearing potential with epilepsy (epi)

suture of esophageal wound or injury; transthoracic or transabdominal approach

closure of esophagostomy or fistula; transthoracic or transabdominal approach

dilation of esophagus, by unguided sound or bougie, single or multiple passes

gastrotomy; with suture repair of pre-existing esophagogastric laceration (eg, mallory-weiss)

counseling provided on symptom management, end of life decisions, and palliation (dem)

gastrotomy; with esophageal dilation and insertion of permanent intraluminal tube (eg, celestin or mousseaux-barbin)

pyloromyotomy, cutting of pyloric muscle (fredet-ramstedt type operation)

gastrectomy, total; with formation of intestinal pouch, any type

gastrectomy, partial, distal; with formation of intestinal pouch

vagotomy when performed with partial distal gastrectomy (list separately in addition to code[s] for primary procedure)

vagotomy including pyloroplasty, with or without gastrostomy; truncal or selective

vagotomy including pyloroplasty, with or without gastrostomy; parietal cell (highly selective)

laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and roux-en-y gastroenterostomy (roux limb 150 cm or less)

laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and small intestine reconstruction to limit absorption

laparoscopy, surgical; implantation or replacement of gastric neurostimulator electrodes, antrum

laparoscopy, surgical; revision or removal of gastric neurostimulator electrodes, antrum

laparoscopy, surgical; transection of vagus nerves, selective or highly selective

laparoscopy, surgical; gastrostomy, without construction of gastric tube (eg, stamm procedure) (separate procedure)

naso- or oro-gastric tube placement, requiring physician's skill and fluoroscopic guidance (includes fluoroscopy, image documentation and report)

gastric intubation and aspiration(s) therapeutic, necessitating physician's skill (eg, for gastrointestinal hemorrhage), including lavage if performed

gastric intubation and aspiration, diagnostic; single specimen (eg, acid analysis)

gastric intubation and aspiration, diagnostic; collection of multiple fractional specimens with gastric stimulation, single or double lumen tube (gastric secretory study) (eg, histamine, insulin, pentagastrin, calcium, secretin), includes drug administration

duodenal intubation and aspiration, diagnostic, includes image guidance; single specimen (eg, bile study for crystals or afferent loop culture)

duodenal intubation and aspiration, diagnostic, includes image guidance; collection of multiple fractional specimens with pancreatic or gallbladder stimulation, single or double lumen tube, includes drug administration

change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance

repositioning of a naso- or oro-gastric feeding tube, through the duodenum for enteric nutrition

laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric restrictive device (eg, gastric band and subcutaneous port components)

laparoscopy, surgical, gastric restrictive procedure; revision of adjustable gastric restrictive device component only

laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device component only

laparoscopy, surgical, gastric restrictive procedure; removal and replacement of adjustable gastric restrictive device component only

laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device and subcutaneous port components

laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (ie, sleeve gastrectomy)

gastrostomy, open; without construction of gastric tube (eg, stamm procedure) (separate procedure)

gastrostomy, open; with construction of gastric tube (eg, janeway procedure)

gastrorrhaphy, suture of perforated duodenal or gastric ulcer, wound, or injury

gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical-banded gastroplasty

gastric restrictive procedure, without gastric bypass, for morbid obesity; other than vertical-banded gastroplasty

gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy and ileoileostomy (50 to 100 cm common channel) to limit absorption (biliopancreatic diversion with duodenal switch)

gastric restrictive procedure, with gastric bypass for morbid obesity; with short limb (150 cm or less) roux-en-y gastroenterostomy

gastric restrictive procedure, with gastric bypass for morbid obesity; with small intestine reconstruction to limit absorption

revision, open, of gastric restrictive procedure for morbid obesity, other than adjustable gastric restrictive device (separate procedure)

revision of gastroduodenal anastomosis (gastroduodenostomy) with reconstruction; without vagotomy

revision of gastroduodenal anastomosis (gastroduodenostomy) with reconstruction; with vagotomy

revision of gastrojejunal anastomosis (gastrojejunostomy) with reconstruction, with or without partial gastrectomy or intestine resection; without vagotomy

revision of gastrojejunal anastomosis (gastrojejunostomy) with reconstruction, with or without partial gastrectomy or intestine resection; with vagotomy

implantation or replacement of gastric neurostimulator electrodes, antrum, open

revision or removal of gastric neurostimulator electrodes, antrum, open

gastric restrictive procedure, open; revision of subcutaneous port component only

gastric restrictive procedure, open; removal of subcutaneous port component only

gastric restrictive procedure, open; removal and replacement of subcutaneous port component only

enterolysis (freeing of intestinal adhesion) (separate procedure)

rehabilitative therapy options discussed with patient (or caregiver) (prkns)

duodenotomy, for exploration, biopsy(s), or foreign body removal

tube or needle catheter jejunostomy for enteral alimentation, intraoperative, any method (list separately in addition to primary procedure)

enterotomy, small intestine, other than duodenum; for exploration, biopsy(s), or foreign body removal

enterotomy, small intestine, other than duodenum; for decompression (eg, baker tube)

reduction of volvulus, intussusception, internal hernia, by laparotomy

correction of malrotation by lysis of duodenal bands and/or reduction of midgut volvulus (eg, ladd procedure)

biopsy of intestine by capsule, tube, peroral (1 or more specimens)

excision of 1 or more lesions of small or large intestine not requiring anastomosis, exteriorization, or fistulization; single enterotomy

excision of 1 or more lesions of small or large intestine not requiring anastomosis, exteriorization, or fistulization; multiple enterotomies

enterectomy, resection of small intestine; single resection and anastomosis

enterectomy, resection of small intestine; each additional resection and anastomosis (list separately in addition to code for primary procedure)

enterectomy, resection of small intestine for congenital atresia, single resection and anastomosis of proximal segment of intestine; without tapering

enterectomy, resection of small intestine for congenital atresia, single resection and anastomosis of proximal segment of intestine; with tapering

enterectomy, resection of small intestine for congenital atresia, single resection and anastomosis of proximal segment of intestine; each additional resection and anastomosis (list separately in addition to code for primary procedure)

enteroenterostomy, anastomosis of intestine, with or without cutaneous enterostomy (separate procedure)

donor enterectomy (including cold preservation), open; from cadaver donor

donor enterectomy (including cold preservation), open; partial, from living donor

mobilization (take-down) of splenic flexure performed in conjunction with partial colectomy (list separately in addition to primary procedure)

colectomy, partial; with end colostomy and closure of distal segment (hartmann type procedure)

colectomy, partial; with resection, with colostomy or ileostomy and creation of mucofistula

colectomy, partial; with coloproctostomy (low pelvic anastomosis)

colectomy, partial; with coloproctostomy (low pelvic anastomosis), with colostomy

colectomy, total, abdominal, without proctectomy; with ileostomy or ileoproctostomy

colectomy, total, abdominal, without proctectomy; with continent ileostomy

colectomy, total, abdominal, with proctectomy; with continent ileostomy

colectomy, total, abdominal, with proctectomy; with ileoanal anastomosis, includes loop ileostomy, and rectal mucosectomy, when performed

colectomy, total, abdominal, with proctectomy; with ileoanal anastomosis, creation of ileal reservoir (s or j), includes loop ileostomy, and rectal mucosectomy, when performed

colectomy, partial, with removal of terminal ileum with ileocolostomy

laparoscopy, surgical, enterolysis (freeing of intestinal adhesion) (separate procedure)

laparoscopy, surgical; jejunostomy (eg, for decompression or feeding)

laparoscopy, surgical; enterectomy, resection of small intestine, single resection and anastomosis

laparoscopy, surgical; each additional small intestine resection and anastomosis (list separately in addition to code for primary procedure)

laparoscopy, surgical; colectomy, partial, with removal of terminal ileum with ileocolostomy

laparoscopy, surgical; colectomy, partial, with end colostomy and closure of distal segment (hartmann type procedure)

laparoscopy, surgical; colectomy, partial, with anastomosis, with coloproctostomy (low pelvic anastomosis)

laparoscopy, surgical; colectomy, partial, with anastomosis, with coloproctostomy (low pelvic anastomosis) with colostomy

laparoscopy, surgical; colectomy, total, abdominal, without proctectomy, with ileostomy or ileoproctostomy

laparoscopy, surgical; colectomy, total, abdominal, with proctectomy, with ileoanal anastomosis, creation of ileal reservoir (s or j), with loop ileostomy, includes rectal mucosectomy, when performed

laparoscopy, surgical; colectomy, total, abdominal, with proctectomy, with ileostomy

laparoscopy, surgical, mobilization (take-down) of splenic flexure performed in conjunction with partial colectomy (list separately in addition to primary procedure)

laparoscopy, surgical, closure of enterostomy, large or small intestine, with resection and anastomosis

placement, enterostomy or cecostomy, tube open (eg, for feeding or decompression) (separate procedure)

revision of ileostomy; simple (release of superficial scar) (separate procedure)

revision of ileostomy; complicated (reconstruction in-depth) (separate procedure)

colostomy or skin level cecostomy; with multiple biopsies (eg, for congenital megacolon) (separate procedure)

revision of colostomy; simple (release of superficial scar) (separate procedure)

revision of colostomy; complicated (reconstruction in-depth) (separate procedure)

revision of colostomy; with repair of paracolostomy hernia (separate procedure)

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; with biopsy, single or multiple

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; with removal of foreign body(s)

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps or bipolar cautery

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; with control of bleeding (eg, injection, bipolar cautery, unipolar cautery, laser, heater probe, stapler, plasma coagulator)

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; with transendoscopic stent placement (includes predilation)

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; with placement of percutaneous jejunostomy tube

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; with conversion of percutaneous gastrostomy tube to percutaneous jejunostomy tube

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, including ileum; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure)

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, including ileum; with biopsy, single or multiple

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, including ileum; with control of bleeding (eg, injection, bipolar cautery, unipolar cautery, laser, heater probe, stapler, plasma coagulator)

small intestinal endoscopy, enteroscopy beyond second portion of duodenum, including ileum; with transendoscopic stent placement (includes predilation)

ileoscopy, through stoma; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

ileoscopy, through stoma; with placement of endoscopic stent (includes pre- and post-dilation and guide wire passage, when performed)

endoscopic evaluation of small intestinal pouch (eg, kock pouch, ileal reservoir [s or j]); diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

endoscopic evaluation of small intestinal pouch (eg, kock pouch, ileal reservoir [s or j]); with biopsy, single or multiple

colonoscopy through stoma; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

colonoscopy through stoma; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps

colonoscopy through stoma; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique

colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre-and post-dilation and guide wire passage, when performed)

colonoscopy through stoma; with endoscopic stent placement (including pre- and post-dilation and guide wire passage, when performed)

colonoscopy through stoma; with directed submucosal injection(s), any substance

colonoscopy through stoma; with transendoscopic balloon dilation

colonoscopy through stoma; with endoscopic ultrasound examination, limited to the sigmoid, descending, transverse, or ascending colon and cecum and adjacent structures

colonoscopy through stoma; with transendoscopic ultrasound guided intramural or transmural fine needle aspiration/biopsy(s), includes endoscopic ultrasound examination limited to the sigmoid, descending, transverse, or ascending colon and cecum and adjacent structures

colonoscopy through stoma; with decompression (for pathologic distention) (eg, volvulus, megacolon), including placement of decompression tube, when performed

introduction of long gastrointestinal tube (eg, miller-abbott) (separate procedure)

suture of small intestine (enterorrhaphy) for perforated ulcer, diverticulum, wound, injury or rupture; single perforation

suture of small intestine (enterorrhaphy) for perforated ulcer, diverticulum, wound, injury or rupture; multiple perforations

suture of large intestine (colorrhaphy) for perforated ulcer, diverticulum, wound, injury or rupture (single or multiple perforations); without colostomy

suture of large intestine (colorrhaphy) for perforated ulcer, diverticulum, wound, injury or rupture (single or multiple perforations); with colostomy

intestinal stricturoplasty (enterotomy and enterorrhaphy) with or without dilation, for intestinal obstruction

closure of enterostomy, large or small intestine; with resection and anastomosis other than colorectal

closure of enterostomy, large or small intestine; with resection and colorectal anastomosis (eg, closure of hartmann type procedure)

closure of enterovesical fistula; without intestinal or bladder resection

closure of enterovesical fistula; with intestine and/or bladder resection

exclusion of small intestine from pelvis by mesh or other prosthesis, or native tissue (eg, bladder or omentum)

intraoperative colonic lavage (list separately in addition to code for primary procedure)

preparation of fecal microbiota for instillation, including assessment of donor specimen

implantable cardioverter-defibrillator (icd) counseling provided (hf)

backbench standard preparation of cadaver or living donor intestine allograft prior to transplantation, including mobilization and fashioning of the superior mesenteric artery and vein

backbench reconstruction of cadaver or living donor intestine allograft prior to transplantation; venous anastomosis, each

backbench reconstruction of cadaver or living donor intestine allograft prior to transplantation; arterial anastomosis, each

excision of meckel's diverticulum (diverticulectomy) or omphalomesenteric duct

patient receiving ace inhibitor/arb therapy and beta-blocker therapy for 3 months or longer (hf)

patient receiving ace inhibitor/arb therapy and beta-blocker therapy for less than 3 months or patient not receiving ace inhibitor/arb therapy and beta-blocker therapy (hf)

appendectomy; when done for indicated purpose at time of other major procedure (not as separate procedure) (list separately in addition to code for primary procedure)

appendectomy; for ruptured appendix with abscess or generalized peritonitis

incision and drainage of deep supralevator, pelvirectal, or retrorectal abscess

biopsy of anorectal wall, anal approach (eg, congenital megacolon)

previous cardiac rehabilitation for qualifying cardiac event completed (cad)

proctectomy; complete, combined abdominoperineal, with colostomy

proctectomy; partial resection of rectum, transabdominal approach

proctectomy, combined abdominoperineal, pull-through procedure (eg, colo-anal anastomosis)

proctectomy, partial, with rectal mucosectomy, ileoanal anastomosis, creation of ileal reservoir (s or j), with or without loop ileostomy

proctectomy, partial, with anastomosis; abdominal and transsacral approach

proctectomy, partial, with anastomosis; transsacral approach only (kraske type)

proctectomy, combined abdominoperineal pull-through procedure (eg, colo-anal anastomosis), with creation of colonic reservoir (eg, j-pouch), with diverting enterostomy when performed

proctectomy, complete (for congenital megacolon), abdominal and perineal approach; with pull-through procedure and anastomosis (eg, swenson, duhamel, or soave type operation)

proctectomy, complete (for congenital megacolon), abdominal and perineal approach; with subtotal or total colectomy, with multiple biopsies

pelvic exenteration for colorectal malignancy, with proctectomy (with or without colostomy), with removal of bladder and ureteral transplantations, and/or hysterectomy, or cervicectomy, with or without removal of tube(s), with or without removal of ovary(s), or any combination thereof

excision of rectal procidentia, with anastomosis; perineal approach

excision of rectal procidentia, with anastomosis; abdominal and perineal approach

excision of rectal tumor by proctotomy, transsacral or transcoccygeal approach

excision of rectal tumor, transanal approach; not including muscularis propria (ie, partial thickness)

excision of rectal tumor, transanal approach; including muscularis propria (ie, full thickness)

destruction of rectal tumor (eg, electrodesiccation, electrosurgery, laser ablation, laser resection, cryosurgery) transanal approach

proctosigmoidoscopy, rigid; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure)

proctosigmoidoscopy, rigid; with dilation (eg, balloon, guide wire, bougie)

proctosigmoidoscopy, rigid; with removal of single tumor, polyp, or other lesion by hot biopsy forceps or bipolar cautery

proctosigmoidoscopy, rigid; with removal of single tumor, polyp, or other lesion by snare technique

proctosigmoidoscopy, rigid; with removal of multiple tumors, polyps, or other lesions by hot biopsy forceps, bipolar cautery or snare technique

proctosigmoidoscopy, rigid; with control of bleeding (eg, injection, bipolar cautery, unipolar cautery, laser, heater probe, stapler, plasma coagulator)

proctosigmoidoscopy, rigid; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique (eg, laser)

proctosigmoidoscopy, rigid; with transendoscopic stent placement (includes predilation)

sigmoidoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

sigmoidoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps

sigmoidoscopy, flexible; with directed submucosal injection(s), any substance

sigmoidoscopy, flexible; with decompression (for pathologic distention) (eg, volvulus, megacolon), including placement of decompression tube, when performed

sigmoidoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique

sigmoidoscopy, flexible; with transendoscopic ultrasound guided intramural or transmural fine needle aspiration/biopsy(s)

sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed)

sigmoidoscopy, flexible; with placement of endoscopic stent (includes pre- and post-dilation and guide wire passage, when performed)

sigmoidoscopy, flexible; with band ligation(s) (eg, hemorrhoids)

colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

colonoscopy, flexible; with directed submucosal injection(s), any substance

colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps

colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique

colonoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed)

colonoscopy, flexible; with endoscopic stent placement (includes pre- and post-dilation and guide wire passage, when performed)

colonoscopy, flexible; with endoscopic ultrasound examination limited to the rectum, sigmoid, descending, transverse, or ascending colon and cecum, and adjacent structures

colonoscopy, flexible; with transendoscopic ultrasound guided intramural or transmural fine needle aspiration/biopsy(s), includes endoscopic ultrasound examination limited to the rectum, sigmoid, descending, transverse, or ascending colon and cecum, and adjacent structures

colonoscopy, flexible; with decompression (for pathologic distention) (eg, volvulus, megacolon), including placement of decompression tube, when performed

laparoscopy, surgical; proctectomy, complete, combined abdominoperineal, with colostomy

laparoscopy, surgical; proctectomy, combined abdominoperineal pull-through procedure (eg, colo-anal anastomosis), with creation of colonic reservoir (eg, j-pouch), with diverting enterostomy, when performed

laparoscopy, surgical; proctopexy (for prolapse), with sigmoid resection

patient offered treatment for pseudobulbar affect, sialorrhea, or als-related symptoms (als)

options for noninvasive respiratory support discussed with patient (als)

patient offered assistance in planning for end of life issues (als)

proctopexy (eg, for prolapse); with sigmoid resection, abdominal approach

exploration, repair, and presacral drainage for rectal injury; with colostomy

patient exhibits 3 or more risk factors for post-operative nausea and vomiting (peri2)

patient does not exhibit 3 or more risk factors for post-operative nausea and vomiting (peri2)

patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and intraoperatively (peri2)

at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) recorded within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time (peri2)

anesthesia technique did not involve general or neuraxial anesthesia (peri2)

patient received aspirin within 24 hours prior to anesthesia start time (peri2)

dilation of anal sphincter (separate procedure) under anesthesia other than local

dilation of rectal stricture (separate procedure) under anesthesia other than local

removal of fecal impaction or foreign body (separate procedure) under anesthesia

anorectal exam, surgical, requiring anesthesia (general, spinal, or epidural), diagnostic

incision and drainage of ischiorectal and/or perirectal abscess (separate procedure)

incision and drainage of intramural, intramuscular, or submucosal abscess, transanal, under anesthesia

incision and drainage of ischiorectal or intramural abscess, with fistulectomy or fistulotomy, submuscular, with or without placement of seton

sphincterotomy, anal, division of sphincter (separate procedure)

hemorrhoidectomy, internal and external, single column/group; with fissurectomy

hemorrhoidectomy, internal and external, single column/group; with fistulectomy, including fissurectomy, when performed

hemorrhoidectomy, internal and external, 2 or more columns/groups

hemorrhoidectomy, internal and external, 2 or more columns/groups; with fissurectomy

hemorrhoidectomy, internal and external, 2 or more columns/groups; with fistulectomy, including fissurectomy, when performed

surgical treatment of anal fistula (fistulectomy/fistulotomy); subcutaneous

surgical treatment of anal fistula (fistulectomy/fistulotomy); intersphincteric

surgical treatment of anal fistula (fistulectomy/fistulotomy); transsphincteric, suprasphincteric, extrasphincteric or multiple, including placement of seton, when performed

surgical treatment of anal fistula (fistulectomy/fistulotomy); second stage

anoscopy; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)

anoscopy; diagnostic, with high-resolution magnification (hra) (eg, colposcope, operating microscope) and chemical agent enhancement, including collection of specimen(s) by brushing or washing, when performed

anoscopy; with high-resolution magnification (hra) (eg, colposcope, operating microscope) and chemical agent enhancement, with biopsy, single or multiple

anoscopy; with removal of single tumor, polyp, or other lesion by hot biopsy forceps or bipolar cautery

anoscopy; with removal of single tumor, polyp, or other lesion by snare technique

anoscopy; with removal of multiple tumors, polyps, or other lesions by hot biopsy forceps, bipolar cautery or snare technique

anoscopy; with control of bleeding (eg, injection, bipolar cautery, unipolar cautery, laser, heater probe, stapler, plasma coagulator)

anoscopy; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique

repair of anorectal fistula with plug (eg, porcine small intestine submucosa [sis])

repair of ileoanal pouch fistula/sinus (eg, perineal or vaginal), pouch advancement; transperineal approach

repair of ileoanal pouch fistula/sinus (eg, perineal or vaginal), pouch advancement; combined transperineal and transabdominal approach

repair of low imperforate anus; with anoperineal fistula (cut-back procedure)

repair of low imperforate anus; with transposition of anoperineal or anovestibular fistula

repair of high imperforate anus without fistula; perineal or sacroperineal approach

repair of high imperforate anus without fistula; combined transabdominal and sacroperineal approaches

repair of high imperforate anus with rectourethral or rectovaginal fistula; perineal or sacroperineal approach

repair of high imperforate anus with rectourethral or rectovaginal fistula; combined transabdominal and sacroperineal approaches

repair of cloacal anomaly by anorectovaginoplasty and urethroplasty, sacroperineal approach

repair of cloacal anomaly by anorectovaginoplasty and urethroplasty, combined abdominal and sacroperineal approach

repair of cloacal anomaly by anorectovaginoplasty and urethroplasty, combined abdominal and sacroperineal approach; with vaginal lengthening by intestinal graft or pedicle flaps

graft (thiersch operation) for rectal incontinence and/or prolapse

sphincteroplasty, anal, for incontinence, adult; muscle transplant

sphincteroplasty, anal, for incontinence, adult; levator muscle imbrication (park posterior anal repair)

sphincteroplasty, anal, for incontinence, adult; implantation artificial sphincter

destruction of lesion(s), anus (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; chemical

destruction of lesion(s), anus (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; electrodesiccation

destruction of lesion(s), anus (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; cryosurgery

destruction of lesion(s), anus (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; laser surgery

destruction of lesion(s), anus (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; surgical excision

destruction of lesion(s), anus (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), extensive (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery)

destruction of internal hemorrhoid(s) by thermal energy (eg, infrared coagulation, cautery, radiofrequency)

curettage or cautery of anal fissure, including dilation of anal sphincter (separate procedure); initial

curettage or cautery of anal fissure, including dilation of anal sphincter (separate procedure); subsequent

hemorrhoidectomy, internal, by ligation other than rubber band; single hemorrhoid column/group

hemorrhoidectomy, internal, by ligation other than rubber band; 2 or more hemorrhoid columns/groups

hemorrhoidopexy (eg, for prolapsing internal hemorrhoids) by stapling

biopsy of liver, needle; when done for indicated purpose at time of other major procedure (list separately in addition to code for primary procedure)

laparotomy, with aspiration and/or injection of hepatic parasitic (eg, amoebic or echinococcal) cyst(s) or abscess(es)

donor hepatectomy (including cold preservation), from cadaver donor

liver allotransplantation, orthotopic, partial or whole, from cadaver or living donor, any age

donor hepatectomy (including cold preservation), from living donor; left lateral segment only (segments ii and iii)

donor hepatectomy (including cold preservation), from living donor; total left lobectomy (segments ii, iii and iv)

donor hepatectomy (including cold preservation), from living donor; total right lobectomy (segments v, vi, vii and viii)

backbench standard preparation of cadaver donor whole liver graft prior to allotransplantation, including cholecystectomy, if necessary, and dissection and removal of surrounding soft tissues to prepare the vena cava, portal vein, hepatic artery, and common bile duct for implantation; without trisegment or lobe split

backbench standard preparation of cadaver donor whole liver graft prior to allotransplantation, including cholecystectomy, if necessary, and dissection and removal of surrounding soft tissues to prepare the vena cava, portal vein, hepatic artery, and common bile duct for implantation; with trisegment split of whole liver graft into 2 partial liver grafts (ie, left lateral segment [segments ii and iii] and right trisegment [segments i and iv through viii])

backbench standard preparation of cadaver donor whole liver graft prior to allotransplantation, including cholecystectomy, if necessary, and dissection and removal of surrounding soft tissues to prepare the vena cava, portal vein, hepatic artery, and common bile duct for implantation; with lobe split of whole liver graft into 2 partial liver grafts (ie, left lobe [segments ii, iii, and iv] and right lobe [segments i and v through viii])

backbench reconstruction of cadaver or living donor liver graft prior to allotransplantation; venous anastomosis, each

backbench reconstruction of cadaver or living donor liver graft prior to allotransplantation; arterial anastomosis, each

management of liver hemorrhage; simple suture of liver wound or injury

management of liver hemorrhage; complex suture of liver wound or injury, with or without hepatic artery ligation

management of liver hemorrhage; exploration of hepatic wound, extensive debridement, coagulation and/or suture, with or without packing of liver

management of liver hemorrhage; re-exploration of hepatic wound for removal of packing

laparoscopy, surgical, ablation of 1 or more liver tumor(s); radiofrequency

laparoscopy, surgical, ablation of 1 or more liver tumor(s); cryosurgical

ablation, 1 or more liver tumor(s), percutaneous, radiofrequency

hepaticotomy or hepaticostomy with exploration, drainage, or removal of calculus

choledochotomy or choledochostomy with exploration, drainage, or removal of calculus, with or without cholecystotomy; without transduodenal sphincterotomy or sphincteroplasty

choledochotomy or choledochostomy with exploration, drainage, or removal of calculus, with or without cholecystotomy; with transduodenal sphincterotomy or sphincteroplasty

transduodenal sphincterotomy or sphincteroplasty, with or without transduodenal extraction of calculus (separate procedure)

cholecystotomy or cholecystostomy, open, with exploration, drainage, or removal of calculus (separate procedure)

cholecystostomy, percutaneous, complete procedure, including imaging guidance, catheter placement, cholecystogram when performed, and radiological supervision and interpretation

injection procedure for cholangiography, percutaneous, complete diagnostic procedure including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation; existing access

injection procedure for cholangiography, percutaneous, complete diagnostic procedure including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation; new access (eg, percutaneous transhepatic cholangiogram)

placement of biliary drainage catheter, percutaneous, including diagnostic cholangiography when performed, imaging guidance (eg, ultrasound and/or fluoroscopy), and all associated radiological supervision and interpretation; external

placement of biliary drainage catheter, percutaneous, including diagnostic cholangiography when performed, imaging guidance (eg, ultrasound and/or fluoroscopy), and all associated radiological supervision and interpretation; internal-external

conversion of external biliary drainage catheter to internal-external biliary drainage catheter, percutaneous, including diagnostic cholangiography when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation

exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), percutaneous, including diagnostic cholangiography when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation

removal of biliary drainage catheter, percutaneous, requiring fluoroscopic guidance (eg, with concurrent indwelling biliary stents), including diagnostic cholangiography when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation

placement of stent(s) into a bile duct, percutaneous, including diagnostic cholangiography, imaging guidance (eg, fluoroscopy and/or ultrasound), balloon dilation, catheter exchange(s) and catheter removal(s) when performed, and all associated radiological supervision and interpretation; existing access

placement of stent(s) into a bile duct, percutaneous, including diagnostic cholangiography, imaging guidance (eg, fluoroscopy and/or ultrasound), balloon dilation, catheter exchange(s) and catheter removal(s) when performed, and all associated radiological supervision and interpretation; new access, without placement of separate biliary drainage catheter

placement of stent(s) into a bile duct, percutaneous, including diagnostic cholangiography, imaging guidance (eg, fluoroscopy and/or ultrasound), balloon dilation, catheter exchange(s) and catheter removal(s) when performed, and all associated radiological supervision and interpretation; new access, with placement of separate biliary drainage catheter (eg, external or internal-external)

placement of access through the biliary tree and into small bowel to assist with an endoscopic biliary procedure (eg, rendezvous procedure), percutaneous, including diagnostic cholangiography when performed, imaging guidance (eg, ultrasound and/or fluoroscopy), and all associated radiological supervision and interpretation, new access

balloon dilation of biliary duct(s) or of ampulla (sphincteroplasty), percutaneous, including imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation, each duct (list separately in addition to code for primary procedure)

endoluminal biopsy(ies) of biliary tree, percutaneous, any method(s) (eg, brush, forceps, and/or needle), including imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation, single or multiple (list separately in addition to code for primary procedure)

removal of calculi/debris from biliary duct(s) and/or gallbladder, percutaneous, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation (list separately in addition to code for primary procedure)

biliary endoscopy, intraoperative (choledochoscopy) (list separately in addition to code for primary procedure)

biliary endoscopy, percutaneous via t-tube or other tract; diagnostic, with collection of specimen(s) by brushing and/or washing, when performed (separate procedure)

biliary endoscopy, percutaneous via t-tube or other tract; with biopsy, single or multiple

biliary endoscopy, percutaneous via t-tube or other tract; with removal of calculus/calculi

biliary endoscopy, percutaneous via t-tube or other tract; with dilation of biliary duct stricture(s) without stent

biliary endoscopy, percutaneous via t-tube or other tract; with dilation of biliary duct stricture(s) with stent

laparoscopy, surgical; cholecystectomy with exploration of common duct

cholecystectomy with exploration of common duct; with choledochoenterostomy

cholecystectomy with exploration of common duct; with transduodenal sphincterotomy or sphincteroplasty, with or without cholangiography

exploration for congenital atresia of bile ducts, without repair, with or without liver biopsy, with or without cholangiography

excision of bile duct tumor, with or without primary repair of bile duct; extrahepatic

excision of bile duct tumor, with or without primary repair of bile duct; intrahepatic

anastomosis, of extrahepatic biliary ducts and gastrointestinal tract

anastomosis, roux-en-y, of extrahepatic biliary ducts and gastrointestinal tract

anastomosis, roux-en-y, of intrahepatic biliary ducts and gastrointestinal tract

reconstruction, plastic, of extrahepatic biliary ducts with end-to-end anastomosis

suture of extrahepatic biliary duct for pre-existing injury (separate procedure)

placement of drains, peripancreatic, for acute pancreatitis; with cholecystostomy, gastrostomy, and jejunostomy

biopsy of pancreas, open (eg, fine needle aspiration, needle core biopsy, wedge biopsy)

resection or debridement of pancreas and peripancreatic tissue for acute necrotizing pancreatitis

pancreatectomy, distal subtotal, with or without splenectomy; without pancreaticojejunostomy

pancreatectomy, distal subtotal, with or without splenectomy; with pancreaticojejunostomy

pancreatectomy, distal, near-total with preservation of duodenum (child-type procedure)

pancreatectomy, proximal subtotal with total duodenectomy, partial gastrectomy, choledochoenterostomy and gastrojejunostomy (whipple-type procedure); with pancreatojejunostomy

pancreatectomy, proximal subtotal with total duodenectomy, partial gastrectomy, choledochoenterostomy and gastrojejunostomy (whipple-type procedure); without pancreatojejunostomy

pancreatectomy, proximal subtotal with near-total duodenectomy, choledochoenterostomy and duodenojejunostomy (pylorus-sparing, whipple-type procedure); with pancreatojejunostomy

pancreatectomy, proximal subtotal with near-total duodenectomy, choledochoenterostomy and duodenojejunostomy (pylorus-sparing, whipple-type procedure); without pancreatojejunostomy

pancreatectomy, total or subtotal, with autologous transplantation of pancreas or pancreatic islet cells

injection procedure for intraoperative pancreatography (list separately in addition to code for primary procedure)

internal anastomosis of pancreatic cyst to gastrointestinal tract; direct

internal anastomosis of pancreatic cyst to gastrointestinal tract; roux-en-y

pancreaticojejunostomy, side-to-side anastomosis (puestow-type operation)

donor pancreatectomy (including cold preservation), with or without duodenal segment for transplantation

backbench standard preparation of cadaver donor pancreas allograft prior to transplantation, including dissection of allograft from surrounding soft tissues, splenectomy, duodenotomy, ligation of bile duct, ligation of mesenteric vessels, and y-graft arterial anastomoses from iliac artery to superior mesenteric artery and to splenic artery

backbench reconstruction of cadaver donor pancreas allograft prior to transplantation, venous anastomosis, each

exploratory laparotomy, exploratory celiotomy with or without biopsy(s) (separate procedure)

exploration, retroperitoneal area with or without biopsy(s) (separate procedure)

drainage of peritoneal abscess or localized peritonitis, exclusive of appendiceal abscess, open

drainage of extraperitoneal lymphocele to peritoneal cavity, open

abdominal paracentesis (diagnostic or therapeutic); without imaging guidance

abdominal paracentesis (diagnostic or therapeutic); with imaging guidance

sclerotherapy of a fluid collection (eg, lymphocele, cyst, or seroma), percutaneous, including contrast injection(s), sclerosant injection(s), diagnostic study, imaging guidance (eg, ultrasound, fluoroscopy) and radiological supervision and interpretation when performed

excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor 5 cm diameter or less

excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor 5.1-10.0 cm diameter

excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor greater than 10.0 cm diameter

staging laparotomy for hodgkins disease or lymphoma (includes splenectomy, needle or open biopsies of both liver lobes, possibly also removal of abdominal nodes, abdominal node and/or bone marrow biopsies, ovarian repositioning)

umbilectomy, omphalectomy, excision of umbilicus (separate procedure)

omentectomy, epiploectomy, resection of omentum (separate procedure)

laparoscopy, abdomen, peritoneum, and omentum, diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure)

laparoscopy, surgical; with aspiration of cavity or cyst (eg, ovarian cyst) (single or multiple)

laparoscopy, surgical; with drainage of lymphocele to peritoneal cavity

laparoscopy, surgical; with insertion of tunneled intraperitoneal catheter

laparoscopy, surgical; with revision of previously placed intraperitoneal cannula or catheter, with removal of intraluminal obstructive material if performed

laparoscopy, surgical; with omentopexy (omental tacking procedure) (list separately in addition to code for primary procedure)

laparoscopy, surgical; with placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), intra-abdominal, intrapelvic, and/or retroperitoneum, including imaging guidance, if performed, single or multiple (list separately in addition to code for primary procedure)

injection of air or contrast into peritoneal cavity (separate procedure)

image-guided fluid collection drainage by catheter (eg, abscess, hematoma, seroma, lymphocele, cyst); visceral (eg, kidney, liver, spleen, lung/mediastinum), percutaneous

image-guided fluid collection drainage by catheter (eg, abscess, hematoma, seroma, lymphocele, cyst); peritoneal or retroperitoneal, percutaneous

image-guided fluid collection drainage by catheter (eg, abscess, hematoma, seroma, lymphocele, cyst); peritoneal or retroperitoneal, transvaginal or transrectal

placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), percutaneous, intra-abdominal, intra-pelvic (except prostate), and/or retroperitoneum, single or multiple

placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), open, intra-abdominal, intrapelvic, and/or retroperitoneum, including image guidance, if performed, single or multiple (list separately in addition to code for primary procedure)

insertion of tunneled intraperitoneal catheter (eg, dialysis, intraperitoneal chemotherapy instillation, management of ascites), complete procedure, including imaging guidance, catheter placement, contrast injection when performed, and radiological supervision and interpretation, percutaneous

insertion of tunneled intraperitoneal catheter, with subcutaneous port (ie, totally implantable)

insertion of tunneled intraperitoneal catheter for dialysis, open

exchange of previously placed abscess or cyst drainage catheter under radiological guidance (separate procedure)

contrast injection for assessment of abscess or cyst via previously placed drainage catheter or tube (separate procedure)

injection procedure (eg, contrast media) for evaluation of previously placed peritoneal-venous shunt

insertion of subcutaneous extension to intraperitoneal cannula or catheter with remote chest exit site (list separately in addition to code for primary procedure)

delayed creation of exit site from embedded subcutaneous segment of intraperitoneal cannula or catheter

insertion of gastrostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report

insertion of duodenostomy or jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report

insertion of cecostomy or other colonic tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report

conversion of gastrostomy tube to gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report

replacement of gastrostomy or cecostomy (or other colonic) tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report

replacement of duodenostomy or jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report

replacement of gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report

mechanical removal of obstructive material from gastrostomy, duodenostomy, jejunostomy, gastro-jejunostomy, or cecostomy (or other colonic) tube, any method, under fluoroscopic guidance including contrast injection(s), if performed, image documentation and report

contrast injection(s) for radiological evaluation of existing gastrostomy, duodenostomy, jejunostomy, gastro-jejunostomy, or cecostomy (or other colonic) tube, from a percutaneous approach including image documentation and report

repair, initial inguinal hernia, preterm infant (younger than 37 weeks gestation at birth), performed from birth up to 50 weeks postconception age, with or without hydrocelectomy; reducible

repair, initial inguinal hernia, preterm infant (younger than 37 weeks gestation at birth), performed from birth up to 50 weeks postconception age, with or without hydrocelectomy; incarcerated or strangulated

repair, initial inguinal hernia, full term infant younger than age 6 months, or preterm infant older than 50 weeks postconception age and younger than age 6 months at the time of surgery, with or without hydrocelectomy; reducible

repair, initial inguinal hernia, full term infant younger than age 6 months, or preterm infant older than 50 weeks postconception age and younger than age 6 months at the time of surgery, with or without hydrocelectomy; incarcerated or strangulated

repair initial inguinal hernia, age 6 months to younger than 5 years, with or without hydrocelectomy; reducible

repair initial inguinal hernia, age 6 months to younger than 5 years, with or without hydrocelectomy; incarcerated or strangulated

repair initial inguinal hernia, age 5 years or older; incarcerated or strangulated

repair recurrent inguinal hernia, any age; incarcerated or strangulated

repair initial femoral hernia, any age; incarcerated or strangulated

repair initial incisional or ventral hernia; incarcerated or strangulated

repair recurrent incisional or ventral hernia; incarcerated or strangulated

implantation of mesh or other prosthesis for open incisional or ventral hernia repair or mesh for closure of debridement for necrotizing soft tissue infection (list separately in addition to code for the incisional or ventral hernia repair)

repair epigastric hernia (eg, preperitoneal fat); reducible (separate procedure)

repair epigastric hernia (eg, preperitoneal fat); incarcerated or strangulated

repair umbilical hernia, younger than age 5 years; incarcerated or strangulated

repair umbilical hernia, age 5 years or older; incarcerated or strangulated

repair of large omphalocele or gastroschisis; with or without prosthesis

repair of large omphalocele or gastroschisis; with removal of prosthesis, final reduction and closure, in operating room

laparoscopy, surgical, repair, ventral, umbilical, spigelian or epigastric hernia (includes mesh insertion, when performed); reducible

laparoscopy, surgical, repair, ventral, umbilical, spigelian or epigastric hernia (includes mesh insertion, when performed); incarcerated or strangulated

laparoscopy, surgical, repair, incisional hernia (includes mesh insertion, when performed); reducible

laparoscopy, surgical, repair, incisional hernia (includes mesh insertion, when performed); incarcerated or strangulated

laparoscopy, surgical, repair, recurrent incisional hernia (includes mesh insertion, when performed); reducible

laparoscopy, surgical, repair, recurrent incisional hernia (includes mesh insertion, when performed); incarcerated or strangulated

unlisted laparoscopy procedure, hernioplasty, herniorrhaphy, herniotomy

suture, secondary, of abdominal wall for evisceration or dehiscence

omental flap, extra-abdominal (eg, for reconstruction of sternal and chest wall defects)

omental flap, intra-abdominal (list separately in addition to code for primary procedure)

patient counseled on self-examination for new or changing moles (ml)

nephrolithotomy; removal of large staghorn calculus filling renal pelvis and calyces (including anatrophic pyelolithotomy)

percutaneous nephrostolithotomy or pyelostolithotomy, with or without dilation, endoscopy, lithotripsy, stenting, or basket extraction; up to 2 cm

percutaneous nephrostolithotomy or pyelostolithotomy, with or without dilation, endoscopy, lithotripsy, stenting, or basket extraction; over 2 cm

transection or repositioning of aberrant renal vessels (separate procedure)

findings of dilated macular or fundus exam communicated to the physician or other qualified health care professional managing the diabetes care (ec)

pyelotomy; with removal of calculus (pyelolithotomy, pelviolithotomy, including coagulum pyelolithotomy)

pyelotomy; complicated (eg, secondary operation, congenital kidney abnormality)

documentation of communication that a fracture occurred and that the patient was or should be tested or treated for osteoporosis (op)

treatment summary report communicated to physician(s) or other qualified health care professional(s) managing continuing care and to the patient within 1 month of completing treatment (onc)

nephrectomy, including partial ureterectomy, any open approach including rib resection

nephrectomy, including partial ureterectomy, any open approach including rib resection; complicated because of previous surgery on same kidney

nephrectomy, including partial ureterectomy, any open approach including rib resection; radical, with regional lymphadenectomy and/or vena caval thrombectomy

nephrectomy with total ureterectomy and bladder cuff; through same incision

nephrectomy with total ureterectomy and bladder cuff; through separate incision

ablation, open, 1 or more renal mass lesion(s), cryosurgical, including intraoperative ultrasound guidance and monitoring, if performed

donor nephrectomy (including cold preservation); from cadaver donor, unilateral or bilateral

donor nephrectomy (including cold preservation); open, from living donor

backbench standard preparation of cadaver donor renal allograft prior to transplantation, including dissection and removal of perinephric fat, diaphragmatic and retroperitoneal attachments, excision of adrenal gland, and preparation of ureter(s), renal vein(s), and renal artery(s), ligating branches, as necessary

backbench standard preparation of living donor renal allograft (open or laparoscopic) prior to transplantation, including dissection and removal of perinephric fat and preparation of ureter(s), renal vein(s), and renal artery(s), ligating branches, as necessary

backbench reconstruction of cadaver or living donor renal allograft prior to transplantation; venous anastomosis, each

backbench reconstruction of cadaver or living donor renal allograft prior to transplantation; arterial anastomosis, each

backbench reconstruction of cadaver or living donor renal allograft prior to transplantation; ureteral anastomosis, each

renal allotransplantation, implantation of graft; without recipient nephrectomy

renal allotransplantation, implantation of graft; with recipient nephrectomy

removal (via snare/capture) and replacement of internally dwelling ureteral stent via percutaneous approach, including radiological supervision and interpretation

removal (via snare/capture) of internally dwelling ureteral stent via percutaneous approach, including radiological supervision and interpretation

removal (via snare/capture) and replacement of internally dwelling ureteral stent via transurethral approach, without use of cystoscopy, including radiological supervision and interpretation

removal (via snare/capture) of internally dwelling ureteral stent via transurethral approach, without use of cystoscopy, including radiological supervision and interpretation

removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, including radiological supervision and interpretation

removal of nephrostomy tube, requiring fluoroscopic guidance (eg, with concurrent indwelling ureteral stent)

aspiration and/or injection of renal cyst or pelvis by needle, percutaneous

instillation(s) of therapeutic agent into renal pelvis and/or ureter through established nephrostomy, pyelostomy or ureterostomy tube (eg, anticarcinogenic or antifungal agent)

introduction of guide into renal pelvis and/or ureter with dilation to establish nephrostomy tract, percutaneous

manometric studies through nephrostomy or pyelostomy tube, or indwelling ureteral catheter

pyeloplasty (foley y-pyeloplasty), plastic operation on renal pelvis, with or without plastic operation on ureter, nephropexy, nephrostomy, pyelostomy, or ureteral splinting; simple

pyeloplasty (foley y-pyeloplasty), plastic operation on renal pelvis, with or without plastic operation on ureter, nephropexy, nephrostomy, pyelostomy, or ureteral splinting; complicated (congenital kidney abnormality, secondary pyeloplasty, solitary kidney, calycoplasty)

injection procedure for antegrade nephrostogram and/or ureterogram, complete diagnostic procedure including imaging guidance (eg, ultrasound and fluoroscopy) and all associated radiological supervision and interpretation; new access

injection procedure for antegrade nephrostogram and/or ureterogram, complete diagnostic procedure including imaging guidance (eg, ultrasound and fluoroscopy) and all associated radiological supervision and interpretation; existing access

placement of nephrostomy catheter, percutaneous, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation

placement of nephroureteral catheter, percutaneous, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation, new access

convert nephrostomy catheter to nephroureteral catheter, percutaneous, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation, via pre-existing nephrostomy tract

exchange nephrostomy catheter, percutaneous, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation

treatment plan communicated to provider(s) managing continuing care within 1 month of diagnosis (ml)

closure of nephrovisceral fistula (eg, renocolic), including visceral repair; abdominal approach

closure of nephrovisceral fistula (eg, renocolic), including visceral repair; thoracic approach

symphysiotomy for horseshoe kidney with or without pyeloplasty and/or other plastic procedure, unilateral or bilateral (1 operation)

laparoscopy, surgical; ablation of renal mass lesion(s), including intraoperative ultrasound guidance and monitoring, when performed

laparoscopy, surgical; radical nephrectomy (includes removal of gerota's fascia and surrounding fatty tissue, removal of regional lymph nodes, and adrenalectomy)

laparoscopy, surgical; nephrectomy, including partial ureterectomy

laparoscopy, surgical; donor nephrectomy (including cold preservation), from living donor

renal endoscopy through established nephrostomy or pyelostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service

renal endoscopy through established nephrostomy or pyelostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with ureteral catheterization, with or without dilation of ureter

renal endoscopy through established nephrostomy or pyelostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with biopsy

renal endoscopy through established nephrostomy or pyelostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with fulguration and/or incision, with or without biopsy

renal endoscopy through established nephrostomy or pyelostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with removal of foreign body or calculus

renal endoscopy through established nephrostomy or pyelostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with resection of tumor

renal endoscopy through nephrotomy or pyelotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service

renal endoscopy through nephrotomy or pyelotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with ureteral catheterization, with or without dilation of ureter

renal endoscopy through nephrotomy or pyelotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with biopsy

renal endoscopy through nephrotomy or pyelotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with endopyelotomy (includes cystoscopy, ureteroscopy, dilation of ureter and ureteral pelvic junction, incision of ureteral pelvic junction and insertion of endopyelotomy stent)

renal endoscopy through nephrotomy or pyelotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with fulguration and/or incision, with or without biopsy

renal endoscopy through nephrotomy or pyelotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with removal of foreign body or calculus

ablation, 1 or more renal tumor(s), percutaneous, unilateral, radiofrequency

endoluminal biopsy of ureter and/or renal pelvis, non-endoscopic, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation (list separately in addition to code for primary procedure)

findings from diagnostic mammogram communicated to practice managing patient's on-going care within 3 business days of exam interpretation (rad)

findings from diagnostic mammogram communicated to the patient within 5 days of exam interpretation (rad)

ureterectomy, total, ectopic ureter, combination abdominal, vaginal and/or perineal approach

injection procedure for ureterography or ureteropyelography through ureterostomy or indwelling ureteral catheter

manometric studies through ureterostomy or indwelling ureteral catheter

change of ureterostomy tube or externally accessible ureteral stent via ileal conduit

injection procedure for visualization of ileal conduit and/or ureteropyelography, exclusive of radiologic service

placement of ureteral stent, percutaneous, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy), and all associated radiological supervision and interpretation; pre-existing nephrostomy tract

placement of ureteral stent, percutaneous, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy), and all associated radiological supervision and interpretation; new access, without separate nephrostomy catheter

placement of ureteral stent, percutaneous, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy), and all associated radiological supervision and interpretation; new access, with separate nephrostomy catheter

ureteral embolization or occlusion, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation (list separately in addition to code for primary procedure)

balloon dilation, ureteral stricture, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation (list separately in addition to code for primary procedure)

ureterolysis, with or without repositioning of ureter for retroperitoneal fibrosis

ureterolysis for retrocaval ureter, with reanastomosis of upper urinary tract or vena cava

revision of urinary-cutaneous anastomosis (any type urostomy); with repair of fascial defect and hernia

transureteroureterostomy, anastomosis of ureter to contralateral ureter

ureteroneocystostomy; anastomosis of duplicated ureter to bladder

ureterosigmoidostomy, with creation of sigmoid bladder and establishment of abdominal or perineal colostomy, including intestine anastomosis

ureteroileal conduit (ileal bladder), including intestine anastomosis (bricker operation)

continent diversion, including intestine anastomosis using any segment of small and/or large intestine (kock pouch or camey enterocystoplasty)

urinary undiversion (eg, taking down of ureteroileal conduit, ureterosigmoidostomy or ureteroenterostomy with ureteroureterostomy or ureteroneocystostomy)

replacement of all or part of ureter by intestine segment, including intestine anastomosis

laparoscopy, surgical; ureteroneocystostomy with cystoscopy and ureteral stent placement

laparoscopy, surgical; ureteroneocystostomy without cystoscopy and ureteral stent placement

ureteral endoscopy through established ureterostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service

ureteral endoscopy through established ureterostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with ureteral catheterization, with or without dilation of ureter

ureteral endoscopy through established ureterostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with biopsy

ureteral endoscopy through established ureterostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with fulguration and/or incision, with or without biopsy

ureteral endoscopy through established ureterostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with removal of foreign body or calculus

ureteral endoscopy through ureterotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service

ureteral endoscopy through ureterotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with ureteral catheterization, with or without dilation of ureter

ureteral endoscopy through ureterotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with biopsy

ureteral endoscopy through ureterotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with fulguration and/or incision, with or without biopsy

ureteral endoscopy through ureterotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with removal of foreign body or calculus

potential risk for fracture communicated to the referring physician or other qualified health care professional within 24 hours of completion of the imaging study (nuc_med)

cystotomy or cystostomy; with fulguration and/or insertion of radioactive material

cystotomy or cystostomy; with cryosurgical destruction of intravesical lesion

cystotomy, with insertion of ureteral catheter or stent (separate procedure)

cystolithotomy, cystotomy with removal of calculus, without vesical neck resection

cystotomy, with calculus basket extraction and/or ultrasonic or electrohydraulic fragmentation of ureteral calculus

excision of urachal cyst or sinus, with or without umbilical hernia repair

cystotomy; for simple excision of vesical neck (separate procedure)

cystotomy; for excision of bladder diverticulum, single or multiple (separate procedure)

cystectomy, partial; complicated (eg, postradiation, previous surgery, difficult location)

cystectomy, partial, with reimplantation of ureter(s) into bladder (ureteroneocystostomy)

cystectomy, complete; with bilateral pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes

cystectomy, complete, with ureterosigmoidostomy or ureterocutaneous transplantations

cystectomy, complete, with ureterosigmoidostomy or ureterocutaneous transplantations; with bilateral pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes

cystectomy, complete, with ureteroileal conduit or sigmoid bladder, including intestine anastomosis

cystectomy, complete, with ureteroileal conduit or sigmoid bladder, including intestine anastomosis; with bilateral pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes

cystectomy, complete, with continent diversion, any open technique, using any segment of small and/or large intestine to construct neobladder

pelvic exenteration, complete, for vesical, prostatic or urethral malignancy, with removal of bladder and ureteral transplantations, with or without hysterectomy and/or abdominoperineal resection of rectum and colon and colostomy, or any combination thereof

injection procedure for cystography or voiding urethrocystography

injection procedure and placement of chain for contrast and/or chain urethrocystography

insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)

insertion of temporary indwelling bladder catheter; simple (eg, foley)

insertion of temporary indwelling bladder catheter; complicated (eg, altered anatomy, fractured catheter/balloon)

endoscopic injection of implant material into the submucosal tissues of the urethra and/or bladder neck

bladder instillation of anticarcinogenic agent (including retention time)

complex cystometrogram (ie, calibrated electronic equipment); with urethral pressure profile studies (ie, urethral closure pressure profile), any technique

complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure), any technique

complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure) and urethral pressure profile studies (ie, urethral closure pressure profile), any technique

simple uroflowmetry (ufr) (eg, stop-watch flow rate, mechanical uroflowmeter)

electromyography studies (emg) of anal or urethral sphincter, other than needle, any technique

needle electromyography studies (emg) of anal or urethral sphincter, any technique

stimulus evoked response (eg, measurement of bulbocavernosus reflex latency time)

voiding pressure studies, intra-abdominal (ie, rectal, gastric, intraperitoneal) (list separately in addition to code for primary procedure)

measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging

cystoplasty or cystourethroplasty, plastic operation on bladder and/or vesical neck (anterior y-plasty, vesical fundus resection), any procedure, with or without wedge resection of posterior vesical neck

cystourethroplasty with unilateral or bilateral ureteroneocystostomy

anterior vesicourethropexy, or urethropexy (eg, marshall-marchetti-krantz, burch); simple

anterior vesicourethropexy, or urethropexy (eg, marshall-marchetti-krantz, burch); complicated (eg, secondary repair)

abdomino-vaginal vesical neck suspension, with or without endoscopic control (eg, stamey, raz, modified pereyra)

cystorrhaphy, suture of bladder wound, injury or rupture; simple

cystorrhaphy, suture of bladder wound, injury or rupture; complicated

laparoscopy, surgical; urethral suspension for stress incontinence

laparoscopy, surgical; sling operation for stress incontinence (eg, fascia or synthetic)

cystourethroscopy with irrigation and evacuation of multiple obstructing clots

cystourethroscopy, with ureteral catheterization, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service

cystourethroscopy, with ureteral catheterization, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with brush biopsy of ureter and/or renal pelvis

consideration of referral for a neurological evaluation of appropriateness for surgical therapy for intractable epilepsy within the past 3 years (epi)

cystourethroscopy, with ejaculatory duct catheterization, with or without irrigation, instillation, or duct radiography, exclusive of radiologic service

cystourethroscopy, with fulguration (including cryosurgery or laser surgery) of trigone, bladder neck, prostatic fossa, urethra, or periurethral glands

cystourethroscopy, with fulguration (including cryosurgery or laser surgery) or treatment of minor (less than 0.5 cm) lesion(s) with or without biopsy

cystourethroscopy, with fulguration (including cryosurgery or laser surgery) and/or resection of; small bladder tumor(s) (0.5 up to 2.0 cm)

cystourethroscopy, with fulguration (including cryosurgery or laser surgery) and/or resection of; medium bladder tumor(s) (2.0 to 5.0 cm)

cystourethroscopy, with fulguration (including cryosurgery or laser surgery) and/or resection of; large bladder tumor(s)

cystourethroscopy with insertion of radioactive substance, with or without biopsy or fulguration

cystourethroscopy, with dilation of bladder for interstitial cystitis; general or conduction (spinal) anesthesia

cystourethroscopy, with dilation of bladder for interstitial cystitis; local anesthesia

cystourethroscopy, with resection of external sphincter (sphincterotomy)

cystourethroscopy, with calibration and/or dilation of urethral stricture or stenosis, with or without meatotomy, with or without injection procedure for cystography, male or female

cystourethroscopy for treatment of the female urethral syndrome with any or all of the following: urethral meatotomy, urethral dilation, internal urethrotomy, lysis of urethrovaginal septal fibrosis, lateral incisions of the bladder neck, and fulguration of polyp(s) of urethra, bladder neck, and/or trigone

cystourethroscopy, with injection(s) for chemodenervation of the bladder

cystourethroscopy; with ureteral meatotomy, unilateral or bilateral

cystourethroscopy; with resection or fulguration of orthotopic ureterocele(s), unilateral or bilateral

cystourethroscopy; with resection or fulguration of ectopic ureterocele(s), unilateral or bilateral

cystourethroscopy; with incision or resection of orifice of bladder diverticulum, single or multiple

cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); simple

cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); complicated

litholapaxy: crushing or fragmentation of calculus by any means in bladder and removal of fragments; simple or small (less than 2.5 cm)

litholapaxy: crushing or fragmentation of calculus by any means in bladder and removal of fragments; complicated or large (over 2.5 cm)

cystourethroscopy (including ureteral catheterization); with removal of ureteral calculus

cystourethroscopy (including ureteral catheterization); with fragmentation of ureteral calculus (eg, ultrasonic or electro-hydraulic technique)

cystourethroscopy (including ureteral catheterization); with subureteric injection of implant material

cystourethroscopy (including ureteral catheterization); with manipulation, without removal of ureteral calculus

cystourethroscopy, with insertion of indwelling ureteral stent (eg, gibbons or double-j type)

cystourethroscopy with insertion of ureteral guide wire through kidney to establish a percutaneous nephrostomy, retrograde

cystourethroscopy; with treatment of ureteral stricture (eg, balloon dilation, laser, electrocautery, and incision)

cystourethroscopy; with treatment of ureteropelvic junction stricture (eg, balloon dilation, laser, electrocautery, and incision)

cystourethroscopy; with treatment of intra-renal stricture (eg, balloon dilation, laser, electrocautery, and incision)

cystourethroscopy with ureteroscopy; with treatment of ureteral stricture (eg, balloon dilation, laser, electrocautery, and incision)

cystourethroscopy with ureteroscopy; with treatment of ureteropelvic junction stricture (eg, balloon dilation, laser, electrocautery, and incision)

cystourethroscopy with ureteroscopy; with treatment of intra-renal stricture (eg, balloon dilation, laser, electrocautery, and incision)

cystourethroscopy, with ureteroscopy and/or pyeloscopy; diagnostic

cystourethroscopy, with ureteroscopy and/or pyeloscopy; with removal or manipulation of calculus (ureteral catheterization is included)

cystourethroscopy, with ureteroscopy and/or pyeloscopy; with lithotripsy (ureteral catheterization is included)

cystourethroscopy, with ureteroscopy and/or pyeloscopy; with biopsy and/or fulguration of ureteral or renal pelvic lesion

cystourethroscopy, with ureteroscopy and/or pyeloscopy; with resection of ureteral or renal pelvic tumor

cystourethroscopy, with ureteroscopy and/or pyeloscopy; with lithotripsy including insertion of indwelling ureteral stent (eg, gibbons or double-j type)

cystourethroscopy with incision, fulguration, or resection of congenital posterior urethral valves, or congenital obstructive hypertrophic mucosal folds

cystourethroscopy with transurethral resection or incision of ejaculatory ducts

cystourethroscopy, with insertion of permanent adjustable transprostatic implant; single implant

cystourethroscopy, with insertion of permanent adjustable transprostatic implant; each additional permanent adjustable transprostatic implant (list separately in addition to code for primary procedure)

transurethral electrosurgical resection of prostate, including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included)

transurethral resection; residual or regrowth of obstructive prostate tissue including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included)

transurethral resection; of postoperative bladder neck contracture

laser coagulation of prostate, including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included if performed)

laser vaporization of prostate, including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, internal urethrotomy and transurethral resection of prostate are included if performed)

laser enucleation of the prostate with morcellation, including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, internal urethrotomy and transurethral resection of prostate are included if performed)

urethrotomy or urethrostomy, external (separate procedure); pendulous urethra

urethrotomy or urethrostomy, external (separate procedure); perineal urethra, external

meatotomy, cutting of meatus (separate procedure); except infant

drainage of perineal urinary extravasation; uncomplicated (separate procedure)

urethroplasty; first stage, for fistula, diverticulum, or stricture (eg, johannsen type)

urethroplasty; second stage (formation of urethra), including urinary diversion

urethroplasty, transpubic or perineal, 1-stage, for reconstruction or repair of prostatic or membranous urethra

urethroplasty, 2-stage reconstruction or repair of prostatic or membranous urethra; first stage

urethroplasty, 2-stage reconstruction or repair of prostatic or membranous urethra; second stage

urethroplasty with tubularization of posterior urethra and/or lower bladder for incontinence (eg, tenago, leadbetter procedure)

sling operation for correction of male urinary incontinence (eg, fascia or synthetic)

removal or revision of sling for male urinary incontinence (eg, fascia or synthetic)

insertion of inflatable urethral/bladder neck sphincter, including placement of pump, reservoir, and cuff

removal of inflatable urethral/bladder neck sphincter, including pump, reservoir, and cuff

removal and replacement of inflatable urethral/bladder neck sphincter including pump, reservoir, and cuff at the same operative session

removal and replacement of inflatable urethral/bladder neck sphincter including pump, reservoir, and cuff through an infected field at the same operative session including irrigation and debridement of infected tissue

repair of inflatable urethral/bladder neck sphincter, including pump, reservoir, and cuff

urethromeatoplasty, with partial excision of distal urethral segment (richardson type procedure)

urethrolysis, transvaginal, secondary, open, including cystourethroscopy (eg, postsurgical obstruction, scarring)

urethrorrhaphy, suture of urethral wound or injury; prostatomembranous

closure of urethrostomy or urethrocutaneous fistula, male (separate procedure)

dilation of urethral stricture by passage of sound or urethral dilator, male; initial

dilation of urethral stricture by passage of sound or urethral dilator, male; subsequent

dilation of urethral stricture or vesical neck by passage of sound or urethral dilator, male, general or conduction (spinal) anesthesia

dilation of urethral stricture by passage of filiform and follower, male; initial

dilation of urethral stricture by passage of filiform and follower, male; subsequent

dilation of female urethra including suppository and/or instillation; initial

dilation of female urethra including suppository and/or instillation; subsequent

dilation of female urethra, general or conduction (spinal) anesthesia

transurethral destruction of prostate tissue; by microwave thermotherapy

transurethral destruction of prostate tissue; by radiofrequency thermotherapy

insertion of a temporary prostatic urethral stent, including urethral measurement

transurethral radiofrequency micro-remodeling of the female bladder neck and proximal urethra for stress urinary incontinence

slitting of prepuce, dorsal or lateral (separate procedure); newborn

slitting of prepuce, dorsal or lateral (separate procedure); except newborn

destruction of lesion(s), penis (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; chemical

destruction of lesion(s), penis (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; electrodesiccation

destruction of lesion(s), penis (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; cryosurgery

destruction of lesion(s), penis (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; laser surgery

destruction of lesion(s), penis (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; surgical excision

destruction of lesion(s), penis (eg, condyloma, papilloma, molluscum contagiosum, herpetic vesicle), extensive (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery)

excision of penile plaque (peyronie disease); with graft to 5 cm in length

excision of penile plaque (peyronie disease); with graft greater than 5 cm in length

removal foreign body from deep penile tissue (eg, plastic implant)

amputation of penis, radical; with bilateral inguinofemoral lymphadenectomy

amputation of penis, radical; in continuity with bilateral pelvic lymphadenectomy, including external iliac, hypogastric and obturator nodes

circumcision, using clamp or other device with regional dorsal penile or ring block

circumcision, surgical excision other than clamp, device, or dorsal slit; neonate (28 days of age or less)

circumcision, surgical excision other than clamp, device, or dorsal slit; older than 28 days of age

injection procedure for peyronie disease; with surgical exposure of plaque

dynamic cavernosometry, including intracavernosal injection of vasoactive drugs (eg, papaverine, phentolamine)

injection of corpora cavernosa with pharmacologic agent(s) (eg, papaverine, phentolamine)

plastic operation of penis for straightening of chordee (eg, hypospadias), with or without mobilization of urethra

plastic operation on penis for correction of chordee or for first stage hypospadias repair with or without transplantation of prepuce and/or skin flaps

urethroplasty for second stage hypospadias repair (including urinary diversion); less than 3 cm

urethroplasty for second stage hypospadias repair (including urinary diversion); greater than 3 cm

urethroplasty for second stage hypospadias repair (including urinary diversion) with free skin graft obtained from site other than genitalia

urethroplasty for third stage hypospadias repair to release penis from scrotum (eg, third stage cecil repair)

1-stage distal hypospadias repair (with or without chordee or circumcision); with simple meatal advancement (eg, magpi, v-flap)

1-stage distal hypospadias repair (with or without chordee or circumcision); with urethroplasty by local skin flaps (eg, flip-flap, prepucial flap)

1-stage distal hypospadias repair (with or without chordee or circumcision); with urethroplasty by local skin flaps and mobilization of urethra

1-stage distal hypospadias repair (with or without chordee or circumcision); with extensive dissection to correct chordee and urethroplasty with local skin flaps, skin graft patch, and/or island flap

1-stage proximal penile or penoscrotal hypospadias repair requiring extensive dissection to correct chordee and urethroplasty by use of skin graft tube and/or island flap

1-stage perineal hypospadias repair requiring extensive dissection to correct chordee and urethroplasty by use of skin graft tube and/or island flap

repair of hypospadias complications (ie, fistula, stricture, diverticula); by closure, incision, or excision, simple

repair of hypospadias complications (ie, fistula, stricture, diverticula); requiring mobilization of skin flaps and urethroplasty with flap or patch graft

repair of hypospadias complications (ie, fistula, stricture, diverticula); requiring extensive dissection and urethroplasty with flap, patch or tubed graft (includes urinary diversion)

repair of hypospadias cripple requiring extensive dissection and excision of previously constructed structures including re-release of chordee and reconstruction of urethra and penis by use of local skin as grafts and island flaps and skin brought in as flaps or grafts

plastic operation on penis for epispadias distal to external sphincter

plastic operation on penis for epispadias distal to external sphincter; with incontinence

plastic operation on penis for epispadias distal to external sphincter; with exstrophy of bladder

insertion of multi-component, inflatable penile prosthesis, including placement of pump, cylinders, and reservoir

removal of all components of a multi-component, inflatable penile prosthesis without replacement of prosthesis

repair of component(s) of a multi-component, inflatable penile prosthesis

removal and replacement of all component(s) of a multi-component, inflatable penile prosthesis at the same operative session

removal and replacement of all components of a multi-component inflatable penile prosthesis through an infected field at the same operative session, including irrigation and debridement of infected tissue

removal of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis, without replacement of prosthesis

removal and replacement of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis at the same operative session

removal and replacement of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis through an infected field at the same operative session, including irrigation and debridement of infected tissue

corpora cavernosa-saphenous vein shunt (priapism operation), unilateral or bilateral

corpora cavernosa-corpus spongiosum shunt (priapism operation), unilateral or bilateral

corpora cavernosa-glans penis fistulization (eg, biopsy needle, winter procedure, rongeur, or punch) for priapism

replantation, penis, complete amputation including urethral repair

foreskin manipulation including lysis of preputial adhesions and stretching

orchiectomy, simple (including subcapsular), with or without testicular prosthesis, scrotal or inguinal approach

reduction of torsion of testis, surgical, with or without fixation of contralateral testis

orchiopexy, abdominal approach, for intra-abdominal testis (eg, fowler-stephens)

transplantation of testis(es) to thigh (because of scrotal destruction)

incision and drainage of epididymis, testis and/or scrotal space (eg, abscess or hematoma)

epididymovasostomy, anastomosis of epididymis to vas deferens; unilateral

epididymovasostomy, anastomosis of epididymis to vas deferens; bilateral

puncture aspiration of hydrocele, tunica vaginalis, with or without injection of medication

vasotomy, cannulization with or without incision of vas, unilateral or bilateral (separate procedure)

vasectomy, unilateral or bilateral (separate procedure), including postoperative semen examination(s)

vasotomy for vasograms, seminal vesiculograms, or epididymograms, unilateral or bilateral

excision of hydrocele of spermatic cord, unilateral (separate procedure)

excision of varicocele or ligation of spermatic veins for varicocele; (separate procedure)

excision of varicocele or ligation of spermatic veins for varicocele; abdominal approach

excision of varicocele or ligation of spermatic veins for varicocele; with hernia repair

laparoscopy, surgical, with ligation of spermatic veins for varicocele

biopsy, prostate; needle or punch, single or multiple, any approach

biopsies, prostate, needle, transperineal, stereotactic template guided saturation sampling, including imaging guidance

prostatotomy, external drainage of prostatic abscess, any approach; simple

prostatotomy, external drainage of prostatic abscess, any approach; complicated

prostatectomy, perineal, subtotal (including control of postoperative bleeding, vasectomy, meatotomy, urethral calibration and/or dilation, and internal urethrotomy)

prostatectomy, perineal radical; with lymph node biopsy(s) (limited pelvic lymphadenectomy)

prostatectomy, perineal radical; with bilateral pelvic lymphadenectomy, including external iliac, hypogastric and obturator nodes

prostatectomy (including control of postoperative bleeding, vasectomy, meatotomy, urethral calibration and/or dilation, and internal urethrotomy); suprapubic, subtotal, 1 or 2 stages

prostatectomy (including control of postoperative bleeding, vasectomy, meatotomy, urethral calibration and/or dilation, and internal urethrotomy); retropubic, subtotal

prostatectomy, retropubic radical, with or without nerve sparing

prostatectomy, retropubic radical, with or without nerve sparing; with lymph node biopsy(s) (limited pelvic lymphadenectomy)

prostatectomy, retropubic radical, with or without nerve sparing; with bilateral pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes

exposure of prostate, any approach, for insertion of radioactive substance

exposure of prostate, any approach, for insertion of radioactive substance; with lymph node biopsy(s) (limited pelvic lymphadenectomy)

exposure of prostate, any approach, for insertion of radioactive substance; with bilateral pelvic lymphadenectomy, including external iliac, hypogastric and obturator nodes

laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing, includes robotic assistance, when performed

cryosurgical ablation of the prostate (includes ultrasonic guidance and monitoring)

transperineal placement of biodegradable material, peri-prostatic, single or multiple injection(s), including image guidance, when performed

transperineal placement of needles or catheters into prostate for interstitial radioelement application, with or without cystoscopy

placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), prostate (via needle, any approach), single or multiple

placement of needles or catheters into pelvic organs and/or genitalia (except prostate) for subsequent interstitial radioelement application

destruction of lesion(s), vulva; simple (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery)

destruction of lesion(s), vulva; extensive (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery)

biopsy of vulva or perineum (separate procedure); each separate additional lesion (list separately in addition to code for primary procedure)

vulvectomy, radical, partial; with unilateral inguinofemoral lymphadenectomy

vulvectomy, radical, partial; with bilateral inguinofemoral lymphadenectomy

vulvectomy, radical, complete; with unilateral inguinofemoral lymphadenectomy

vulvectomy, radical, complete; with bilateral inguinofemoral lymphadenectomy

vulvectomy, radical, complete, with inguinofemoral, iliac, and pelvic lymphadenectomy

perineoplasty, repair of perineum, nonobstetrical (separate procedure)

incision and drainage of vaginal hematoma; obstetrical/postpartum

incision and drainage of vaginal hematoma; non-obstetrical (eg, post-trauma, spontaneous bleeding)

destruction of vaginal lesion(s); simple (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery)

destruction of vaginal lesion(s); extensive (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery)

biopsy of vaginal mucosa; extensive, requiring suture (including cysts)

vaginectomy, partial removal of vaginal wall; with removal of paravaginal tissue (radical vaginectomy)

vaginectomy, partial removal of vaginal wall; with removal of paravaginal tissue (radical vaginectomy) with bilateral total pelvic lymphadenectomy and para-aortic lymph node sampling (biopsy)

vaginectomy, complete removal of vaginal wall; with removal of paravaginal tissue (radical vaginectomy)

vaginectomy, complete removal of vaginal wall; with removal of paravaginal tissue (radical vaginectomy) with bilateral total pelvic lymphadenectomy and para-aortic lymph node sampling (biopsy)

irrigation of vagina and/or application of medicament for treatment of bacterial, parasitic, or fungoid disease

insertion of uterine tandem and/or vaginal ovoids for clinical brachytherapy

insertion of a vaginal radiation afterloading apparatus for clinical brachytherapy

fitting and insertion of pessary or other intravaginal support device

introduction of any hemostatic agent or pack for spontaneous or traumatic nonobstetrical vaginal hemorrhage (separate procedure)

colpoperineorrhaphy, suture of injury of vagina and/or perineum (nonobstetrical)

plastic operation on urethral sphincter, vaginal approach (eg, kelly urethral plication)

anterior colporrhaphy, repair of cystocele with or without repair of urethrocele, including cystourethroscopy, when performed

posterior colporrhaphy, repair of rectocele with or without perineorrhaphy

combined anteroposterior colporrhaphy, including cystourethroscopy, when performed

combined anteroposterior colporrhaphy, including cystourethroscopy, when performed; with enterocele repair

insertion of mesh or other prosthesis for repair of pelvic floor defect, each site (anterior, posterior compartment), vaginal approach (list separately in addition to code for primary procedure)

colpopexy, vaginal; extra-peritoneal approach (sacrospinous, iliococcygeus)

colpopexy, vaginal; intra-peritoneal approach (uterosacral, levator myorrhaphy)

paravaginal defect repair (including repair of cystocele, if performed); open abdominal approach

paravaginal defect repair (including repair of cystocele, if performed); vaginal approach

removal or revision of sling for stress incontinence (eg, fascia or synthetic)

sling operation for stress incontinence (eg, fascia or synthetic)

revision (including removal) of prosthetic vaginal graft; vaginal approach

revision (including removal) of prosthetic vaginal graft; open abdominal approach

closure of rectovaginal fistula; abdominal approach, with concomitant colostomy

closure of rectovaginal fistula; transperineal approach, with perineal body reconstruction, with or without levator plication

closure of urethrovaginal fistula; with bulbocavernosus transplant

closure of vesicovaginal fistula; transvesical and vaginal approach

removal of impacted vaginal foreign body (separate procedure) under anesthesia (other than local)

colposcopy of the entire vagina, with cervix if present; with biopsy(s) of vagina/cervix

paravaginal defect repair (including repair of cystocele, if performed), laparoscopic approach

revision (including removal) of prosthetic vaginal graft, laparoscopic approach

colposcopy of the cervix including upper/adjacent vagina; with biopsy(s) of the cervix and endocervical curettage

colposcopy of the cervix including upper/adjacent vagina; with biopsy(s) of the cervix

colposcopy of the cervix including upper/adjacent vagina; with endocervical curettage

colposcopy of the cervix including upper/adjacent vagina; with loop electrode biopsy(s) of the cervix

colposcopy of the cervix including upper/adjacent vagina; with loop electrode conization of the cervix

biopsy of cervix, single or multiple, or local excision of lesion, with or without fulguration (separate procedure)

endocervical curettage (not done as part of a dilation and curettage)

conization of cervix, with or without fulguration, with or without dilation and curettage, with or without repair; cold knife or laser

conization of cervix, with or without fulguration, with or without dilation and curettage, with or without repair; loop electrode excision

trachelectomy (cervicectomy), amputation of cervix (separate procedure)

radical trachelectomy, with bilateral total pelvic lymphadenectomy and para-aortic lymph node sampling biopsy, with or without removal of tube(s), with or without removal of ovary(s)

excision of cervical stump, abdominal approach; with pelvic floor repair

excision of cervical stump, vaginal approach; with anterior and/or posterior repair

excision of cervical stump, vaginal approach; with repair of enterocele

trachelorrhaphy, plastic repair of uterine cervix, vaginal approach

endometrial sampling (biopsy) with or without endocervical sampling (biopsy), without cervical dilation, any method (separate procedure)

endometrial sampling (biopsy) performed in conjunction with colposcopy (list separately in addition to code for primary procedure)

dilation and curettage, diagnostic and/or therapeutic (nonobstetrical)

myomectomy, excision of fibroid tumor(s) of uterus, 1 to 4 intramural myoma(s) with total weight of 250 g or less and/or removal of surface myomas; abdominal approach

myomectomy, excision of fibroid tumor(s) of uterus, 1 to 4 intramural myoma(s) with total weight of 250 g or less and/or removal of surface myomas; vaginal approach

myomectomy, excision of fibroid tumor(s) of uterus, 5 or more intramural myomas and/or intramural myomas with total weight greater than 250 g, abdominal approach

total abdominal hysterectomy (corpus and cervix), with or without removal of tube(s), with or without removal of ovary(s)

total abdominal hysterectomy (corpus and cervix), with or without removal of tube(s), with or without removal of ovary(s); with colpo-urethrocystopexy (eg, marshall-marchetti-krantz, burch)

supracervical abdominal hysterectomy (subtotal hysterectomy), with or without removal of tube(s), with or without removal of ovary(s)

total abdominal hysterectomy, including partial vaginectomy, with para-aortic and pelvic lymph node sampling, with or without removal of tube(s), with or without removal of ovary(s)

radical abdominal hysterectomy, with bilateral total pelvic lymphadenectomy and para-aortic lymph node sampling (biopsy), with or without removal of tube(s), with or without removal of ovary(s)

pelvic exenteration for gynecologic malignancy, with total abdominal hysterectomy or cervicectomy, with or without removal of tube(s), with or without removal of ovary(s), with removal of bladder and ureteral transplantations, and/or abdominoperineal resection of rectum and colon and colostomy, or any combination thereof

vaginal hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s)

vaginal hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s), with repair of enterocele

vaginal hysterectomy, for uterus 250 g or less; with colpo-urethrocystopexy (marshall-marchetti-krantz type, pereyra type) with or without endoscopic control

vaginal hysterectomy, for uterus 250 g or less; with repair of enterocele

vaginal hysterectomy, with total or partial vaginectomy; with repair of enterocele

vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s)

vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s), with repair of enterocele

vaginal hysterectomy, for uterus greater than 250 g; with colpo-urethrocystopexy (marshall-marchetti-krantz type, pereyra type) with or without endoscopic control

vaginal hysterectomy, for uterus greater than 250 g; with repair of enterocele

catheterization and introduction of saline or contrast material for saline infusion sonohysterography (sis) or hysterosalpingography

transcervical introduction of fallopian tube catheter for diagnosis and/or re-establishing patency (any method), with or without hysterosalpingography

endometrial cryoablation with ultrasonic guidance, including endometrial curettage, when performed

uterine suspension, with or without shortening of round ligaments, with or without shortening of sacrouterine ligaments; (separate procedure)

uterine suspension, with or without shortening of round ligaments, with or without shortening of sacrouterine ligaments; with presacral sympathectomy

laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less

laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(s)

laparoscopy, surgical, supracervical hysterectomy, for uterus greater than 250 g

laparoscopy, surgical, supracervical hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s)

laparoscopy, surgical, myomectomy, excision; 1 to 4 intramural myomas with total weight of 250 g or less and/or removal of surface myomas

laparoscopy, surgical, myomectomy, excision; 5 or more intramural myomas and/or intramural myomas with total weight greater than 250 g

laparoscopy, surgical, with radical hysterectomy, with bilateral total pelvic lymphadenectomy and para-aortic lymph node sampling (biopsy), with removal of tube(s) and ovary(s), if performed

laparoscopy, surgical, with vaginal hysterectomy, for uterus 250 g or less

laparoscopy, surgical, with vaginal hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(s)

laparoscopy, surgical, with vaginal hysterectomy, for uterus greater than 250 g

laparoscopy, surgical, with vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s)

hysteroscopy, surgical; with sampling (biopsy) of endometrium and/or polypectomy, with or without d & c

hysteroscopy, surgical; with lysis of intrauterine adhesions (any method)

hysteroscopy, surgical; with division or resection of intrauterine septum (any method)

hysteroscopy, surgical; with endometrial ablation (eg, endometrial resection, electrosurgical ablation, thermoablation)

hysteroscopy, surgical; with bilateral fallopian tube cannulation to induce occlusion by placement of permanent implants

laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less

laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(s)

laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g

laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s)

laparoscopy, surgical, total hysterectomy for resection of malignancy (tumor debulking), with omentectomy including salpingo-oophorectomy, unilateral or bilateral, when performed

ligation or transection of fallopian tube(s), abdominal or vaginal approach, unilateral or bilateral

ligation or transection of fallopian tube(s), abdominal or vaginal approach, postpartum, unilateral or bilateral, during same hospitalization (separate procedure)

ligation or transection of fallopian tube(s) when done at the time of cesarean delivery or intra-abdominal surgery (not a separate procedure) (list separately in addition to code for primary procedure)

occlusion of fallopian tube(s) by device (eg, band, clip, falope ring) vaginal or suprapubic approach

laparoscopy, surgical; with lysis of adhesions (salpingolysis, ovariolysis) (separate procedure)

laparoscopy, surgical; with removal of adnexal structures (partial or total oophorectomy and/or salpingectomy)

laparoscopy, surgical; with fulguration or excision of lesions of the ovary, pelvic viscera, or peritoneal surface by any method

laparoscopy, surgical; with fulguration of oviducts (with or without transection)

laparoscopy, surgical; with occlusion of oviducts by device (eg, band, clip, or falope ring)

laparoscopy, surgical, ablation of uterine fibroid(s) including intraoperative ultrasound guidance and monitoring, radiofrequency

salpingectomy, complete or partial, unilateral or bilateral (separate procedure)

salpingo-oophorectomy, complete or partial, unilateral or bilateral (separate procedure)

drainage of ovarian cyst(s), unilateral or bilateral (separate procedure); vaginal approach

drainage of ovarian cyst(s), unilateral or bilateral (separate procedure); abdominal approach

oophorectomy, partial or total, unilateral or bilateral; for ovarian, tubal or primary peritoneal malignancy, with para-aortic and pelvic lymph node biopsies, peritoneal washings, peritoneal biopsies, diaphragmatic assessments, with or without salpingectomy(s), with or without omentectomy

resection (initial) of ovarian, tubal or primary peritoneal malignancy with bilateral salpingo-oophorectomy and omentectomy

resection (initial) of ovarian, tubal or primary peritoneal malignancy with bilateral salpingo-oophorectomy and omentectomy; with total abdominal hysterectomy, pelvic and limited para-aortic lymphadenectomy

resection (initial) of ovarian, tubal or primary peritoneal malignancy with bilateral salpingo-oophorectomy and omentectomy; with radical dissection for debulking (ie, radical excision or destruction, intra-abdominal or retroperitoneal tumors)

bilateral salpingo-oophorectomy with omentectomy, total abdominal hysterectomy and radical dissection for debulking

bilateral salpingo-oophorectomy with omentectomy, total abdominal hysterectomy and radical dissection for debulking; with pelvic lymphadenectomy and limited para-aortic lymphadenectomy

bilateral salpingo-oophorectomy with total omentectomy, total abdominal hysterectomy for malignancy

resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed

resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed; with pelvic lymphadenectomy and limited para-aortic lymphadenectomy

laparotomy, for staging or restaging of ovarian, tubal, or primary peritoneal malignancy (second look), with or without omentectomy, peritoneal washing, biopsy of abdominal and pelvic peritoneum, diaphragmatic assessment with pelvic and limited para-aortic lymphadenectomy

amniocentesis; therapeutic amniotic fluid reduction (includes ultrasound guidance)

fetal monitoring during labor by consulting physician (ie, non-attending physician) with written report; supervision and interpretation

fetal monitoring during labor by consulting physician (ie, non-attending physician) with written report; interpretation only

fetal fluid drainage (eg, vesicocentesis, thoracocentesis, paracentesis), including ultrasound guidance

surgical treatment of ectopic pregnancy; tubal or ovarian, requiring salpingectomy and/or oophorectomy, abdominal or vaginal approach

surgical treatment of ectopic pregnancy; tubal or ovarian, without salpingectomy and/or oophorectomy

surgical treatment of ectopic pregnancy; interstitial, uterine pregnancy requiring total hysterectomy

surgical treatment of ectopic pregnancy; interstitial, uterine pregnancy with partial resection of uterus

surgical treatment of ectopic pregnancy; cervical, with evacuation

laparoscopic treatment of ectopic pregnancy; without salpingectomy and/or oophorectomy

laparoscopic treatment of ectopic pregnancy; with salpingectomy and/or oophorectomy

insertion of cervical dilator (eg, laminaria, prostaglandin) (separate procedure)

routine obstetric care including antepartum care, vaginal delivery (with or without episiotomy, and/or forceps) and postpartum care

vaginal delivery only (with or without episiotomy and/or forceps)

vaginal delivery only (with or without episiotomy and/or forceps); including postpartum care

routine obstetric care including antepartum care, cesarean delivery, and postpartum care

subtotal or total hysterectomy after cesarean delivery (list separately in addition to code for primary procedure)

routine obstetric care including antepartum care, vaginal delivery (with or without episiotomy, and/or forceps) and postpartum care, after previous cesarean delivery

vaginal delivery only, after previous cesarean delivery (with or without episiotomy and/or forceps)

vaginal delivery only, after previous cesarean delivery (with or without episiotomy and/or forceps); including postpartum care

routine obstetric care including antepartum care, cesarean delivery, and postpartum care, following attempted vaginal delivery after previous cesarean delivery

cesarean delivery only, following attempted vaginal delivery after previous cesarean delivery

cesarean delivery only, following attempted vaginal delivery after previous cesarean delivery; including postpartum care

treatment of incomplete abortion, any trimester, completed surgically

treatment of missed abortion, completed surgically; first trimester

treatment of missed abortion, completed surgically; second trimester

induced abortion, by 1 or more intra-amniotic injections (amniocentesis-injections), including hospital admission and visits, delivery of fetus and secundines

induced abortion, by 1 or more intra-amniotic injections (amniocentesis-injections), including hospital admission and visits, delivery of fetus and secundines; with dilation and curettage and/or evacuation

induced abortion, by 1 or more intra-amniotic injections (amniocentesis-injections), including hospital admission and visits, delivery of fetus and secundines; with hysterotomy (failed intra-amniotic injection)

induced abortion, by 1 or more vaginal suppositories (eg, prostaglandin) with or without cervical dilation (eg, laminaria), including hospital admission and visits, delivery of fetus and secundines

induced abortion, by 1 or more vaginal suppositories (eg, prostaglandin) with or without cervical dilation (eg, laminaria), including hospital admission and visits, delivery of fetus and secundines; with dilation and curettage and/or evacuation

induced abortion, by 1 or more vaginal suppositories (eg, prostaglandin) with or without cervical dilation (eg, laminaria), including hospital admission and visits, delivery of fetus and secundines; with hysterotomy (failed medical evacuation)

unlisted fetal invasive procedure, including ultrasound guidance, when performed

rationale (eg, severity of illness and safety) for level of care (eg, home, hospital) documented (cap)

dysphagia screening conducted prior to order for or receipt of any foods, fluids, or medication by mouth (str)

patient receiving or eligible to receive foods, fluids, or medication by mouth (str)

excision of cyst or adenoma of thyroid, or transection of isthmus

partial thyroid lobectomy, unilateral; with or without isthmusectomy

partial thyroid lobectomy, unilateral; with contralateral subtotal lobectomy, including isthmusectomy

total thyroid lobectomy, unilateral; with or without isthmusectomy

total thyroid lobectomy, unilateral; with contralateral subtotal lobectomy, including isthmusectomy

thyroidectomy, total or subtotal for malignancy; with limited neck dissection

thyroidectomy, total or subtotal for malignancy; with radical neck dissection

thyroidectomy, removal of all remaining thyroid tissue following previous removal of a portion of thyroid

thyroidectomy, including substernal thyroid; sternal split or transthoracic approach

all elements of maximal sterile barrier technique, hand hygiene, skin preparation and, if ultrasound is used, sterile ultrasound techniques followed (crit)

use of appropriate radiation dose reduction devices or manual techniques for appropriate moderation of exposure, documented (rad)

radiation exposure or exposure time in final report for procedure using fluoroscopy, documented (rad)

parathyroidectomy or exploration of parathyroid(s); re-exploration

parathyroidectomy or exploration of parathyroid(s); with mediastinal exploration, sternal split or transthoracic approach

parathyroid autotransplantation (list separately in addition to code for primary procedure)

thymectomy, partial or total; transcervical approach (separate procedure)

thymectomy, partial or total; sternal split or transthoracic approach, without radical mediastinal dissection (separate procedure)

thymectomy, partial or total; sternal split or transthoracic approach, with radical mediastinal dissection (separate procedure)

adrenalectomy, partial or complete, or exploration of adrenal gland with or without biopsy, transabdominal, lumbar or dorsal (separate procedure)

adrenalectomy, partial or complete, or exploration of adrenal gland with or without biopsy, transabdominal, lumbar or dorsal (separate procedure); with excision of adjacent retroperitoneal tumor

excision of carotid body tumor; without excision of carotid artery

laparoscopy, surgical, with adrenalectomy, partial or complete, or exploration of adrenal gland with or without biopsy, transabdominal, lumbar or dorsal

patient queried and counseled about anti-epileptic drug (aed) side effects (epi)

patient (or caregiver) counseled about safety issues appropriate to patient's stage of disease (prkns)

subdural tap through fontanelle, or suture, infant, unilateral or bilateral; initial

subdural tap through fontanelle, or suture, infant, unilateral or bilateral; subsequent taps

timeout to verify correct patient, correct site, and correct procedure, documented (path)

ventricular puncture through previous burr hole, fontanelle, suture, or implanted ventricular catheter/reservoir; without injection

ventricular puncture through previous burr hole, fontanelle, suture, or implanted ventricular catheter/reservoir; with injection of medication or other substance for diagnosis or treatment

cisternal or lateral cervical (c1-c2) puncture; without injection (separate procedure)

cisternal or lateral cervical (c1-c2) puncture; with injection of medication or other substance for diagnosis or treatment

puncture of shunt tubing or reservoir for aspiration or injection procedure

twist drill hole(s) for subdural, intracerebral, or ventricular puncture; for implanting ventricular catheter, pressure recording device, or other intracerebral monitoring device

twist drill hole(s) for subdural, intracerebral, or ventricular puncture; for evacuation and/or drainage of subdural hematoma

counseling provided regarding risks of driving and the alternatives to driving (dem)

burr hole(s) for ventricular puncture (including injection of gas, contrast media, dye, or radioactive material)

burr hole(s) or trephine; with biopsy of brain or intracranial lesion

burr hole(s) or trephine; with drainage of brain abscess or cyst

burr hole(s) or trephine; with subsequent tapping (aspiration) of intracranial abscess or cyst

burr hole(s) with evacuation and/or drainage of hematoma, extradural or subdural

burr hole(s); with aspiration of hematoma or cyst, intracerebral

burr hole(s); for implanting ventricular catheter, reservoir, eeg electrode(s), pressure recording device, or other cerebral monitoring device (separate procedure)

insertion of subcutaneous reservoir, pump or continuous infusion system for connection to ventricular catheter

burr hole(s) or trephine, supratentorial, exploratory, not followed by other surgery

burr hole(s) or trephine, infratentorial, unilateral or bilateral

craniectomy or craniotomy, exploratory; infratentorial (posterior fossa)

craniectomy or craniotomy for evacuation of hematoma, supratentorial; extradural or subdural

craniectomy or craniotomy for evacuation of hematoma, supratentorial; intracerebral

craniectomy or craniotomy for evacuation of hematoma, infratentorial; extradural or subdural

craniectomy or craniotomy for evacuation of hematoma, infratentorial; intracerebellar

incision and subcutaneous placement of cranial bone graft (list separately in addition to code for primary procedure)

craniectomy or craniotomy, drainage of intracranial abscess; supratentorial

craniectomy or craniotomy, drainage of intracranial abscess; infratentorial

craniectomy or craniotomy, decompressive, with or without duraplasty, for treatment of intracranial hypertension, without evacuation of associated intraparenchymal hematoma; without lobectomy

craniectomy or craniotomy, decompressive, with or without duraplasty, for treatment of intracranial hypertension, without evacuation of associated intraparenchymal hematoma; with lobectomy

exploration of orbit (transcranial approach); with removal of lesion

subtemporal cranial decompression (pseudotumor cerebri, slit ventricle syndrome)

craniectomy, suboccipital with cervical laminectomy for decompression of medulla and spinal cord, with or without dural graft (eg, arnold-chiari malformation)

craniectomy, subtemporal, for section, compression, or decompression of sensory root of gasserian ganglion

craniectomy, suboccipital; for exploration or decompression of cranial nerves

craniectomy, suboccipital; for section of 1 or more cranial nerves

craniectomy, suboccipital; for mesencephalic tractotomy or pedunculotomy

craniectomy; with excision of tumor or other bone lesion of skull

patient not receiving a first course of anti-tnf (tumor necrosis factor) therapy (ibd)

craniectomy, trephination, bone flap craniotomy; for excision of brain tumor, supratentorial, except meningioma

craniectomy, trephination, bone flap craniotomy; for excision of meningioma, supratentorial

craniectomy, trephination, bone flap craniotomy; for excision of brain abscess, supratentorial

craniectomy, trephination, bone flap craniotomy; for excision or fenestration of cyst, supratentorial

implantation of brain intracavitary chemotherapy agent (list separately in addition to code for primary procedure)

craniectomy for excision of brain tumor, infratentorial or posterior fossa; except meningioma, cerebellopontine angle tumor, or midline tumor at base of skull

craniectomy for excision of brain tumor, infratentorial or posterior fossa; meningioma

craniectomy for excision of brain tumor, infratentorial or posterior fossa; cerebellopontine angle tumor

craniectomy for excision of brain tumor, infratentorial or posterior fossa; midline tumor at base of skull

craniectomy, infratentorial or posterior fossa; for excision of brain abscess

craniectomy, infratentorial or posterior fossa; for excision or fenestration of cyst

craniectomy, bone flap craniotomy, transtemporal (mastoid) for excision of cerebellopontine angle tumor

craniectomy, bone flap craniotomy, transtemporal (mastoid) for excision of cerebellopontine angle tumor; combined with middle/posterior fossa craniotomy/craniectomy

subdural implantation of strip electrodes through 1 or more burr or trephine hole(s) for long-term seizure monitoring

craniotomy with elevation of bone flap; for subdural implantation of an electrode array, for long-term seizure monitoring

craniotomy with elevation of bone flap; for excision of epileptogenic focus without electrocorticography during surgery

craniotomy with elevation of bone flap; for removal of epidural or subdural electrode array, without excision of cerebral tissue (separate procedure)

craniotomy with elevation of bone flap; for excision of cerebral epileptogenic focus, with electrocorticography during surgery (includes removal of electrode array)

craniotomy with elevation of bone flap; for lobectomy, temporal lobe, without electrocorticography during surgery

craniotomy with elevation of bone flap; for lobectomy, temporal lobe, with electrocorticography during surgery

craniotomy with elevation of bone flap; for lobectomy, other than temporal lobe, partial or total, with electrocorticography during surgery

craniotomy with elevation of bone flap; for lobectomy, other than temporal lobe, partial or total, without electrocorticography during surgery

craniotomy with elevation of bone flap; for transection of corpus callosum

craniotomy with elevation of bone flap; for partial or subtotal (functional) hemispherectomy

craniotomy with elevation of bone flap; for excision or coagulation of choroid plexus

craniotomy with elevation of bone flap; for excision of craniopharyngioma

craniotomy for hypophysectomy or excision of pituitary tumor, intracranial approach

hypophysectomy or excision of pituitary tumor, transnasal or transseptal approach, nonstereotactic

extensive craniectomy for multiple cranial suture craniosynostosis (eg, cloverleaf skull); not requiring bone grafts

extensive craniectomy for multiple cranial suture craniosynostosis (eg, cloverleaf skull); recontouring with multiple osteotomies and bone autografts (eg, barrel-stave procedure) (includes obtaining grafts)

excision, intra and extracranial, benign tumor of cranial bone (eg, fibrous dysplasia); without optic nerve decompression

excision, intra and extracranial, benign tumor of cranial bone (eg, fibrous dysplasia); with optic nerve decompression

craniotomy with elevation of bone flap; for selective amygdalohippocampectomy

craniotomy with elevation of bone flap; for multiple subpial transections, with electrocorticography during surgery

craniectomy or craniotomy; with excision of foreign body from brain

craniectomy or craniotomy; with treatment of penetrating wound of brain

transoral approach to skull base, brain stem or upper spinal cord for biopsy, decompression or excision of lesion

transoral approach to skull base, brain stem or upper spinal cord for biopsy, decompression or excision of lesion; requiring splitting of tongue and/or mandible (including tracheostomy)

craniofacial approach to anterior cranial fossa; extradural, including lateral rhinotomy, ethmoidectomy, sphenoidectomy, without maxillectomy or orbital exenteration

craniofacial approach to anterior cranial fossa; extradural, including lateral rhinotomy, orbital exenteration, ethmoidectomy, sphenoidectomy and/or maxillectomy

craniofacial approach to anterior cranial fossa; extradural, including unilateral or bifrontal craniotomy, elevation of frontal lobe(s), osteotomy of base of anterior cranial fossa

craniofacial approach to anterior cranial fossa; intradural, including unilateral or bifrontal craniotomy, elevation or resection of frontal lobe, osteotomy of base of anterior cranial fossa

orbitocranial approach to anterior cranial fossa, extradural, including supraorbital ridge osteotomy and elevation of frontal and/or temporal lobe(s); without orbital exenteration

orbitocranial approach to anterior cranial fossa, extradural, including supraorbital ridge osteotomy and elevation of frontal and/or temporal lobe(s); with orbital exenteration

bicoronal, transzygomatic and/or lefort i osteotomy approach to anterior cranial fossa with or without internal fixation, without bone graft

infratemporal pre-auricular approach to middle cranial fossa (parapharyngeal space, infratemporal and midline skull base, nasopharynx), with or without disarticulation of the mandible, including parotidectomy, craniotomy, decompression and/or mobilization of the facial nerve and/or petrous carotid artery

infratemporal post-auricular approach to middle cranial fossa (internal auditory meatus, petrous apex, tentorium, cavernous sinus, parasellar area, infratemporal fossa) including mastoidectomy, resection of sigmoid sinus, with or without decompression and/or mobilization of contents of auditory canal or petrous carotid artery

orbitocranial zygomatic approach to middle cranial fossa (cavernous sinus and carotid artery, clivus, basilar artery or petrous apex) including osteotomy of zygoma, craniotomy, extra- or intradural elevation of temporal lobe

transtemporal approach to posterior cranial fossa, jugular foramen or midline skull base, including mastoidectomy, decompression of sigmoid sinus and/or facial nerve, with or without mobilization

transcochlear approach to posterior cranial fossa, jugular foramen or midline skull base, including labyrinthectomy, decompression, with or without mobilization of facial nerve and/or petrous carotid artery

transcondylar (far lateral) approach to posterior cranial fossa, jugular foramen or midline skull base, including occipital condylectomy, mastoidectomy, resection of c1-c3 vertebral body(s), decompression of vertebral artery, with or without mobilization

transpetrosal approach to posterior cranial fossa, clivus or foramen magnum, including ligation of superior petrosal sinus and/or sigmoid sinus

resection or excision of neoplastic, vascular or infectious lesion of base of anterior cranial fossa; extradural

resection or excision of neoplastic, vascular or infectious lesion of base of anterior cranial fossa; intradural, including dural repair, with or without graft

resection or excision of neoplastic, vascular or infectious lesion of infratemporal fossa, parapharyngeal space, petrous apex; extradural

resection or excision of neoplastic, vascular or infectious lesion of infratemporal fossa, parapharyngeal space, petrous apex; intradural, including dural repair, with or without graft

resection or excision of neoplastic, vascular or infectious lesion of parasellar area, cavernous sinus, clivus or midline skull base; extradural

resection or excision of neoplastic, vascular or infectious lesion of parasellar area, cavernous sinus, clivus or midline skull base; intradural, including dural repair, with or without graft

transection or ligation, carotid artery in cavernous sinus, with repair by anastomosis or graft (list separately in addition to code for primary procedure)

transection or ligation, carotid artery in petrous canal; without repair (list separately in addition to code for primary procedure)

transection or ligation, carotid artery in petrous canal; with repair by anastomosis or graft (list separately in addition to code for primary procedure)

obliteration of carotid aneurysm, arteriovenous malformation, or carotid-cavernous fistula by dissection within cavernous sinus

resection or excision of neoplastic, vascular or infectious lesion of base of posterior cranial fossa, jugular foramen, foramen magnum, or c1-c3 vertebral bodies; extradural

resection or excision of neoplastic, vascular or infectious lesion of base of posterior cranial fossa, jugular foramen, foramen magnum, or c1-c3 vertebral bodies; intradural, including dural repair, with or without graft

secondary repair of dura for cerebrospinal fluid leak, anterior, middle or posterior cranial fossa following surgery of the skull base; by free tissue graft (eg, pericranium, fascia, tensor fascia lata, adipose tissue, homologous or synthetic grafts)

secondary repair of dura for cerebrospinal fluid leak, anterior, middle or posterior cranial fossa following surgery of the skull base; by local or regionalized vascularized pedicle flap or myocutaneous flap (including galea, temporalis, frontalis or occipitalis muscle)

endovascular temporary balloon arterial occlusion, head or neck (extracranial/intracranial) including selective catheterization of vessel to be occluded, positioning and inflation of occlusion balloon, concomitant neurological monitoring, and radiologic supervision and interpretation of all angiography required for balloon occlusion and to exclude vascular injury post occlusion

transcatheter permanent occlusion or embolization (eg, for tumor destruction, to achieve hemostasis, to occlude a vascular malformation), percutaneous, any method; central nervous system (intracranial, spinal cord)

transcatheter permanent occlusion or embolization (eg, for tumor destruction, to achieve hemostasis, to occlude a vascular malformation), percutaneous, any method; non-central nervous system, head or neck (extracranial, brachiocephalic branch)

balloon angioplasty, intracranial (eg, atherosclerotic stenosis), percutaneous

transcatheter placement of intravascular stent(s), intracranial (eg, atherosclerotic stenosis), including balloon angioplasty, if performed

balloon dilatation of intracranial vasospasm, percutaneous; initial vessel

balloon dilatation of intracranial vasospasm, percutaneous; each additional vessel in same vascular family (list separately in addition to code for primary procedure)

balloon dilatation of intracranial vasospasm, percutaneous; each additional vessel in different vascular family (list separately in addition to code for primary procedure)

percutaneous arterial transluminal mechanical thrombectomy and/or infusion for thrombolysis, intracranial, any method, including diagnostic angiography, fluoroscopic guidance, catheter placement, and intraprocedural pharmacological thrombolytic injection(s)

endovascular intracranial prolonged administration of pharmacologic agent(s) other than for thrombolysis, arterial, including catheter placement, diagnostic angiography, and imaging guidance; initial vascular territory

endovascular intracranial prolonged administration of pharmacologic agent(s) other than for thrombolysis, arterial, including catheter placement, diagnostic angiography, and imaging guidance; each additional vascular territory (list separately in addition to code for primary procedure)

surgery of intracranial arteriovenous malformation; supratentorial, simple

surgery of intracranial arteriovenous malformation; supratentorial, complex

surgery of intracranial arteriovenous malformation; infratentorial, simple

surgery of intracranial arteriovenous malformation; infratentorial, complex

surgery of intracranial arteriovenous malformation; dural, simple

surgery of intracranial arteriovenous malformation; dural, complex

surgery of complex intracranial aneurysm, intracranial approach; carotid circulation

surgery of complex intracranial aneurysm, intracranial approach; vertebrobasilar circulation

surgery of simple intracranial aneurysm, intracranial approach; carotid circulation

surgery of simple intracranial aneurysm, intracranial approach; vertebrobasilar circulation

surgery of intracranial aneurysm, cervical approach by application of occluding clamp to cervical carotid artery (selverstone-crutchfield type)

surgery of aneurysm, vascular malformation or carotid-cavernous fistula; by intracranial and cervical occlusion of carotid artery

surgery of aneurysm, vascular malformation or carotid-cavernous fistula; by intracranial electrothrombosis

surgery of aneurysm, vascular malformation or carotid-cavernous fistula; by intra-arterial embolization, injection procedure, or balloon catheter

anastomosis, arterial, extracranial-intracranial (eg, middle cerebral/cortical) arteries

creation of lesion by stereotactic method, including burr hole(s) and localizing and recording techniques, single or multiple stages; globus pallidus or thalamus

creation of lesion by stereotactic method, including burr hole(s) and localizing and recording techniques, single or multiple stages; subcortical structure(s) other than globus pallidus or thalamus

stereotactic biopsy, aspiration, or excision, including burr hole(s), for intracranial lesion

stereotactic biopsy, aspiration, or excision, including burr hole(s), for intracranial lesion; with computed tomography and/or magnetic resonance guidance

stereotactic implantation of depth electrodes into the cerebrum for long-term seizure monitoring

stereotactic localization, including burr hole(s), with insertion of catheter(s) or probe(s) for placement of radiation source

stereotactic computer-assisted (navigational) procedure; cranial, intradural (list separately in addition to code for primary procedure)

stereotactic computer-assisted (navigational) procedure; cranial, extradural (list separately in addition to code for primary procedure)

stereotactic computer-assisted (navigational) procedure; spinal (list separately in addition to code for primary procedure)

creation of lesion by stereotactic method, percutaneous, by neurolytic agent (eg, alcohol, thermal, electrical, radiofrequency); gasserian ganglion

creation of lesion by stereotactic method, percutaneous, by neurolytic agent (eg, alcohol, thermal, electrical, radiofrequency); trigeminal medullary tract

stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 simple cranial lesion

stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); each additional cranial lesion, simple (list separately in addition to code for primary procedure)

stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 complex cranial lesion

stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); each additional cranial lesion, complex (list separately in addition to code for primary procedure)

application of stereotactic headframe for stereotactic radiosurgery (list separately in addition to code for primary procedure)

twist drill or burr hole(s) for implantation of neurostimulator electrodes, cortical

craniectomy or craniotomy for implantation of neurostimulator electrodes, cerebral, cortical

twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (eg, thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), without use of intraoperative microelectrode recording; first array

twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (eg, thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), without use of intraoperative microelectrode recording; each additional array (list separately in addition to primary procedure)

twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (eg, thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), with use of intraoperative microelectrode recording; first array

twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (eg, thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), with use of intraoperative microelectrode recording; each additional array (list separately in addition to primary procedure)

craniectomy for implantation of neurostimulator electrodes, cerebellar, cortical

insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to a single electrode array

insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to 2 or more electrode arrays

revision or removal of cranial neurostimulator pulse generator or receiver

elevation of depressed skull fracture; compound or comminuted, extradural

elevation of depressed skull fracture; with repair of dura and/or debridement of brain

craniotomy for repair of dural/cerebrospinal fluid leak, including surgery for rhinorrhea/otorrhea

reduction of craniomegalic skull (eg, treated hydrocephalus); not requiring bone grafts or cranioplasty

reduction of craniomegalic skull (eg, treated hydrocephalus); requiring craniotomy and reconstruction with or without bone graft (includes obtaining grafts)

cranioplasty with autograft (includes obtaining bone grafts); up to 5 cm diameter

cranioplasty with autograft (includes obtaining bone grafts); larger than 5 cm diameter

incision and retrieval of subcutaneous cranial bone graft for cranioplasty (list separately in addition to code for primary procedure)

neuroendoscopy, intracranial, for placement or replacement of ventricular catheter and attachment to shunt system or external drainage (list separately in addition to code for primary procedure)

neuroendoscopy, intracranial; with dissection of adhesions, fenestration of septum pellucidum or intraventricular cysts (including placement, replacement, or removal of ventricular catheter)

neuroendoscopy, intracranial; with fenestration or excision of colloid cyst, including placement of external ventricular catheter for drainage

neuroendoscopy, intracranial; with excision of brain tumor, including placement of external ventricular catheter for drainage

neuroendoscopy, intracranial; with excision of pituitary tumor, transnasal or trans-sphenoidal approach

creation of shunt; subarachnoid/subdural-atrial, -jugular, -auricular

creation of shunt; subarachnoid/subdural-peritoneal, -pleural, other terminus

ventriculocisternostomy, third ventricle; stereotactic, neuroendoscopic method

creation of shunt; ventriculo-peritoneal, -pleural, other terminus

replacement or revision of cerebrospinal fluid shunt, obstructed valve, or distal catheter in shunt system

removal of complete cerebrospinal fluid shunt system; without replacement

removal of complete cerebrospinal fluid shunt system; with replacement by similar or other shunt at same operation

percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 2 or more days

percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 1 day

percutaneous aspiration within the nucleus pulposus, intervertebral disc, or paravertebral tissue for diagnostic purposes

spinal puncture, therapeutic, for drainage of cerebrospinal fluid (by needle or catheter)

injection/infusion of neurolytic substance (eg, alcohol, phenol, iced saline solutions), with or without other therapeutic substance; subarachnoid

injection/infusion of neurolytic substance (eg, alcohol, phenol, iced saline solutions), with or without other therapeutic substance; epidural, cervical or thoracic

injection/infusion of neurolytic substance (eg, alcohol, phenol, iced saline solutions), with or without other therapeutic substance; epidural, lumbar, sacral (caudal)

injection procedure for myelography and/or computed tomography, lumbar

decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, any method utilizing needle based technique to remove disc material under fluoroscopic imaging or other form of indirect visualization, with discography and/or epidural injection(s) at the treated level(s), when performed, single or multiple levels, lumbar

injection procedure for discography, each level; cervical or thoracic

injection procedure for chemonucleolysis, including discography, intervertebral disc, single or multiple levels, lumbar

injection procedure, arterial, for occlusion of arteriovenous malformation, spinal

myelography via lumbar injection, including radiological supervision and interpretation; cervical

myelography via lumbar injection, including radiological supervision and interpretation; thoracic

myelography via lumbar injection, including radiological supervision and interpretation; lumbosacral

myelography via lumbar injection, including radiological supervision and interpretation; 2 or more regions (eg, lumbar/thoracic, cervical/thoracic, lumbar/cervical, lumbar/thoracic/cervical)

injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance

injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance (ie, fluoroscopy or ct)

injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance

injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or ct)

injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance

injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance (ie, fluoroscopy or ct)

injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance

injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or ct)

implantation, revision or repositioning of tunneled intrathecal or epidural catheter, for long-term medication administration via an external pump or implantable reservoir/infusion pump; without laminectomy

implantation, revision or repositioning of tunneled intrathecal or epidural catheter, for long-term medication administration via an external pump or implantable reservoir/infusion pump; with laminectomy

removal of previously implanted intrathecal or epidural catheter

implantation or replacement of device for intrathecal or epidural drug infusion; subcutaneous reservoir

implantation or replacement of device for intrathecal or epidural drug infusion; nonprogrammable pump

implantation or replacement of device for intrathecal or epidural drug infusion; programmable pump, including preparation of pump, with or without programming

removal of subcutaneous reservoir or pump, previously implanted for intrathecal or epidural infusion

electronic analysis of programmable, implanted pump for intrathecal or epidural drug infusion (includes evaluation of reservoir status, alarm status, drug prescription status); without reprogramming or refill

electronic analysis of programmable, implanted pump for intrathecal or epidural drug infusion (includes evaluation of reservoir status, alarm status, drug prescription status); with reprogramming

electronic analysis of programmable, implanted pump for intrathecal or epidural drug infusion (includes evaluation of reservoir status, alarm status, drug prescription status); with reprogramming and refill

electronic analysis of programmable, implanted pump for intrathecal or epidural drug infusion (includes evaluation of reservoir status, alarm status, drug prescription status); with reprogramming and refill (requiring skill of a physician or other qualified health care professional)

endoscopic decompression of spinal cord, nerve root(s), including laminotomy, partial facetectomy, foraminotomy, discectomy and/or excision of herniated intervertebral disc, 1 interspace, lumbar

laminectomy with exploration and/or decompression of spinal cord and/or cauda equina, without facetectomy, foraminotomy or discectomy (eg, spinal stenosis), 1 or 2 vertebral segments; cervical

laminectomy with exploration and/or decompression of spinal cord and/or cauda equina, without facetectomy, foraminotomy or discectomy (eg, spinal stenosis), 1 or 2 vertebral segments; thoracic

laminectomy with exploration and/or decompression of spinal cord and/or cauda equina, without facetectomy, foraminotomy or discectomy (eg, spinal stenosis), 1 or 2 vertebral segments; lumbar, except for spondylolisthesis

laminectomy with exploration and/or decompression of spinal cord and/or cauda equina, without facetectomy, foraminotomy or discectomy (eg, spinal stenosis), 1 or 2 vertebral segments; sacral

laminectomy with removal of abnormal facets and/or pars inter-articularis with decompression of cauda equina and nerve roots for spondylolisthesis, lumbar (gill type procedure)

laminectomy with exploration and/or decompression of spinal cord and/or cauda equina, without facetectomy, foraminotomy or discectomy (eg, spinal stenosis), more than 2 vertebral segments; cervical

laminectomy with exploration and/or decompression of spinal cord and/or cauda equina, without facetectomy, foraminotomy or discectomy (eg, spinal stenosis), more than 2 vertebral segments; thoracic

laminectomy with exploration and/or decompression of spinal cord and/or cauda equina, without facetectomy, foraminotomy or discectomy (eg, spinal stenosis), more than 2 vertebral segments; lumbar

laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and/or excision of herniated intervertebral disc; 1 interspace, cervical

laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and/or excision of herniated intervertebral disc; 1 interspace, lumbar

laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and/or excision of herniated intervertebral disc; each additional interspace, cervical or lumbar (list separately in addition to code for primary procedure)

laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and/or excision of herniated intervertebral disc, reexploration, single interspace; cervical

laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and/or excision of herniated intervertebral disc, reexploration, single interspace; lumbar

laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and/or excision of herniated intervertebral disc, reexploration, single interspace; each additional cervical interspace (list separately in addition to code for primary procedure)

laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and/or excision of herniated intervertebral disc, reexploration, single interspace; each additional lumbar interspace (list separately in addition to code for primary procedure)

laminectomy, facetectomy and foraminotomy (unilateral or bilateral with decompression of spinal cord, cauda equina and/or nerve root[s], [eg, spinal or lateral recess stenosis]), single vertebral segment; cervical

laminectomy, facetectomy and foraminotomy (unilateral or bilateral with decompression of spinal cord, cauda equina and/or nerve root[s], [eg, spinal or lateral recess stenosis]), single vertebral segment; thoracic

laminectomy, facetectomy and foraminotomy (unilateral or bilateral with decompression of spinal cord, cauda equina and/or nerve root[s], [eg, spinal or lateral recess stenosis]), single vertebral segment; lumbar

laminectomy, facetectomy and foraminotomy (unilateral or bilateral with decompression of spinal cord, cauda equina and/or nerve root[s], [eg, spinal or lateral recess stenosis]), single vertebral segment; each additional segment, cervical, thoracic, or lumbar (list separately in addition to code for primary procedure)

laminoplasty, cervical, with decompression of the spinal cord, 2 or more vertebral segments

laminoplasty, cervical, with decompression of the spinal cord, 2 or more vertebral segments; with reconstruction of the posterior bony elements (including the application of bridging bone graft and non-segmental fixation devices [eg, wire, suture, mini-plates], when performed)

transpedicular approach with decompression of spinal cord, equina and/or nerve root(s) (eg, herniated intervertebral disc), single segment; thoracic

transpedicular approach with decompression of spinal cord, equina and/or nerve root(s) (eg, herniated intervertebral disc), single segment; lumbar (including transfacet, or lateral extraforaminal approach) (eg, far lateral herniated intervertebral disc)

transpedicular approach with decompression of spinal cord, equina and/or nerve root(s) (eg, herniated intervertebral disc), single segment; each additional segment, thoracic or lumbar (list separately in addition to code for primary procedure)

costovertebral approach with decompression of spinal cord or nerve root(s) (eg, herniated intervertebral disc), thoracic; single segment

costovertebral approach with decompression of spinal cord or nerve root(s) (eg, herniated intervertebral disc), thoracic; each additional segment (list separately in addition to code for primary procedure)

discectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; cervical, single interspace

discectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; cervical, each additional interspace (list separately in addition to code for primary procedure)

discectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; thoracic, single interspace

discectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; thoracic, each additional interspace (list separately in addition to code for primary procedure)

vertebral corpectomy (vertebral body resection), partial or complete, anterior approach with decompression of spinal cord and/or nerve root(s); cervical, single segment

vertebral corpectomy (vertebral body resection), partial or complete, anterior approach with decompression of spinal cord and/or nerve root(s); cervical, each additional segment (list separately in addition to code for primary procedure)

vertebral corpectomy (vertebral body resection), partial or complete, transthoracic approach with decompression of spinal cord and/or nerve root(s); thoracic, single segment

vertebral corpectomy (vertebral body resection), partial or complete, transthoracic approach with decompression of spinal cord and/or nerve root(s); thoracic, each additional segment (list separately in addition to code for primary procedure)

vertebral corpectomy (vertebral body resection), partial or complete, combined thoracolumbar approach with decompression of spinal cord, cauda equina or nerve root(s), lower thoracic or lumbar; single segment

vertebral corpectomy (vertebral body resection), partial or complete, combined thoracolumbar approach with decompression of spinal cord, cauda equina or nerve root(s), lower thoracic or lumbar; each additional segment (list separately in addition to code for primary procedure)

vertebral corpectomy (vertebral body resection), partial or complete, transperitoneal or retroperitoneal approach with decompression of spinal cord, cauda equina or nerve root(s), lower thoracic, lumbar, or sacral; single segment

vertebral corpectomy (vertebral body resection), partial or complete, transperitoneal or retroperitoneal approach with decompression of spinal cord, cauda equina or nerve root(s), lower thoracic, lumbar, or sacral; each additional segment (list separately in addition to code for primary procedure)

vertebral corpectomy (vertebral body resection), partial or complete, lateral extracavitary approach with decompression of spinal cord and/or nerve root(s) (eg, for tumor or retropulsed bone fragments); thoracic, single segment

vertebral corpectomy (vertebral body resection), partial or complete, lateral extracavitary approach with decompression of spinal cord and/or nerve root(s) (eg, for tumor or retropulsed bone fragments); lumbar, single segment

vertebral corpectomy (vertebral body resection), partial or complete, lateral extracavitary approach with decompression of spinal cord and/or nerve root(s) (eg, for tumor or retropulsed bone fragments); thoracic or lumbar, each additional segment (list separately in addition to code for primary procedure)

laminectomy with myelotomy (eg, bischof or drez type), cervical, thoracic, or thoracolumbar

laminectomy with drainage of intramedullary cyst/syrinx; to subarachnoid space

laminectomy with drainage of intramedullary cyst/syrinx; to peritoneal or pleural space

laminectomy and section of dentate ligaments, with or without dural graft, cervical; 1 or 2 segments

laminectomy and section of dentate ligaments, with or without dural graft, cervical; more than 2 segments

laminectomy with cordotomy, with section of 1 spinothalamic tract, 1 stage; cervical

laminectomy with cordotomy, with section of 1 spinothalamic tract, 1 stage; thoracic

laminectomy with cordotomy, with section of both spinothalamic tracts, 1 stage; cervical

laminectomy with cordotomy, with section of both spinothalamic tracts, 1 stage; thoracic

laminectomy with cordotomy with section of both spinothalamic tracts, 2 stages within 14 days; cervical

laminectomy with cordotomy with section of both spinothalamic tracts, 2 stages within 14 days; thoracic

laminectomy for excision or occlusion of arteriovenous malformation of spinal cord; cervical

laminectomy for excision or occlusion of arteriovenous malformation of spinal cord; thoracic

laminectomy for excision or occlusion of arteriovenous malformation of spinal cord; thoracolumbar

laminectomy for excision or evacuation of intraspinal lesion other than neoplasm, extradural; cervical

laminectomy for excision or evacuation of intraspinal lesion other than neoplasm, extradural; thoracic

laminectomy for excision or evacuation of intraspinal lesion other than neoplasm, extradural; lumbar

laminectomy for excision or evacuation of intraspinal lesion other than neoplasm, extradural; sacral

laminectomy for excision of intraspinal lesion other than neoplasm, intradural; cervical

laminectomy for excision of intraspinal lesion other than neoplasm, intradural; thoracic

laminectomy for excision of intraspinal lesion other than neoplasm, intradural; lumbar

laminectomy for excision of intraspinal lesion other than neoplasm, intradural; sacral

laminectomy for biopsy/excision of intraspinal neoplasm; extradural, cervical

laminectomy for biopsy/excision of intraspinal neoplasm; extradural, thoracic

laminectomy for biopsy/excision of intraspinal neoplasm; extradural, lumbar

laminectomy for biopsy/excision of intraspinal neoplasm; extradural, sacral

laminectomy for biopsy/excision of intraspinal neoplasm; intradural, extramedullary, cervical

laminectomy for biopsy/excision of intraspinal neoplasm; intradural, extramedullary, thoracic

laminectomy for biopsy/excision of intraspinal neoplasm; intradural, extramedullary, lumbar

laminectomy for biopsy/excision of intraspinal neoplasm; intradural, sacral

laminectomy for biopsy/excision of intraspinal neoplasm; intradural, intramedullary, cervical

laminectomy for biopsy/excision of intraspinal neoplasm; intradural, intramedullary, thoracic

laminectomy for biopsy/excision of intraspinal neoplasm; intradural, intramedullary, thoracolumbar

laminectomy for biopsy/excision of intraspinal neoplasm; combined extradural-intradural lesion, any level

osteoplastic reconstruction of dorsal spinal elements, following primary intraspinal procedure (list separately in addition to code for primary procedure)

vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; extradural, cervical

vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; extradural, thoracic by transthoracic approach

vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; extradural, thoracic by thoracolumbar approach

vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; extradural, lumbar or sacral by transperitoneal or retroperitoneal approach

vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; intradural, cervical

vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; intradural, thoracic by transthoracic approach

vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; intradural, thoracic by thoracolumbar approach

vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; intradural, lumbar or sacral by transperitoneal or retroperitoneal approach

vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; each additional segment (list separately in addition to codes for single segment)

creation of lesion of spinal cord by stereotactic method, percutaneous, any modality (including stimulation and/or recording)

stereotactic stimulation of spinal cord, percutaneous, separate procedure not followed by other surgery

stereotactic biopsy, aspiration, or excision of lesion, spinal cord

stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 spinal lesion

stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); each additional spinal lesion (list separately in addition to code for primary procedure)

percutaneous implantation of neurostimulator electrode array, epidural

laminectomy for implantation of neurostimulator electrodes, plate/paddle, epidural

removal of spinal neurostimulator electrode percutaneous array(s), including fluoroscopy, when performed

removal of spinal neurostimulator electrode plate/paddle(s) placed via laminotomy or laminectomy, including fluoroscopy, when performed

revision including replacement, when performed, of spinal neurostimulator electrode percutaneous array(s), including fluoroscopy, when performed

revision including replacement, when performed, of spinal neurostimulator electrode plate/paddle(s) placed via laminotomy or laminectomy, including fluoroscopy, when performed

insertion or replacement of spinal neurostimulator pulse generator or receiver, direct or inductive coupling

revision or removal of implanted spinal neurostimulator pulse generator or receiver

repair of dural/cerebrospinal fluid leak, not requiring laminectomy

repair of dural/cerebrospinal fluid leak or pseudomeningocele, with laminectomy

creation of shunt, lumbar, subarachnoid-peritoneal, -pleural, or other; including laminectomy

creation of shunt, lumbar, subarachnoid-peritoneal, -pleural, or other; percutaneous, not requiring laminectomy

removal of entire lumbosubarachnoid shunt system without replacement

injection, anesthetic agent; trigeminal nerve, any division or branch

injection, anesthetic agent; brachial plexus, continuous infusion by catheter (including catheter placement)

injection, anesthetic agent; intercostal nerves, multiple, regional block

injection, anesthetic agent; ilioinguinal, iliohypogastric nerves

injection, anesthetic agent; sciatic nerve, continuous infusion by catheter (including catheter placement)

injection, anesthetic agent; femoral nerve, continuous infusion by catheter (including catheter placement)

injection, anesthetic agent; lumbar plexus, posterior approach, continuous infusion by catheter (including catheter placement)

injection(s), anesthetic agent and/or steroid, plantar common digital nerve(s) (eg, morton's neuroma)

paravertebral block (pvb) (paraspinous block), thoracic; single injection site (includes imaging guidance, when performed)

paravertebral block (pvb) (paraspinous block), thoracic; second and any additional injection site(s) (includes imaging guidance, when performed) (list separately in addition to code for primary procedure)

paravertebral block (pvb) (paraspinous block), thoracic; continuous infusion by catheter (includes imaging guidance, when performed)

injection(s), anesthetic agent and/or steroid, transforaminal epidural, with imaging guidance (fluoroscopy or ct); cervical or thoracic, single level

injection(s), anesthetic agent and/or steroid, transforaminal epidural, with imaging guidance (fluoroscopy or ct); cervical or thoracic, each additional level (list separately in addition to code for primary procedure)

injection(s), anesthetic agent and/or steroid, transforaminal epidural, with imaging guidance (fluoroscopy or ct); lumbar or sacral, single level

injection(s), anesthetic agent and/or steroid, transforaminal epidural, with imaging guidance (fluoroscopy or ct); lumbar or sacral, each additional level (list separately in addition to code for primary procedure)

transversus abdominis plane (tap) block (abdominal plane block, rectus sheath block) unilateral; by injection(s) (includes imaging guidance, when performed)

transversus abdominis plane (tap) block (abdominal plane block, rectus sheath block) unilateral; by continuous infusion(s) (includes imaging guidance, when performed)

transversus abdominis plane (tap) block (abdominal plane block, rectus sheath block) bilateral; by injections (includes imaging guidance, when performed)

transversus abdominis plane (tap) block (abdominal plane block, rectus sheath block) bilateral; by continuous infusions (includes imaging guidance, when performed)

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or ct), cervical or thoracic; single level

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or ct), cervical or thoracic; second level (list separately in addition to code for primary procedure)

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or ct), cervical or thoracic; third and any additional level(s) (list separately in addition to code for primary procedure)

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or ct), lumbar or sacral; single level

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or ct), lumbar or sacral; second level (list separately in addition to code for primary procedure)

injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or ct), lumbar or sacral; third and any additional level(s) (list separately in addition to code for primary procedure)

injection, anesthetic agent; stellate ganglion (cervical sympathetic)

injection, anesthetic agent; lumbar or thoracic (paravertebral sympathetic)

injection, anesthetic agent; celiac plexus, with or without radiologic monitoring

application of surface (transcutaneous) neurostimulator (eg, tens unit)

percutaneous implantation of neurostimulator electrode array; cranial nerve

percutaneous implantation of neurostimulator electrode array; peripheral nerve (excludes sacral nerve)

percutaneous implantation of neurostimulator electrode array; sacral nerve (transforaminal placement) including image guidance, if performed

posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming

incision for implantation of cranial nerve (eg, vagus nerve) neurostimulator electrode array and pulse generator

revision or replacement of cranial nerve (eg, vagus nerve) neurostimulator electrode array, including connection to existing pulse generator

removal of cranial nerve (eg, vagus nerve) neurostimulator electrode array and pulse generator

incision for implantation of neurostimulator electrode array; peripheral nerve (excludes sacral nerve)

incision for implantation of neurostimulator electrode array; neuromuscular

incision for implantation of neurostimulator electrode array; sacral nerve (transforaminal placement)

revision or removal of peripheral neurostimulator electrode array

insertion or replacement of peripheral or gastric neurostimulator pulse generator or receiver, direct or inductive coupling

revision or removal of peripheral or gastric neurostimulator pulse generator or receiver

destruction by neurolytic agent, trigeminal nerve; supraorbital, infraorbital, mental, or inferior alveolar branch

destruction by neurolytic agent, trigeminal nerve; second and third division branches at foramen ovale

destruction by neurolytic agent, trigeminal nerve; second and third division branches at foramen ovale under radiologic monitoring

chemodenervation of parotid and submandibular salivary glands, bilateral

chemodenervation of muscle(s); muscle(s) innervated by facial nerve, unilateral (eg, for blepharospasm, hemifacial spasm)

chemodenervation of muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (eg, for chronic migraine)

chemodenervation of muscle(s); neck muscle(s), excluding muscles of the larynx, unilateral (eg, for cervical dystonia, spasmodic torticollis)

chemodenervation of muscle(s); larynx, unilateral, percutaneous (eg, for spasmodic dysphonia), includes guidance by needle electromyography, when performed

destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or ct); cervical or thoracic, single facet joint

destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or ct); cervical or thoracic, each additional facet joint (list separately in addition to code for primary procedure)

destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or ct); lumbar or sacral, single facet joint

destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or ct); lumbar or sacral, each additional facet joint (list separately in addition to code for primary procedure)

destruction by neurolytic agent; other peripheral nerve or branch

chemodenervation of one extremity; each additional extremity, 1-4 muscle(s) (list separately in addition to code for primary procedure)

chemodenervation of one extremity; each additional extremity, 5 or more muscles (list separately in addition to code for primary procedure)

chemodenervation of eccrine glands; other area(s) (eg, scalp, face, neck), per day

destruction by neurolytic agent, with or without radiologic monitoring; celiac plexus

destruction by neurolytic agent, with or without radiologic monitoring; superior hypogastric plexus

neuroplasty, major peripheral nerve, arm or leg, open; other than specified

neuroplasty, major peripheral nerve, arm or leg, open; sciatic nerve

neuroplasty, major peripheral nerve, arm or leg, open; brachial plexus

neuroplasty, major peripheral nerve, arm or leg, open; lumbar plexus

internal neurolysis, requiring use of operating microscope (list separately in addition to code for neuroplasty) (neuroplasty includes external neurolysis)

transection or avulsion of; inferior alveolar nerve by osteotomy

transection or avulsion of; facial nerve, differential or complete

transection or avulsion of; vagus nerves limited to proximal stomach (selective proximal vagotomy, proximal gastric vagotomy, parietal cell vagotomy, supra- or highly selective vagotomy)

transection or avulsion of obturator nerve, extrapelvic, with or without adductor tenotomy

transection or avulsion of obturator nerve, intrapelvic, with or without adductor tenotomy

excision of neuroma; digital nerve, each additional digit (list separately in addition to code for primary procedure)

excision of neuroma; hand or foot, each additional nerve, except same digit (list separately in addition to code for primary procedure)

implantation of nerve end into bone or muscle (list separately in addition to neuroma excision)

excision of neurofibroma or neurolemmoma; major peripheral nerve

excision of neurofibroma or neurolemmoma; extensive (including malignant type)

suture of digital nerve, hand or foot; each additional digital nerve (list separately in addition to code for primary procedure)

suture of each additional nerve, hand or foot (list separately in addition to code for primary procedure)

suture of major peripheral nerve, arm or leg, except sciatic; including transposition

suture of major peripheral nerve, arm or leg, except sciatic; without transposition

suture of each additional major peripheral nerve (list separately in addition to code for primary procedure)

suture of nerve; requiring secondary or delayed suture (list separately in addition to code for primary neurorrhaphy)

suture of nerve; requiring extensive mobilization, or transposition of nerve (list separately in addition to code for nerve suture)

suture of nerve; requiring shortening of bone of extremity (list separately in addition to code for nerve suture)

nerve graft (includes obtaining graft), head or neck; up to 4 cm in length

nerve graft (includes obtaining graft), head or neck; more than 4 cm length

nerve graft (includes obtaining graft), single strand, hand or foot; up to 4 cm length

nerve graft (includes obtaining graft), single strand, hand or foot; more than 4 cm length

nerve graft (includes obtaining graft), single strand, arm or leg; up to 4 cm length

nerve graft (includes obtaining graft), single strand, arm or leg; more than 4 cm length

nerve graft (includes obtaining graft), multiple strands (cable), hand or foot; up to 4 cm length

nerve graft (includes obtaining graft), multiple strands (cable), hand or foot; more than 4 cm length

nerve graft (includes obtaining graft), multiple strands (cable), arm or leg; up to 4 cm length

nerve graft (includes obtaining graft), multiple strands (cable), arm or leg; more than 4 cm length

nerve graft, each additional nerve; single strand (list separately in addition to code for primary procedure)

nerve graft, each additional nerve; multiple strands (cable) (list separately in addition to code for primary procedure)

nerve repair; with synthetic conduit or vein allograft (eg, nerve tube), each nerve

nerve repair; with autogenous vein graft (includes harvest of vein graft), each nerve

nerve repair; with nerve allograft, each nerve, first strand (cable)

nerve repair; with nerve allograft, each additional strand (list separately in addition to code for primary procedure)

enucleation of eye; with implant, muscles not attached to implant

exenteration of orbit (does not include skin graft), removal of orbital contents; only

exenteration of orbit (does not include skin graft), removal of orbital contents; with therapeutic removal of bone

exenteration of orbit (does not include skin graft), removal of orbital contents; with muscle or myocutaneous flap

modification of ocular implant with placement or replacement of pegs (eg, drilling receptacle for prosthesis appendage) (separate procedure)

insertion of ocular implant secondary; after evisceration, in scleral shell

insertion of ocular implant secondary; after enucleation, muscles not attached to implant

insertion of ocular implant secondary; after enucleation, muscles attached to implant

reinsertion of ocular implant; with or without conjunctival graft

reinsertion of ocular implant; with use of foreign material for reinforcement and/or attachment of muscles to implant

removal of foreign body, external eye; conjunctival embedded (includes concretions), subconjunctival, or scleral nonperforating

removal of foreign body, external eye; corneal, without slit lamp

removal of foreign body, intraocular; from anterior chamber of eye or lens

removal of foreign body, intraocular; from posterior segment, magnetic extraction, anterior or posterior route

removal of foreign body, intraocular; from posterior segment, nonmagnetic extraction

repair of laceration; conjunctiva, with or without nonperforating laceration sclera, direct closure

repair of laceration; conjunctiva, by mobilization and rearrangement, without hospitalization

repair of laceration; conjunctiva, by mobilization and rearrangement, with hospitalization

repair of laceration; cornea, nonperforating, with or without removal foreign body

repair of laceration; cornea and/or sclera, perforating, not involving uveal tissue

repair of laceration; cornea and/or sclera, perforating, with reposition or resection of uveal tissue

repair of laceration; application of tissue glue, wounds of cornea and/or sclera

repair of wound, extraocular muscle, tendon and/or tenon's capsule

excision of lesion, cornea (keratectomy, lamellar, partial), except pterygium

removal of corneal epithelium; with or without chemocauterization (abrasion, curettage)

removal of corneal epithelium; with application of chelating agent (eg, edta)

destruction of lesion of cornea by cryotherapy, photocoagulation or thermocauterization

multiple punctures of anterior cornea (eg, for corneal erosion, tattoo)

keratoplasty (corneal transplant); penetrating (except in aphakia or pseudophakia)

keratoplasty (corneal transplant); penetrating (in pseudophakia)

backbench preparation of corneal endothelial allograft prior to transplantation (list separately in addition to code for primary procedure)

corneal relaxing incision for correction of surgically induced astigmatism

corneal wedge resection for correction of surgically induced astigmatism

placement of amniotic membrane on the ocular surface; without sutures

placement of amniotic membrane on the ocular surface; single layer, sutured

ocular surface reconstruction; amniotic membrane transplantation, multiple layers

ocular surface reconstruction; limbal stem cell allograft (eg, cadaveric or living donor)

ocular surface reconstruction; limbal conjunctival autograft (includes obtaining graft)

paracentesis of anterior chamber of eye (separate procedure); with removal of aqueous

paracentesis of anterior chamber of eye (separate procedure); with removal of vitreous and/or discission of anterior hyaloid membrane, with or without air injection

paracentesis of anterior chamber of eye (separate procedure); with removal of blood, with or without irrigation and/or air injection

severing adhesions of anterior segment, laser technique (separate procedure)

severing adhesions of anterior segment of eye, incisional technique (with or without injection of air or liquid) (separate procedure); goniosynechiae

severing adhesions of anterior segment of eye, incisional technique (with or without injection of air or liquid) (separate procedure); anterior synechiae, except goniosynechiae

severing adhesions of anterior segment of eye, incisional technique (with or without injection of air or liquid) (separate procedure); posterior synechiae

severing adhesions of anterior segment of eye, incisional technique (with or without injection of air or liquid) (separate procedure); corneovitreal adhesions

injection, anterior chamber of eye (separate procedure); air or liquid

injection, anterior chamber of eye (separate procedure); medication

fistulization of sclera for glaucoma; trephination with iridectomy

fistulization of sclera for glaucoma; thermocauterization with iridectomy

fistulization of sclera for glaucoma; sclerectomy with punch or scissors, with iridectomy

fistulization of sclera for glaucoma; trabeculectomy ab externo in absence of previous surgery

fistulization of sclera for glaucoma; trabeculectomy ab externo with scarring from previous ocular surgery or trauma (includes injection of antifibrotic agents)

transluminal dilation of aqueous outflow canal; without retention of device or stent

transluminal dilation of aqueous outflow canal; with retention of device or stent

aqueous shunt to extraocular equatorial plate reservoir, external approach; without graft

aqueous shunt to extraocular equatorial plate reservoir, external approach; with graft

insertion of anterior segment aqueous drainage device, without extraocular reservoir, external approach

revision of aqueous shunt to extraocular equatorial plate reservoir; without graft

revision of aqueous shunt to extraocular equatorial plate reservoir; with graft

revision or repair of operative wound of anterior segment, any type, early or late, major or minor procedure

iridotomy by stab incision (separate procedure); except transfixion

iridotomy by stab incision (separate procedure); with transfixion as for iris bombe

iridectomy, with corneoscleral or corneal section; for removal of lesion

iridectomy, with corneoscleral or corneal section; with cyclectomy

iridectomy, with corneoscleral or corneal section; peripheral for glaucoma (separate procedure)

iridectomy, with corneoscleral or corneal section; sector for glaucoma (separate procedure)

iridectomy, with corneoscleral or corneal section; optical (separate procedure)

suture of iris, ciliary body (separate procedure) with retrieval of suture through small incision (eg, mccannel suture)

iridotomy/iridectomy by laser surgery (eg, for glaucoma) (per session)

iridoplasty by photocoagulation (1 or more sessions) (eg, for improvement of vision, for widening of anterior chamber angle)

destruction of cyst or lesion iris or ciliary body (nonexcisional procedure)

discission of secondary membranous cataract (opacified posterior lens capsule and/or anterior hyaloid); stab incision technique (ziegler or wheeler knife)

discission of secondary membranous cataract (opacified posterior lens capsule and/or anterior hyaloid); laser surgery (eg, yag laser) (1 or more stages)

repositioning of intraocular lens prosthesis, requiring an incision (separate procedure)

removal of secondary membranous cataract (opacified posterior lens capsule and/or anterior hyaloid) with corneo-scleral section, with or without iridectomy (iridocapsulotomy, iridocapsulectomy)

removal of lens material; aspiration technique, 1 or more stages

removal of lens material; phacofragmentation technique (mechanical or ultrasonic) (eg, phacoemulsification), with aspiration

removal of lens material; pars plana approach, with or without vitrectomy

removal of lens material; extracapsular (other than 66840, 66850, 66852)

extracapsular cataract removal with insertion of intraocular lens prosthesis (1-stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification), complex, requiring devices or techniques not generally used in routine cataract surgery (eg, iris expansion device, suture support for intraocular lens, or primary posterior capsulorrhexis) or performed on patients in the amblyogenic developmental stage

intracapsular cataract extraction with insertion of intraocular lens prosthesis (1 stage procedure)

extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification)

insertion of intraocular lens prosthesis (secondary implant), not associated with concurrent cataract removal

use of ophthalmic endoscope (list separately in addition to code for primary procedure)

removal of vitreous, anterior approach (open sky technique or limbal incision); partial removal

removal of vitreous, anterior approach (open sky technique or limbal incision); subtotal removal with mechanical vitrectomy

aspiration or release of vitreous, subretinal or choroidal fluid, pars plana approach (posterior sclerotomy)

injection of vitreous substitute, pars plana or limbal approach (fluid-gas exchange), with or without aspiration (separate procedure)

implantation of intravitreal drug delivery system (eg, ganciclovir implant), includes concomitant removal of vitreous

intravitreal injection of a pharmacologic agent (separate procedure)

discission of vitreous strands (without removal), pars plana approach

severing of vitreous strands, vitreous face adhesions, sheets, membranes or opacities, laser surgery (1 or more stages)

vitrectomy, mechanical, pars plana approach; with focal endolaser photocoagulation

vitrectomy, mechanical, pars plana approach; with endolaser panretinal photocoagulation

vitrectomy, mechanical, pars plana approach; with removal of preretinal cellular membrane (eg, macular pucker)

vitrectomy, mechanical, pars plana approach; with removal of internal limiting membrane of retina (eg, for repair of macular hole, diabetic macular edema), includes, if performed, intraocular tamponade (ie, air, gas or silicone oil)

vitrectomy, mechanical, pars plana approach; with removal of subretinal membrane (eg, choroidal neovascularization), includes, if performed, intraocular tamponade (ie, air, gas or silicone oil) and laser photocoagulation

repair of retinal detachment, including drainage of subretinal fluid when performed; cryotherapy

repair of retinal detachment, including drainage of subretinal fluid when performed; photocoagulation

repair of retinal detachment; scleral buckling (such as lamellar scleral dissection, imbrication or encircling procedure), including, when performed, implant, cryotherapy, photocoagulation, and drainage of subretinal fluid

repair of retinal detachment; with vitrectomy, any method, including, when performed, air or gas tamponade, focal endolaser photocoagulation, cryotherapy, drainage of subretinal fluid, scleral buckling, and/or removal of lens by same technique

repair of retinal detachment; by injection of air or other gas (eg, pneumatic retinopexy)

repair of complex retinal detachment (eg, proliferative vitreoretinopathy, stage c-1 or greater, diabetic traction retinal detachment, retinopathy of prematurity, retinal tear of greater than 90 degrees), with vitrectomy and membrane peeling, including, when performed, air, gas, or silicone oil tamponade, cryotherapy, endolaser photocoagulation, drainage of subretinal fluid, scleral buckling, and/or removal of lens

prophylaxis of retinal detachment (eg, retinal break, lattice degeneration) without drainage, 1 or more sessions; cryotherapy, diathermy

prophylaxis of retinal detachment (eg, retinal break, lattice degeneration) without drainage, 1 or more sessions; photocoagulation (laser or xenon arc)

destruction of localized lesion of retina (eg, macular edema, tumors), 1 or more sessions; cryotherapy, diathermy

destruction of localized lesion of retina (eg, macular edema, tumors), 1 or more sessions; photocoagulation

destruction of localized lesion of retina (eg, macular edema, tumors), 1 or more sessions; radiation by implantation of source (includes removal of source)

destruction of localized lesion of choroid (eg, choroidal neovascularization); photocoagulation (eg, laser), 1 or more sessions

destruction of localized lesion of choroid (eg, choroidal neovascularization); photodynamic therapy (includes intravenous infusion)

destruction of localized lesion of choroid (eg, choroidal neovascularization); photodynamic therapy, second eye, at single session (list separately in addition to code for primary eye treatment)

destruction of extensive or progressive retinopathy (eg, diabetic retinopathy), cryotherapy, diathermy

treatment of extensive or progressive retinopathy (eg, diabetic retinopathy), photocoagulation

treatment of extensive or progressive retinopathy, 1 or more sessions, preterm infant (less than 37 weeks gestation at birth), performed from birth up to 1 year of age (eg, retinopathy of prematurity), photocoagulation or cryotherapy

strabismus surgery, recession or resection procedure; 1 horizontal muscle

strabismus surgery, recession or resection procedure; 2 horizontal muscles

strabismus surgery, recession or resection procedure; 1 vertical muscle (excluding superior oblique)

strabismus surgery, recession or resection procedure; 2 or more vertical muscles (excluding superior oblique)

transposition procedure (eg, for paretic extraocular muscle), any extraocular muscle (specify) (list separately in addition to code for primary procedure)

strabismus surgery on patient with previous eye surgery or injury that did not involve the extraocular muscles (list separately in addition to code for primary procedure)

strabismus surgery on patient with scarring of extraocular muscles (eg, prior ocular injury, strabismus or retinal detachment surgery) or restrictive myopathy (eg, dysthyroid ophthalmopathy) (list separately in addition to code for primary procedure)

strabismus surgery by posterior fixation suture technique, with or without muscle recession (list separately in addition to code for primary procedure)

placement of adjustable suture(s) during strabismus surgery, including postoperative adjustment(s) of suture(s) (list separately in addition to code for specific strabismus surgery)

strabismus surgery involving exploration and/or repair of detached extraocular muscle(s) (list separately in addition to code for primary procedure)

release of extensive scar tissue without detaching extraocular muscle (separate procedure)

orbitotomy without bone flap (frontal or transconjunctival approach); for exploration, with or without biopsy

orbitotomy without bone flap (frontal or transconjunctival approach); with drainage only

orbitotomy without bone flap (frontal or transconjunctival approach); with removal of lesion

orbitotomy without bone flap (frontal or transconjunctival approach); with removal of foreign body

orbitotomy without bone flap (frontal or transconjunctival approach); with removal of bone for decompression

orbitotomy with bone flap or window, lateral approach (eg, kroenlein); with removal of lesion

orbitotomy with bone flap or window, lateral approach (eg, kroenlein); with removal of foreign body

orbitotomy with bone flap or window, lateral approach (eg, kroenlein); with drainage

orbitotomy with bone flap or window, lateral approach (eg, kroenlein); with removal of bone for decompression

orbitotomy with bone flap or window, lateral approach (eg, kroenlein); for exploration, with or without biopsy

retrobulbar injection; medication (separate procedure, does not include supply of medication)

orbital implant (implant outside muscle cone); removal or revision

optic nerve decompression (eg, incision or fenestration of optic nerve sheath)

excision of chalazion; under general anesthesia and/or requiring hospitalization, single or multiple

correction of trichiasis; epilation by other than forceps (eg, by electrosurgery, cryotherapy, laser surgery)

correction of trichiasis; incision of lid margin, with free mucous membrane graft

excision of lesion of eyelid (except chalazion) without closure or with simple direct closure

construction of intermarginal adhesions, median tarsorrhaphy, or canthorrhaphy

construction of intermarginal adhesions, median tarsorrhaphy, or canthorrhaphy; with transposition of tarsal plate

repair of brow ptosis (supraciliary, mid-forehead or coronal approach)

repair of blepharoptosis; frontalis muscle technique with suture or other material (eg, banked fascia)

repair of blepharoptosis; frontalis muscle technique with autologous fascial sling (includes obtaining fascia)

repair of blepharoptosis; (tarso) levator resection or advancement, internal approach

repair of blepharoptosis; (tarso) levator resection or advancement, external approach

repair of blepharoptosis; superior rectus technique with fascial sling (includes obtaining fascia)

repair of blepharoptosis; conjunctivo-tarso-muller's muscle-levator resection (eg, fasanella-servat type)

correction of lagophthalmos, with implantation of upper eyelid lid load (eg, gold weight)

repair of entropion; extensive (eg, tarsal strip or capsulopalpebral fascia repairs operation)

suture of recent wound, eyelid, involving lid margin, tarsus, and/or palpebral conjunctiva direct closure; partial thickness

suture of recent wound, eyelid, involving lid margin, tarsus, and/or palpebral conjunctiva direct closure; full thickness

excision and repair of eyelid, involving lid margin, tarsus, conjunctiva, canthus, or full thickness, may include preparation for skin graft or pedicle flap with adjacent tissue transfer or rearrangement; up to one-fourth of lid margin

excision and repair of eyelid, involving lid margin, tarsus, conjunctiva, canthus, or full thickness, may include preparation for skin graft or pedicle flap with adjacent tissue transfer or rearrangement; over one-fourth of lid margin

reconstruction of eyelid, full thickness by transfer of tarsoconjunctival flap from opposing eyelid; up to two-thirds of eyelid, 1 stage or first stage

reconstruction of eyelid, full thickness by transfer of tarsoconjunctival flap from opposing eyelid; total eyelid, lower, 1 stage or first stage

reconstruction of eyelid, full thickness by transfer of tarsoconjunctival flap from opposing eyelid; total eyelid, upper, 1 stage or first stage

reconstruction of eyelid, full thickness by transfer of tarsoconjunctival flap from opposing eyelid; second stage

conjunctivoplasty; with conjunctival graft or extensive rearrangement

conjunctivoplasty; with buccal mucous membrane graft (includes obtaining graft)

conjunctivoplasty, reconstruction cul-de-sac; with conjunctival graft or extensive rearrangement

conjunctivoplasty, reconstruction cul-de-sac; with buccal mucous membrane graft (includes obtaining graft)

repair of symblepharon; with free graft conjunctiva or buccal mucous membrane (includes obtaining graft)

repair of symblepharon; division of symblepharon, with or without insertion of conformer or contact lens

conjunctival flap; total (such as gunderson thin flap or purse string flap)

incision, drainage of lacrimal sac (dacryocystotomy or dacryocystostomy)

excision of lacrimal gland (dacryoadenectomy), except for tumor; total

excision of lacrimal gland (dacryoadenectomy), except for tumor; partial

dacryocystorhinostomy (fistulization of lacrimal sac to nasal cavity)

conjunctivorhinostomy (fistulization of conjunctiva to nasal cavity); without tube

conjunctivorhinostomy (fistulization of conjunctiva to nasal cavity); with insertion of tube or stent

closure of the lacrimal punctum; by thermocauterization, ligation, or laser surgery

probing of nasolacrimal duct, with or without irrigation; requiring general anesthesia

probing of nasolacrimal duct, with or without irrigation; with insertion of tube or stent

probing of nasolacrimal duct, with or without irrigation; with transluminal balloon catheter dilation

radical excision external auditory canal lesion; without neck dissection

radical excision external auditory canal lesion; with neck dissection

removal foreign body from external auditory canal; without general anesthesia

removal foreign body from external auditory canal; with general anesthesia

debridement, mastoidectomy cavity, simple (eg, routine cleaning)

debridement, mastoidectomy cavity, complex (eg, with anesthesia or more than routine cleaning)

reconstruction of external auditory canal (meatoplasty) (eg, for stenosis due to injury, infection) (separate procedure)

reconstruction external auditory canal for congenital atresia, single stage

myringotomy including aspiration and/or eustachian tube inflation

myringotomy including aspiration and/or eustachian tube inflation requiring general anesthesia

tympanostomy (requiring insertion of ventilating tube), local or topical anesthesia

tympanostomy (requiring insertion of ventilating tube), general anesthesia

middle ear exploration through postauricular or ear canal incision

revision mastoidectomy; resulting in modified radical mastoidectomy

tympanic membrane repair, with or without site preparation of perforation for closure, with or without patch

tympanoplasty without mastoidectomy (including canalplasty, atticotomy and/or middle ear surgery), initial or revision; without ossicular chain reconstruction

tympanoplasty without mastoidectomy (including canalplasty, atticotomy and/or middle ear surgery), initial or revision; with ossicular chain reconstruction (eg, postfenestration)

tympanoplasty without mastoidectomy (including canalplasty, atticotomy and/or middle ear surgery), initial or revision; with ossicular chain reconstruction and synthetic prosthesis (eg, partial ossicular replacement prosthesis [porp], total ossicular replacement prosthesis [torp])

tympanoplasty with antrotomy or mastoidotomy (including canalplasty, atticotomy, middle ear surgery, and/or tympanic membrane repair); without ossicular chain reconstruction

tympanoplasty with antrotomy or mastoidotomy (including canalplasty, atticotomy, middle ear surgery, and/or tympanic membrane repair); with ossicular chain reconstruction

tympanoplasty with antrotomy or mastoidotomy (including canalplasty, atticotomy, middle ear surgery, and/or tympanic membrane repair); with ossicular chain reconstruction and synthetic prosthesis (eg, partial ossicular replacement prosthesis [porp], total ossicular replacement prosthesis [torp])

tympanoplasty with mastoidectomy (including canalplasty, middle ear surgery, tympanic membrane repair); without ossicular chain reconstruction

tympanoplasty with mastoidectomy (including canalplasty, middle ear surgery, tympanic membrane repair); with ossicular chain reconstruction

tympanoplasty with mastoidectomy (including canalplasty, middle ear surgery, tympanic membrane repair); with intact or reconstructed wall, without ossicular chain reconstruction

tympanoplasty with mastoidectomy (including canalplasty, middle ear surgery, tympanic membrane repair); with intact or reconstructed canal wall, with ossicular chain reconstruction

tympanoplasty with mastoidectomy (including canalplasty, middle ear surgery, tympanic membrane repair); radical or complete, without ossicular chain reconstruction

tympanoplasty with mastoidectomy (including canalplasty, middle ear surgery, tympanic membrane repair); radical or complete, with ossicular chain reconstruction

stapedectomy or stapedotomy with reestablishment of ossicular continuity, with or without use of foreign material

stapedectomy or stapedotomy with reestablishment of ossicular continuity, with or without use of foreign material; with footplate drill out

implantation or replacement of electromagnetic bone conduction hearing device in temporal bone

removal or repair of electromagnetic bone conduction hearing device in temporal bone

implantation, osseointegrated implant, temporal bone, with percutaneous attachment to external speech processor/cochlear stimulator; without mastoidectomy

implantation, osseointegrated implant, temporal bone, with percutaneous attachment to external speech processor/cochlear stimulator; with mastoidectomy

replacement (including removal of existing device), osseointegrated implant, temporal bone, with percutaneous attachment to external speech processor/cochlear stimulator; without mastoidectomy

replacement (including removal of existing device), osseointegrated implant, temporal bone, with percutaneous attachment to external speech processor/cochlear stimulator; with mastoidectomy

decompression facial nerve, intratemporal; lateral to geniculate ganglion

decompression facial nerve, intratemporal; including medial to geniculate ganglion

suture facial nerve, intratemporal, with or without graft or decompression; lateral to geniculate ganglion

suture facial nerve, intratemporal, with or without graft or decompression; including medial to geniculate ganglion

labyrinthotomy, with perfusion of vestibuloactive drug(s), transcanal

total facial nerve decompression and/or repair (may include graft)

microsurgical techniques, requiring use of operating microscope (list separately in addition to code for primary procedure)

myelography, posterior fossa, radiological supervision and interpretation

cisternography, positive contrast, radiological supervision and interpretation

patient information entered into a recall system that includes: target date for the next exam specified and a process to follow up with patients regarding missed or unscheduled appointments (ml)

radiologic examination, mastoids; complete, minimum of 3 views per side

radiologic examination, facial bones; complete, minimum of 3 views

radiologic examination, nasal bones, complete, minimum of 3 views

dacryocystography, nasolacrimal duct, radiological supervision and interpretation

mammogram assessment category (eg, mammography quality standards act [mqsa], breast imaging reporting and data system [bi-rads], or fda approved equivalent categories) entered into an internal database to allow for analysis of abnormal interpretation (recall) rate (rad)

radiologic examination, sinuses, paranasal, complete, minimum of 3 views

patient information entered into a reminder system with a target due date for the next mammogram (rad)

radiologic examination, teeth; partial examination, less than full mouth

radiologic examination, temporomandibular joint, open and closed mouth; unilateral

radiologic examination, temporomandibular joint, open and closed mouth; bilateral

temporomandibular joint arthrography, radiological supervision and interpretation

magnetic resonance (eg, proton) imaging, temporomandibular joint(s)

radiologic examination; pharynx or larynx, including fluoroscopy and/or magnification technique

complex dynamic pharyngeal and speech evaluation by cine or video recording

computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections

computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; without contrast material

computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; with contrast material(s)

computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; without contrast material, followed by contrast material(s) and further sections

computed tomography, maxillofacial area; without contrast material

computed tomography, maxillofacial area; with contrast material(s)

computed tomography, maxillofacial area; without contrast material, followed by contrast material(s) and further sections

computed tomography, soft tissue neck; without contrast material

computed tomography, soft tissue neck; with contrast material(s)

computed tomography, soft tissue neck; without contrast material followed by contrast material(s) and further sections

computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing

computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing

magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s)

magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; with contrast material(s)

magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences

magnetic resonance angiography, head; without contrast material(s)

magnetic resonance angiography, head; without contrast material(s), followed by contrast material(s) and further sequences

magnetic resonance angiography, neck; without contrast material(s)

magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences

magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material

magnetic resonance (eg, proton) imaging, brain (including brain stem); with contrast material(s)

magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences

magnetic resonance imaging, brain, functional mri; including test selection and administration of repetitive body part movement and/or visual stimulation, not requiring physician or psychologist administration

magnetic resonance imaging, brain, functional mri; requiring physician or psychologist administration of entire neurofunctional testing

magnetic resonance (eg, proton) imaging, brain (including brain stem and skull base), during open intracranial procedure (eg, to assess for residual tumor or residual vascular malformation); without contrast material

magnetic resonance (eg, proton) imaging, brain (including brain stem and skull base), during open intracranial procedure (eg, to assess for residual tumor or residual vascular malformation); with contrast material(s)

magnetic resonance (eg, proton) imaging, brain (including brain stem and skull base), during open intracranial procedure (eg, to assess for residual tumor or residual vascular malformation); without contrast material(s), followed by contrast material(s) and further sequences

radiologic examination, ribs, unilateral; including posteroanterior chest, minimum of 3 views

radiologic examination, ribs, bilateral; including posteroanterior chest, minimum of 4 views

radiologic examination; sternoclavicular joint or joints, minimum of 3 views

computed tomography, thorax; without contrast material, followed by contrast material(s) and further sections

computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing

magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); without contrast material(s)

magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); with contrast material(s)

magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); without contrast material(s), followed by contrast material(s) and further sequences

magnetic resonance angiography, chest (excluding myocardium), with or without contrast material(s)

radiologic examination, spine; thoracolumbar junction, minimum of 2 views

radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); one view

radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); 2 or 3 views

radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); 4 or 5 views

radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); minimum of 6 views

radiologic examination, spine, lumbosacral; complete, including bending views, minimum of 6 views

radiologic examination, spine, lumbosacral; bending views only, 2 or 3 views

computed tomography, cervical spine; without contrast material, followed by contrast material(s) and further sections

computed tomography, thoracic spine; without contrast material, followed by contrast material(s) and further sections

computed tomography, lumbar spine; without contrast material, followed by contrast material(s) and further sections

magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; without contrast material

magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; with contrast material(s)

magnetic resonance (eg, proton) imaging, spinal canal and contents, thoracic; without contrast material

magnetic resonance (eg, proton) imaging, spinal canal and contents, thoracic; with contrast material(s)

magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material

magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; with contrast material(s)

magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; cervical

magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; thoracic

magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar

magnetic resonance angiography, spinal canal and contents, with or without contrast material(s)

computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing

computed tomography, pelvis; without contrast material, followed by contrast material(s) and further sections

magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)

magnetic resonance (eg, proton) imaging, pelvis; with contrast material(s)

magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences

magnetic resonance angiography, pelvis, with or without contrast material(s)

myelography, cervical, radiological supervision and interpretation

myelography, thoracic, radiological supervision and interpretation

myelography, lumbosacral, radiological supervision and interpretation

myelography, 2 or more regions (eg, lumbar/thoracic, cervical/thoracic, lumbar/cervical, lumbar/thoracic/cervical), radiological supervision and interpretation

discography, cervical or thoracic, radiological supervision and interpretation

discography, lumbar, radiological supervision and interpretation

radiologic examination, shoulder, arthrography, radiological supervision and interpretation

radiologic examination; acromioclavicular joints, bilateral, with or without weighted distraction

radiologic examination, elbow, arthrography, radiological supervision and interpretation

radiologic examination; upper extremity, infant, minimum of 2 views

radiologic examination, wrist, arthrography, radiological supervision and interpretation

computed tomography, upper extremity; without contrast material, followed by contrast material(s) and further sections

computed tomographic angiography, upper extremity, with contrast material(s), including noncontrast images, if performed, and image postprocessing

magnetic resonance (eg, proton) imaging, upper extremity, other than joint; without contrast material(s)

magnetic resonance (eg, proton) imaging, upper extremity, other than joint; with contrast material(s)

magnetic resonance (eg, proton) imaging, upper extremity, other than joint; without contrast material(s), followed by contrast material(s) and further sequences

magnetic resonance (eg, proton) imaging, any joint of upper extremity; without contrast material(s)

magnetic resonance (eg, proton) imaging, any joint of upper extremity; with contrast material(s)

magnetic resonance (eg, proton) imaging, any joint of upper extremity; without contrast material(s), followed by contrast material(s) and further sequences

magnetic resonance angiography, upper extremity, with or without contrast material(s)

radiologic examination, hip, unilateral, with pelvis when performed; 1 view

radiologic examination, hip, unilateral, with pelvis when performed; 2-3 views

radiologic examination, hip, unilateral, with pelvis when performed; minimum of 4 views

radiologic examination, hips, bilateral, with pelvis when performed; 2 views

radiologic examination, hips, bilateral, with pelvis when performed; 3-4 views

radiologic examination, hips, bilateral, with pelvis when performed; minimum of 5 views

radiologic examination, hip, arthrography, radiological supervision and interpretation

radiologic examination, knee; both knees, standing, anteroposterior

radiologic examination, knee, arthrography, radiological supervision and interpretation

radiologic examination; lower extremity, infant, minimum of 2 views

radiologic examination, ankle, arthrography, radiological supervision and interpretation

computed tomography, lower extremity; without contrast material, followed by contrast material(s) and further sections

computed tomographic angiography, lower extremity, with contrast material(s), including noncontrast images, if performed, and image postprocessing

magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s)

magnetic resonance (eg, proton) imaging, lower extremity other than joint; with contrast material(s)

magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s), followed by contrast material(s) and further sequences

magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material

magnetic resonance (eg, proton) imaging, any joint of lower extremity; with contrast material(s)

magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material(s), followed by contrast material(s) and further sequences

magnetic resonance angiography, lower extremity, with or without contrast material(s)

radiologic examination, abdomen; complete acute abdomen series, including supine, erect, and/or decubitus views, single view chest

computed tomography, abdomen; without contrast material, followed by contrast material(s) and further sections

computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing

computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing

computed tomography, abdomen and pelvis; without contrast material

computed tomography, abdomen and pelvis; with contrast material(s)

computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions

magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)

magnetic resonance (eg, proton) imaging, abdomen; with contrast material(s)

magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences

magnetic resonance angiography, abdomen, with or without contrast material(s)

peritoneogram (eg, after injection of air or contrast), radiological supervision and interpretation

removal of foreign body(s), esophageal, with use of balloon catheter, radiological supervision and interpretation

radiologic examination, gastrointestinal tract, upper; with or without delayed images, without kub

radiologic examination, gastrointestinal tract, upper; with or without delayed images, with kub

radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images

radiological examination, gastrointestinal tract, upper, air contrast, with specific high density barium, effervescent agent, with or without glucagon; with or without delayed images, without kub

radiological examination, gastrointestinal tract, upper, air contrast, with specific high density barium, effervescent agent, with or without glucagon; with or without delayed images, with kub

radiological examination, gastrointestinal tract, upper, air contrast, with specific high density barium, effervescent agent, with or without glucagon; with small intestine follow-through

radiologic examination, small intestine, includes multiple serial images

radiologic examination, small intestine, includes multiple serial images; via enteroclysis tube

computed tomographic (ct) colonography, diagnostic, including image postprocessing; without contrast material

computed tomographic (ct) colonography, diagnostic, including image postprocessing; with contrast material(s) including non-contrast images, if performed

computed tomographic (ct) colonography, screening, including image postprocessing

radiologic examination, colon; contrast (eg, barium) enema, with or without kub

radiologic examination, colon; air contrast with specific high density barium, with or without glucagon

therapeutic enema, contrast or air, for reduction of intussusception or other intraluminal obstruction (eg, meconium ileus)

cholangiography and/or pancreatography; intraoperative, radiological supervision and interpretation

cholangiography and/or pancreatography; additional set intraoperative, radiological supervision and interpretation (list separately in addition to code for primary procedure)

endoscopic catheterization of the biliary ductal system, radiological supervision and interpretation

endoscopic catheterization of the pancreatic ductal system, radiological supervision and interpretation

combined endoscopic catheterization of the biliary and pancreatic ductal systems, radiological supervision and interpretation

introduction of long gastrointestinal tube (eg, miller-abbott), including multiple fluoroscopies and images, radiological supervision and interpretation

percutaneous placement of enteroclysis tube, radiological supervision and interpretation

intraluminal dilation of strictures and/or obstructions (eg, esophagus), radiological supervision and interpretation

percutaneous transhepatic dilation of biliary duct stricture with or without placement of stent, radiological supervision and interpretation

urography (pyelography), intravenous, with or without kub, with or without tomography

urography, infusion, drip technique and/or bolus technique; with nephrotomography

urography, antegrade (pyelostogram, nephrostogram, loopogram), radiological supervision and interpretation

cystography, minimum of 3 views, radiological supervision and interpretation

vasography, vesiculography, or epididymography, radiological supervision and interpretation

corpora cavernosography, radiological supervision and interpretation

urethrocystography, retrograde, radiological supervision and interpretation

urethrocystography, voiding, radiological supervision and interpretation

radiologic examination, renal cyst study, translumbar, contrast visualization, radiological supervision and interpretation

dilation of nephrostomy, ureters, or urethra, radiological supervision and interpretation

magnetic resonance (eg, proton) imaging, fetal, including placental and maternal pelvic imaging when performed; single or first gestation

magnetic resonance (eg, proton) imaging, fetal, including placental and maternal pelvic imaging when performed; each additional gestation (list separately in addition to code for primary procedure)

hysterosalpingography, radiological supervision and interpretation

transcervical catheterization of fallopian tube, radiological supervision and interpretation

perineogram (eg, vaginogram, for sex determination or extent of anomalies)

cardiac magnetic resonance imaging for morphology and function without contrast material

cardiac magnetic resonance imaging for morphology and function without contrast material; with stress imaging

cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences

cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences; with stress imaging

cardiac magnetic resonance imaging for velocity flow mapping (list separately in addition to code for primary procedure)

computed tomography, heart, without contrast material, with quantitative evaluation of coronary calcium

computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology (including 3d image postprocessing, assessment of cardiac function, and evaluation of venous structures, if performed)

computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology in the setting of congenital heart disease (including 3d image postprocessing, assessment of lv cardiac function, rv structure and function and evaluation of venous structures, if performed)

computed tomographic angiography, heart, coronary arteries and bypass grafts (when present), with contrast material, including 3d image postprocessing (including evaluation of cardiac structure and morphology, assessment of cardiac function, and evaluation of venous structures, if performed)

aortography, thoracic, without serialography, radiological supervision and interpretation

aortography, thoracic, by serialography, radiological supervision and interpretation

aortography, abdominal, by serialography, radiological supervision and interpretation

aortography, abdominal plus bilateral iliofemoral lower extremity, catheter, by serialography, radiological supervision and interpretation

computed tomographic angiography, abdominal aorta and bilateral iliofemoral lower extremity runoff, with contrast material(s), including noncontrast images, if performed, and image postprocessing

angiography, spinal, selective, radiological supervision and interpretation

angiography, extremity, unilateral, radiological supervision and interpretation

angiography, extremity, bilateral, radiological supervision and interpretation

angiography, visceral, selective or supraselective (with or without flush aortogram), radiological supervision and interpretation

angiography, adrenal, unilateral, selective, radiological supervision and interpretation

angiography, adrenal, bilateral, selective, radiological supervision and interpretation

angiography, pelvic, selective or supraselective, radiological supervision and interpretation

angiography, pulmonary, unilateral, selective, radiological supervision and interpretation

angiography, pulmonary, bilateral, selective, radiological supervision and interpretation

angiography, pulmonary, by nonselective catheter or venous injection, radiological supervision and interpretation

angiography, internal mammary, radiological supervision and interpretation

angiography, selective, each additional vessel studied after basic examination, radiological supervision and interpretation (list separately in addition to code for primary procedure)

lymphangiography, extremity only, unilateral, radiological supervision and interpretation

lymphangiography, extremity only, bilateral, radiological supervision and interpretation

lymphangiography, pelvic/abdominal, unilateral, radiological supervision and interpretation

lymphangiography, pelvic/abdominal, bilateral, radiological supervision and interpretation

shuntogram for investigation of previously placed indwelling nonvascular shunt (eg, leveen shunt, ventriculoperitoneal shunt, indwelling infusion pump), radiological supervision and interpretation

venography, extremity, unilateral, radiological supervision and interpretation

venography, extremity, bilateral, radiological supervision and interpretation

venography, caval, inferior, with serialography, radiological supervision and interpretation

venography, caval, superior, with serialography, radiological supervision and interpretation

venography, renal, unilateral, selective, radiological supervision and interpretation

venography, renal, bilateral, selective, radiological supervision and interpretation

venography, adrenal, unilateral, selective, radiological supervision and interpretation

venography, adrenal, bilateral, selective, radiological supervision and interpretation

venography, venous sinus (eg, petrosal and inferior sagittal) or jugular, catheter, radiological supervision and interpretation

venography, superior sagittal sinus, radiological supervision and interpretation

venography, epidural, radiological supervision and interpretation

venography, orbital, radiological supervision and interpretation

percutaneous transhepatic portography with hemodynamic evaluation, radiological supervision and interpretation

percutaneous transhepatic portography without hemodynamic evaluation, radiological supervision and interpretation

hepatic venography, wedged or free, with hemodynamic evaluation, radiological supervision and interpretation

hepatic venography, wedged or free, without hemodynamic evaluation, radiological supervision and interpretation

venous sampling through catheter, with or without angiography (eg, for parathyroid hormone, renin), radiological supervision and interpretation

transcatheter therapy, embolization, any method, radiological supervision and interpretation

angiography through existing catheter for follow-up study for transcatheter therapy, embolization or infusion, other than for thrombolysis

mechanical removal of pericatheter obstructive material (eg, fibrin sheath) from central venous device via separate venous access, radiologic supervision and interpretation

mechanical removal of intraluminal (intracatheter) obstructive material from central venous device through device lumen, radiologic supervision and interpretation

endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); involving coverage of left subclavian artery origin, initial endoprosthesis plus descending thoracic aortic extension(s), if required, to level of celiac artery origin, radiological supervision and interpretation

endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); not involving coverage of left subclavian artery origin, initial endoprosthesis plus descending thoracic aortic extension(s), if required, to level of celiac artery origin, radiological supervision and interpretation

placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption), radiological supervision and interpretation

placement of distal extension prosthesis(s) (delayed) after endovascular repair of descending thoracic aorta, as needed, to level of celiac origin, radiological supervision and interpretation

transcatheter biopsy, radiological supervision and interpretation

change of percutaneous tube or drainage catheter with contrast monitoring (eg, genitourinary system, abscess), radiological supervision and interpretation

radiological guidance (ie, fluoroscopy, ultrasound, or computed tomography), for percutaneous drainage (eg, abscess, specimen collection), with placement of catheter, radiological supervision and interpretation

fluoroscopy (separate procedure), up to 1 hour physician or other qualified health care professional time

fluoroscopy, physician or other qualified health care professional time more than 1 hour, assisting a nonradiologic physician or other qualified health care professional (eg, nephrostolithotomy, ercp, bronchoscopy, transbronchial biopsy)

radiologic examination from nose to rectum for foreign body, single view, child

radiologic examination, abscess, fistula or sinus tract study, radiological supervision and interpretation

radiologic examination, single plane body section (eg, tomography), other than with urography

radiologic examination, complex motion (ie, hypercycloidal) body section (eg, mastoid polytomography), other than with urography; unilateral

radiologic examination, complex motion (ie, hypercycloidal) body section (eg, mastoid polytomography), other than with urography; bilateral

cineradiography/videoradiography, except where specifically included

cineradiography/videoradiography to complement routine examination (list separately in addition to code for primary procedure)

consultation on x-ray examination made elsewhere, written report

3d rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; not requiring image postprocessing on an independent workstation

3d rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstation

unlisted fluoroscopic procedure (eg, diagnostic, interventional)

unlisted computed tomography procedure (eg, diagnostic, interventional)

unlisted magnetic resonance procedure (eg, diagnostic, interventional)

echoencephalography, real time with image documentation (gray scale) (for determination of ventricular size, delineation of cerebral contents, and detection of fluid masses or other intracranial abnormalities), including a-mode encephalography as secondary component where indicated

ophthalmic ultrasound, diagnostic; b-scan and quantitative a-scan performed during the same patient encounter

ophthalmic ultrasound, diagnostic; b-scan (with or without superimposed non-quantitative a-scan)

ophthalmic ultrasound, diagnostic; anterior segment ultrasound, immersion (water bath) b-scan or high resolution biomicroscopy

ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness)

ophthalmic biometry by ultrasound echography, a-scan; with intraocular lens power calculation

ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation

ultrasound, chest (includes mediastinum), real time with image documentation

ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; complete

ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited

ultrasound, abdominal, real time with image documentation; complete

ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)

ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (aaa)

ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete

ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; limited

ultrasound, transplanted kidney, real time and duplex doppler with image documentation

ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation

ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; each additional gestation (list separately in addition to code for primary procedure)

ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation

ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; each additional gestation (list separately in addition to code for primary procedure)

ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation

ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; each additional gestation (list separately in addition to code for primary procedure)

ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation

ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; each additional gestation (list separately in addition to code for primary procedure)

ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses

ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus

ultrasound, pregnant uterus, real time with image documentation, transvaginal

echocardiography, fetal, cardiovascular system, real time with image documentation (2d), with or without m-mode recording

echocardiography, fetal, cardiovascular system, real time with image documentation (2d), with or without m-mode recording; follow-up or repeat study

doppler echocardiography, fetal, pulsed wave and/or continuous wave with spectral display; complete

doppler echocardiography, fetal, pulsed wave and/or continuous wave with spectral display; follow-up or repeat study

saline infusion sonohysterography (sis), including color flow doppler, when performed

ultrasound, pelvic (nonobstetric), real time with image documentation; complete

ultrasound, pelvic (nonobstetric), real time with image documentation; limited or follow-up (eg, for follicles)

ultrasound, transrectal; prostate volume study for brachytherapy treatment planning (separate procedure)

ultrasound, complete joint (ie, joint space and peri-articular soft tissue structures) real-time with image documentation

ultrasound, limited, joint or other nonvascular extremity structure(s) (eg, joint space, peri-articular tendon[s], muscle[s], nerve[s], other soft tissue structure[s], or soft tissue mass[es]), real-time with image documentation

ultrasound, infant hips, real time with imaging documentation; dynamic (requiring physician or other qualified health care professional manipulation)

ultrasound, infant hips, real time with imaging documentation; limited, static (not requiring physician or other qualified health care professional manipulation)

ultrasonic guidance for pericardiocentesis, imaging supervision and interpretation

ultrasonic guidance for endomyocardial biopsy, imaging supervision and interpretation

ultrasound guided compression repair of arterial pseudoaneurysm or arteriovenous fistulae (includes diagnostic ultrasound evaluation, compression of lesion and imaging)

ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (list separately in addition to code for primary procedure)

ultrasound guidance for, and monitoring of, parenchymal tissue ablation

ultrasonic guidance for intrauterine fetal transfusion or cordocentesis, imaging supervision and interpretation

ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation

ultrasonic guidance for chorionic villus sampling, imaging supervision and interpretation

ultrasonic guidance for amniocentesis, imaging supervision and interpretation

ultrasonic guidance for aspiration of ova, imaging supervision and interpretation

gastrointestinal endoscopic ultrasound, supervision and interpretation

ultrasound bone density measurement and interpretation, peripheral site(s), any method

fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or catheter with related venography radiologic supervision and interpretation, and radiographic documentation of final catheter position) (list separately in addition to code for primary procedure)

fluoroscopic guidance for needle placement (eg, biopsy, aspiration, injection, localization device) (list separately in addition to code for primary procedure)

fluoroscopic guidance and localization of needle or catheter tip for spine or paraspinous diagnostic or therapeutic injection procedures (epidural or subarachnoid) (list separately in addition to code for primary procedure)

computed tomography guidance for needle placement (eg, biopsy, aspiration, injection, localization device), radiological supervision and interpretation

computed tomography guidance for, and monitoring of, parenchymal tissue ablation

computed tomography guidance for placement of radiation therapy fields

magnetic resonance guidance for needle placement (eg, for biopsy, needle aspiration, injection, or placement of localization device) radiological supervision and interpretation

magnetic resonance guidance for, and monitoring of, parenchymal tissue ablation

mammary ductogram or galactogram, single duct, radiological supervision and interpretation

mammary ductogram or galactogram, multiple ducts, radiological supervision and interpretation

magnetic resonance imaging, breast, without and/or with contrast material(s); unilateral

magnetic resonance imaging, breast, without and/or with contrast material(s); bilateral

screening digital breast tomosynthesis, bilateral (list separately in addition to code for primary procedure)

diagnostic mammography, including computer-aided detection (cad) when performed; unilateral

diagnostic mammography, including computer-aided detection (cad) when performed; bilateral

screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed

manual application of stress performed by physician or other qualified health care professional for joint radiography, including contralateral joint if indicated

radiologic examination, osseous survey; limited (eg, for metastases)

radiologic examination, osseous survey; complete (axial and appendicular skeleton)

computed tomography, bone mineral density study, 1 or more sites, axial skeleton (eg, hips, pelvis, spine)

dual-energy x-ray absorptiometry (dxa), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)

dual-energy x-ray absorptiometry (dxa), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)

magnetic resonance (eg, proton) imaging, bone marrow blood supply

dual-energy x-ray absorptiometry (dxa), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment

vertebral fracture assessment via dual-energy x-ray absorptiometry (dxa)

therapeutic radiology simulation-aided field setting; intermediate

respiratory motion management simulation (list separately in addition to code for primary procedure)

3-dimensional radiotherapy plan, including dose-volume histograms

unlisted procedure, therapeutic radiology clinical treatment planning

basic radiation dosimetry calculation, central axis depth dose calculation, tdf, nsd, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, only when prescribed by the treating physician

intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications

teletherapy isodose plan; simple (1 or 2 unmodified ports directed to a single area of interest), includes basic dosimetry calculation(s)

teletherapy isodose plan; complex (multiple treatment areas, tangential ports, the use of wedges, blocking, rotational beam, or special beam considerations), includes basic dosimetry calculation(s)

brachytherapy isodose plan; simple (calculation[s] made from 1 to 4 sources, or remote afterloading brachytherapy, 1 channel), includes basic dosimetry calculation(s)

brachytherapy isodose plan; intermediate (calculation[s] made from 5 to 10 sources, or remote afterloading brachytherapy, 2-12 channels), includes basic dosimetry calculation(s)

brachytherapy isodose plan; complex (calculation[s] made from over 10 sources, or remote afterloading brachytherapy, over 12 channels), includes basic dosimetry calculation(s)

special dosimetry (eg, tld, microdosimetry) (specify), only when prescribed by the treating physician

treatment devices, design and construction; simple (simple block, simple bolus)

treatment devices, design and construction; intermediate (multiple blocks, stents, bite blocks, special bolus)

treatment devices, design and construction; complex (irregular blocks, special shields, compensators, wedges, molds or casts)

continuing medical physics consultation, including assessment of treatment parameters, quality assurance of dose delivery, and review of patient treatment documentation in support of the radiation oncologist, reported per week of therapy

multi-leaf collimator (mlc) device(s) for intensity modulated radiation therapy (imrt), design and construction per imrt plan

radiation treatment delivery, stereotactic radiosurgery (srs), complete course of treatment of cranial lesion(s) consisting of 1 session; multi-source cobalt 60 based

radiation treatment delivery, stereotactic radiosurgery (srs), complete course of treatment of cranial lesion(s) consisting of 1 session; linear accelerator based

stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions

intensity modulated radiation treatment delivery (imrt), includes guidance and tracking, when performed; simple

intensity modulated radiation treatment delivery (imrt), includes guidance and tracking, when performed; complex

guidance for localization of target volume for delivery of radiation treatment delivery, includes intrafraction tracking, when performed

unlisted procedure, medical radiation physics, dosimetry and treatment devices, and special services

radiation treatment delivery, superficial and/or ortho voltage, per day

high energy neutron radiation treatment delivery, 1 or more isocenter(s) with coplanar or non-coplanar geometry with blocking and/or wedge, and/or compensator(s)

intraoperative radiation treatment delivery, x-ray, single treatment session

intraoperative radiation treatment delivery, electrons, single treatment session

radiation therapy management with complete course of therapy consisting of 1 or 2 fractions only

stereotactic radiation treatment management of cranial lesion(s) (complete course of treatment consisting of 1 session)

stereotactic body radiation therapy, treatment management, per treatment course, to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions

special treatment procedure (eg, total body irradiation, hemibody radiation, per oral or endocavitary irradiation)

hyperthermia, externally generated; superficial (ie, heating to a depth of 4 cm or less)

hyperthermia, externally generated; deep (ie, heating to depths greater than 4 cm)

hyperthermia generated by interstitial probe(s); 5 or fewer interstitial applicators

hyperthermia generated by interstitial probe(s); more than 5 interstitial applicators

infusion or instillation of radioelement solution (includes 3-month follow-up care)

remote afterloading high dose rate radionuclide skin surface brachytherapy, includes basic dosimetry, when performed; lesion diameter up to 2.0 cm or 1 channel

remote afterloading high dose rate radionuclide skin surface brachytherapy, includes basic dosimetry, when performed; lesion diameter over 2.0 cm and 2 or more channels, or multiple lesions

remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; 1 channel

remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; 2-12 channels

remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; over 12 channels

interstitial radiation source application, complex, includes supervision, handling, loading of radiation source, when performed

thyroid uptake, single or multiple quantitative measurement(s) (including stimulation, suppression, or discharge, when performed)

thyroid imaging (including vascular flow, when performed); with single or multiple uptake(s) quantitative measurement(s) (including stimulation, suppression, or discharge, when performed)

thyroid carcinoma metastases imaging; limited area (eg, neck and chest only)

thyroid carcinoma metastases imaging; with additional studies (eg, urinary recovery)

thyroid carcinoma metastases uptake (list separately in addition to code for primary procedure)

parathyroid planar imaging (including subtraction, when performed)

parathyroid planar imaging (including subtraction, when performed); with tomographic (spect)

parathyroid planar imaging (including subtraction, when performed); with tomographic (spect), and concurrently acquired computed tomography (ct) for anatomical localization

plasma volume, radiopharmaceutical volume-dilution technique (separate procedure); single sampling

plasma volume, radiopharmaceutical volume-dilution technique (separate procedure); multiple samplings

red cell volume determination (separate procedure); single sampling

red cell volume determination (separate procedure); multiple samplings

whole blood volume determination, including separate measurement of plasma volume and red cell volume (radiopharmaceutical volume-dilution technique)

red cell survival study; differential organ/tissue kinetics (eg, splenic and/or hepatic sequestration)

labeled red cell sequestration, differential organ/tissue (eg, splenic and/or hepatic)

unlisted hematopoietic, reticuloendothelial and lymphatic procedure, diagnostic nuclear medicine

hepatobiliary system imaging, including gallbladder when present

hepatobiliary system imaging, including gallbladder when present; with pharmacologic intervention, including quantitative measurement(s) when performed

gastric emptying imaging study (eg, solid, liquid, or both); with small bowel transit

gastric emptying imaging study (eg, solid, liquid, or both); with small bowel and colon transit, multiple days

vitamin b-12 absorption study (eg, schilling test); without intrinsic factor

vitamin b-12 absorption study (eg, schilling test); with intrinsic factor

vitamin b-12 absorption studies combined, with and without intrinsic factor

intestine imaging (eg, ectopic gastric mucosa, meckel's localization, volvulus)

peritoneal-venous shunt patency test (eg, for leveen, denver shunt)

unlisted gastrointestinal procedure, diagnostic nuclear medicine

bone density (bone mineral content) study, 1 or more sites; single photon absorptiometry

bone density (bone mineral content) study, 1 or more sites; dual photon absorptiometry, 1 or more sites

determination of central c-v hemodynamics (non-imaging) (eg, ejection fraction with probe technique) with or without pharmacologic intervention or exercise, single or multiple determinations

myocardial perfusion imaging, tomographic (spect) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); single study, at rest or stress (exercise or pharmacologic)

myocardial perfusion imaging, tomographic (spect) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection

myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); single study, at rest or stress (exercise or pharmacologic)

myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection

myocardial imaging, positron emission tomography (pet), metabolic evaluation

myocardial imaging, infarct avid, planar; qualitative or quantitative

myocardial imaging, infarct avid, planar; with ejection fraction by first pass technique

myocardial imaging, infarct avid, planar; tomographic spect with or without quantification

cardiac blood pool imaging, gated equilibrium; planar, single study at rest or stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without additional quantitative processing

cardiac blood pool imaging, gated equilibrium; multiple studies, wall motion study plus ejection fraction, at rest and stress (exercise and/or pharmacologic), with or without additional quantification

cardiac blood pool imaging (planar), first pass technique; single study, at rest or with stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without quantification

cardiac blood pool imaging (planar), first pass technique; multiple studies, at rest and with stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without quantification

myocardial imaging, positron emission tomography (pet), perfusion; single study at rest or stress

myocardial imaging, positron emission tomography (pet), perfusion; multiple studies at rest and/or stress

cardiac blood pool imaging, gated equilibrium, spect, at rest, wall motion study plus ejection fraction, with or without quantitative processing

cardiac blood pool imaging, gated equilibrium, single study, at rest, with right ventricular ejection fraction by first pass technique (list separately in addition to code for primary procedure)

pulmonary ventilation (eg, aerosol or gas) and perfusion imaging

quantitative differential pulmonary perfusion, including imaging when performed

quantitative differential pulmonary perfusion and ventilation (eg, aerosol or gas), including imaging when performed

brain imaging, positron emission tomography (pet); metabolic evaluation

brain imaging, positron emission tomography (pet); perfusion evaluation

cerebrospinal fluid flow, imaging (not including introduction of material); cisternography

cerebrospinal fluid flow, imaging (not including introduction of material); ventriculography

cerebrospinal fluid flow, imaging (not including introduction of material); shunt evaluation

cerebrospinal fluid flow, imaging (not including introduction of material); tomographic (spect)

kidney imaging morphology; with vascular flow and function, single study without pharmacological intervention

kidney imaging morphology; with vascular flow and function, single study, with pharmacological intervention (eg, angiotensin converting enzyme inhibitor and/or diuretic)

kidney imaging morphology; with vascular flow and function, multiple studies, with and without pharmacological intervention (eg, angiotensin converting enzyme inhibitor and/or diuretic)

urinary bladder residual study (list separately in addition to code for primary procedure)

radiopharmaceutical localization of tumor or distribution of radiopharmaceutical agent(s); limited area

radiopharmaceutical localization of tumor or distribution of radiopharmaceutical agent(s); multiple areas

radiopharmaceutical localization of tumor or distribution of radiopharmaceutical agent(s); whole body, single day imaging

radiopharmaceutical localization of tumor or distribution of radiopharmaceutical agent(s); tomographic (spect)

radiopharmaceutical localization of tumor or distribution of radiopharmaceutical agent(s); whole body, requiring 2 or more days imaging

radiopharmaceutical localization of inflammatory process; limited area

radiopharmaceutical localization of inflammatory process; whole body

radiopharmaceutical localization of inflammatory process; tomographic (spect)

injection procedure for radiopharmaceutical localization by non-imaging probe study, intravenous (eg, parathyroid adenoma)

positron emission tomography (pet) imaging; limited area (eg, chest, head/neck)

positron emission tomography (pet) imaging; skull base to mid-thigh

positron emission tomography (pet) with concurrently acquired computed tomography (ct) for attenuation correction and anatomical localization imaging; limited area (eg, chest, head/neck)

positron emission tomography (pet) with concurrently acquired computed tomography (ct) for attenuation correction and anatomical localization imaging; skull base to mid-thigh

positron emission tomography (pet) with concurrently acquired computed tomography (ct) for attenuation correction and anatomical localization imaging; whole body

radiopharmaceutical therapy, by interstitial radioactive colloid administration

radiopharmaceutical therapy, radiolabeled monoclonal antibody by intravenous infusion

radiopharmaceutical therapy, by intra-arterial particulate administration

basic metabolic panel (calcium, ionized) this panel must include the following: calcium, ionized (82330) carbon dioxide (bicarbonate) (82374) chloride (82435) creatinine (82565) glucose (82947) potassium (84132) sodium (84295) urea nitrogen (bun) (84520)

basic metabolic panel (calcium, total) this panel must include the following: calcium, total (82310) carbon dioxide (bicarbonate) (82374) chloride (82435) creatinine (82565) glucose (82947) potassium (84132) sodium (84295) urea nitrogen (bun) (84520)

general health panel this panel must include the following: comprehensive metabolic panel (80053) blood count, complete (cbc), automated and automated differential wbc count (85025 or 85027 and 85004) or blood count, complete (cbc), automated (85027) and appropriate manual differential wbc count (85007 or 85009) thyroid stimulating hormone (tsh) (84443)

electrolyte panel this panel must include the following: carbon dioxide (bicarbonate) (82374) chloride (82435) potassium (84132) sodium (84295)

comprehensive metabolic panel this panel must include the following: albumin (82040) bilirubin, total (82247) calcium, total (82310) carbon dioxide (bicarbonate) (82374) chloride (82435) creatinine (82565) glucose (82947) phosphatase, alkaline (84075) potassium (84132) protein, total (84155) sodium (84295) transferase, alanine amino (alt) (sgpt) (84460) transferase, aspartate amino (ast) (sgot) (84450) urea nitrogen (bun) (84520)

obstetric panel this panel must include the following: blood count, complete (cbc), automated and automated differential wbc count (85025 or 85027 and 85004) or blood count, complete (cbc), automated (85027) and appropriate manual differential wbc count (85007 or 85009) hepatitis b surface antigen (hbsag) (87340) antibody, rubella (86762) syphilis test, non-treponemal antibody; qualitative (eg, vdrl, rpr, art) (86592) antibody screen, rbc, each serum technique (86850) blood typing, abo (86900) and blood typing, rh (d) (86901)

lipid panel this panel must include the following: cholesterol, serum, total (82465) lipoprotein, direct measurement, high density cholesterol (hdl cholesterol) (83718) triglycerides (84478)

renal function panel this panel must include the following: albumin (82040) calcium, total (82310) carbon dioxide (bicarbonate) (82374) chloride (82435) creatinine (82565) glucose (82947) phosphorus inorganic (phosphate) (84100) potassium (84132) sodium (84295) urea nitrogen (bun) (84520)

acute hepatitis panel this panel must include the following: hepatitis a antibody (haab), igm antibody (86709) hepatitis b core antibody (hbcab), igm antibody (86705) hepatitis b surface antigen (hbsag) (87340) hepatitis c antibody (86803)

hepatic function panel this panel must include the following: albumin (82040) bilirubin, total (82247) bilirubin, direct (82248) phosphatase, alkaline (84075) protein, total (84155) transferase, alanine amino (alt) (sgpt) (84460) transferase, aspartate amino (ast) (sgot) (84450)

obstetric panel (includes hiv testing) this panel must include the following: blood count, complete (cbc), and automated differential wbc count (85025 or 85027 and 85004) or blood count, complete (cbc), automated (85027) and appropriate manual differential wbc count (85007 or 85009) hepatitis b surface antigen (hbsag) (87340) hiv-1 antigen(s), with hiv-1 and hiv-2 antibodies, single result (87389) antibody, rubella (86762) syphilis test, non-treponemal antibody; qualitative (eg, vdrl, rpr, art) (86592) antibody screen, rbc, each serum technique (86850) blood typing, abo (86900) and blood typing, rh (d) (86901)

drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service

drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service

drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, eia, elisa, emit, fpia, ia, kims, ria]), chromatography (eg, gc, hplc), and mass spectrometry either with or without chromatography, (eg, dart, desi, gc-ms, gc-ms/ms, lc-ms, lc-ms/ms, ldtd, maldi, tof) includes sample validation when performed, per date of service

drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 1-3

drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 4-6

drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 7 or more

acth stimulation panel; for adrenal insufficiency this panel must include the following: cortisol (82533 x 2)

acth stimulation panel; for 21 hydroxylase deficiency this panel must include the following: cortisol (82533 x 2) 17 hydroxyprogesterone (83498 x 2)

acth stimulation panel; for 3 beta-hydroxydehydrogenase deficiency this panel must include the following: cortisol (82533 x 2) 17 hydroxypregnenolone (84143 x 2)

aldosterone suppression evaluation panel (eg, saline infusion) this panel must include the following: aldosterone (82088 x 2) renin (84244 x 2)

calcitonin stimulation panel (eg, calcium, pentagastrin) this panel must include the following: calcitonin (82308 x 3)

corticotropic releasing hormone (crh) stimulation panel this panel must include the following: cortisol (82533 x 6) adrenocorticotropic hormone (acth) (82024 x 6)

chorionic gonadotropin stimulation panel; testosterone response this panel must include the following: testosterone (84403 x 2 on 3 pooled blood samples)

chorionic gonadotropin stimulation panel; estradiol response this panel must include the following: estradiol (82670 x 2 on 3 pooled blood samples)

renal vein renin stimulation panel (eg, captopril) this panel must include the following: renin (84244 x 6)

peripheral vein renin stimulation panel (eg, captopril) this panel must include the following: renin (84244 x 2)

combined rapid anterior pituitary evaluation panel this panel must include the following: adrenocorticotropic hormone (acth) (82024 x 4) luteinizing hormone (lh) (83002 x 4) follicle stimulating hormone (fsh) (83001 x 4) prolactin (84146 x 4) human growth hormone (hgh) (83003 x 4) cortisol (82533 x 4) thyroid stimulating hormone (tsh) (84443 x 4)

dexamethasone suppression panel, 48 hour this panel must include the following: free cortisol, urine (82530 x 2) cortisol (82533 x 2) volume measurement for timed collection (81050 x 2)

glucagon tolerance panel; for insulinoma this panel must include the following: glucose (82947 x 3) insulin (83525 x 3)

glucagon tolerance panel; for pheochromocytoma this panel must include the following: catecholamines, fractionated (82384 x 2)

gonadotropin releasing hormone stimulation panel this panel must include the following: follicle stimulating hormone (fsh) (83001 x 4) luteinizing hormone (lh) (83002 x 4)

growth hormone stimulation panel (eg, arginine infusion, l-dopa administration) this panel must include the following: human growth hormone (hgh) (83003 x 4)

growth hormone suppression panel (glucose administration) this panel must include the following: glucose (82947 x 3) human growth hormone (hgh) (83003 x 4)

insulin-induced c-peptide suppression panel this panel must include the following: insulin (83525) c-peptide (84681 x 5) glucose (82947 x 5)

insulin tolerance panel; for acth insufficiency this panel must include the following: cortisol (82533 x 5) glucose (82947 x 5)

insulin tolerance panel; for growth hormone deficiency this panel must include the following: glucose (82947 x 5) human growth hormone (hgh) (83003 x 5)

metyrapone panel this panel must include the following: cortisol (82533 x 2) 11 deoxycortisol (82634 x 2)

thyrotropin releasing hormone (trh) stimulation panel; 1 hour this panel must include the following: thyroid stimulating hormone (tsh) (84443 x 3)

thyrotropin releasing hormone (trh) stimulation panel; 2 hour this panel must include the following: thyroid stimulating hormone (tsh) (84443 x 4)

clinical pathology consultation; limited, without review of patient's history and medical records

clinical pathology consultation; comprehensive, for a complex diagnostic problem, with review of patient's history and medical records

urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, ph, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy

urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, ph, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy

urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, ph, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy

urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, ph, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy

urinalysis; qualitative or semiquantitative, except immunoassays

human platelet antigen 1 genotyping (hpa-1), itgb3 (integrin, beta 3 [platelet glycoprotein iiia], antigen cd61 [gpiiia]) (eg, neonatal alloimmune thrombocytopenia [nait], post-transfusion purpura), gene analysis, common variant, hpa-1a/b (l33p)

human platelet antigen 2 genotyping (hpa-2), gp1ba (glycoprotein ib [platelet], alpha polypeptide [gpiba]) (eg, neonatal alloimmune thrombocytopenia [nait], post-transfusion purpura), gene analysis, common variant, hpa-2a/b (t145m)

human platelet antigen 3 genotyping (hpa-3), itga2b (integrin, alpha 2b [platelet glycoprotein iib of iib/iiia complex], antigen cd41 [gpiib]) (eg, neonatal alloimmune thrombocytopenia [nait], post-transfusion purpura), gene analysis, common variant, hpa-3a/b (i843s)

human platelet antigen 4 genotyping (hpa-4), itgb3 (integrin, beta 3 [platelet glycoprotein iiia], antigen cd61 [gpiiia]) (eg, neonatal alloimmune thrombocytopenia [nait], post-transfusion purpura), gene analysis, common variant, hpa-4a/b (r143q)

human platelet antigen 5 genotyping (hpa-5), itga2 (integrin, alpha 2 [cd49b, alpha 2 subunit of vla-2 receptor] [gpia]) (eg, neonatal alloimmune thrombocytopenia [nait], post-transfusion purpura), gene analysis, common variant (eg, hpa-5a/b (k505e))

human platelet antigen 6 genotyping (hpa-6w), itgb3 (integrin, beta 3 [platelet glycoprotein iiia, antigen cd61] [gpiiia]) (eg, neonatal alloimmune thrombocytopenia [nait], post-transfusion purpura), gene analysis, common variant, hpa-6a/b (r489q)

human platelet antigen 9 genotyping (hpa-9w), itga2b (integrin, alpha 2b [platelet glycoprotein iib of iib/iiia complex, antigen cd41] [gpiib]) (eg, neonatal alloimmune thrombocytopenia [nait], post-transfusion purpura), gene analysis, common variant, hpa-9a/b (v837m)

human platelet antigen 15 genotyping (hpa-15), cd109 (cd109 molecule) (eg, neonatal alloimmune thrombocytopenia [nait], post-transfusion purpura), gene analysis, common variant, hpa-15a/b (s682y)

idh1 (isocitrate dehydrogenase 1 [nadp+], soluble) (eg, glioma), common variants (eg, r132h, r132c)

idh2 (isocitrate dehydrogenase 2 [nadp+], mitochondrial) (eg, glioma), common variants (eg, r140w, r172m)

dmd (dystrophin) (eg, duchenne/becker muscular dystrophy) deletion analysis, and duplication analysis, if performed

brca1, brca2 (breast cancer 1 and 2) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplication/deletion analysis

abl1 (abl proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib tyrosine kinase inhibitor resistance), gene analysis, variants in the kinase domain

asxl1 (additional sex combs like 1, transcriptional regulator) (eg, myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; full gene sequence

asxl1 (additional sex combs like 1, transcriptional regulator) (eg, myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; targeted sequence analysis (eg, exon 12)

aspa (aspartoacylase) (eg, canavan disease) gene analysis, common variants (eg, e285a, y231x)

apc (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [fap], attenuated fap) gene analysis; full gene sequence

apc (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [fap], attenuated fap) gene analysis; known familial variants

apc (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [fap], attenuated fap) gene analysis; duplication/deletion variants

bckdhb (branched-chain keto acid dehydrogenase e1, beta polypeptide) (eg, maple syrup urine disease) gene analysis, common variants (eg, r183p, g278s, e422x)

bcr/abl1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; major breakpoint, qualitative or quantitative

bcr/abl1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; minor breakpoint, qualitative or quantitative

bcr/abl1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; other breakpoint, qualitative or quantitative

blm (bloom syndrome, recq helicase-like) (eg, bloom syndrome) gene analysis, 2281del6ins7 variant

braf (b-raf proto-oncogene, serine/threonine kinase) (eg, colon cancer, melanoma), gene analysis, v600 variant(s)

brca1, brca2 (breast cancer 1 and 2) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and common duplication/deletion variants in brca1 (ie, exon 13 del 3.835kb, exon 13 dup 6kb, exon 14-20 del 26kb, exon 22 del 510bp, exon 8-9 del 7.1kb)

brca1, brca2 (breast cancer 1 and 2) (eg, hereditary breast and ovarian cancer) gene analysis; 185delag, 5385insc, 6174delt variants

brca1, brca2 (breast cancer 1 and 2) (eg, hereditary breast and ovarian cancer) gene analysis; uncommon duplication/deletion variants

brca1 (breast cancer 1) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and common duplication/deletion variants (ie, exon 13 del 3.835kb, exon 13 dup 6kb, exon 14-20 del 26kb, exon 22 del 510bp, exon 8-9 del 7.1kb)

brca1 (breast cancer 1) (eg, hereditary breast and ovarian cancer) gene analysis; known familial variant

brca2 (breast cancer 2) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis

brca2 (breast cancer 2) (eg, hereditary breast and ovarian cancer) gene analysis; known familial variant

cebpa (ccaat/enhancer binding protein [c/ebp], alpha) (eg, acute myeloid leukemia), gene analysis, full gene sequence

calr (calreticulin) (eg, myeloproliferative disorders), gene analysis, common variants in exon 9

cftr (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; common variants (eg, acmg/acog guidelines)

cftr (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; known familial variants

cftr (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; duplication/deletion variants

cftr (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; full gene sequence

cftr (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; intron 8 poly-t analysis (eg, male infertility)

cyp2c19 (cytochrome p450, family 2, subfamily c, polypeptide 19) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *8, *17)

cyp2d6 (cytochrome p450, family 2, subfamily d, polypeptide 6) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *5, *6, *9, *10, *17, *19, *29, *35, *41, *1xn, *2xn, *4xn)

cyp2c9 (cytochrome p450, family 2, subfamily c, polypeptide 9) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *5, *6)

cytogenomic constitutional (genome-wide) microarray analysis; interrogation of genomic regions for copy number variants (eg, bacterial artificial chromosome [bac] or oligo-based comparative genomic hybridization [cgh] microarray analysis)

cytogenomic constitutional (genome-wide) microarray analysis; interrogation of genomic regions for copy number and single nucleotide polymorphism (snp) variants for chromosomal abnormalities

cyp3a4 (cytochrome p450 family 3 subfamily a member 4) (eg, drug metabolism), gene analysis, common variant(s) (eg, *2, *22)

cyp3a5 (cytochrome p450 family 3 subfamily a member 5) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *5, *6, *7)

dpyd (dihydropyrimidine dehydrogenase) (eg, 5-fluorouracil/5-fu and capecitabine drug metabolism), gene analysis, common variant(s) (eg, *2a, *4, *5, *6)

egfr (epidermal growth factor receptor) (eg, non-small cell lung cancer) gene analysis, common variants (eg, exon 19 lrea deletion, l858r, t790m, g719a, g719s, l861q)

f9 (coagulation factor ix) (eg, hemophilia b), full gene sequence

f2 (prothrombin, coagulation factor ii) (eg, hereditary hypercoagulability) gene analysis, 20210g>a variant

f5 (coagulation factor v) (eg, hereditary hypercoagulability) gene analysis, leiden variant

fancc (fanconi anemia, complementation group c) (eg, fanconi anemia, type c) gene analysis, common variant (eg, ivs4+4a>t)

fmr1 (fragile x mental retardation 1) (eg, fragile x mental retardation) gene analysis; evaluation to detect abnormal (eg, expanded) alleles

fmr1 (fragile x mental retardation 1) (eg, fragile x mental retardation) gene analysis; characterization of alleles (eg, expanded size and methylation status)

flt3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis; internal tandem duplication (itd) variants (ie, exons 14, 15)

flt3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis; tyrosine kinase domain (tkd) variants (eg, d835, i836)

g6pd (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; common variant(s) (eg, a, a-)

g6pd (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; known familial variant(s)

g6pd (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; full gene sequence

g6pc (glucose-6-phosphatase, catalytic subunit) (eg, glycogen storage disease, type 1a, von gierke disease) gene analysis, common variants (eg, r83c, q347x)

gba (glucosidase, beta, acid) (eg, gaucher disease) gene analysis, common variants (eg, n370s, 84gg, l444p, ivs2+1g>a)

gjb2 (gap junction protein, beta 2, 26kda, connexin 26) (eg, nonsyndromic hearing loss) gene analysis; full gene sequence

gjb2 (gap junction protein, beta 2, 26kda, connexin 26) (eg, nonsyndromic hearing loss) gene analysis; known familial variants

gjb6 (gap junction protein, beta 6, 30kda, connexin 30) (eg, nonsyndromic hearing loss) gene analysis, common variants (eg, 309kb [del(gjb6-d13s1830)] and 232kb [del(gjb6-d13s1854)])

hexa (hexosaminidase a [alpha polypeptide]) (eg, tay-sachs disease) gene analysis, common variants (eg, 1278instatc, 1421+1g>c, g269s)

hfe (hemochromatosis) (eg, hereditary hemochromatosis) gene analysis, common variants (eg, c282y, h63d)

hba1/hba2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, hb bart hydrops fetalis syndrome, hbh disease), gene analysis; common deletions or variant (eg, southeast asian, thai, filipino, mediterranean, alpha3.7, alpha4.2, alpha20.5, constant spring)

hba1/hba2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, hb bart hydrops fetalis syndrome, hbh disease), gene analysis; known familial variant

hba1/hba2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, hb bart hydrops fetalis syndrome, hbh disease), gene analysis; full gene sequence

ikbkap (inhibitor of kappa light polypeptide gene enhancer in b-cells, kinase complex-associated protein) (eg, familial dysautonomia) gene analysis, common variants (eg, 2507+6t>c, r696p)

igh@ (immunoglobulin heavy chain locus) (eg, leukemias and lymphomas, b-cell), gene rearrangement analysis to detect abnormal clonal population(s); amplified methodology (eg, polymerase chain reaction)

igh@ (immunoglobulin heavy chain locus) (eg, leukemias and lymphomas, b-cell), gene rearrangement analysis to detect abnormal clonal population(s); direct probe methodology (eg, southern blot)

igh@ (immunoglobulin heavy chain locus) (eg, leukemia and lymphoma, b-cell), variable region somatic mutation analysis

igk@ (immunoglobulin kappa light chain locus) (eg, leukemia and lymphoma, b-cell), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)

comparative analysis using short tandem repeat (str) markers; patient and comparative specimen (eg, pre-transplant recipient and donor germline testing, post-transplant non-hematopoietic recipient germline [eg, buccal swab or other germline tissue sample] and donor testing, twin zygosity testing, or maternal cell contamination of fetal cells)

comparative analysis using short tandem repeat (str) markers; each additional specimen (eg, additional cord blood donor, additional fetal samples from different cultures, or additional zygosity in multiple birth pregnancies) (list separately in addition to code for primary procedure)

chimerism (engraftment) analysis, post transplantation specimen (eg, hematopoietic stem cell), includes comparison to previously performed baseline analyses; without cell selection

chimerism (engraftment) analysis, post transplantation specimen (eg, hematopoietic stem cell), includes comparison to previously performed baseline analyses; with cell selection (eg, cd3, cd33), each cell type

hba1/hba2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, hb bart hydrops fetalis syndrome, hbh disease), gene analysis; duplication/deletion variants

jak2 (janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.val617phe (v617f) variant

kit (v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog) (eg, gastrointestinal stromal tumor [gist], acute myeloid leukemia, melanoma), gene analysis, targeted sequence analysis (eg, exons 8, 11, 13, 17, 18)

kit (v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog) (eg, mastocytosis), gene analysis, d816 variant(s)

kras (kirsten rat sarcoma viral oncogene homolog) (eg, carcinoma) gene analysis; variants in exon 2 (eg, codons 12 and 13)

kras (kirsten rat sarcoma viral oncogene homolog) (eg, carcinoma) gene analysis; additional variant(s) (eg, codon 61, codon 146)

ifnl3 (interferon, lambda 3) (eg, drug response), gene analysis, rs12979860 variant

mgmt (o-6-methylguanine-dna methyltransferase) (eg, glioblastoma multiforme), methylation analysis

mlh1 (mutl homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; promoter methylation analysis

mcoln1 (mucolipin 1) (eg, mucolipidosis, type iv) gene analysis, common variants (eg, ivs3-2a>g, del6.4kb)

mthfr (5,10-methylenetetrahydrofolate reductase) (eg, hereditary hypercoagulability) gene analysis, common variants (eg, 677t, 1298c)

mlh1 (mutl homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; full sequence analysis

mlh1 (mutl homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; known familial variants

mlh1 (mutl homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; duplication/deletion variants

msh2 (muts homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; full sequence analysis

msh2 (muts homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; known familial variants

msh2 (muts homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; duplication/deletion variants

msh6 (muts homolog 6 [e. coli]) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; full sequence analysis

msh6 (muts homolog 6 [e. coli]) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; known familial variants

msh6 (muts homolog 6 [e. coli]) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; duplication/deletion variants

microsatellite instability analysis (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) of markers for mismatch repair deficiency (eg, bat25, bat26), includes comparison of neoplastic and normal tissue, if performed

mecp2 (methyl cpg binding protein 2) (eg, rett syndrome) gene analysis; full sequence analysis

mecp2 (methyl cpg binding protein 2) (eg, rett syndrome) gene analysis; known familial variant

mecp2 (methyl cpg binding protein 2) (eg, rett syndrome) gene analysis; duplication/deletion variants

npm1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, exon 12 variants

nras (neuroblastoma ras viral [v-ras] oncogene homolog) (eg, colorectal carcinoma), gene analysis, variants in exon 2 (eg, codons 12 and 13) and exon 3 (eg, codon 61)

pca3/klk3 (prostate cancer antigen 3 [non-protein coding]/kallikrein-related peptidase 3 [prostate specific antigen]) ratio (eg, prostate cancer)

pdgfra (platelet-derived growth factor receptor, alpha polypeptide) (eg, gastrointestinal stromal tumor [gist]), gene analysis, targeted sequence analysis (eg, exons 12, 18)

pml/raralpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (eg, promyelocytic leukemia) translocation analysis; common breakpoints (eg, intron 3 and intron 6), qualitative or quantitative

pml/raralpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (eg, promyelocytic leukemia) translocation analysis; single breakpoint (eg, intron 3, intron 6 or exon 6), qualitative or quantitative

pms2 (postmeiotic segregation increased 2 [s. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; full sequence analysis

pms2 (postmeiotic segregation increased 2 [s. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; known familial variants

pms2 (postmeiotic segregation increased 2 [s. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) gene analysis; duplication/deletion variants

pten (phosphatase and tensin homolog) (eg, cowden syndrome, pten hamartoma tumor syndrome) gene analysis; full sequence analysis

pten (phosphatase and tensin homolog) (eg, cowden syndrome, pten hamartoma tumor syndrome) gene analysis; known familial variant

pten (phosphatase and tensin homolog) (eg, cowden syndrome, pten hamartoma tumor syndrome) gene analysis; duplication/deletion variant

pmp22 (peripheral myelin protein 22) (eg, charcot-marie-tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; duplication/deletion analysis

pmp22 (peripheral myelin protein 22) (eg, charcot-marie-tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; full sequence analysis

pmp22 (peripheral myelin protein 22) (eg, charcot-marie-tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; known familial variant

slco1b1 (solute carrier organic anion transporter family, member 1b1) (eg, adverse drug reaction), gene analysis, common variant(s) (eg, *5)

smpd1(sphingomyelin phosphodiesterase 1, acid lysosomal) (eg, niemann-pick disease, type a) gene analysis, common variants (eg, r496l, l302p, fsp330)

snrpn/ube3a (small nuclear ribonucleoprotein polypeptide n and ubiquitin protein ligase e3a) (eg, prader-willi syndrome and/or angelman syndrome), methylation analysis

serpina1 (serpin peptidase inhibitor, clade a, alpha-1 antiproteinase, antitrypsin, member 1) (eg, alpha-1-antitrypsin deficiency), gene analysis, common variants (eg, *s and *z)

runx1 (runt related transcription factor 1) (eg, acute myeloid leukemia, familial platelet disorder with associated myeloid malignancy), gene analysis, targeted sequence analysis (eg, exons 3-8)

tpmt (thiopurine s-methyltransferase) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3)

trb@ (t cell antigen receptor, beta) (eg, leukemia and lymphoma), gene rearrangement analysis to detect abnormal clonal population(s); using amplification methodology (eg, polymerase chain reaction)

trb@ (t cell antigen receptor, beta) (eg, leukemia and lymphoma), gene rearrangement analysis to detect abnormal clonal population(s); using direct probe methodology (eg, southern blot)

trg@ (t cell antigen receptor, gamma) (eg, leukemia and lymphoma), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)

tyms (thymidylate synthetase) (eg, 5-fluorouracil/5-fu drug metabolism), gene analysis, common variant(s) (eg, tandem repeat variant)

ugt1a1 (udp glucuronosyltransferase 1 family, polypeptide a1) (eg, irinotecan metabolism), gene analysis, common variants (eg, *28, *36, *37)

vkorc1 (vitamin k epoxide reductase complex, subunit 1) (eg, warfarin metabolism), gene analysis, common variant(s) (eg, -1639g>a, c.173+1000c>t)

hbb (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); common variant(s) (eg, hbs, hbc, hbe)

hbb (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); known familial variant(s)

hbb (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); duplication/deletion variant(s)

hbb (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); full gene sequence

hla class i and ii typing, low resolution (eg, antigen equivalents); hla-a, -b, -c, -drb1/3/4/5, and -dqb1

hla class i and ii typing, low resolution (eg, antigen equivalents); hla-a, -b, and -drb1 (eg, verification typing)

hla class i typing, low resolution (eg, antigen equivalents); complete (ie, hla-a, -b, and -c)

hla class i typing, low resolution (eg, antigen equivalents); one locus (eg, hla-a, -b, or -c), each

hla class i typing, low resolution (eg, antigen equivalents); one antigen equivalent (eg, b*27), each

hla class ii typing, low resolution (eg, antigen equivalents); hla-drb1/3/4/5 and -dqb1

hla class ii typing, low resolution (eg, antigen equivalents); one locus (eg, hla-drb1, -drb3/4/5, -dqb1, -dqa1, -dpb1, or -dpa1), each

hla class ii typing, low resolution (eg, antigen equivalents); one antigen equivalent, each

hla class i and ii typing, high resolution (ie, alleles or allele groups), hla-a, -b, -c, and -drb1

hla class i typing, high resolution (ie, alleles or allele groups); complete (ie, hla-a, -b, and -c)

hla class i typing, high resolution (ie, alleles or allele groups); one locus (eg, hla-a, -b, or -c), each

hla class i typing, high resolution (ie, alleles or allele groups); one allele or allele group (eg, b*57:01p), each

hla class ii typing, high resolution (ie, alleles or allele groups); one locus (eg, hla-drb1, -drb3/4/5, -dqb1, -dqa1, -dpb1, or -dpa1), each

hla class ii typing, high resolution (ie, alleles or allele groups); one allele or allele group (eg, hla-dqb1*06:02p), each

molecular pathology procedure, level 1 (eg, identification of single germline variant [eg, snp] by techniques such as restriction enzyme digestion or melt curve analysis) acadm (acyl-coa dehydrogenase, c-4 to c-12 straight chain, mcad) (eg, medium chain acyl dehydrogenase deficiency), k304e variant ace (angiotensin converting enzyme) (eg, hereditary blood pressure regulation), insertion/deletion variant agtr1 (angiotensin ii receptor, type 1) (eg, essential hypertension), 1166a>c variant bckdha (branched chain keto acid dehydrogenase e1, alpha polypeptide) (eg, maple syrup urine disease, type 1a), y438n variant ccr5 (chemokine c-c motif receptor 5) (eg, hiv resistance), 32-bp deletion mutation/794 825del32 deletion clrn1 (clarin 1) (eg, usher syndrome, type 3), n48k variant f2 (coagulation factor 2) (eg, hereditary hypercoagulability), 1199g>a variant f5 (coagulation factor v) (eg, hereditary hypercoagulability), hr2 variant f7 (coagulation factor vii [serum prothrombin conversion accelerator]) (eg, hereditary hypercoagulability), r353q variant f13b (coagulation factor xiii, b polypeptide) (eg, hereditary hypercoagulability), v34l variant fgb (fibrinogen beta chain) (eg, hereditary ischemic heart disease), -455g>a variant fgfr1 (fibroblast growth factor receptor 1) (eg, pfeiffer syndrome type 1, craniosynostosis), p252r variant fgfr3 (fibroblast growth factor receptor 3) (eg, muenke syndrome), p250r variant fktn (fukutin) (eg, fukuyama congenital muscular dystrophy), retrotransposon insertion variant gne (glucosamine [udp-n-acetyl]-2-epimerase/n-acetylmannosamine kinase) (eg, inclusion body myopathy 2 [ibm2], nonaka myopathy), m712t variant ivd (isovaleryl-coa dehydrogenase) (eg, isovaleric acidemia), a282v variant lct (lactase-phlorizin hydrolase) (eg, lactose intolerance), 13910 c>t variant neb (nebulin) (eg, nemaline myopathy 2), exon 55 deletion variant pcdh15 (protocadherin-related 15) (eg, usher syndrome type 1f), r245x variant serpine1 (serpine peptidase inhibitor clade e, member 1, plasminogen activator inhibitor -1, pai-1) (eg, thrombophilia), 4g variant shoc2 (soc-2 suppressor of clear homolog) (eg, noonan-like syndrome with loose anagen hair), s2g variant smn1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy), exon 7 deletion sry (sex determining region y) (eg, 46,xx testicular disorder of sex development, gonadal dysgenesis), gene analysis tor1a (torsin family 1, member a [torsin a]) (eg, early-onset primary dystonia [dyt1]), 907_909delgag (904_906delgag) variant

molecular pathology procedure, level 2 (eg, 2-10 snps, 1 methylated variant, or 1 somatic variant [typically using nonsequencing target variant analysis], or detection of a dynamic mutation disorder/triplet repeat) abcc8 (atp-binding cassette, sub-family c [cftr/mrp], member 8) (eg, familial hyperinsulinism), common variants (eg, c.3898-9g>a [c.3992-9g>a], f1388del) abl1 (abl proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib resistance), t315i variant acadm (acyl-coa dehydrogenase, c-4 to c-12 straight chain, mcad) (eg, medium chain acyl dehydrogenase deficiency), commons variants (eg, k304e, y42h) adrb2 (adrenergic beta-2 receptor surface) (eg, drug metabolism), common variants (eg, g16r, q27e) aff2 (af4/fmr2 family, member 2 [fmr2]) (eg, fragile x mental retardation 2 [fraxe]), evaluation to detect abnormal (eg, expanded) alleles apob (apolipoprotein b) (eg, familial hypercholesterolemia type b), common variants (eg, r3500q, r3500w) apoe (apolipoprotein e) (eg, hyperlipoproteinemia type iii, cardiovascular disease, alzheimer disease), common variants (eg, *2, *3, *4) ar (androgen receptor) (eg, spinal and bulbar muscular atrophy, kennedy disease, x chromosome inactivation), characterization of alleles (eg, expanded size or methylation status) atn1 (atrophin 1) (eg, dentatorubral-pallidoluysian atrophy), evaluation to detect abnormal (eg, expanded) alleles atxn1 (ataxin 1) (eg, spinocerebellar ataxia), evaluation to detect abnormal (eg, expanded) alleles atxn2 (ataxin 2) (eg, spinocerebellar ataxia), evaluation to detect abnormal (eg, expanded) alleles atxn3 (ataxin 3) (eg, spinocerebellar ataxia, machado-joseph disease), evaluation to detect abnormal (eg, expanded) alleles atxn7 (ataxin 7) (eg, spinocerebellar ataxia), evaluation to detect abnormal (eg, expanded) alleles atxn8os (atxn8 opposite strand [non-protein coding]) (eg, spinocerebellar ataxia), evaluation to detect abnormal (eg, expanded) alleles atxn10 (ataxin 10) (eg, spinocerebellar ataxia), evaluation to detect abnormal (eg, expanded) alleles cacna1a (calcium channel, voltage-dependent, p/q type, alpha 1a subunit) (eg, spinocerebellar ataxia), evaluation to detect abnormal (eg, expanded) alleles cbfb/myh11 (inv(16)) (eg, acute myeloid leukemia), qualitative, and quantitative, if performed cbs (cystathionine-beta-synthase) (eg, homocystinuria, cystathionine beta-synthase deficiency), common variants (eg, i278t, g307s) ccnd1/igh (bcl1/igh, t(11;14)) (eg, mantle cell lymphoma) translocation analysis, major breakpoint, qualitative, and quantitative, if performed cfh/arms2 (complement factor h/age-related maculopathy susceptibility 2) (eg, macular degeneration), common variants (eg, y402h [cfh], a69s [arms2]) cnbp (cchc-type zinc finger, nucleic acid binding protein) (eg, myotonic dystrophy type 2), evaluation to detect abnormal (eg, expanded) alleles cstb (cystatin b [stefin b]) (eg, unverricht-lundborg disease), evaluation to detect abnormal (eg, expanded) alleles dek/nup214 (t(6;9)) (eg, acute myeloid leukemia), translocation analysis, qualitative, and quantitative, if performed dmpk (dystrophia myotonica-protein kinase) (eg, myotonic dystrophy, type 1), evaluation to detect abnormal (eg, expanded) alleles e2a/pbx1 (t(1;19)) (eg, acute lymphocytic leukemia), translocation analysis, qualitative, and quantitative, if performed eml4/alk (inv(2)) (eg, non-small cell lung cancer), translocation or inversion analysis etv6/ntrk3 (t(12;15)) (eg, congenital/infantile fibrosarcoma), translocation analysis, qualitative, and quantitative, if performed etv6/runx1 (t(12;21)) (eg, acute lymphocytic leukemia), translocation analysis, qualitative, and quantitative, if performed ewsr1/atf1 (t(12;22)) (eg, clear cell sarcoma), translocation analysis, qualitative, and quantitative, if performed ewsr1/erg (t(21;22)) (eg, ewing sarcoma/peripheral neuroectodermal tumor), translocation analysis, qualitative, and quantitative, if performed ewsr1/fli1 (t(11;22)) (eg, ewing sarcoma/peripheral neuroectodermal tumor), translocation analysis, qualitative, and quantitative, if performed ewsr1/wt1 (t(11;22)) (eg, desmoplastic small round cell tumor), translocation analysis, qualitative, and quantitative, if performed f11 (coagulation factor xi) (eg, coagulation disorder), common variants (eg, e117x [type ii], f283l [type iii], ivs14del14, and ivs14+1g>a [type i]) fgfr3 (fibroblast growth factor receptor 3) (eg, achondroplasia, hypochondroplasia), common variants (eg, 1138g>a, 1138g>c, 1620c>a, 1620c>g) fip1l1/pdgfra (del[4q12]) (eg, imatinib-sensitive chronic eosinophilic leukemia), qualitative, and quantitative, if performed flg (filaggrin) (eg, ichthyosis vulgaris), common variants (eg, r501x, 2282del4, r2447x, s3247x, 3702delg) foxo1/pax3 (t(2;13)) (eg, alveolar rhabdomyosarcoma), translocation analysis, qualitative, and quantitative, if performed foxo1/pax7 (t(1;13)) (eg, alveolar rhabdomyosarcoma), translocation analysis, qualitative, and quantitative, if performed fus/ddit3 (t(12;16)) (eg, myxoid liposarcoma), translocation analysis, qualitative, and quantitative, if performed fxn (frataxin) (eg, friedreich ataxia), evaluation to detect abnormal (expanded) alleles galc (galactosylceramidase) (eg, krabbe disease), common variants (eg, c.857g>a, 30-kb deletion) galt (galactose-1-phosphate uridylyltransferase) (eg, galactosemia), common variants (eg, q188r, s135l, k285n, t138m, l195p, y209c, ivs2-2a>g, p171s, del5kb, n314d, l218l/n314d) h19 (imprinted maternally expressed transcript [non-protein coding]) (eg, beckwith-wiedemann syndrome), methylation analysis htt (huntingtin) (eg, huntington disease), evaluation to detect abnormal (eg, expanded) alleles igh@/bcl2 (t(14;18)) (eg, follicular lymphoma), translocation analysis; single breakpoint (eg, major breakpoint region [mbr] or minor cluster region [mcr]), qualitative or quantitative (when both mbr and mcr breakpoints are performed, use 81402) kcnq1ot1 (kcnq1 overlapping transcript 1 [non-protein coding]) (eg, beckwith-wiedemann syndrome), methylation analysis linc00518 (long intergenic non-protein coding rna 518) (eg, melanoma), expression analysis lrrk2 (leucine-rich repeat kinase 2) (eg, parkinson disease), common variants (eg, r1441g, g2019s, i2020t) med12 (mediator complex subunit 12) (eg, fg syndrome type 1, lujan syndrome), common variants (eg, r961w, n1007s) meg3/dlk1 (maternally expressed 3 [non-protein coding]/delta-like 1 homolog [drosophila]) (eg, intrauterine growth retardation), methylation analysis mll/aff1 (t(4;11)) (eg, acute lymphoblastic leukemia), translocation analysis, qualitative, and quantitative, if performed mll/mllt3 (t(9;11)) (eg, acute myeloid leukemia), translocation analysis, qualitative, and quantitative, if performed mt-atp6 (mitochondrially encoded atp synthase 6) (eg, neuropathy with ataxia and retinitis pigmentosa [narp], leigh syndrome), common variants (eg, m.8993t>g, m.8993t>c) mt-nd4, mt-nd6 (mitochondrially encoded nadh dehydrogenase 4, mitochondrially encoded nadh dehydrogenase 6) (eg, leber hereditary optic neuropathy [lhon]), common variants (eg, m.11778g>a, m.3460g>a, m.14484t>c) mt-nd5 (mitochondrially encoded trna leucine 1 [uua/g], mitochondrially encoded nadh dehydrogenase 5) (eg, mitochondrial encephalopathy with lactic acidosis and stroke-like episodes [melas]), common variants (eg, m.3243a>g, m.3271t>c, m.3252a>g, m.13513g>a) mt-rnr1 (mitochondrially encoded 12s rna) (eg, nonsyndromic hearing loss), common variants (eg, m.1555a>g, m.1494c>t) mt-tk (mitochondrially encoded trna lysine) (eg, myoclonic epilepsy with ragged-red fibers [merrf]), common variants (eg, m.8344a>g, m.8356t>c) mt-tl1 (mitochondrially encoded trna leucine 1 [uua/g]) (eg, diabetes and hearing loss), common variants (eg, m.3243a>g, m.14709 t>c) mt-tl1 mt-ts1, mt-rnr1 (mitochondrially encoded trna serine 1 [ucn], mitochondrially encoded 12s rna) (eg, nonsyndromic sensorineural deafness [including aminoglycoside-induced nonsyndromic deafness]), common variants (eg, m.7445a>g, m.1555a>g) mutyh (muty homolog [e. coli]) (eg, myh-associated polyposis), common variants (eg, y165c, g382d) nod2 (nucleotide-binding oligomerization domain containing 2) (eg, crohn's disease, blau syndrome), common variants (eg, snp 8, snp 12, snp 13) npm1/alk (t(2;5)) (eg, anaplastic large cell lymphoma), translocation analysis pabpn1 (poly[a] binding protein, nuclear 1) (eg, oculopharyngeal muscular dystrophy), evaluation to detect abnormal (eg, expanded) alleles pax8/pparg (t(2;3) (q13;p25)) (eg, follicular thyroid carcinoma), translocation analysis ppp2r2b (protein phosphatase 2, regulatory subunit b, beta) (eg, spinocerebellar ataxia), evaluation to detect abnormal (eg, expanded) alleles prss1 (protease, serine, 1 [trypsin 1]) (eg, hereditary pancreatitis), common variants (eg, n29i, a16v, r122h) prame (preferentially expressed antigen in melanoma) (eg, melanoma), expression analysis pygm (phosphorylase, glycogen, muscle) (eg, glycogen storage disease type v, mcardle disease), common variants (eg, r50x, g205s) runx1/runx1t1 (t(8;21)) (eg, acute myeloid leukemia) translocation analysis, qualitative, and quantitative, if performed smn1/smn2 (survival of motor neuron 1, telomeric/survival of motor neuron 2, centromeric) (eg, spinal muscular atrophy), dosage analysis (eg, carrier testing) (for duplication/deletion analysis of smn1/smn2, use 81401) ss18/ssx1 (t(x;18)) (eg, synovial sarcoma), translocation analysis, qualitative, and quantitative, if performed ss18/ssx2 (t(x;18)) (eg, synovial sarcoma), translocation analysis, qualitative, and quantitative, if performed tbp (tata box binding protein) (eg, spinocerebellar ataxia), evaluation to detect abnormal (eg, expanded) alleles vwf (von willebrand factor) (eg, von willebrand disease type 2n), common variants (eg, t791m, r816w, r854q)

molecular pathology procedure, level 3 (eg, >10 snps, 2-10 methylated variants, or 2-10 somatic variants [typically using non-sequencing target variant analysis], immunoglobulin and t-cell receptor gene rearrangements, duplication/deletion variants of 1 exon, loss of heterozygosity [loh], uniparental disomy [upd]) chromosome 1p-/19q- (eg, glial tumors), deletion analysis chromosome 18q- (eg, d18s55, d18s58, d18s61, d18s64, and d18s69) (eg, colon cancer), allelic imbalance assessment (ie, loss of heterozygosity) col1a1/pdgfb (t(17;22)) (eg, dermatofibrosarcoma protuberans), translocation analysis, multiple breakpoints, qualitative, and quantitative, if performed cyp21a2 (cytochrome p450, family 21, subfamily a, polypeptide 2) (eg, congenital adrenal hyperplasia, 21-hydroxylase deficiency), common variants (eg, ivs2-13g, p30l, i172n, exon 6 mutation cluster [i235n, v236e, m238k], v281l, l307ffsx6, q318x, r356w, p453s, g110vfsx21, 30-kb deletion variant) esr1/pgr (receptor 1/progesterone receptor) ratio (eg, breast cancer) igh@/bcl2 (t(14;18)) (eg, follicular lymphoma), translocation analysis; major breakpoint region (mbr) and minor cluster region (mcr) breakpoints, qualitative or quantitative mefv (mediterranean fever) (eg, familial mediterranean fever), common variants (eg, e148q, p369s, f479l, m680i, i692del, m694v, m694i, k695r, v726a, a744s, r761h) mpl (myeloproliferative leukemia virus oncogene, thrombopoietin receptor, tpor) (eg, myeloproliferative disorder), common variants (eg, w515a, w515k, w515l, w515r) trd@ (t cell antigen receptor, delta) (eg, leukemia and lymphoma), gene rearrangement analysis, evaluation to detect abnormal clonal population uniparental disomy (upd) (eg, russell-silver syndrome, prader-willi/angelman syndrome), short tandem repeat (str) analysis

molecular pathology procedure, level 4 (eg, analysis of single exon by dna sequence analysis, analysis of >10 amplicons using multiplex pcr in 2 or more independent reactions, mutation scanning or duplication/deletion variants of 2-5 exons) ang (angiogenin, ribonuclease, rnase a family, 5) (eg, amyotrophic lateral sclerosis), full gene sequence arx (aristaless-related homeobox) (eg, x-linked lissencephaly with ambiguous genitalia, x-linked mental retardation), duplication/deletion analysis cel (carboxyl ester lipase [bile salt-stimulated lipase]) (eg, maturity-onset diabetes of the young [mody]), targeted sequence analysis of exon 11 (eg, c.1785delc, c.1686delt) ctnnb1 (catenin [cadherin-associated protein], beta 1, 88kda) (eg, desmoid tumors), targeted sequence analysis (eg, exon 3) daz/sry (deleted in azoospermia and sex determining region y) (eg, male infertility), common deletions (eg, azfa, azfb, azfc, azfd) dnmt3a (dna [cytosine-5-]-methyltransferase 3 alpha) (eg, acute myeloid leukemia), targeted sequence analysis (eg, exon 23) epcam (epithelial cell adhesion molecule) (eg, lynch syndrome), duplication/deletion analysis f8 (coagulation factor viii) (eg, hemophilia a), inversion analysis, intron 1 and intron 22a f12 (coagulation factor xii [hageman factor]) (eg, angioedema, hereditary, type iii; factor xii deficiency), targeted sequence analysis of exon 9 fgfr3 (fibroblast growth factor receptor 3) (eg, isolated craniosynostosis), targeted sequence analysis (eg, exon 7) (for targeted sequence analysis of multiple fgfr3 exons, use 81404) gjb1 (gap junction protein, beta 1) (eg, charcot-marie-tooth x-linked), full gene sequence gnaq (guanine nucleotide-binding protein g[q] subunit alpha) (eg, uveal melanoma), common variants (eg, r183, q209) human erythrocyte antigen gene analyses (eg, slc14a1 [kidd blood group], bcam [lutheran blood group], icam4 [landsteiner-wiener blood group], slc4a1 [diego blood group], aqp1 [colton blood group], ermap [scianna blood group], rhce [rh blood group, ccee antigens], kel [kell blood group], darc [duffy blood group], gypa, gypb, gype [mns blood group], art4 [dombrock blood group]) (eg, sickle-cell disease, thalassemia, hemolytic transfusion reactions, hemolytic disease of the fetus or newborn), common variants hras (v-ha-ras harvey rat sarcoma viral oncogene homolog) (eg, costello syndrome), exon 2 sequence jak2 (janus kinase 2) (eg, myeloproliferative disorder), exon 12 sequence and exon 13 sequence, if performed kcnc3 (potassium voltage-gated channel, shaw-related subfamily, member 3) (eg, spinocerebellar ataxia), targeted sequence analysis (eg, exon 2) kcnj2 (potassium inwardly-rectifying channel, subfamily j, member 2) (eg, andersen-tawil syndrome), full gene sequence kcnj11 (potassium inwardly-rectifying channel, subfamily j, member 11) (eg, familial hyperinsulinism), full gene sequence killer cell immunoglobulin-like receptor (kir) gene family (eg, hematopoietic stem cell transplantation), genotyping of kir family genes known familial variant not otherwise specified, for gene listed in tier 1 or tier 2, or identified during a genomic sequencing procedure, dna sequence analysis, each variant exon (for a known familial variant that is considered a common variant, use specific common variant tier 1 or tier 2 code) mc4r (melanocortin 4 receptor) (eg, obesity), full gene sequence mica (mhc class i polypeptide-related sequence a) (eg, solid organ transplantation), common variants (eg, *001, *002) mpl (myeloproliferative leukemia virus oncogene, thrombopoietin receptor, tpor) (eg, myeloproliferative disorder), exon 10 sequence mt-rnr1 (mitochondrially encoded 12s rna) (eg, nonsyndromic hearing loss), full gene sequence mt-ts1 (mitochondrially encoded trna serine 1) (eg, nonsyndromic hearing loss), full gene sequence ndp (norrie disease [pseudoglioma]) (eg, norrie disease), duplication/deletion analysis nhlrc1 (nhl repeat containing 1) (eg, progressive myoclonus epilepsy), full gene sequence phox2b (paired-like homeobox 2b) (eg, congenital central hypoventilation syndrome), duplication/deletion analysis pln (phospholamban) (eg, dilated cardiomyopathy, hypertrophic cardiomyopathy), full gene sequence rhd (rh blood group, d antigen) (eg, hemolytic disease of the fetus and newborn, rh maternal/fetal compatibility), deletion analysis (eg, exons 4, 5, and 7, pseudogene) rhd (rh blood group, d antigen) (eg, hemolytic disease of the fetus and newborn, rh maternal/fetal compatibility), deletion analysis (eg, exons 4, 5, and 7, pseudogene), performed on cell-free fetal dna in maternal blood (for human erythrocyte gene analysis of rhd, use a separate unit of 81403) sh2d1a (sh2 domain containing 1a) (eg, x-linked lymphoproliferative syndrome), duplication/deletion analysis smn1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy), known familial sequence variant(s) twist1 (twist homolog 1 [drosophila]) (eg, saethre-chotzen syndrome), duplication/deletion analysis uba1 (ubiquitin-like modifier activating enzyme 1) (eg, spinal muscular atrophy, x-linked), targeted sequence analysis (eg, exon 15) vhl (von hippel-lindau tumor suppressor) (eg, von hippel-lindau familial cancer syndrome), deletion/duplication analysis vwf (von willebrand factor) (eg, von willebrand disease types 2a, 2b, 2m), targeted sequence analysis (eg, exon 28)

molecular pathology procedure, level 5 (eg, analysis of 2-5 exons by dna sequence analysis, mutation scanning or duplication/deletion variants of 6-10 exons, or characterization of a dynamic mutation disorder/triplet repeat by southern blot analysis) acads (acyl-coa dehydrogenase, c-2 to c-3 short chain) (eg, short chain acyl-coa dehydrogenase deficiency), targeted sequence analysis (eg, exons 5 and 6) aff2 (af4/fmr2 family, member 2 [fmr2]) (eg, fragile x mental retardation 2 [fraxe]), characterization of alleles (eg, expanded size and methylation status) aqp2 (aquaporin 2 [collecting duct]) (eg, nephrogenic diabetes insipidus), full gene sequence arx (aristaless related homeobox) (eg, x-linked lissencephaly with ambiguous genitalia, x-linked mental retardation), full gene sequence avpr2 (arginine vasopressin receptor 2) (eg, nephrogenic diabetes insipidus), full gene sequence bbs10 (bardet-biedl syndrome 10) (eg, bardet-biedl syndrome), full gene sequence btd (biotinidase) (eg, biotinidase deficiency), full gene sequence c10orf2 (chromosome 10 open reading frame 2) (eg, mitochondrial dna depletion syndrome), full gene sequence cav3 (caveolin 3) (eg, cav3-related distal myopathy, limb-girdle muscular dystrophy type 1c), full gene sequence cd40lg (cd40 ligand) (eg, x-linked hyper igm syndrome), full gene sequence cdkn2a (cyclin-dependent kinase inhibitor 2a) (eg, cdkn2a-related cutaneous malignant melanoma, familial atypical mole-malignant melanoma syndrome), full gene sequence clrn1 (clarin 1) (eg, usher syndrome, type 3), full gene sequence cox6b1 (cytochrome c oxidase subunit vib polypeptide 1) (eg, mitochondrial respiratory chain complex iv deficiency), full gene sequence cpt2 (carnitine palmitoyltransferase 2) (eg, carnitine palmitoyltransferase ii deficiency), full gene sequence crx (cone-rod homeobox) (eg, cone-rod dystrophy 2, leber congenital amaurosis), full gene sequence cstb (cystatin b [stefin b]) (eg, unverricht-lundborg disease), full gene sequence cyp1b1 (cytochrome p450, family 1, subfamily b, polypeptide 1) (eg, primary congenital glaucoma), full gene sequence dmpk (dystrophia myotonica-protein kinase) (eg, myotonic dystrophy type 1), characterization of abnormal (eg, expanded) alleles egr2 (early growth response 2) (eg, charcot-marie-tooth), full gene sequence emd (emerin) (eg, emery-dreifuss muscular dystrophy), duplication/deletion analysis epm2a (epilepsy, progressive myoclonus type 2a, lafora disease [laforin]) (eg, progressive myoclonus epilepsy), full gene sequence fgf23 (fibroblast growth factor 23) (eg, hypophosphatemic rickets), full gene sequence fgfr2 (fibroblast growth factor receptor 2) (eg, craniosynostosis, apert syndrome, crouzon syndrome), targeted sequence analysis (eg, exons 8, 10) fgfr3 (fibroblast growth factor receptor 3) (eg, achondroplasia, hypochondroplasia), targeted sequence analysis (eg, exons 8, 11, 12, 13) fhl1 (four and a half lim domains 1) (eg, emery-dreifuss muscular dystrophy), full gene sequence fkrp (fukutin related protein) (eg, congenital muscular dystrophy type 1c [mdc1c], limb-girdle muscular dystrophy [lgmd] type 2i), full gene sequence foxg1 (forkhead box g1) (eg, rett syndrome), full gene sequence fshmd1a (facioscapulohumeral muscular dystrophy 1a) (eg, facioscapulohumeral muscular dystrophy), evaluation to detect abnormal (eg, deleted) alleles fshmd1a (facioscapulohumeral muscular dystrophy 1a) (eg, facioscapulohumeral muscular dystrophy), characterization of haplotype(s) (ie, chromosome 4a and 4b haplotypes) fxn (frataxin) (eg, friedreich ataxia), full gene sequence gh1 (growth hormone 1) (eg, growth hormone deficiency), full gene sequence gp1bb (glycoprotein ib [platelet], beta polypeptide) (eg, bernard-soulier syndrome type b), full gene sequence (for common deletion variants of alpha globin 1 and alpha globin 2 genes, use 81257) hnf1b (hnf1 homeobox b) (eg, maturity-onset diabetes of the young [mody]), duplication/deletion analysis hras (v-ha-ras harvey rat sarcoma viral oncogene homolog) (eg, costello syndrome), full gene sequence hsd3b2 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2) (eg, 3-beta-hydroxysteroid dehydrogenase type ii deficiency), full gene sequence hsd11b2 (hydroxysteroid [11-beta] dehydrogenase 2) (eg, mineralocorticoid excess syndrome), full gene sequence hspb1 (heat shock 27kda protein 1) (eg, charcot-marie-tooth disease), full gene sequence ins (insulin) (eg, diabetes mellitus), full gene sequence kcnj1 (potassium inwardly-rectifying channel, subfamily j, member 1) (eg, bartter syndrome), full gene sequence kcnj10 (potassium inwardly-rectifying channel, subfamily j, member 10) (eg, sesame syndrome, east syndrome, sensorineural hearing loss), full gene sequence litaf (lipopolysaccharide-induced tnf factor) (eg, charcot-marie-tooth), full gene sequence mefv (mediterranean fever) (eg, familial mediterranean fever), full gene sequence men1 (multiple endocrine neoplasia i) (eg, multiple endocrine neoplasia type 1, wermer syndrome), duplication/deletion analysis mmachc (methylmalonic aciduria [cobalamin deficiency] cblc type, with homocystinuria) (eg, methylmalonic acidemia and homocystinuria), full gene sequence mpv17 (mpv17 mitochondrial inner membrane protein) (eg, mitochondrial dna depletion syndrome), duplication/deletion analysis ndp (norrie disease [pseudoglioma]) (eg, norrie disease), full gene sequence ndufa1 (nadh dehydrogenase [ubiquinone] 1 alpha subcomplex, 1, 7.5kda) (eg, leigh syndrome, mitochondrial complex i deficiency), full gene sequence ndufaf2 (nadh dehydrogenase [ubiquinone] 1 alpha subcomplex, assembly factor 2) (eg, leigh syndrome, mitochondrial complex i deficiency), full gene sequence ndufs4 (nadh dehydrogenase [ubiquinone] fe-s protein 4, 18kda [nadh-coenzyme q reductase]) (eg, leigh syndrome, mitochondrial complex i deficiency), full gene sequence nipa1 (non-imprinted in prader-willi/angelman syndrome 1) (eg, spastic paraplegia), full gene sequence nlgn4x (neuroligin 4, x-linked) (eg, autism spectrum disorders), duplication/deletion analysis npc2 (niemann-pick disease, type c2 [epididymal secretory protein e1]) (eg, niemann-pick disease type c2), full gene sequence nr0b1 (nuclear receptor subfamily 0, group b, member 1) (eg, congenital adrenal hypoplasia), full gene sequence pdx1 (pancreatic and duodenal homeobox 1) (eg, maturity-onset diabetes of the young [mody]), full gene sequence phox2b (paired-like homeobox 2b) (eg, congenital central hypoventilation syndrome), full gene sequence pik3ca (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) (eg, colorectal cancer), targeted sequence analysis (eg, exons 9 and 20) plp1 (proteolipid protein 1) (eg, pelizaeus-merzbacher disease, spastic paraplegia), duplication/deletion analysis pqbp1 (polyglutamine binding protein 1) (eg, renpenning syndrome), duplication/deletion analysis prnp (prion protein) (eg, genetic prion disease), full gene sequence prop1 (prop paired-like homeobox 1) (eg, combined pituitary hormone deficiency), full gene sequence prph2 (peripherin 2 [retinal degeneration, slow]) (eg, retinitis pigmentosa), full gene sequence prss1 (protease, serine, 1 [trypsin 1]) (eg, hereditary pancreatitis), full gene sequence raf1 (v-raf-1 murine leukemia viral oncogene homolog 1) (eg, leopard syndrome), targeted sequence analysis (eg, exons 7, 12, 14, 17) ret (ret proto-oncogene) (eg, multiple endocrine neoplasia, type 2b and familial medullary thyroid carcinoma), common variants (eg, m918t, 2647_2648delinstt, a883f) rho (rhodopsin) (eg, retinitis pigmentosa), full gene sequence rp1 (retinitis pigmentosa 1) (eg, retinitis pigmentosa), full gene sequence scn1b (sodium channel, voltage-gated, type i, beta) (eg, brugada syndrome), full gene sequence sco2 (sco cytochrome oxidase deficient homolog 2 [sco1l]) (eg, mitochondrial respiratory chain complex iv deficiency), full gene sequence sdhc (succinate dehydrogenase complex, subunit c, integral membrane protein, 15kda) (eg, hereditary paraganglioma-pheochromocytoma syndrome), duplication/deletion analysis sdhd (succinate dehydrogenase complex, subunit d, integral membrane protein) (eg, hereditary paraganglioma), full gene sequence sgcg (sarcoglycan, gamma [35kda dystrophin-associated glycoprotein]) (eg, limb-girdle muscular dystrophy), duplication/deletion analysis sh2d1a (sh2 domain containing 1a) (eg, x-linked lymphoproliferative syndrome), full gene sequence slc16a2 (solute carrier family 16, member 2 [thyroid hormone transporter]) (eg, specific thyroid hormone cell transporter deficiency, allan-herndon-dudley syndrome), duplication/deletion analysis slc25a20 (solute carrier family 25 [carnitine/acylcarnitine translocase], member 20) (eg, carnitine-acylcarnitine translocase deficiency), duplication/deletion analysis slc25a4 (solute carrier family 25 [mitochondrial carrier; adenine nucleotide translocator], member 4) (eg, progressive external ophthalmoplegia), full gene sequence sod1 (superoxide dismutase 1, soluble) (eg, amyotrophic lateral sclerosis), full gene sequence spink1 (serine peptidase inhibitor, kazal type 1) (eg, hereditary pancreatitis), full gene sequence stk11 (serine/threonine kinase 11) (eg, peutz-jeghers syndrome), duplication/deletion analysis taco1 (translational activator of mitochondrial encoded cytochrome c oxidase i) (eg, mitochondrial respiratory chain complex iv deficiency), full gene sequence thap1 (thap domain containing, apoptosis associated protein 1) (eg, torsion dystonia), full gene sequence tor1a (torsin family 1, member a [torsin a]) (eg, torsion dystonia), full gene sequence tp53 (tumor protein 53) (eg, tumor samples), targeted sequence analysis of 2-5 exons ttpa (tocopherol [alpha] transfer protein) (eg, ataxia), full gene sequence ttr (transthyretin) (eg, familial transthyretin amyloidosis), full gene sequence twist1 (twist homolog 1 [drosophila]) (eg, saethre-chotzen syndrome), full gene sequence tyr (tyrosinase [oculocutaneous albinism ia]) (eg, oculocutaneous albinism ia), full gene sequence ush1g (usher syndrome 1g [autosomal recessive]) (eg, usher syndrome, type 1), full gene sequence vhl (von hippel-lindau tumor suppressor) (eg, von hippel-lindau familial cancer syndrome), full gene sequence vwf (von willebrand factor) (eg, von willebrand disease type 1c), targeted sequence analysis (eg, exons 26, 27, 37) zeb2 (zinc finger e-box binding homeobox 2) (eg, mowat-wilson syndrome), duplication/deletion analysis znf41 (zinc finger protein 41) (eg, x-linked mental retardation 89), full gene sequence

molecular pathology procedure, level 6 (eg, analysis of 6-10 exons by dna sequence analysis, mutation scanning or duplication/deletion variants of 11-25 exons, regionally targeted cytogenomic array analysis) abcd1 (atp-binding cassette, sub-family d [ald], member 1) (eg, adrenoleukodystrophy), full gene sequence acads (acyl-coa dehydrogenase, c-2 to c-3 short chain) (eg, short chain acyl-coa dehydrogenase deficiency), full gene sequence acta2 (actin, alpha 2, smooth muscle, aorta) (eg, thoracic aortic aneurysms and aortic dissections), full gene sequence actc1 (actin, alpha, cardiac muscle 1) (eg, familial hypertrophic cardiomyopathy), full gene sequence ankrd1 (ankyrin repeat domain 1) (eg, dilated cardiomyopathy), full gene sequence aptx (aprataxin) (eg, ataxia with oculomotor apraxia 1), full gene sequence ar (androgen receptor) (eg, androgen insensitivity syndrome), full gene sequence arsa (arylsulfatase a) (eg, arylsulfatase a deficiency), full gene sequence bckdha (branched chain keto acid dehydrogenase e1, alpha polypeptide) (eg, maple syrup urine disease, type 1a), full gene sequence bcs1l (bcs1-like [s. cerevisiae]) (eg, leigh syndrome, mitochondrial complex iii deficiency, gracile syndrome), full gene sequence bmpr2 (bone morphogenetic protein receptor, type ii [serine/threonine kinase]) (eg, heritable pulmonary arterial hypertension), duplication/deletion analysis casq2 (calsequestrin 2 [cardiac muscle]) (eg, catecholaminergic polymorphic ventricular tachycardia), full gene sequence casr (calcium-sensing receptor) (eg, hypocalcemia), full gene sequence cdkl5 (cyclin-dependent kinase-like 5) (eg, early infantile epileptic encephalopathy), duplication/deletion analysis chrna4 (cholinergic receptor, nicotinic, alpha 4) (eg, nocturnal frontal lobe epilepsy), full gene sequence chrnb2 (cholinergic receptor, nicotinic, beta 2 [neuronal]) (eg, nocturnal frontal lobe epilepsy), full gene sequence cox10 (cox10 homolog, cytochrome c oxidase assembly protein) (eg, mitochondrial respiratory chain complex iv deficiency), full gene sequence cox15 (cox15 homolog, cytochrome c oxidase assembly protein) (eg, mitochondrial respiratory chain complex iv deficiency), full gene sequence cpox (coproporphyrinogen oxidase) (eg, hereditary coproporphyria), full gene sequence ctrc (chymotrypsin c) (eg, hereditary pancreatitis), full gene sequence cyp11b1 (cytochrome p450, family 11, subfamily b, polypeptide 1) (eg, congenital adrenal hyperplasia), full gene sequence cyp17a1 (cytochrome p450, family 17, subfamily a, polypeptide 1) (eg, congenital adrenal hyperplasia), full gene sequence cyp21a2 (cytochrome p450, family 21, subfamily a, polypeptide2) (eg, steroid 21-hydroxylase isoform, congenital adrenal hyperplasia), full gene sequence cytogenomic constitutional targeted microarray analysis of chromosome 22q13 by interrogation of genomic regions for copy number and single nucleotide polymorphism (snp) variants for chromosomal abnormalities (when performing genome-wide cytogenomic constitutional microarray analysis, see 81228, 81229) (do not report analyte-specific molecular pathology procedures separately when the specific analytes are included as part of the microarray analysis of chromosome 22q13) (do not report 88271 when performing cytogenomic microarray analysis) dbt (dihydrolipoamide branched chain transacylase e2) (eg, maple syrup urine disease, type 2), duplication/deletion analysis dcx (doublecortin) (eg, x-linked lissencephaly), full gene sequence des (desmin) (eg, myofibrillar myopathy), full gene sequence dfnb59 (deafness, autosomal recessive 59) (eg, autosomal recessive nonsyndromic hearing impairment), full gene sequence dguok (deoxyguanosine kinase) (eg, hepatocerebral mitochondrial dna depletion syndrome), full gene sequence dhcr7 (7-dehydrocholesterol reductase) (eg, smith-lemli-opitz syndrome), full gene sequence eif2b2 (eukaryotic translation initiation factor 2b, subunit 2 beta, 39kda) (eg, leukoencephalopathy with vanishing white matter), full gene sequence emd (emerin) (eg, emery-dreifuss muscular dystrophy), full gene sequence eng (endoglin) (eg, hereditary hemorrhagic telangiectasia, type 1), duplication/deletion analysis eya1 (eyes absent homolog 1 [drosophila]) (eg, branchio-oto-renal [bor] spectrum disorders), duplication/deletion analysis fgfr1 (fibroblast growth factor receptor 1) (eg, kallmann syndrome 2), full gene sequence fh (fumarate hydratase) (eg, fumarate hydratase deficiency, hereditary leiomyomatosis with renal cell cancer), full gene sequence fktn (fukutin) (eg, limb-girdle muscular dystrophy [lgmd] type 2m or 2l), full gene sequence ftsj1 (ftsj rna methyltransferase homolog 1 [e. coli]) (eg, x-linked mental retardation 9), duplication/deletion analysis gabrg2 (gamma-aminobutyric acid [gaba] a receptor, gamma 2) (eg, generalized epilepsy with febrile seizures), full gene sequence gch1 (gtp cyclohydrolase 1) (eg, autosomal dominant dopa-responsive dystonia), full gene sequence gdap1 (ganglioside-induced differentiation-associated protein 1) (eg, charcot-marie-tooth disease), full gene sequence gfap (glial fibrillary acidic protein) (eg, alexander disease), full gene sequence ghr (growth hormone receptor) (eg, laron syndrome), full gene sequence ghrhr (growth hormone releasing hormone receptor) (eg, growth hormone deficiency), full gene sequence gla (galactosidase, alpha) (eg, fabry disease), full gene sequence hnf1a (hnf1 homeobox a) (eg, maturity-onset diabetes of the young [mody]), full gene sequence hnf1b (hnf1 homeobox b) (eg, maturity-onset diabetes of the young [mody]), full gene sequence htra1 (htra serine peptidase 1) (eg, macular degeneration), full gene sequence ids (iduronate 2-sulfatase) (eg, mucopolysacchridosis, type ii), full gene sequence il2rg (interleukin 2 receptor, gamma) (eg, x-linked severe combined immunodeficiency), full gene sequence ispd (isoprenoid synthase domain containing) (eg, muscle-eye-brain disease, walker-warburg syndrome), full gene sequence kras (kirsten rat sarcoma viral oncogene homolog) (eg, noonan syndrome), full gene sequence lamp2 (lysosomal-associated membrane protein 2) (eg, danon disease), full gene sequence ldlr (low density lipoprotein receptor) (eg, familial hypercholesterolemia), duplication/deletion analysis men1 (multiple endocrine neoplasia i) (eg, multiple endocrine neoplasia type 1, wermer syndrome), full gene sequence mmaa (methylmalonic aciduria [cobalamine deficiency] type a) (eg, mmaa-related methylmalonic acidemia), full gene sequence mmab (methylmalonic aciduria [cobalamine deficiency] type b) (eg, mmaa-related methylmalonic acidemia), full gene sequence mpi (mannose phosphate isomerase) (eg, congenital disorder of glycosylation 1b), full gene sequence mpv17 (mpv17 mitochondrial inner membrane protein) (eg, mitochondrial dna depletion syndrome), full gene sequence mpz (myelin protein zero) (eg, charcot-marie-tooth), full gene sequence mtm1 (myotubularin 1) (eg, x-linked centronuclear myopathy), duplication/deletion analysis myl2 (myosin, light chain 2, regulatory, cardiac, slow) (eg, familial hypertrophic cardiomyopathy), full gene sequence myl3 (myosin, light chain 3, alkali, ventricular, skeletal, slow) (eg, familial hypertrophic cardiomyopathy), full gene sequence myot (myotilin) (eg, limb-girdle muscular dystrophy), full gene sequence ndufs7 (nadh dehydrogenase [ubiquinone] fe-s protein 7, 20kda [nadh-coenzyme q reductase]) (eg, leigh syndrome, mitochondrial complex i deficiency), full gene sequence ndufs8 (nadh dehydrogenase [ubiquinone] fe-s protein 8, 23kda [nadh-coenzyme q reductase]) (eg, leigh syndrome, mitochondrial complex i deficiency), full gene sequence ndufv1 (nadh dehydrogenase [ubiquinone] flavoprotein 1, 51kda) (eg, leigh syndrome, mitochondrial complex i deficiency), full gene sequence nefl (neurofilament, light polypeptide) (eg, charcot-marie-tooth), full gene sequence nf2 (neurofibromin 2 [merlin]) (eg, neurofibromatosis, type 2), duplication/deletion analysis nlgn3 (neuroligin 3) (eg, autism spectrum disorders), full gene sequence nlgn4x (neuroligin 4, x-linked) (eg, autism spectrum disorders), full gene sequence nphp1 (nephronophthisis 1 [juvenile]) (eg, joubert syndrome), deletion analysis, and duplication analysis, if performed nphs2 (nephrosis 2, idiopathic, steroid-resistant [podocin]) (eg, steroid-resistant nephrotic syndrome), full gene sequence nsd1 (nuclear receptor binding set domain protein 1) (eg, sotos syndrome), duplication/deletion analysis otc (ornithine carbamoyltransferase) (eg, ornithine transcarbamylase deficiency), full gene sequence pafah1b1 (platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 [45kda]) (eg, lissencephaly, miller-dieker syndrome), duplication/deletion analysis park2 (parkinson protein 2, e3 ubiquitin protein ligase [parkin]) (eg, parkinson disease), duplication/deletion analysis pcca (propionyl coa carboxylase, alpha polypeptide) (eg, propionic acidemia, type 1), duplication/deletion analysis pcdh19 (protocadherin 19) (eg, epileptic encephalopathy), full gene sequence pdha1 (pyruvate dehydrogenase [lipoamide] alpha 1) (eg, lactic acidosis), duplication/deletion analysis pdhb (pyruvate dehydrogenase [lipoamide] beta) (eg, lactic acidosis), full gene sequence pink1 (pten induced putative kinase 1) (eg, parkinson disease), full gene sequence pklr (pyruvate kinase, liver and rbc) (eg, pyruvate kinase deficiency), full gene sequence plp1 (proteolipid protein 1) (eg, pelizaeus-merzbacher disease, spastic paraplegia), full gene sequence pou1f1 (pou class 1 homeobox 1) (eg, combined pituitary hormone deficiency), full gene sequence prx (periaxin) (eg, charcot-marie-tooth disease), full gene sequence pqbp1 (polyglutamine binding protein 1) (eg, renpenning syndrome), full gene sequence psen1 (presenilin 1) (eg, alzheimer disease), full gene sequence rab7a (rab7a, member ras oncogene family) (eg, charcot-marie-tooth disease), full gene sequence rai1 (retinoic acid induced 1) (eg, smith-magenis syndrome), full gene sequence reep1 (receptor accessory protein 1) (eg, spastic paraplegia), full gene sequence ret (ret proto-oncogene) (eg, multiple endocrine neoplasia, type 2a and familial medullary thyroid carcinoma), targeted sequence analysis (eg, exons 10, 11, 13-16) rps19 (ribosomal protein s19) (eg, diamond-blackfan anemia), full gene sequence rrm2b (ribonucleotide reductase m2 b [tp53 inducible]) (eg, mitochondrial dna depletion), full gene sequence sco1 (sco cytochrome oxidase deficient homolog 1) (eg, mitochondrial respiratory chain complex iv deficiency), full gene sequence sdhb (succinate dehydrogenase complex, subunit b, iron sulfur) (eg, hereditary paraganglioma), full gene sequence sdhc (succinate dehydrogenase complex, subunit c, integral membrane protein, 15kda) (eg, hereditary paraganglioma-pheochromocytoma syndrome), full gene sequence sgca (sarcoglycan, alpha [50kda dystrophin-associated glycoprotein]) (eg, limb-girdle muscular dystrophy), full gene sequence sgcb (sarcoglycan, beta [43kda dystrophin-associated glycoprotein]) (eg, limb-girdle muscular dystrophy), full gene sequence sgcd (sarcoglycan, delta [35kda dystrophin-associated glycoprotein]) (eg, limb-girdle muscular dystrophy), full gene sequence sgce (sarcoglycan, epsilon) (eg, myoclonic dystonia), duplication/deletion analysis sgcg (sarcoglycan, gamma [35kda dystrophin-associated glycoprotein]) (eg, limb-girdle muscular dystrophy), full gene sequence shoc2 (soc-2 suppressor of clear homolog) (eg, noonan-like syndrome with loose anagen hair), full gene sequence shox (short stature homeobox) (eg, langer mesomelic dysplasia), full gene sequence sil1 (sil1 homolog, endoplasmic reticulum chaperone [s. cerevisiae]) (eg, ataxia), full gene sequence slc2a1 (solute carrier family 2 [facilitated glucose transporter], member 1) (eg, glucose transporter type 1 [glut 1] deficiency syndrome), full gene sequence slc16a2 (solute carrier family 16, member 2 [thyroid hormone transporter]) (eg, specific thyroid hormone cell transporter deficiency, allan-herndon-dudley syndrome), full gene sequence slc22a5 (solute carrier family 22 [organic cation/carnitine transporter], member 5) (eg, systemic primary carnitine deficiency), full gene sequence slc25a20 (solute carrier family 25 [carnitine/acylcarnitine translocase], member 20) (eg, carnitine-acylcarnitine translocase deficiency), full gene sequence smad4 (smad family member 4) (eg, hemorrhagic telangiectasia syndrome, juvenile polyposis), duplication/deletion analysis smn1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy), full gene sequence spast (spastin) (eg, spastic paraplegia), duplication/deletion analysis spg7 (spastic paraplegia 7 [pure and complicated autosomal recessive]) (eg, spastic paraplegia), duplication/deletion analysis spred1 (sprouty-related, evh1 domain containing 1) (eg, legius syndrome), full gene sequence stat3 (signal transducer and activator of transcription 3 [acute-phase response factor]) (eg, autosomal dominant hyper-ige syndrome), targeted sequence analysis (eg, exons 12, 13, 14, 16, 17, 20, 21) stk11 (serine/threonine kinase 11) (eg, peutz-jeghers syndrome), full gene sequence surf1 (surfeit 1) (eg, mitochondrial respiratory chain complex iv deficiency), full gene sequence tardbp (tar dna binding protein) (eg, amyotrophic lateral sclerosis), full gene sequence tbx5 (t-box 5) (eg, holt-oram syndrome), full gene sequence tcf4 (transcription factor 4) (eg, pitt-hopkins syndrome), duplication/deletion analysis tgfbr1 (transforming growth factor, beta receptor 1) (eg, marfan syndrome), full gene sequence tgfbr2 (transforming growth factor, beta receptor 2) (eg, marfan syndrome), full gene sequence thrb (thyroid hormone receptor, beta) (eg, thyroid hormone resistance, thyroid hormone beta receptor deficiency), full gene sequence or targeted sequence analysis of >5 exons tk2 (thymidine kinase 2, mitochondrial) (eg, mitochondrial dna depletion syndrome), full gene sequence tnnc1 (troponin c type 1 [slow]) (eg, hypertrophic cardiomyopathy or dilated cardiomyopathy), full gene sequence tnni3 (troponin i, type 3 [cardiac]) (eg, familial hypertrophic cardiomyopathy), full gene sequence tp53 (tumor protein 53) (eg, li-fraumeni syndrome, tumor samples), full gene sequence or targeted sequence analysis of >5 exons tpm1 (tropomyosin 1 [alpha]) (eg, familial hypertrophic cardiomyopathy), full gene sequence tsc1 (tuberous sclerosis 1) (eg, tuberous sclerosis), duplication/deletion analysis tymp (thymidine phosphorylase) (eg, mitochondrial dna depletion syndrome), full gene sequence vwf (von willebrand factor) (eg, von willebrand disease type 2n), targeted sequence analysis (eg, exons 18-20, 23-25) wt1 (wilms tumor 1) (eg, denys-drash syndrome, familial wilms tumor), full gene sequence zeb2 (zinc finger e-box binding homeobox 2) (eg, mowat-wilson syndrome), full gene sequence

molecular pathology procedure, level 7 (eg, analysis of 11-25 exons by dna sequence analysis, mutation scanning or duplication/deletion variants of 26-50 exons, cytogenomic array analysis for neoplasia) acadvl (acyl-coa dehydrogenase, very long chain) (eg, very long chain acyl-coenzyme a dehydrogenase deficiency), full gene sequence actn4 (actinin, alpha 4) (eg, focal segmental glomerulosclerosis), full gene sequence afg3l2 (afg3 atpase family gene 3-like 2 [s. cerevisiae]) (eg, spinocerebellar ataxia), full gene sequence aire (autoimmune regulator) (eg, autoimmune polyendocrinopathy syndrome type 1), full gene sequence aldh7a1 (aldehyde dehydrogenase 7 family, member a1) (eg, pyridoxine-dependent epilepsy), full gene sequence ano5 (anoctamin 5) (eg, limb-girdle muscular dystrophy), full gene sequence anos1 (anosmin-1) (eg, kallmann syndrome 1), full gene sequence app (amyloid beta [a4] precursor protein) (eg, alzheimer disease), full gene sequence ass1 (argininosuccinate synthase 1) (eg, citrullinemia type i), full gene sequence atl1 (atlastin gtpase 1) (eg, spastic paraplegia), full gene sequence atp1a2 (atpase, na+/k+ transporting, alpha 2 polypeptide) (eg, familial hemiplegic migraine), full gene sequence atp7b (atpase, cu++ transporting, beta polypeptide) (eg, wilson disease), full gene sequence bbs1 (bardet-biedl syndrome 1) (eg, bardet-biedl syndrome), full gene sequence bbs2 (bardet-biedl syndrome 2) (eg, bardet-biedl syndrome), full gene sequence bckdhb (branched-chain keto acid dehydrogenase e1, beta polypeptide) (eg, maple syrup urine disease, type 1b), full gene sequence best1 (bestrophin 1) (eg, vitelliform macular dystrophy), full gene sequence bmpr2 (bone morphogenetic protein receptor, type ii [serine/threonine kinase]) (eg, heritable pulmonary arterial hypertension), full gene sequence braf (b-raf proto-oncogene, serine/threonine kinase) (eg, noonan syndrome), full gene sequence bscl2 (berardinelli-seip congenital lipodystrophy 2 [seipin]) (eg, berardinelli-seip congenital lipodystrophy), full gene sequence btk (bruton agammaglobulinemia tyrosine kinase) (eg, x-linked agammaglobulinemia), full gene sequence cacnb2 (calcium channel, voltage-dependent, beta 2 subunit) (eg, brugada syndrome), full gene sequence capn3 (calpain 3) (eg, limb-girdle muscular dystrophy [lgmd] type 2a, calpainopathy), full gene sequence cbs (cystathionine-beta-synthase) (eg, homocystinuria, cystathionine beta-synthase deficiency), full gene sequence cdh1 (cadherin 1, type 1, e-cadherin [epithelial]) (eg, hereditary diffuse gastric cancer), full gene sequence cdkl5 (cyclin-dependent kinase-like 5) (eg, early infantile epileptic encephalopathy), full gene sequence clcn1 (chloride channel 1, skeletal muscle) (eg, myotonia congenita), full gene sequence clcnkb (chloride channel, voltage-sensitive kb) (eg, bartter syndrome 3 and 4b), full gene sequence cntnap2 (contactin-associated protein-like 2) (eg, pitt-hopkins-like syndrome 1), full gene sequence col6a2 (collagen, type vi, alpha 2) (eg, collagen type vi-related disorders), duplication/deletion analysis cpt1a (carnitine palmitoyltransferase 1a [liver]) (eg, carnitine palmitoyltransferase 1a [cpt1a] deficiency), full gene sequence crb1 (crumbs homolog 1 [drosophila]) (eg, leber congenital amaurosis), full gene sequence crebbp (creb binding protein) (eg, rubinstein-taybi syndrome), duplication/deletion analysis cytogenomic microarray analysis, neoplasia (eg, interrogation of copy number, and loss-of-heterozygosity via single nucleotide polymorphism [snp]-based comparative genomic hybridization [cgh] microarray analysis) (do not report analyte-specific molecular pathology procedures separately when the specific analytes are included as part of the cytogenomic microarray analysis for neoplasia) (do not report 88271 when performing cytogenomic microarray analysis) dbt (dihydrolipoamide branched chain transacylase e2) (eg, maple syrup urine disease, type 2), full gene sequence dlat (dihydrolipoamide s-acetyltransferase) (eg, pyruvate dehydrogenase e2 deficiency), full gene sequence dld (dihydrolipoamide dehydrogenase) (eg, maple syrup urine disease, type iii), full gene sequence dsc2 (desmocollin) (eg, arrhythmogenic right ventricular dysplasia/cardiomyopathy 11), full gene sequence dsg2 (desmoglein 2) (eg, arrhythmogenic right ventricular dysplasia/cardiomyopathy 10), full gene sequence dsp (desmoplakin) (eg, arrhythmogenic right ventricular dysplasia/cardiomyopathy 8), full gene sequence efhc1 (ef-hand domain [c-terminal] containing 1) (eg, juvenile myoclonic epilepsy), full gene sequence eif2b3 (eukaryotic translation initiation factor 2b, subunit 3 gamma, 58kda) (eg, leukoencephalopathy with vanishing white matter), full gene sequence eif2b4 (eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda) (eg, leukoencephalopathy with vanishing white matter), full gene sequence eif2b5 (eukaryotic translation initiation factor 2b, subunit 5 epsilon, 82kda) (eg, childhood ataxia with central nervous system hypomyelination/vanishing white matter), full gene sequence eng (endoglin) (eg, hereditary hemorrhagic telangiectasia, type 1), full gene sequence eya1 (eyes absent homolog 1 [drosophila]) (eg, branchio-oto-renal [bor] spectrum disorders), full gene sequence f8 (coagulation factor viii) (eg, hemophilia a), duplication/deletion analysis fah (fumarylacetoacetate hydrolase [fumarylacetoacetase]) (eg, tyrosinemia, type 1), full gene sequence fastkd2 (fast kinase domains 2) (eg, mitochondrial respiratory chain complex iv deficiency), full gene sequence fig4 (fig4 homolog, sac1 lipid phosphatase domain containing [s. cerevisiae]) (eg, charcot-marie-tooth disease), full gene sequence ftsj1 (ftsj rna methyltransferase homolog 1 [e. coli]) (eg, x-linked mental retardation 9), full gene sequence fus (fused in sarcoma) (eg, amyotrophic lateral sclerosis), full gene sequence gaa (glucosidase, alpha; acid) (eg, glycogen storage disease type ii [pompe disease]), full gene sequence galc (galactosylceramidase) (eg, krabbe disease), full gene sequence galt (galactose-1-phosphate uridylyltransferase) (eg, galactosemia), full gene sequence gars (glycyl-trna synthetase) (eg, charcot-marie-tooth disease), full gene sequence gcdh (glutaryl-coa dehydrogenase) (eg, glutaricacidemia type 1), full gene sequence gck (glucokinase [hexokinase 4]) (eg, maturity-onset diabetes of the young [mody]), full gene sequence glud1 (glutamate dehydrogenase 1) (eg, familial hyperinsulinism), full gene sequence gne (glucosamine [udp-n-acetyl]-2-epimerase/n-acetylmannosamine kinase) (eg, inclusion body myopathy 2 [ibm2], nonaka myopathy), full gene sequence grn (granulin) (eg, frontotemporal dementia), full gene sequence hadha (hydroxyacyl-coa dehydrogenase/3-ketoacyl-coa thiolase/enoyl-coa hydratase [trifunctional protein] alpha subunit) (eg, long chain acyl-coenzyme a dehydrogenase deficiency), full gene sequence hadhb (hydroxyacyl-coa dehydrogenase/3-ketoacyl-coa thiolase/enoyl-coa hydratase [trifunctional protein], beta subunit) (eg, trifunctional protein deficiency), full gene sequence hexa (hexosaminidase a, alpha polypeptide) (eg, tay-sachs disease), full gene sequence hlcs (hlcs holocarboxylase synthetase) (eg, holocarboxylase synthetase deficiency), full gene sequence hmbs (hydroxymethylbilane synthase) (eg, acute intermittent porphyria), full gene sequence hnf4a (hepatocyte nuclear factor 4, alpha) (eg, maturity-onset diabetes of the young [mody]), full gene sequence idua (iduronidase, alpha-l-) (eg, mucopolysaccharidosis type i), full gene sequence inf2 (inverted formin, fh2 and wh2 domain containing) (eg, focal segmental glomerulosclerosis), full gene sequence ivd (isovaleryl-coa dehydrogenase) (eg, isovaleric acidemia), full gene sequence jag1 (jagged 1) (eg, alagille syndrome), duplication/deletion analysis jup (junction plakoglobin) (eg, arrhythmogenic right ventricular dysplasia/cardiomyopathy 11), full gene sequence kcnh2 (potassium voltage-gated channel, subfamily h [eag-related], member 2) (eg, short qt syndrome, long qt syndrome), full gene sequence kcnq1 (potassium voltage-gated channel, kqt-like subfamily, member 1) (eg, short qt syndrome, long qt syndrome), full gene sequence kcnq2 (potassium voltage-gated channel, kqt-like subfamily, member 2) (eg, epileptic encephalopathy), full gene sequence ldb3 (lim domain binding 3) (eg, familial dilated cardiomyopathy, myofibrillar myopathy), full gene sequence ldlr (low density lipoprotein receptor) (eg, familial hypercholesterolemia), full gene sequence lepr (leptin receptor) (eg, obesity with hypogonadism), full gene sequence lhcgr (luteinizing hormone/choriogonadotropin receptor) (eg, precocious male puberty), full gene sequence lmna (lamin a/c) (eg, emery-dreifuss muscular dystrophy [edmd1, 2 and 3] limb-girdle muscular dystrophy [lgmd] type 1b, dilated cardiomyopathy [cmd1a], familial partial lipodystrophy [fpld2]), full gene sequence lrp5 (low density lipoprotein receptor-related protein 5) (eg, osteopetrosis), full gene sequence map2k1 (mitogen-activated protein kinase 1) (eg, cardiofaciocutaneous syndrome), full gene sequence map2k2 (mitogen-activated protein kinase 2) (eg, cardiofaciocutaneous syndrome), full gene sequence mapt (microtubule-associated protein tau) (eg, frontotemporal dementia), full gene sequence mccc1 (methylcrotonoyl-coa carboxylase 1 [alpha]) (eg, 3-methylcrotonyl-coa carboxylase deficiency), full gene sequence mccc2 (methylcrotonoyl-coa carboxylase 2 [beta]) (eg, 3-methylcrotonyl carboxylase deficiency), full gene sequence mfn2 (mitofusin 2) (eg, charcot-marie-tooth disease), full gene sequence mtm1 (myotubularin 1) (eg, x-linked centronuclear myopathy), full gene sequence mut (methylmalonyl coa mutase) (eg, methylmalonic acidemia), full gene sequence mutyh (muty homolog [e. coli]) (eg, myh-associated polyposis), full gene sequence ndufs1 (nadh dehydrogenase [ubiquinone] fe-s protein 1, 75kda [nadh-coenzyme q reductase]) (eg, leigh syndrome, mitochondrial complex i deficiency), full gene sequence nf2 (neurofibromin 2 [merlin]) (eg, neurofibromatosis, type 2), full gene sequence notch3 (notch 3) (eg, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy [cadasil]), targeted sequence analysis (eg, exons 1-23) npc1 (niemann-pick disease, type c1) (eg, niemann-pick disease), full gene sequence nphp1 (nephronophthisis 1 [juvenile]) (eg, joubert syndrome), full gene sequence nsd1 (nuclear receptor binding set domain protein 1) (eg, sotos syndrome), full gene sequence opa1 (optic atrophy 1) (eg, optic atrophy), duplication/deletion analysis optn (optineurin) (eg, amyotrophic lateral sclerosis), full gene sequence pafah1b1 (platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 [45kda]) (eg, lissencephaly, miller-dieker syndrome), full gene sequence pah (phenylalanine hydroxylase) (eg, phenylketonuria), full gene sequence palb2 (partner and localizer of brca2) (eg, breast and pancreatic cancer), full gene sequence park2 (parkinson protein 2, e3 ubiquitin protein ligase [parkin]) (eg, parkinson disease), full gene sequence pax2 (paired box 2) (eg, renal coloboma syndrome), full gene sequence pc (pyruvate carboxylase) (eg, pyruvate carboxylase deficiency), full gene sequence pcca (propionyl coa carboxylase, alpha polypeptide) (eg, propionic acidemia, type 1), full gene sequence pccb (propionyl coa carboxylase, beta polypeptide) (eg, propionic acidemia), full gene sequence pcdh15 (protocadherin-related 15) (eg, usher syndrome type 1f), duplication/deletion analysis pcsk9 (proprotein convertase subtilisin/kexin type 9) (eg, familial hypercholesterolemia), full gene sequence pdha1 (pyruvate dehydrogenase [lipoamide] alpha 1) (eg, lactic acidosis), full gene sequence pdhx (pyruvate dehydrogenase complex, component x) (eg, lactic acidosis), full gene sequence phex (phosphate-regulating endopeptidase homolog, x-linked) (eg, hypophosphatemic rickets), full gene sequence pkd2 (polycystic kidney disease 2 [autosomal dominant]) (eg, polycystic kidney disease), full gene sequence pkp2 (plakophilin 2) (eg, arrhythmogenic right ventricular dysplasia/cardiomyopathy 9), full gene sequence pnkd (paroxysmal nonkinesigenic dyskinesia) (eg, paroxysmal nonkinesigenic dyskinesia), full gene sequence polg (polymerase [dna directed], gamma) (eg, alpers-huttenlocher syndrome, autosomal dominant progressive external ophthalmoplegia), full gene sequence pomgnt1 (protein o-linked mannose beta1,2-n acetylglucosaminyltransferase) (eg, muscle-eye-brain disease, walker-warburg syndrome), full gene sequence pomt1 (protein-o-mannosyltransferase 1) (eg, limb-girdle muscular dystrophy [lgmd] type 2k, walker-warburg syndrome), full gene sequence pomt2 (protein-o-mannosyltransferase 2) (eg, limb-girdle muscular dystrophy [lgmd] type 2n, walker-warburg syndrome), full gene sequence ppox (protoporphyrinogen oxidase) (eg, variegate porphyria), full gene sequence prkag2 (protein kinase, amp-activated, gamma 2 non-catalytic subunit) (eg, familial hypertrophic cardiomyopathy with wolff-parkinson-white syndrome, lethal congenital glycogen storage disease of heart), full gene sequence prkcg (protein kinase c, gamma) (eg, spinocerebellar ataxia), full gene sequence psen2 (presenilin 2 [alzheimer disease 4]) (eg, alzheimer disease), full gene sequence ptpn11 (protein tyrosine phosphatase, non-receptor type 11) (eg, noonan syndrome, leopard syndrome), full gene sequence pygm (phosphorylase, glycogen, muscle) (eg, glycogen storage disease type v, mcardle disease), full gene sequence raf1 (v-raf-1 murine leukemia viral oncogene homolog 1) (eg, leopard syndrome), full gene sequence ret (ret proto-oncogene) (eg, hirschsprung disease), full gene sequence rpe65 (retinal pigment epithelium-specific protein 65kda) (eg, retinitis pigmentosa, leber congenital amaurosis), full gene sequence ryr1 (ryanodine receptor 1, skeletal) (eg, malignant hyperthermia), targeted sequence analysis of exons with functionally-confirmed mutations scn4a (sodium channel, voltage-gated, type iv, alpha subunit) (eg, hyperkalemic periodic paralysis), full gene sequence scnn1a (sodium channel, nonvoltage-gated 1 alpha) (eg, pseudohypoaldosteronism), full gene sequence scnn1b (sodium channel, nonvoltage-gated 1, beta) (eg, liddle syndrome, pseudohypoaldosteronism), full gene sequence scnn1g (sodium channel, nonvoltage-gated 1, gamma) (eg, liddle syndrome, pseudohypoaldosteronism), full gene sequence sdha (succinate dehydrogenase complex, subunit a, flavoprotein [fp]) (eg, leigh syndrome, mitochondrial complex ii deficiency), full gene sequence setx (senataxin) (eg, ataxia), full gene sequence sgce (sarcoglycan, epsilon) (eg, myoclonic dystonia), full gene sequence sh3tc2 (sh3 domain and tetratricopeptide repeats 2) (eg, charcot-marie-tooth disease), full gene sequence slc9a6 (solute carrier family 9 [sodium/hydrogen exchanger], member 6) (eg, christianson syndrome), full gene sequence slc26a4 (solute carrier family 26, member 4) (eg, pendred syndrome), full gene sequence slc37a4 (solute carrier family 37 [glucose-6-phosphate transporter], member 4) (eg, glycogen storage disease type ib), full gene sequence smad4 (smad family member 4) (eg, hemorrhagic telangiectasia syndrome, juvenile polyposis), full gene sequence sos1 (son of sevenless homolog 1) (eg, noonan syndrome, gingival fibromatosis), full gene sequence spast (spastin) (eg, spastic paraplegia), full gene sequence spg7 (spastic paraplegia 7 [pure and complicated autosomal recessive]) (eg, spastic paraplegia), full gene sequence stxbp1 (syntaxin-binding protein 1) (eg, epileptic encephalopathy), full gene sequence taz (tafazzin) (eg, methylglutaconic aciduria type 2, barth syndrome), full gene sequence tcf4 (transcription factor 4) (eg, pitt-hopkins syndrome), full gene sequence th (tyrosine hydroxylase) (eg, segawa syndrome), full gene sequence tmem43 (transmembrane protein 43) (eg, arrhythmogenic right ventricular cardiomyopathy), full gene sequence tnnt2 (troponin t, type 2 [cardiac]) (eg, familial hypertrophic cardiomyopathy), full gene sequence trpc6 (transient receptor potential cation channel, subfamily c, member 6) (eg, focal segmental glomerulosclerosis), full gene sequence tsc1 (tuberous sclerosis 1) (eg, tuberous sclerosis), full gene sequence tsc2 (tuberous sclerosis 2) (eg, tuberous sclerosis), duplication/deletion analysis ube3a (ubiquitin protein ligase e3a) (eg, angelman syndrome), full gene sequence umod (uromodulin) (eg, glomerulocystic kidney disease with hyperuricemia and isosthenuria), full gene sequence vwf (von willebrand factor) (von willebrand disease type 2a), extended targeted sequence analysis (eg, exons 11-16, 24-26, 51, 52) was (wiskott-aldrich syndrome [eczema-thrombocytopenia]) (eg, wiskott-aldrich syndrome), full gene sequence

molecular pathology procedure, level 8 (eg, analysis of 26-50 exons by dna sequence analysis, mutation scanning or duplication/deletion variants of >50 exons, sequence analysis of multiple genes on one platform) abcc8 (atp-binding cassette, sub-family c [cftr/mrp], member 8) (eg, familial hyperinsulinism), full gene sequence agl (amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase) (eg, glycogen storage disease type iii), full gene sequence ahi1 (abelson helper integration site 1) (eg, joubert syndrome), full gene sequence aspm (asp [abnormal spindle] homolog, microcephaly associated [drosophila]) (eg, primary microcephaly), full gene sequence cacna1a (calcium channel, voltage-dependent, p/q type, alpha 1a subunit) (eg, familial hemiplegic migraine), full gene sequence chd7 (chromodomain helicase dna binding protein 7) (eg, charge syndrome), full gene sequence col4a4 (collagen, type iv, alpha 4) (eg, alport syndrome), full gene sequence col4a5 (collagen, type iv, alpha 5) (eg, alport syndrome), duplication/deletion analysis col6a1 (collagen, type vi, alpha 1) (eg, collagen type vi-related disorders), full gene sequence col6a2 (collagen, type vi, alpha 2) (eg, collagen type vi-related disorders), full gene sequence col6a3 (collagen, type vi, alpha 3) (eg, collagen type vi-related disorders), full gene sequence crebbp (creb binding protein) (eg, rubinstein-taybi syndrome), full gene sequence f8 (coagulation factor viii) (eg, hemophilia a), full gene sequence jag1 (jagged 1) (eg, alagille syndrome), full gene sequence kdm5c (lysine [k]-specific demethylase 5c) (eg, x-linked mental retardation), full gene sequence kiaa0196 (kiaa0196) (eg, spastic paraplegia), full gene sequence l1cam (l1 cell adhesion molecule) (eg, masa syndrome, x-linked hydrocephaly), full gene sequence lamb2 (laminin, beta 2 [laminin s]) (eg, pierson syndrome), full gene sequence mybpc3 (myosin binding protein c, cardiac) (eg, familial hypertrophic cardiomyopathy), full gene sequence myh6 (myosin, heavy chain 6, cardiac muscle, alpha) (eg, familial dilated cardiomyopathy), full gene sequence myh7 (myosin, heavy chain 7, cardiac muscle, beta) (eg, familial hypertrophic cardiomyopathy, liang distal myopathy), full gene sequence myo7a (myosin viia) (eg, usher syndrome, type 1), full gene sequence notch1 (notch 1) (eg, aortic valve disease), full gene sequence nphs1 (nephrosis 1, congenital, finnish type [nephrin]) (eg, congenital finnish nephrosis), full gene sequence opa1 (optic atrophy 1) (eg, optic atrophy), full gene sequence pcdh15 (protocadherin-related 15) (eg, usher syndrome, type 1), full gene sequence pkd1 (polycystic kidney disease 1 [autosomal dominant]) (eg, polycystic kidney disease), full gene sequence plce1 (phospholipase c, epsilon 1) (eg, nephrotic syndrome type 3), full gene sequence scn1a (sodium channel, voltage-gated, type 1, alpha subunit) (eg, generalized epilepsy with febrile seizures), full gene sequence scn5a (sodium channel, voltage-gated, type v, alpha subunit) (eg, familial dilated cardiomyopathy), full gene sequence slc12a1 (solute carrier family 12 [sodium/potassium/chloride transporters], member 1) (eg, bartter syndrome), full gene sequence slc12a3 (solute carrier family 12 [sodium/chloride transporters], member 3) (eg, gitelman syndrome), full gene sequence spg11 (spastic paraplegia 11 [autosomal recessive]) (eg, spastic paraplegia), full gene sequence sptbn2 (spectrin, beta, non-erythrocytic 2) (eg, spinocerebellar ataxia), full gene sequence tmem67 (transmembrane protein 67) (eg, joubert syndrome), full gene sequence tsc2 (tuberous sclerosis 2) (eg, tuberous sclerosis), full gene sequence ush1c (usher syndrome 1c [autosomal recessive, severe]) (eg, usher syndrome, type 1), full gene sequence vps13b (vacuolar protein sorting 13 homolog b [yeast]) (eg, cohen syndrome), duplication/deletion analysis wdr62 (wd repeat domain 62) (eg, primary autosomal recessive microcephaly), full gene sequence

molecular pathology procedure, level 9 (eg, analysis of >50 exons in a single gene by dna sequence analysis) abca4 (atp-binding cassette, sub-family a [abc1], member 4) (eg, stargardt disease, age-related macular degeneration), full gene sequence atm (ataxia telangiectasia mutated) (eg, ataxia telangiectasia), full gene sequence cdh23 (cadherin-related 23) (eg, usher syndrome, type 1), full gene sequence cep290 (centrosomal protein 290kda) (eg, joubert syndrome), full gene sequence col1a1 (collagen, type i, alpha 1) (eg, osteogenesis imperfecta, type i), full gene sequence col1a2 (collagen, type i, alpha 2) (eg, osteogenesis imperfecta, type i), full gene sequence col4a1 (collagen, type iv, alpha 1) (eg, brain small-vessel disease with hemorrhage), full gene sequence col4a3 (collagen, type iv, alpha 3 [goodpasture antigen]) (eg, alport syndrome), full gene sequence col4a5 (collagen, type iv, alpha 5) (eg, alport syndrome), full gene sequence dmd (dystrophin) (eg, duchenne/becker muscular dystrophy), full gene sequence dysf (dysferlin, limb girdle muscular dystrophy 2b [autosomal recessive]) (eg, limb-girdle muscular dystrophy), full gene sequence fbn1 (fibrillin 1) (eg, marfan syndrome), full gene sequence itpr1 (inositol 1,4,5-trisphosphate receptor, type 1) (eg, spinocerebellar ataxia), full gene sequence lama2 (laminin, alpha 2) (eg, congenital muscular dystrophy), full gene sequence lrrk2 (leucine-rich repeat kinase 2) (eg, parkinson disease), full gene sequence myh11 (myosin, heavy chain 11, smooth muscle) (eg, thoracic aortic aneurysms and aortic dissections), full gene sequence neb (nebulin) (eg, nemaline myopathy 2), full gene sequence nf1 (neurofibromin 1) (eg, neurofibromatosis, type 1), full gene sequence pkhd1 (polycystic kidney and hepatic disease 1) (eg, autosomal recessive polycystic kidney disease), full gene sequence ryr1 (ryanodine receptor 1, skeletal) (eg, malignant hyperthermia), full gene sequence ryr2 (ryanodine receptor 2 [cardiac]) (eg, catecholaminergic polymorphic ventricular tachycardia, arrhythmogenic right ventricular dysplasia), full gene sequence or targeted sequence analysis of > 50 exons ush2a (usher syndrome 2a [autosomal recessive, mild]) (eg, usher syndrome, type 2), full gene sequence vps13b (vacuolar protein sorting 13 homolog b [yeast]) (eg, cohen syndrome), full gene sequence vwf (von willebrand factor) (eg, von willebrand disease types 1 and 3), full gene sequence

aortic dysfunction or dilation (eg, marfan syndrome, loeys dietz syndrome, ehler danlos syndrome type iv, arterial tortuosity syndrome); genomic sequence analysis panel, must include sequencing of at least 9 genes, including fbn1, tgfbr1, tgfbr2, col3a1, myh11, acta2, slc2a10, smad3, and mylk

aortic dysfunction or dilation (eg, marfan syndrome, loeys dietz syndrome, ehler danlos syndrome type iv, arterial tortuosity syndrome); duplication/deletion analysis panel, must include analyses for tgfbr1, tgfbr2, myh11, and col3a1

ashkenazi jewish associated disorders (eg, bloom syndrome, canavan disease, cystic fibrosis, familial dysautonomia, fanconi anemia group c, gaucher disease, tay-sachs disease), genomic sequence analysis panel, must include sequencing of at least 9 genes, including aspa, blm, cftr, fancc, gba, hexa, ikbkap, mcoln1, and smpd1

cardiac ion channelopathies (eg, brugada syndrome, long qt syndrome, short qt syndrome, catecholaminergic polymorphic ventricular tachycardia); genomic sequence analysis panel, must include sequencing of at least 10 genes, including ank2, casq2, cav3, kcne1, kcne2, kcnh2, kcnj2, kcnq1, ryr2, and scn5a

cardiac ion channelopathies (eg, brugada syndrome, long qt syndrome, short qt syndrome, catecholaminergic polymorphic ventricular tachycardia); duplication/deletion gene analysis panel, must include analysis of at least 2 genes, including kcnh2 and kcnq1

exome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis

exome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis, each comparator exome (eg, parents, siblings) (list separately in addition to code for primary procedure)

exome (eg, unexplained constitutional or heritable disorder or syndrome); re-evaluation of previously obtained exome sequence (eg, updated knowledge or unrelated condition/syndrome)

fetal chromosomal aneuploidy (eg, trisomy 21, monosomy x) genomic sequence analysis panel, circulating cell-free fetal dna in maternal blood, must include analysis of chromosomes 13, 18, and 21

fetal chromosomal microdeletion(s) genomic sequence analysis (eg, digeorge syndrome, cri-du-chat syndrome), circulating cell-free fetal dna in maternal blood

genome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis

genome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis, each comparator genome (eg, parents, siblings) (list separately in addition to code for primary procedure)

genome (eg, unexplained constitutional or heritable disorder or syndrome); re-evaluation of previously obtained genome sequence (eg, updated knowledge or unrelated condition/syndrome)

hearing loss (eg, nonsyndromic hearing loss, usher syndrome, pendred syndrome); genomic sequence analysis panel, must include sequencing of at least 60 genes, including cdh23, clrn1, gjb2, gpr98, mtrnr1, myo7a, myo15a, pcdh15, otof, slc26a4, tmc1, tmprss3, ush1c, ush1g, ush2a, and wfs1

hearing loss (eg, nonsyndromic hearing loss, usher syndrome, pendred syndrome); duplication/deletion analysis panel, must include copy number analyses for strc and dfnb1 deletions in gjb2 and gjb6 genes

hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer); genomic sequence analysis panel, must include sequencing of at least 10 genes, always including brca1, brca2, cdh1, mlh1, msh2, msh6, palb2, pten, stk11, and tp53

hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer); duplication/deletion analysis panel, must include analyses for brca1, brca2, mlh1, msh2, and stk11

hereditary retinal disorders (eg, retinitis pigmentosa, leber congenital amaurosis, cone-rod dystrophy), genomic sequence analysis panel, must include sequencing of at least 15 genes, including abca4, cnga1, crb1, eys, pde6a, pde6b, prpf31, prph2, rdh12, rho, rp1, rp2, rpe65, rpgr, and ush2a

hereditary colon cancer disorders (eg, lynch syndrome, pten hamartoma syndrome, cowden syndrome, familial adenomatosis polyposis); genomic sequence analysis panel, must include sequencing of at least 10 genes, including apc, bmpr1a, cdh1, mlh1, msh2, msh6, mutyh, pten, smad4, and stk11

hereditary colon cancer disorders (eg, lynch syndrome, pten hamartoma syndrome, cowden syndrome, familial adenomatosis polyposis); duplication/deletion analysis panel, must include analysis of at least 5 genes, including mlh1, msh2, epcam, smad4, and stk11

hereditary neuroendocrine tumor disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, malignant pheochromocytoma or paraganglioma); genomic sequence analysis panel, must include sequencing of at least 6 genes, including max, sdhb, sdhc, sdhd, tmem127, and vhl

hereditary neuroendocrine tumor disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, malignant pheochromocytoma or paraganglioma); duplication/deletion analysis panel, must include analyses for sdhb, sdhc, sdhd, and vhl

hereditary cardiomyopathy (eg, hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy), genomic sequence analysis panel, must include sequencing of at least 5 cardiomyopathy-related genes (eg, dsg2, mybpc3, myh7, pkp2, ttn)

nuclear encoded mitochondrial genes (eg, neurologic or myopathic phenotypes), genomic sequence panel, must include analysis of at least 100 genes, including bcs1l, c10orf2, coq2, cox10, dguok, mpv17, opa1, pdss2, polg, polg2, rrm2b, sco1, sco2, slc25a4, sucla2, suclg1, taz, tk2, and tymp

noonan spectrum disorders (eg, noonan syndrome, cardio-facio-cutaneous syndrome, costello syndrome, leopard syndrome, noonan-like syndrome), genomic sequence analysis panel, must include sequencing of at least 12 genes, including braf, cbl, hras, kras, map2k1, map2k2, nras, ptpn11, raf1, rit1, shoc2, and sos1

targeted genomic sequence analysis panel, solid organ neoplasm, dna analysis, and rna analysis when performed, 5-50 genes (eg, alk, braf, cdkn2a, egfr, erbb2, kit, kras, nras, met, pdgfra, pdgfrb, pgr, pik3ca, pten, ret), interrogation for sequence variants and copy number variants or rearrangements, if performed

hereditary peripheral neuropathies (eg, charcot-marie-tooth, spastic paraplegia), genomic sequence analysis panel, must include sequencing of at least 5 peripheral neuropathy-related genes (eg, bscl2, gjb1, mfn2, mpz, reep1, spast, spg11, sptlc1)

targeted genomic sequence analysis panel, hematolymphoid neoplasm or disorder, dna analysis, and rna analysis when performed, 5-50 genes (eg, braf, cebpa, dnmt3a, ezh2, flt3, idh1, idh2, jak2, kras, kit, mll, nras, npm1, notch1), interrogation for sequence variants, and copy number variants or rearrangements, or isoform expression or mrna expression levels, if performed

targeted genomic sequence analysis panel, solid organ or hematolymphoid neoplasm, dna analysis, and rna analysis when performed, 51 or greater genes (eg, alk, braf, cdkn2a, cebpa, dnmt3a, egfr, erbb2, ezh2, flt3, idh1, idh2, jak2, kit, kras, mll, npm1, nras, met, notch1, pdgfra, pdgfrb, pgr, pik3ca, pten, ret), interrogation for sequence variants and copy number variants or rearrangements, if performed

whole mitochondrial genome (eg, leigh syndrome, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [melas], myoclonic epilepsy with ragged-red fibers [merff], neuropathy, ataxia, and retinitis pigmentosa [narp], leber hereditary optic neuropathy [lhon]), genomic sequence, must include sequence analysis of entire mitochondrial genome with heteroplasmy detection

whole mitochondrial genome large deletion analysis panel (eg, kearns-sayre syndrome, chronic progressive external ophthalmoplegia), including heteroplasmy detection, if performed

x-linked intellectual disability (xlid) (eg, syndromic and non-syndromic xlid); genomic sequence analysis panel, must include sequencing of at least 60 genes, including arx, atrx, cdkl5, fgd1, fmr1, huwe1, il1rapl, kdm5c, l1cam, mecp2, med12, mid1, ocrl, rps6ka3, and slc16a2

x-linked intellectual disability (xlid) (eg, syndromic and non-syndromic xlid); duplication/deletion gene analysis, must include analysis of at least 60 genes, including arx, atrx, cdkl5, fgd1, fmr1, huwe1, il1rapl, kdm5c, l1cam, mecp2, med12, mid1, ocrl, rps6ka3, and slc16a2

autoimmune (rheumatoid arthritis), analysis of 12 biomarkers using immunoassays, utilizing serum, prognostic algorithm reported as a disease activity score

coronary artery disease, mrna, gene expression profiling by real-time rt-pcr of 23 genes, utilizing whole peripheral blood, algorithm reported as a risk score

oncology (ovarian), biochemical assays of two proteins (ca-125 and he4), utilizing serum, with menopausal status, algorithm reported as a risk score

oncology (ovarian), biochemical assays of five proteins (ca-125, apolipoprotein a1, beta-2 microglobulin, transferrin, and pre-albumin), utilizing serum, algorithm reported as a risk score

oncology (tissue of origin), microarray gene expression profiling of > 2000 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as tissue similarity scores

endocrinology (type 2 diabetes), biochemical assays of seven analytes (glucose, hba1c, insulin, hs-crp, adiponectin, ferritin, interleukin 2-receptor alpha), utilizing serum or plasma, algorithm reporting a risk score

fetal aneuploidy (trisomy 21, 18, and 13) dna sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy

fetal congenital abnormalities, biochemical assays of two proteins (papp-a, hcg [any form]), utilizing maternal serum, algorithm reported as a risk score

fetal congenital abnormalities, biochemical assays of three proteins (papp-a, hcg [any form], dia), utilizing maternal serum, algorithm reported as a risk score

fetal congenital abnormalities, biochemical assays of three analytes (afp, ue3, hcg [any form]), utilizing maternal serum, algorithm reported as a risk score

fetal congenital abnormalities, biochemical assays of four analytes (afp, ue3, hcg [any form], dia) utilizing maternal serum, algorithm reported as a risk score (may include additional results from previous biochemical testing)

fetal congenital abnormalities, biochemical assays of five analytes (afp, ue3, total hcg, hyperglycosylated hcg, dia) utilizing maternal serum, algorithm reported as a risk score

oncology (breast), mrna, gene expression profiling by real-time rt-pcr of 21 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence score

oncology (breast), mrna gene expression profiling by hybrid capture of 58 genes (50 content and 8 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence risk score

oncology (breast), mrna, microarray gene expression profiling of 70 content genes and 465 housekeeping genes, utilizing fresh frozen or formalin-fixed paraffin-embedded tissue, algorithm reported as index related to risk of distant metastasis

oncology (colon), mrna, gene expression profiling by real-time rt-pcr of 12 genes (7 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence score

oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 dna markers (kras mutations, promoter methylation of ndrg4 and bmp3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result

oncology (gynecologic), live tumor cell culture and chemotherapeutic response by dapi stain and morphology, predictive algorithm reported as a drug response score; first single drug or drug combination

oncology (gynecologic), live tumor cell culture and chemotherapeutic response by dapi stain and morphology, predictive algorithm reported as a drug response score; each additional single drug or drug combination (list separately in addition to code for primary procedure)

oncology (lung), mass spectrometric 8-protein signature, including amyloid a, utilizing serum, prognostic and predictive algorithm reported as good versus poor overall survival

oncology (high-grade prostate cancer), biochemical assay of four proteins (total psa, free psa, intact psa, and human kallikrein-2 [hk2]), utilizing plasma or serum, prognostic algorithm reported as a probability score

oncology (tumor of unknown origin), mrna, gene expression profiling by real-time rt-pcr of 92 genes (87 content and 5 housekeeping) to classify tumor into main cancer type and subtype, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a probability of a predicted main cancer type and subtype

oncology (prostate), mrna gene expression profiling by real-time rt-pcr of 46 genes (31 content and 15 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a disease-specific mortality risk score

oncology (thyroid), gene expression analysis of 142 genes, utilizing fine needle aspirate, algorithm reported as a categorical result (eg, benign or suspicious)

oncology (prostate), promoter methylation profiling by real-time pcr of 3 genes (gstp1, apc, rassf1), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a likelihood of prostate cancer detection on repeat biopsy

cardiology (heart transplant), mrna, gene expression profiling by real-time quantitative pcr of 20 genes (11 content and 9 housekeeping), utilizing subfraction of peripheral blood, algorithm reported as a rejection risk score

ketone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); qualitative

ketone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); quantitative

albumin; urine (eg, microalbumin), semiquantitative (eg, reagent strip assay)

alpha-fetoprotein (afp); afp-l3 fraction isoform and total afp (including ratio)

blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected specimens with single determination, for colorectal neoplasm screening (ie, patient was provided 3 cards or single triple card for consecutive collection)

blood, occult, by peroxidase activity (eg, guaiac), qualitative; other sources

blood, occult, by peroxidase activity (eg, guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal neoplasm screening

blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations

column chromatography, includes mass spectrometry, if performed (eg, hplc, lc, lc/ms, lc/ms-ms, gc, gc/ms-ms, gc/ms, hplc/ms), non-drug analyte(s) not elsewhere specified, qualitative or quantitative, each specimen

elastase, pancreatic (el-1), fecal, qualitative or semi-quantitative

enzyme activity in blood cells, cultured cells, or tissue, not elsewhere specified; nonradioactive substrate, each specimen

enzyme activity in blood cells, cultured cells, or tissue, not elsewhere specified; radioactive substrate, each specimen

gammaglobulin (immunoglobulin); immunoglobulin subclasses (eg, igg1, 2, 3, or 4), each

gases, blood, any combination of ph, pco2, po2, co2, hco3 (including calculated o2 saturation)

gases, blood, any combination of ph, pco2, po2, co2, hco3 (including calculated o2 saturation); with o2 saturation, by direct measurement, except pulse oximetry

gases, blood, o2 saturation only, by direct measurement, except pulse oximetry

hemoglobin-oxygen affinity (po2 for 50% hemoglobin saturation with oxygen)

glucose; tolerance test, each additional beyond 3 specimens (list separately in addition to code for primary procedure)

glucose, blood by glucose monitoring device(s) cleared by the fda specifically for home use

growth stimulation expressed gene 2 (st2, interleukin 1 receptor like-1)

helicobacter pylori, blood test analysis for urease activity, non-radioactive isotope (eg, c-13)

helicobacter pylori; breath test analysis for urease activity, non-radioactive isotope (eg, c-13)

heavy metal (eg, arsenic, barium, beryllium, bismuth, antimony, mercury); qualitative, any number of analytes

heavy metal (eg, arsenic, barium, beryllium, bismuth, antimony, mercury); quantitative, each, not elsewhere specified

hemoglobin fractionation and quantitation; electrophoresis (eg, a2, s, c, and/or f)

hemoglobin fractionation and quantitation; chromatography (eg, a2, s, c, and/or f)

hemoglobin; glycosylated (a1c) by device cleared by fda for home use

immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple step method

immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, single step method (eg, reagent strip)

immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, by radioimmunoassay (eg, ria)

immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, not otherwise specified

lactate dehydrogenase (ld), (ldh); isoenzymes, separation and quantitation

lactogen, human placental (hpl) human chorionic somatomammotropin

fetal lung maturity assessment; lecithin sphingomyelin (l/s) ratio

lipoprotein, blood; high resolution fractionation and quantitation of lipoproteins including lipoprotein subclasses when performed (eg, electrophoresis, ultracentrifugation)

lipoprotein, blood; quantitation of lipoprotein particle number(s) (eg, by nuclear magnetic resonance spectroscopy), includes lipoprotein particle subclass(es), when performed

lipoprotein, direct measurement; high density cholesterol (hdl cholesterol)

mass spectrometry and tandem mass spectrometry (eg, ms, ms/ms, maldi, ms-tof, qtof), non-drug analyte(s) not elsewhere specified, qualitative or quantitative, each specimen

microfluidic analysis utilizing an integrated collection and analysis device, tear osmolarity

evaluation of cervicovaginal fluid for specific amniotic fluid protein(s) (eg, placental alpha microglobulin-1 [pamg-1], placental protein 12 [pp12], alpha-fetoprotein), qualitative, each specimen

protein, total, except by refractometry; serum, plasma or whole blood

protein, total, except by refractometry; other source (eg, synovial fluid, cerebrospinal fluid)

protein; electrophoretic fractionation and quantitation, other fluids with concentration (eg, urine, csf)

protein; western blot, with interpretation and report, blood or other body fluid

protein; western blot, with interpretation and report, blood or other body fluid, immunological probe for band identification, each

receptor assay; endocrine, other than estrogen or progesterone (specify hormone)

sugars (mono-, di-, and oligosaccharides); single qualitative, each specimen

sugars (mono-, di-, and oligosaccharides); multiple qualitative, each specimen

sugars (mono-, di-, and oligosaccharides); single quantitative, each specimen

sugars (mono-, di-, and oligosaccharides); multiple quantitative, each specimen

testosterone; bioavailable, direct measurement (eg, differential precipitation)

thromboxane metabolite(s), including thromboxane if performed, urine

thyroid hormone (t3 or t4) uptake or thyroid hormone binding ratio (thbr)

ovulation tests, by visual color comparison methods for human luteinizing hormone

blood count; blood smear, microscopic examination with manual differential wbc count

blood count; blood smear, microscopic examination without manual differential wbc count

blood count; complete (cbc), automated (hgb, hct, rbc, wbc and platelet count) and automated differential wbc count

blood count; complete (cbc), automated (hgb, hct, rbc, wbc and platelet count)

blood count; manual cell count (erythrocyte, leukocyte, or platelet) each

blood count; reticulocytes, automated, including 1 or more cellular parameters (eg, reticulocyte hemoglobin content [chr], immature reticulocyte fraction [irf], reticulocyte volume [mrv], rna content), direct measurement

blood smear, peripheral, interpretation by physician with written report

clotting; factor viii, von willebrand factor, multimetric analysis

clotting; high molecular weight kininogen assay (fitzgerald factor assay)

clotting inhibitors or anticoagulants; antithrombin iii, activity

clotting inhibitors or anticoagulants; antithrombin iii, antigen assay

fibrin(ogen) degradation (split) products (fdp) (fsp); agglutination slide, semiquantitative

fibrin(ogen) degradation (split) products (fdp) (fsp); paracoagulation

fibrin(ogen) degradation (split) products (fdp) (fsp); quantitative

fibrin degradation products, d-dimer; qualitative or semiquantitative

fibrin degradation products, d-dimer; ultrasensitive (eg, for evaluation for venous thromboembolism), qualitative or semiquantitative

coagulation/fibrinolysis assay, whole blood (eg, viscoelastic clot assessment), including use of any pharmacologic additive(s), as indicated, including interpretation and written report, per day

coagulation and fibrinolysis, functional activity, not otherwise specified (eg, adamts-13), each analyte

fibrinolytic factors and inhibitors; plasminogen, except antigenic assay

fibrinolytic factors and inhibitors; plasminogen, antigenic assay

hemoglobin or rbcs, fetal, for fetomaternal hemorrhage; differential lysis (kleihauer-betke)

thromboplastin time, partial (ptt); substitution, plasma fractions, each

agglutinins, febrile (eg, brucella, francisella, murine typhus, q fever, rocky mountain spotted fever, scrub typhus), each antigen

allergen specific igg quantitative or semiquantitative, each allergen

allergen specific ige; quantitative or semiquantitative, crude allergen extract, each

allergen specific ige; qualitative, multiallergen screen (eg, disk, sponge, card)

allergen specific ige; quantitative or semiquantitative, recombinant or purified component, each

antibody identification; platelet associated immunoglobulin assay

blood bank physician services; difficult cross match and/or evaluation of irregular antibody(s), interpretation and written report

blood bank physician services; investigation of transfusion reaction including suspicion of transmissible disease, interpretation and written report

blood bank physician services; authorization for deviation from standard blood banking procedures (eg, use of outdated blood, transfusion of rh incompatible units), with written report

cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating tumor cells in blood)

cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating tumor cells in blood); physician interpretation and report, when required

extractable nuclear antigen, antibody to, any method (eg, nrnp, ss-a, ss-b, sm, rnp, sc170, j01), each antibody

immunoassay for tumor antigen, qualitative or semiquantitative (eg, bladder tumor antigen)

heterophile antibodies; titers after absorption with beef cells and guinea pig kidney

immunoassay for tumor antigen, other antigen, quantitative (eg, ca 50, 72-4, 549), each

immunoassay for infectious agent antibody, quantitative, not otherwise specified

immunoassay for infectious agent antibody, qualitative or semiquantitative, single step method (eg, reagent strip)

immunoelectrophoresis; other fluids (eg, urine, cerebrospinal fluid) with concentration

immunodiffusion; gel diffusion, qualitative (ouchterlony), each antigen or antibody

immunofixation electrophoresis; other fluids with concentration (eg, urine, csf)

cellular function assay involving stimulation (eg, mitogen or antigen) and detection of biomarker (eg, atp)

lymphocyte transformation, mitogen (phytomitogen) or antigen induced blastogenesis

mononuclear cell antigen, quantitative (eg, flow cytometry), not otherwise specified, each antigen

tuberculosis test, cell mediated immunity antigen response measurement; gamma interferon

tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing t-cells in cell suspension

syphilis test, non-treponemal antibody; qualitative (eg, vdrl, rpr, art)

antibody; borrelia burgdorferi (lyme disease) confirmatory test (eg, western blot or immunoblot)

antibody; htlv or hiv antibody, confirmatory test (eg, western blot)

serum screening for cytotoxic percent reactive antibody (pra); standard method

serum screening for cytotoxic percent reactive antibody (pra); quick method

human leukocyte antigen (hla) crossmatch, non-cytotoxic (eg, using flow cytometry); first serum sample or dilution

human leukocyte antigen (hla) crossmatch, non-cytotoxic (eg, using flow cytometry); each additional serum sample or sample dilution (list separately in addition to primary procedure)

antibody to human leukocyte antigens (hla), solid phase assays (eg, microspheres or beads, elisa, flow cytometry); qualitative assessment of the presence or absence of antibody(ies) to hla class i and class ii hla antigens

antibody to human leukocyte antigens (hla), solid phase assays (eg, microspheres or beads, elisa, flow cytometry); qualitative assessment of the presence or absence of antibody(ies) to hla class i or class ii hla antigens

antibody to human leukocyte antigens (hla), solid phase assays (eg, microspheres or beads, elisa, flow cytometry); antibody identification by qualitative panel using complete hla phenotypes, hla class i

antibody to human leukocyte antigens (hla), solid phase assays (eg, microspheres or beads, elisa, flow cytometry); antibody identification by qualitative panel using complete hla phenotypes, hla class ii

antibody to human leukocyte antigens (hla), solid phase assays (eg, microspheres or beads, elisa, flow cytometry); high definition qualitative panel for identification of antibody specificities (eg, individual antigen per bead methodology), hla class i

antibody to human leukocyte antigens (hla), solid phase assays (eg, microspheres or beads, elisa, flow cytometry); high definition qualitative panel for identification of antibody specificities (eg, individual antigen per bead methodology), hla class ii

antibody to human leukocyte antigens (hla), solid phase assays (eg, microspheres or beads, elisa, flow cytometry); semi-quantitative panel (eg, titer), hla class i

antibody to human leukocyte antigens (hla), solid phase assays (eg, microspheres or beads, elisa, flow cytometry); semi-quantitative panel (eg, titer), hla class ii

antibody identification, rbc antibodies, each panel for each serum technique

antihuman globulin test (coombs test); indirect, qualitative, each reagent red cell

antihuman globulin test (coombs test); indirect, each antibody titer

autologous blood or component, collection processing and storage; predeposited

autologous blood or component, collection processing and storage; intra- or postoperative salvage

blood typing, serologic; antigen testing of donor blood using reagent serum, each antigen test

blood typing, serologic; antigen screening for compatible unit using patient serum, per unit screened

blood typing, serologic; rbc antigens, other than abo or rh (d), each

blood typing, for paternity testing, per individual; abo, rh and mn

blood typing, for paternity testing, per individual; each additional antigen system

frozen blood, each unit; freezing (includes preparation) and thawing

volume reduction of blood or blood product (eg, red blood cells or platelets), each unit

pretreatment of rbcs for use in rbc antibody detection, identification, and/or compatibility testing; incubation with chemical agents or drugs, each

pretreatment of rbcs for use in rbc antibody detection, identification, and/or compatibility testing; incubation with enzymes, each

pretreatment of rbcs for use in rbc antibody detection, identification, and/or compatibility testing; by density gradient separation

pretreatment of serum for use in rbc antibody identification; incubation with drugs, each

pretreatment of serum for use in rbc antibody identification; by dilution

pretreatment of serum for use in rbc antibody identification; incubation with inhibitors, each

pretreatment of serum for use in rbc antibody identification; by differential red cell absorption using patient rbcs or rbcs of known phenotype, each absorption

animal inoculation, small animal, with observation and dissection

culture, bacterial; blood, aerobic, with isolation and presumptive identification of isolates (includes anaerobic culture, if appropriate)

culture, bacterial; stool, aerobic, with isolation and preliminary examination (eg, kia, lia), salmonella and shigella species

culture, bacterial; stool, aerobic, additional pathogens, isolation and presumptive identification of isolates, each plate

culture, bacterial; any other source except urine, blood or stool, aerobic, with isolation and presumptive identification of isolates

culture, bacterial; quantitative, aerobic with isolation and presumptive identification of isolates, any source except urine, blood or stool

culture, bacterial; quantitative, anaerobic with isolation and presumptive identification of isolates, any source except urine, blood or stool

culture, bacterial; any source, except blood, anaerobic with isolation and presumptive identification of isolates

culture, bacterial; anaerobic isolate, additional methods required for definitive identification, each isolate

culture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolate

culture, presumptive, pathogenic organisms, screening only; with colony estimation from density chart

culture, bacterial; with isolation and presumptive identification of each isolate, urine

culture, fungi (mold or yeast) isolation, with presumptive identification of isolates; skin, hair, or nail

culture, fungi (mold or yeast) isolation, with presumptive identification of isolates; other source (except blood)

culture, fungi (mold or yeast) isolation, with presumptive identification of isolates; blood

culture, tubercle or other acid-fast bacilli (eg, tb, afb, mycobacteria) any source, with isolation and presumptive identification of isolates

culture, typing; gas liquid chromatography (glc) or high pressure liquid chromatography (hplc) method

culture, typing; immunologic method, other than immunofluorescence (eg, agglutination grouping), per antiserum

culture, typing; identification by nucleic acid (dna or rna) probe, direct probe technique, per culture or isolate, each organism probed

culture, typing; identification by nucleic acid (dna or rna) probe, amplified probe technique, per culture or isolate, each organism probed

culture, typing; identification by nucleic acid sequencing method, each isolate (eg, sequencing of the 16s rrna gene)

dark field examination, any source (eg, penile, vaginal, oral, skin); includes specimen collection

dark field examination, any source (eg, penile, vaginal, oral, skin); without collection

ova and parasites, direct smears, concentration and identification

susceptibility studies, antimicrobial agent; agar dilution method, per agent (eg, antibiotic gradient strip)

susceptibility studies, antimicrobial agent; disk method, per plate (12 or fewer agents)

susceptibility studies, antimicrobial agent; enzyme detection (eg, beta lactamase), per enzyme

susceptibility studies, antimicrobial agent; microdilution or agar dilution (minimum inhibitory concentration [mic] or breakpoint), each multi-antimicrobial, per plate

susceptibility studies, antimicrobial agent; microdilution or agar dilution, minimum lethal concentration (mlc), each plate (list separately in addition to code for primary procedure)

susceptibility studies, antimicrobial agent; macrobroth dilution method, each agent

susceptibility studies, antimicrobial agent; mycobacteria, proportion method, each agent

smear, primary source with interpretation; gram or giemsa stain for bacteria, fungi, or cell types

smear, primary source with interpretation; fluorescent and/or acid fast stain for bacteria, fungi, parasites, viruses or cell types

smear, primary source with interpretation; special stain for inclusion bodies or parasites (eg, malaria, coccidia, microsporidia, trypanosomes, herpes viruses)

smear, primary source with interpretation; complex special stain (eg, trichrome, iron hemotoxylin) for ova and parasites

smear, primary source with interpretation; wet mount for infectious agents (eg, saline, india ink, koh preps)

tissue examination by koh slide of samples from skin, hair, or nails for fungi or ectoparasite ova or mites (eg, scabies)

toxin or antitoxin assay, tissue culture (eg, clostridium difficile toxin)

virus isolation; inoculation of embryonated eggs, or small animal, includes observation and dissection

virus isolation; tissue culture inoculation, observation, and presumptive identification by cytopathic effect

virus isolation; tissue culture, additional studies or definitive identification (eg, hemabsorption, neutralization, immunofluorescence stain), each isolate

virus isolation; centrifuge enhanced (shell vial) technique, includes identification with immunofluorescence stain, each virus

virus isolation; including identification by non-immunologic method, other than by cytopathic effect (eg, virus specific enzymatic activity)

infectious agent antigen detection by immunofluorescent technique; adenovirus

infectious agent antigen detection by immunofluorescent technique; bordetella pertussis/parapertussis

infectious agent antigen detection by immunofluorescent technique; enterovirus, direct fluorescent antibody (dfa)

infectious agent antigen detection by immunofluorescent technique; giardia

infectious agent antigen detection by immunofluorescent technique; chlamydia trachomatis

infectious agent antigen detection by immunofluorescent technique; cytomegalovirus, direct fluorescent antibody (dfa)

infectious agent antigen detection by immunofluorescent technique; cryptosporidium

infectious agent antigen detection by immunofluorescent technique; herpes simplex virus type 2

infectious agent antigen detection by immunofluorescent technique; herpes simplex virus type 1

infectious agent antigen detection by immunofluorescent technique; influenza b virus

infectious agent antigen detection by immunofluorescent technique; influenza a virus

infectious agent antigen detection by immunofluorescent technique; legionella pneumophila

infectious agent antigen detection by immunofluorescent technique; parainfluenza virus, each type

infectious agent antigen detection by immunofluorescent technique; respiratory syncytial virus

infectious agent antigen detection by immunofluorescent technique; pneumocystis carinii

infectious agent antigen detection by immunofluorescent technique; rubeola

infectious agent antigen detection by immunofluorescent technique; treponema pallidum

infectious agent antigen detection by immunofluorescent technique; varicella zoster virus

infectious agent antigen detection by immunofluorescent technique; not otherwise specified, each organism

infectious agent antigen detection by immunofluorescent technique, polyvalent for multiple organisms, each polyvalent antiserum

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; adenovirus enteric types 40/41

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; aspergillus

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; chlamydia trachomatis

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; clostridium difficile toxin(s)

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; cryptococcus neoformans

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; cryptosporidium

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; giardia

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; cytomegalovirus

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; escherichia coli 0157

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; entamoeba histolytica dispar group

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; entamoeba histolytica group

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; helicobacter pylori, stool

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; helicobacter pylori

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; hepatitis b surface antigen (hbsag)

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; hepatitis b surface antigen (hbsag) neutralization

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; hepatitis be antigen (hbeag)

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; hepatitis, delta agent

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; histoplasma capsulatum

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; hiv-1 antigen(s), with hiv-1 and hiv-2 antibodies, single result

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; hiv-1

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; hiv-2

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; influenza, a or b, each

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; respiratory syncytial virus

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; rotavirus

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; shiga-like toxin

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]) qualitative or semiquantitative, multiple-step method; streptococcus, group a

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]), qualitative or semiquantitative; multiple-step method, not otherwise specified, each organism

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]), qualitative or semiquantitative; single step method, not otherwise specified, each organism

infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]), qualitative or semiquantitative; multiple step method, polyvalent for multiple organisms, each polyvalent antiserum

infectious agent detection by nucleic acid (dna or rna); bartonella henselae and bartonella quintana, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); bartonella henselae and bartonella quintana, quantification

infectious agent detection by nucleic acid (dna or rna); borrelia burgdorferi, direct probe technique

infectious agent detection by nucleic acid (dna or rna); borrelia burgdorferi, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); candida species, direct probe technique

infectious agent detection by nucleic acid (dna or rna); candida species, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); candida species, quantification

infectious agent detection by nucleic acid (dna or rna); central nervous system pathogen (eg, neisseria meningitidis, streptococcus pneumoniae, listeria, haemophilus influenzae, e. coli, streptococcus agalactiae, enterovirus, human parechovirus, herpes simplex virus type 1 and 2, human herpesvirus 6, cytomegalovirus, varicella zoster virus, cryptococcus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets

infectious agent detection by nucleic acid (dna or rna); chlamydia pneumoniae, direct probe technique

infectious agent detection by nucleic acid (dna or rna); chlamydia pneumoniae, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); chlamydia pneumoniae, quantification

infectious agent detection by nucleic acid (dna or rna); chlamydia trachomatis, direct probe technique

infectious agent detection by nucleic acid (dna or rna); chlamydia trachomatis, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); chlamydia trachomatis, quantification

infectious agent detection by nucleic acid (dna or rna); clostridium difficile, toxin gene(s), amplified probe technique

infectious agent detection by nucleic acid (dna or rna); cytomegalovirus, direct probe technique

infectious agent detection by nucleic acid (dna or rna); cytomegalovirus, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); cytomegalovirus, quantification

infectious agent detection by nucleic acid (dna or rna); enterovirus, amplified probe technique, includes reverse transcription when performed

infectious agent detection by nucleic acid (dna or rna); vancomycin resistance (eg, enterococcus species van a, van b), amplified probe technique

infectious agent detection by nucleic acid (dna or rna); influenza virus, includes reverse transcription, when performed, and amplified probe technique, each type or subtype

infectious agent detection by nucleic acid (dna or rna); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types

infectious agent detection by nucleic acid (dna or rna); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, each additional influenza virus type or sub-type beyond 2 (list separately in addition to code for primary procedure)

infectious agent detection by nucleic acid (dna or rna); gastrointestinal pathogen (eg, clostridium difficile, e. coli, salmonella, shigella, norovirus, giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets

infectious agent detection by nucleic acid (dna or rna); gastrointestinal pathogen (eg, clostridium difficile, e. coli, salmonella, shigella, norovirus, giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 6-11 targets

infectious agent detection by nucleic acid (dna or rna); gastrointestinal pathogen (eg, clostridium difficile, e. coli, salmonella, shigella, norovirus, giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets

infectious agent detection by nucleic acid (dna or rna); gardnerella vaginalis, direct probe technique

infectious agent detection by nucleic acid (dna or rna); gardnerella vaginalis, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); gardnerella vaginalis, quantification

infectious agent detection by nucleic acid (dna or rna); hepatitis b virus, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); hepatitis b virus, quantification

infectious agent detection by nucleic acid (dna or rna); hepatitis c, direct probe technique

infectious agent detection by nucleic acid (dna or rna); hepatitis c, amplified probe technique, includes reverse transcription when performed

infectious agent detection by nucleic acid (dna or rna); hepatitis c, quantification, includes reverse transcription when performed

infectious agent detection by nucleic acid (dna or rna); hepatitis g, direct probe technique

infectious agent detection by nucleic acid (dna or rna); hepatitis g, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); hepatitis g, quantification

infectious agent detection by nucleic acid (dna or rna); herpes simplex virus, direct probe technique

infectious agent detection by nucleic acid (dna or rna); herpes simplex virus, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); herpes simplex virus, quantification

infectious agent detection by nucleic acid (dna or rna); herpes virus-6, direct probe technique

infectious agent detection by nucleic acid (dna or rna); herpes virus-6, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); herpes virus-6, quantification

infectious agent detection by nucleic acid (dna or rna); hiv-1, direct probe technique

infectious agent detection by nucleic acid (dna or rna); hiv-1, amplified probe technique, includes reverse transcription when performed

infectious agent detection by nucleic acid (dna or rna); hiv-1, quantification, includes reverse transcription when performed

infectious agent detection by nucleic acid (dna or rna); hiv-2, direct probe technique

infectious agent detection by nucleic acid (dna or rna); hiv-2, amplified probe technique, includes reverse transcription when performed

infectious agent detection by nucleic acid (dna or rna); hiv-2, quantification, includes reverse transcription when performed

infectious agent detection by nucleic acid (dna or rna); legionella pneumophila, direct probe technique

infectious agent detection by nucleic acid (dna or rna); legionella pneumophila, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); legionella pneumophila, quantification

infectious agent detection by nucleic acid (dna or rna); mycobacteria species, direct probe technique

infectious agent detection by nucleic acid (dna or rna); mycobacteria species, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); mycobacteria species, quantification

infectious agent detection by nucleic acid (dna or rna); mycobacteria tuberculosis, direct probe technique

infectious agent detection by nucleic acid (dna or rna); mycobacteria tuberculosis, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); mycobacteria tuberculosis, quantification

infectious agent detection by nucleic acid (dna or rna); mycobacteria avium-intracellulare, direct probe technique

infectious agent detection by nucleic acid (dna or rna); mycobacteria avium-intracellulare, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); mycobacteria avium-intracellulare, quantification

infectious agent detection by nucleic acid (dna or rna); mycoplasma pneumoniae, direct probe technique

infectious agent detection by nucleic acid (dna or rna); mycoplasma pneumoniae, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); mycoplasma pneumoniae, quantification

infectious agent detection by nucleic acid (dna or rna); neisseria gonorrhoeae, direct probe technique

infectious agent detection by nucleic acid (dna or rna); neisseria gonorrhoeae, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); neisseria gonorrhoeae, quantification

infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), low-risk types (eg, 6, 11, 42, 43, 44)

infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68)

infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), types 16 and 18 only, includes type 45, if performed

infectious agent detection by nucleic acid (dna or rna); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets

infectious agent detection by nucleic acid (dna or rna); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 6-11 targets

infectious agent detection by nucleic acid (dna or rna); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets

infectious agent detection by nucleic acid (dna or rna); respiratory syncytial virus, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); staphylococcus aureus, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); staphylococcus aureus, methicillin resistant, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); streptococcus, group a, direct probe technique

infectious agent detection by nucleic acid (dna or rna); streptococcus, group a, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); streptococcus, group a, quantification

infectious agent detection by nucleic acid (dna or rna); streptococcus, group b, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); trichomonas vaginalis, direct probe technique

infectious agent detection by nucleic acid (dna or rna); trichomonas vaginalis, amplified probe technique

infectious agent detection by nucleic acid (dna or rna); zika virus, amplified probe technique

infectious agent detection by nucleic acid (dna or rna), not otherwise specified; direct probe technique, each organism

infectious agent detection by nucleic acid (dna or rna), not otherwise specified; amplified probe technique, each organism

infectious agent detection by nucleic acid (dna or rna), not otherwise specified; quantification, each organism

infectious agent detection by nucleic acid (dna or rna), multiple organisms; direct probe(s) technique

infectious agent detection by nucleic acid (dna or rna), multiple organisms; amplified probe(s) technique

infectious agent antigen detection by immunoassay with direct optical observation; streptococcus, group b

infectious agent antigen detection by immunoassay with direct optical observation; clostridium difficile toxin a

infectious agent antigen detection by immunoassay with direct optical observation; influenza

infectious agent antigen detection by immunoassay with direct optical observation; hiv-1 antigen(s), with hiv-1 and hiv-2 antibodies

infectious agent antigen detection by immunoassay with direct optical observation; respiratory syncytial virus

infectious agent antigen detection by immunoassay with direct optical observation; trichomonas vaginalis

infectious agent antigen detection by immunoassay with direct optical observation; adenovirus

infectious agent antigen detection by immunoassay with direct optical observation; chlamydia trachomatis

infectious agent antigen detection by immunoassay with direct optical observation; neisseria gonorrhoeae

infectious agent antigen detection by immunoassay with direct optical observation; streptococcus, group a

infectious agent antigen detection by immunoassay with direct optical observation; not otherwise specified

infectious agent drug susceptibility phenotype prediction using regularly updated genotypic bioinformatics

infectious agent genotype analysis by nucleic acid (dna or rna); hiv-1, reverse transcriptase and protease regions

infectious agent genotype analysis by nucleic acid (dna or rna); hepatitis c virus

infectious agent phenotype analysis by nucleic acid (dna or rna) with drug resistance tissue culture analysis, hiv 1; first through 10 drugs tested

infectious agent phenotype analysis by nucleic acid (dna or rna) with drug resistance tissue culture analysis, hiv 1; each additional drug tested (list separately in addition to code for primary procedure)

infectious agent enzymatic activity other than virus (eg, sialidase activity in vaginal fluid)

infectious agent genotype analysis by nucleic acid (dna or rna); hiv-1, other region (eg, integrase, fusion)

infectious agent genotype analysis by nucleic acid (dna or rna); cytomegalovirus

infectious agent genotype analysis by nucleic acid (dna or rna); hepatitis b virus

necropsy (autopsy), gross examination only; with brain and spinal cord

necropsy (autopsy), gross examination only; stillborn or newborn with brain

necropsy (autopsy), gross and microscopic; with brain and spinal cord

necropsy (autopsy), gross and microscopic; stillborn or newborn with brain

necropsy (autopsy), limited, gross and/or microscopic; single organ

cytopathology, fluids, washings or brushings, except cervical or vaginal; smears with interpretation

cytopathology, fluids, washings or brushings, except cervical or vaginal; simple filter method with interpretation

cytopathology, concentration technique, smears and interpretation (eg, saccomanno technique)

cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal

cytopathology, in situ hybridization (eg, fish), urinary tract specimen with morphometric analysis, 3-5 molecular probes, each specimen; manual

cytopathology, in situ hybridization (eg, fish), urinary tract specimen with morphometric analysis, 3-5 molecular probes, each specimen; using computer-assisted technology

sex chromatin identification; peripheral blood smear, polymorphonuclear drumsticks

cytopathology, cervical or vaginal (any reporting system), requiring interpretation by physician

cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; manual screening under physician supervision

cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with manual screening and rescreening under physician supervision

cytopathology smears, cervical or vaginal; screening by automated system under physician supervision

cytopathology smears, cervical or vaginal; screening by automated system with manual rescreening under physician supervision

cytopathology, slides, cervical or vaginal; manual screening under physician supervision

cytopathology, slides, cervical or vaginal; with manual screening and computer-assisted rescreening under physician supervision

cytopathology, slides, cervical or vaginal; with manual screening and rescreening under physician supervision

cytopathology, slides, cervical or vaginal, definitive hormonal evaluation (eg, maturation index, karyopyknotic index, estrogenic index) (list separately in addition to code[s] for other technical and interpretation services)

cytopathology, smears, any other source; screening and interpretation

cytopathology, smears, any other source; preparation, screening and interpretation

cytopathology, smears, any other source; extended study involving over 5 slides and/or multiple stains

cytopathology, slides, cervical or vaginal (the bethesda system); manual screening under physician supervision

cytopathology, slides, cervical or vaginal (the bethesda system); with manual screening and rescreening under physician supervision

cytopathology, slides, cervical or vaginal (the bethesda system); with manual screening and computer-assisted rescreening under physician supervision

cytopathology, slides, cervical or vaginal (the bethesda system); with manual screening and computer-assisted rescreening using cell selection and review under physician supervision

cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site

cytopathology, evaluation of fine needle aspirate; interpretation and report

cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; screening by automated system, under physician supervision

cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with screening by automated system and manual rescreening or review, under physician supervision

cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, each separate additional evaluation episode, same site (list separately in addition to code for primary procedure)

flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first marker

flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; each additional marker (list separately in addition to code for first marker)

tissue culture for non-neoplastic disorders; skin or other solid tissue biopsy

tissue culture for non-neoplastic disorders; amniotic fluid or chorionic villus cells

tissue culture for neoplastic disorders; bone marrow, blood cells

chromosome analysis for breakage syndromes; baseline sister chromatid exchange (sce), 20-25 cells

chromosome analysis for breakage syndromes; baseline breakage, score 50-100 cells, count 20 cells, 2 karyotypes (eg, for ataxia telangiectasia, fanconi anemia, fragile x)

chromosome analysis for breakage syndromes; score 100 cells, clastogen stress (eg, diepoxybutane, mitomycin c, ionizing radiation, uv radiation)

chromosome analysis; count 15-20 cells, 2 karyotypes, with banding

chromosome analysis; count 45 cells for mosaicism, 2 karyotypes, with banding

chromosome analysis, amniotic fluid or chorionic villus, count 15 cells, 1 karyotype, with banding

chromosome analysis, in situ for amniotic fluid cells, count cells from 6-12 colonies, 1 karyotype, with banding

molecular cytogenetics; chromosomal in situ hybridization, analyze 3-5 cells (eg, for derivatives and markers)

molecular cytogenetics; chromosomal in situ hybridization, analyze 10-30 cells (eg, for microdeletions)

molecular cytogenetics; interphase in situ hybridization, analyze 25-99 cells

molecular cytogenetics; interphase in situ hybridization, analyze 100-300 cells

chromosome analysis; additional specialized banding technique (eg, nor, c-banding)

cytogenetics and molecular cytogenetics, interpretation and report

level ii - surgical pathology, gross and microscopic examination appendix, incidental fallopian tube, sterilization fingers/toes, amputation, traumatic foreskin, newborn hernia sac, any location hydrocele sac nerve skin, plastic repair sympathetic ganglion testis, castration vaginal mucosa, incidental vas deferens, sterilization

level iii - surgical pathology, gross and microscopic examination abortion, induced abscess aneurysm - arterial/ventricular anus, tag appendix, other than incidental artery, atheromatous plaque bartholin's gland cyst bone fragment(s), other than pathologic fracture bursa/synovial cyst carpal tunnel tissue cartilage, shavings cholesteatoma colon, colostomy stoma conjunctiva - biopsy/pterygium cornea diverticulum - esophagus/small intestine dupuytren's contracture tissue femoral head, other than fracture fissure/fistula foreskin, other than newborn gallbladder ganglion cyst hematoma hemorrhoids hydatid of morgagni intervertebral disc joint, loose body meniscus mucocele, salivary neuroma - morton's/traumatic pilonidal cyst/sinus polyps, inflammatory - nasal/sinusoidal skin - cyst/tag/debridement soft tissue, debridement soft tissue, lipoma spermatocele tendon/tendon sheath testicular appendage thrombus or embolus tonsil and/or adenoids varicocele vas deferens, other than sterilization vein, varicosity

level iv - surgical pathology, gross and microscopic examination abortion - spontaneous/missed artery, biopsy bone marrow, biopsy bone exostosis brain/meninges, other than for tumor resection breast, biopsy, not requiring microscopic evaluation of surgical margins breast, reduction mammoplasty bronchus, biopsy cell block, any source cervix, biopsy colon, biopsy duodenum, biopsy endocervix, curettings/biopsy endometrium, curettings/biopsy esophagus, biopsy extremity, amputation, traumatic fallopian tube, biopsy fallopian tube, ectopic pregnancy femoral head, fracture fingers/toes, amputation, non-traumatic gingiva/oral mucosa, biopsy heart valve joint, resection kidney, biopsy larynx, biopsy leiomyoma(s), uterine myomectomy - without uterus lip, biopsy/wedge resection lung, transbronchial biopsy lymph node, biopsy muscle, biopsy nasal mucosa, biopsy nasopharynx/oropharynx, biopsy nerve, biopsy odontogenic/dental cyst omentum, biopsy ovary with or without tube, non-neoplastic ovary, biopsy/wedge resection parathyroid gland peritoneum, biopsy pituitary tumor placenta, other than third trimester pleura/pericardium - biopsy/tissue polyp, cervical/endometrial polyp, colorectal polyp, stomach/small intestine prostate, needle biopsy prostate, tur salivary gland, biopsy sinus, paranasal biopsy skin, other than cyst/tag/debridement/plastic repair small intestine, biopsy soft tissue, other than tumor/mass/lipoma/debridement spleen stomach, biopsy synovium testis, other than tumor/biopsy/castration thyroglossal duct/brachial cleft cyst tongue, biopsy tonsil, biopsy trachea, biopsy ureter, biopsy urethra, biopsy urinary bladder, biopsy uterus, with or without tubes and ovaries, for prolapse vagina, biopsy vulva/labia, biopsy

level v - surgical pathology, gross and microscopic examination adrenal, resection bone - biopsy/curettings bone fragment(s), pathologic fracture brain, biopsy brain/meninges, tumor resection breast, excision of lesion, requiring microscopic evaluation of surgical margins breast, mastectomy - partial/simple cervix, conization colon, segmental resection, other than for tumor extremity, amputation, non-traumatic eye, enucleation kidney, partial/total nephrectomy larynx, partial/total resection liver, biopsy - needle/wedge liver, partial resection lung, wedge biopsy lymph nodes, regional resection mediastinum, mass myocardium, biopsy odontogenic tumor ovary with or without tube, neoplastic pancreas, biopsy placenta, third trimester prostate, except radical resection salivary gland sentinel lymph node small intestine, resection, other than for tumor soft tissue mass (except lipoma) - biopsy/simple excision stomach - subtotal/total resection, other than for tumor testis, biopsy thymus, tumor thyroid, total/lobe ureter, resection urinary bladder, tur uterus, with or without tubes and ovaries, other than neoplastic/prolapse

level vi - surgical pathology, gross and microscopic examination bone resection breast, mastectomy - with regional lymph nodes colon, segmental resection for tumor colon, total resection esophagus, partial/total resection extremity, disarticulation fetus, with dissection larynx, partial/total resection - with regional lymph nodes lung - total/lobe/segment resection pancreas, total/subtotal resection prostate, radical resection small intestine, resection for tumor soft tissue tumor, extensive resection stomach - subtotal/total resection for tumor testis, tumor tongue/tonsil -resection for tumor urinary bladder, partial/total resection uterus, with or without tubes and ovaries, neoplastic vulva, total/subtotal resection

decalcification procedure (list separately in addition to code for surgical pathology examination)

special stain including interpretation and report; group i for microorganisms (eg, acid fast, methenamine silver)

special stain including interpretation and report; group ii, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry

special stain including interpretation and report; histochemical stain on frozen tissue block (list separately in addition to code for primary procedure)

special stain including interpretation and report; group iii, for enzyme constituents

consultation and report on referred material requiring preparation of slides

consultation, comprehensive, with review of records and specimens, with report on referred material

pathology consultation during surgery; first tissue block, with frozen section(s), single specimen

pathology consultation during surgery; each additional tissue block with frozen section(s) (list separately in addition to code for primary procedure)

pathology consultation during surgery; cytologic examination (eg, touch prep, squash prep), initial site

pathology consultation during surgery; cytologic examination (eg, touch prep, squash prep), each additional site (list separately in addition to code for primary procedure)

immunohistochemistry or immunocytochemistry, per specimen; each additional single antibody stain procedure (list separately in addition to code for primary procedure)

immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure

immunohistochemistry or immunocytochemistry, per specimen; each multiplex antibody stain procedure

immunofluorescence, per specimen; initial single antibody stain procedure

immunofluorescence, per specimen; each additional single antibody stain procedure (list separately in addition to code for primary procedure)

morphometric analysis, tumor immunohistochemistry (eg, her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; manual

morphometric analysis, tumor immunohistochemistry (eg, her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; using computer-assisted technology

examination and selection of retrieved archival (ie, previously diagnosed) tissue(s) for molecular analysis (eg, kras mutational analysis)

in situ hybridization (eg, fish), per specimen; each additional single probe stain procedure (list separately in addition to code for primary procedure)

in situ hybridization (eg, fish), per specimen; initial single probe stain procedure

in situ hybridization (eg, fish), per specimen; each multiplex probe stain procedure

morphometric analysis, in situ hybridization (quantitative or semi-quantitative), using computer-assisted technology, per specimen; initial single probe stain procedure

morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per specimen; initial single probe stain procedure

morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per specimen; each additional single probe stain procedure (list separately in addition to code for primary procedure)

protein analysis of tissue by western blot, with interpretation and report

protein analysis of tissue by western blot, with interpretation and report; immunological probe for band identification, each

morphometric analysis, in situ hybridization (quantitative or semi-quantitative), using computer-assisted technology, per specimen; each additional single probe stain procedure (list separately in addition to code for primary procedure)

morphometric analysis, in situ hybridization (quantitative or semi-quantitative), using computer-assisted technology, per specimen; each multiplex probe stain procedure

optical endomicroscopic image(s), interpretation and report, real-time or referred, each endoscopic session

morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per specimen; each multiplex probe stain procedure

microdissection (ie, sample preparation of microscopically identified target); laser capture

microdissection (ie, sample preparation of microscopically identified target); manual

macroscopic examination, dissection, and preparation of tissue for non-microscopic analytical studies (eg, nucleic acid-based molecular studies); each tissue preparation (eg, a single lymph node)

macroscopic examination, dissection, and preparation of tissue for non-microscopic analytical studies (eg, nucleic acid-based molecular studies); in conjunction with a touch imprint, intraoperative consultation, or frozen section, each tissue preparation (eg, a single lymph node) (list separately in addition to code for primary procedure)

hemoglobin, quantitative, transcutaneous, per day; carboxyhemoglobin

hemoglobin, quantitative, transcutaneous, per day; methemoglobin

caffeine halothane contracture test (chct) for malignant hyperthermia susceptibility, including interpretation and report

cell count, miscellaneous body fluids (eg, cerebrospinal fluid, joint fluid), except blood

cell count, miscellaneous body fluids (eg, cerebrospinal fluid, joint fluid), except blood; with differential count

crystal identification by light microscopy with or without polarizing lens analysis, tissue or any body fluid (except urine)

sputum, obtaining specimen, aerosol induced technique (separate procedure)

culture of oocyte(s)/embryo(s), less than 4 days; with co-culture of oocyte(s)/embryos

sperm isolation; simple prep (eg, sperm wash and swim-up) for insemination or diagnosis with semen analysis

sperm isolation; complex prep (eg, percoll gradient, albumin gradient) for insemination or diagnosis with semen analysis

assisted oocyte fertilization, microtechnique; less than or equal to 10 oocytes

assisted oocyte fertilization, microtechnique; greater than 10 oocytes

biopsy, oocyte polar body or embryo blastomere, microtechnique (for pre-implantation genetic diagnosis); less than or equal to 5 embryos

biopsy, oocyte polar body or embryo blastomere, microtechnique (for pre-implantation genetic diagnosis); greater than 5 embryos

semen analysis; presence and/or motility of sperm including huhner test (post coital)

semen analysis; sperm presence and motility of sperm, if performed

semen analysis; volume, count, motility, and differential using strict morphologic criteria (eg, kruger)

sperm evaluation; cervical mucus penetration test, with or without spinnbarkeit test

sperm evaluation, for retrograde ejaculation, urine (sperm concentration, motility, and morphology, as indicated)

thawing of cryopreserved; reproductive tissue, testicular/ovarian

aortic aneurysm less than 5.0 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct (nma-no measure associated)

aortic aneurysm 5.0 - 5.4 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct (nma-no measure associated)

aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct (nma-no measure associated)

aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct (nma-no measure associated)

asymptomatic carotid stenosis: no history of any transient ischemic attack or stroke in any carotid or vertebrobasilar territory (nma-no measure associated)

symptomatic carotid stenosis: ipsilateral carotid territory tia or stroke less than 120 days prior to procedure (nma-no measure associated)

other carotid stenosis: ipsilateral tia or stroke 120 days or greater prior to procedure or any prior contralateral carotid territory or vertebrobasilar tia or stroke (nma-no measure associated)

immune globulin (scig), human, for use in subcutaneous infusions, 100 mg, each

cytomegalovirus immune globulin (cmv-igiv), human, for intravenous use

hepatitis b immune globulin (hbig), human, for intramuscular use

rabies immune globulin (rig), human, for intramuscular and/or subcutaneous use

rabies immune globulin, heat-treated (rig-ht), human, for intramuscular and/or subcutaneous use

respiratory syncytial virus, monoclonal antibody, recombinant, for intramuscular use, 50 mg, each

rho(d) immune globulin (rhig), human, full-dose, for intramuscular use

rho(d) immune globulin (rhig), human, mini-dose, for intramuscular use

immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered

immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (list separately in addition to code for primary procedure)

immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)

immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (list separately in addition to code for primary procedure)

immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid)

immunization administration by intranasal or oral route; each additional vaccine (single or combination vaccine/toxoid) (list separately in addition to code for primary procedure)

bacillus calmette-guerin vaccine (bcg) for tuberculosis, live, for percutaneous use

bacillus calmette-guerin vaccine (bcg) for bladder cancer, live, for intravesical use

dengue vaccine, quadrivalent, live, 3 dose schedule, for subcutaneous use

meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup b (menb-4c), 2 dose schedule, for intramuscular use

meningococcal recombinant lipoprotein vaccine, serogroup b (menb-fhbp), 2 or 3 dose schedule, for intramuscular use

cholera vaccine, live, adult dosage, 1 dose schedule, for oral use

influenza virus vaccine, quadrivalent (iiv4), split virus, preservative free, for intradermal use

hepatitis a vaccine (hepa), pediatric/adolescent dosage-2 dose schedule, for intramuscular use

hepatitis a vaccine (hepa), pediatric/adolescent dosage-3 dose schedule, for intramuscular use

hepatitis a and hepatitis b vaccine (hepa-hepb), adult dosage, for intramuscular use

meningococcal conjugate vaccine, serogroups c & y and haemophilus influenzae type b vaccine (hib-mency), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use

haemophilus influenzae type b vaccine (hib), prp-omp conjugate, 3 dose schedule, for intramuscular use

haemophilus influenzae type b vaccine (hib), prp-t conjugate, 4 dose schedule, for intramuscular use

human papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vhpv), 3 dose schedule, for intramuscular use

human papillomavirus vaccine, types 16, 18, bivalent (2vhpv), 3 dose schedule, for intramuscular use

human papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vhpv), 2 or 3 dose schedule, for intramuscular use

influenza vaccine, inactivated (iiv), subunit, adjuvanted, for intramuscular use

influenza virus vaccine, trivalent (iiv3), split virus, preservative-free, for intradermal use

influenza virus vaccine, trivalent (iiv3), split virus, preservative free, 0.25 ml dosage, for intramuscular use

influenza virus vaccine, trivalent (iiv3), split virus, preservative free, 0.5 ml dosage, for intramuscular use

influenza virus vaccine, trivalent (iiv3), split virus, 0.25 ml dosage, for intramuscular use

influenza virus vaccine, trivalent (iiv3), split virus, 0.5 ml dosage, for intramuscular use

influenza virus vaccine, trivalent, live (laiv3), for intranasal use

influenza virus vaccine, trivalent (cciiv3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 ml dosage, for intramuscular use

influenza virus vaccine (iiv), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use

influenza virus vaccine, live (laiv), pandemic formulation, for intranasal use

influenza virus vaccine (iiv), pandemic formulation, split virus, preservative free, for intramuscular use

influenza virus vaccine (iiv), pandemic formulation, split virus, adjuvanted, for intramuscular use

influenza virus vaccine (iiv), pandemic formulation, split virus, for intramuscular use

pneumococcal conjugate vaccine, 13 valent (pcv13), for intramuscular use

influenza virus vaccine, quadrivalent, live (laiv4), for intranasal use

influenza virus vaccine, trivalent (riv3), derived from recombinant dna, hemagglutinin (ha) protein only, preservative and antibiotic free, for intramuscular use

influenza virus vaccine, quadrivalent (cciiv4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 ml dosage, for intramuscular use

rotavirus vaccine, pentavalent (rv5), 3 dose schedule, live, for oral use

rotavirus vaccine, human, attenuated (rv1), 2 dose schedule, live, for oral use

influenza virus vaccine, quadrivalent (riv4), derived from recombinant dna, hemagglutinin (ha) protein only, preservative and antibiotic free, for intramuscular use

influenza virus vaccine, quadrivalent (iiv4), split virus, preservative free, 0.25 ml dosage, for intramuscular use

influenza virus vaccine, quadrivalent (iiv4), split virus, preservative free, 0.5 ml dosage, for intramuscular use

influenza virus vaccine, quadrivalent (iiv4), split virus, 0.25 ml dosage, for intramuscular use

influenza virus vaccine, quadrivalent (iiv4), split virus, 0.5 ml dosage, for intramuscular use

typhoid vaccine, vi capsular polysaccharide (vicps), for intramuscular use

diphtheria, tetanus toxoids, acellular pertussis vaccine and inactivated poliovirus vaccine (dtap-ipv), when administered to children 4 through 6 years of age, for intramuscular use

diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, haemophilus influenzae type b prp-omp conjugate vaccine, and hepatitis b vaccine (dtap-ipv-hib-hepb), for intramuscular use

diphtheria, tetanus toxoids, acellular pertussis vaccine, haemophilus influenzae type b, and inactivated poliovirus vaccine, (dtap-ipv/hib), for intramuscular use

diphtheria, tetanus toxoids, and acellular pertussis vaccine (dtap), when administered to individuals younger than 7 years, for intramuscular use

diphtheria and tetanus toxoids adsorbed (dt) when administered to individuals younger than 7 years, for intramuscular use

measles, mumps and rubella virus vaccine (mmr), live, for subcutaneous use

measles, mumps, rubella, and varicella vaccine (mmrv), live, for subcutaneous use

poliovirus vaccine, inactivated (ipv), for subcutaneous or intramuscular use

tetanus and diphtheria toxoids adsorbed (td), preservative free, when administered to individuals 7 years or older, for intramuscular use

tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap), when administered to individuals 7 years or older, for intramuscular use

diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis b, and inactivated poliovirus vaccine (dtap-hepb-ipv), for intramuscular use

pneumococcal polysaccharide vaccine, 23-valent (ppsv23), adult or immunosuppressed patient dosage, when administered to individuals 2 years or older, for subcutaneous or intramuscular use

meningococcal polysaccharide vaccine, serogroups a, c, y, w-135, quadrivalent (mpsv4), for subcutaneous use

meningococcal conjugate vaccine, serogroups a, c, y and w-135, quadrivalent (mcv4 or menacwy), for intramuscular use

zoster (shingles) vaccine (hzv), live, for subcutaneous injection

japanese encephalitis virus vaccine, inactivated, for intramuscular use

hepatitis b vaccine (hepb), adult dosage, 2 dose schedule, for intramuscular use

hepatitis b vaccine (hepb), dialysis or immunosuppressed patient dosage, 3 dose schedule, for intramuscular use

hepatitis b vaccine (hepb), adolescent, 2 dose schedule, for intramuscular use

hepatitis b vaccine (hepb), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use

hepatitis b vaccine (hepb), adult dosage, 3 dose schedule, for intramuscular use

hepatitis b vaccine (hepb), dialysis or immunosuppressed patient dosage, 4 dose schedule, for intramuscular use

hepatitis b and haemophilus influenzae type b vaccine (hib-hepb), for intramuscular use

zoster (shingles) vaccine (hzv), recombinant, subunit, adjuvanted, for intramuscular use

influenza virus vaccine, quadrivalent (cciiv4), derived from cell cultures, subunit, antibiotic free, 0.5 ml dosage, for intramuscular use

interactive complexity (list separately in addition to the code for primary procedure)

psychotherapy, 30 minutes with patient when performed with an evaluation and management service (list separately in addition to the code for primary procedure)

psychotherapy, 45 minutes with patient when performed with an evaluation and management service (list separately in addition to the code for primary procedure)

psychotherapy, 60 minutes with patient when performed with an evaluation and management service (list separately in addition to the code for primary procedure)

psychotherapy for crisis; each additional 30 minutes (list separately in addition to code for primary service)

family psychotherapy (conjoint psychotherapy) (with patient present), 50 minutes

pharmacologic management, including prescription and review of medication, when performed with psychotherapy services (list separately in addition to the code for primary procedure)

narcosynthesis for psychiatric diagnostic and therapeutic purposes (eg, sodium amobarbital (amytal) interview)

therapeutic repetitive transcranial magnetic stimulation (tms) treatment; initial, including cortical mapping, motor threshold determination, delivery and management

therapeutic repetitive transcranial magnetic stimulation (tms) treatment; subsequent delivery and management, per session

therapeutic repetitive transcranial magnetic stimulation (tms) treatment; subsequent motor threshold re-determination with delivery and management

individual psychophysiological therapy incorporating biofeedback training by any modality (face-to-face with the patient), with psychotherapy (eg, insight oriented, behavior modifying or supportive psychotherapy); 30 minutes

individual psychophysiological therapy incorporating biofeedback training by any modality (face-to-face with the patient), with psychotherapy (eg, insight oriented, behavior modifying or supportive psychotherapy); 45 minutes

environmental intervention for medical management purposes on a psychiatric patient's behalf with agencies, employers, or institutions

psychiatric evaluation of hospital records, other psychiatric reports, psychometric and/or projective tests, and other accumulated data for medical diagnostic purposes

interpretation or explanation of results of psychiatric, other medical examinations and procedures, or other accumulated data to family or other responsible persons, or advising them how to assist patient

preparation of report of patient's psychiatric status, history, treatment, or progress (other than for legal or consultative purposes) for other individuals, agencies, or insurance carriers

biofeedback training, perineal muscles, anorectal or urethral sphincter, including emg and/or manometry

hemodialysis procedure with single evaluation by a physician or other qualified health care professional

hemodialysis procedure requiring repeated evaluation(s) with or without substantial revision of dialysis prescription

hemodialysis access flow study to determine blood flow in grafts and arteriovenous fistulae by an indicator method

dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional

dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies) requiring repeated evaluations by a physician or other qualified health care professional, with or without substantial revision of dialysis prescription

end-stage renal disease (esrd) related services monthly, for patients younger than 2 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 4 or more face-to-face visits by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients younger than 2 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 2-3 face-to-face visits by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients younger than 2 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 1 face-to-face visit by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients 2-11 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 4 or more face-to-face visits by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients 2-11 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 2-3 face-to-face visits by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients 2-11 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 1 face-to-face visit by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients 12-19 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 4 or more face-to-face visits by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients 12-19 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 2-3 face-to-face visits by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients 12-19 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 1 face-to-face visit by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month

end-stage renal disease (esrd) related services for home dialysis per full month, for patients younger than 2 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents

end-stage renal disease (esrd) related services for home dialysis per full month, for patients 2-11 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents

end-stage renal disease (esrd) related services for home dialysis per full month, for patients 12-19 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents

end-stage renal disease (esrd) related services for home dialysis per full month, for patients 20 years of age and older

end-stage renal disease (esrd) related services for dialysis less than a full month of service, per day; for patients younger than 2 years of age

end-stage renal disease (esrd) related services for dialysis less than a full month of service, per day; for patients 2-11 years of age

end-stage renal disease (esrd) related services for dialysis less than a full month of service, per day; for patients 12-19 years of age

end-stage renal disease (esrd) related services for dialysis less than a full month of service, per day; for patients 20 years of age and older

dialysis training, patient, including helper where applicable, any mode, completed course

dialysis training, patient, including helper where applicable, any mode, course not completed, per training session

esophageal motility (manometric study of the esophagus and/or gastroesophageal junction) study with interpretation and report

esophageal motility (manometric study of the esophagus and/or gastroesophageal junction) study with interpretation and report; with stimulation or perfusion (eg, stimulant, acid or alkali perfusion) (list separately in addition to code for primary procedure)

esophagus, gastroesophageal reflux test; with nasal catheter ph electrode(s) placement, recording, analysis and interpretation

esophagus, gastroesophageal reflux test; with mucosal attached telemetry ph electrode placement, recording, analysis and interpretation

esophageal function test, gastroesophageal reflux test with nasal catheter intraluminal impedance electrode(s) placement, recording, analysis and interpretation

esophageal function test, gastroesophageal reflux test with nasal catheter intraluminal impedance electrode(s) placement, recording, analysis and interpretation; prolonged (greater than 1 hour, up to 24 hours)

esophageal balloon distension study, diagnostic, with provocation when performed

breath hydrogen or methane test (eg, for detection of lactase deficiency, fructose intolerance, bacterial overgrowth, or oro-cecal gastrointestinal transit)

gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report

gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus with interpretation and report

gastrointestinal transit and pressure measurement, stomach through colon, wireless capsule, with interpretation and report

colon motility (manometric) study, minimum 6 hours continuous recording (including provocation tests, eg, meal, intracolonic balloon distension, pharmacologic agents, if performed), with interpretation and report

rectal sensation, tone, and compliance test (ie, response to graded balloon distention)

electrogastrography, diagnostic, transcutaneous; with provocative testing

liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report

ophthalmological services: medical examination and evaluation with initiation of diagnostic and treatment program; intermediate, new patient

ophthalmological services: medical examination and evaluation with initiation of diagnostic and treatment program; comprehensive, new patient, 1 or more visits

ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient

ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; comprehensive, established patient, 1 or more visits

ophthalmological examination and evaluation, under general anesthesia, with or without manipulation of globe for passive range of motion or other manipulation to facilitate diagnostic examination; complete

ophthalmological examination and evaluation, under general anesthesia, with or without manipulation of globe for passive range of motion or other manipulation to facilitate diagnostic examination; limited

computerized corneal topography, unilateral or bilateral, with interpretation and report

sensorimotor examination with multiple measurements of ocular deviation (eg, restrictive or paretic muscle with diplopia) with interpretation and report (separate procedure)

orthoptic and/or pleoptic training, with continuing medical direction and evaluation

fitting of contact lens for management of keratoconus, initial fitting

visual field examination, unilateral or bilateral, with interpretation and report; limited examination (eg, tangent screen, autoplot, arc perimeter, or single stimulus level automated test, such as octopus 3 or 7 equivalent)

visual field examination, unilateral or bilateral, with interpretation and report; intermediate examination (eg, at least 2 isopters on goldmann perimeter, or semiquantitative, automated suprathreshold screening program, humphrey suprathreshold automatic diagnostic test, octopus program 33)

visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, goldmann visual fields with at least 3 isopters plotted and static determination within the central 30 deg, or quantitative, automated threshold perimetry, octopus program g-1, 32 or 42, humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2)

serial tonometry (separate procedure) with multiple measurements of intraocular pressure over an extended time period with interpretation and report, same day (eg, diurnal curve or medical treatment of acute elevation of intraocular pressure)

scanning computerized ophthalmic diagnostic imaging, anterior segment, with interpretation and report, unilateral or bilateral

scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; optic nerve

scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina

ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation

corneal hysteresis determination, by air impulse stimulation, unilateral or bilateral, with interpretation and report

ophthalmoscopy, extended, with retinal drawing (eg, for retinal detachment, melanoma), with interpretation and report; initial

ophthalmoscopy, extended, with retinal drawing (eg, for retinal detachment, melanoma), with interpretation and report; subsequent

remote imaging for detection of retinal disease (eg, retinopathy in a patient with diabetes) with analysis and report under physician supervision, unilateral or bilateral

remote imaging for monitoring and management of active retinal disease (eg, diabetic retinopathy) with physician review, interpretation and report, unilateral or bilateral

fluorescein angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral

indocyanine-green angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral

fluorescein angiography and indocyanine-green angiography (includes multiframe imaging) performed at the same patient encounter with interpretation and report, unilateral or bilateral

needle oculoelectromyography, 1 or more extraocular muscles, 1 or both eyes, with interpretation and report

color vision examination, extended, eg, anomaloscope or equivalent

external ocular photography with interpretation and report for documentation of medical progress (eg, close-up photography, slit lamp photography, goniophotography, stereo-photography)

anterior segment imaging with interpretation and report; with specular microscopy and endothelial cell analysis

anterior segment imaging with interpretation and report; with fluorescein angiography

prescription of optical and physical characteristics of and fitting of contact lens, with medical supervision of adaptation; corneal lens, both eyes, except for aphakia

prescription of optical and physical characteristics of and fitting of contact lens, with medical supervision of adaptation; corneal lens for aphakia, 1 eye

prescription of optical and physical characteristics of and fitting of contact lens, with medical supervision of adaptation; corneal lens for aphakia, both eyes

prescription of optical and physical characteristics of and fitting of contact lens, with medical supervision of adaptation; corneoscleral lens

prescription of optical and physical characteristics of contact lens, with medical supervision of adaptation and direction of fitting by independent technician; corneal lens, both eyes except for aphakia

prescription of optical and physical characteristics of contact lens, with medical supervision of adaptation and direction of fitting by independent technician; corneal lens for aphakia, 1 eye

prescription of optical and physical characteristics of contact lens, with medical supervision of adaptation and direction of fitting by independent technician; corneal lens for aphakia, both eyes

prescription of optical and physical characteristics of contact lens, with medical supervision of adaptation and direction of fitting by independent technician; corneoscleral lens

modification of contact lens (separate procedure), with medical supervision of adaptation

fitting of spectacles, except for aphakia; multifocal, other than bifocal

fitting of spectacle mounted low vision aid; single element system

fitting of spectacle mounted low vision aid; telescopic or other compound lens system

prosthesis service for aphakia, temporary (disposable or loan, including materials)

repair and refitting spectacles; spectacle prosthesis for aphakia

treatment of speech, language, voice, communication, and/or auditory processing disorder; individual

treatment of speech, language, voice, communication, and/or auditory processing disorder; group, 2 or more individuals

laryngeal function studies (ie, aerodynamic testing and acoustic testing)

evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria)

evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)

treatment of swallowing dysfunction and/or oral function for feeding

caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)

caloric vestibular test with recording, bilateral; bithermal (ie, one warm and one cool irrigation in each ear for a total of four irrigations)

caloric vestibular test with recording, bilateral; monothermal (ie, one irrigation in each ear for a total of two irrigations)

basic vestibular evaluation, includes spontaneous nystagmus test with eccentric gaze fixation nystagmus, with recording, positional nystagmus test, minimum of 4 positions, with recording, optokinetic nystagmus test, bidirectional foveal and peripheral stimulation, with recording, and oscillating tracking test, with recording

spontaneous nystagmus test, including gaze and fixation nystagmus, with recording

positional nystagmus test, minimum of 4 positions, with recording

optokinetic nystagmus test, bidirectional, foveal or peripheral stimulation, with recording

use of vertical electrodes (list separately in addition to code for primary procedure)

comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)

evoked otoacoustic emissions, screening (qualitative measurement of distortion product or transient evoked otoacoustic emissions), automated analysis

acoustic immittance testing, includes tympanometry (impedance testing), acoustic reflex threshold testing, and acoustic reflex decay testing

auditory evoked potentials for evoked response audiometry and/or testing of the central nervous system; comprehensive

auditory evoked potentials for evoked response audiometry and/or testing of the central nervous system; limited

distortion product evoked otoacoustic emissions; limited evaluation (to confirm the presence or absence of hearing disorder, 3-6 frequencies) or transient evoked otoacoustic emissions, with interpretation and report

distortion product evoked otoacoustic emissions; comprehensive diagnostic evaluation (quantitative analysis of outer hair cell function by cochlear mapping, minimum of 12 frequencies), with interpretation and report

evaluation for use and/or fitting of voice prosthetic device to supplement oral speech

diagnostic analysis of cochlear implant, patient younger than 7 years of age; with programming

diagnostic analysis of cochlear implant, patient younger than 7 years of age; subsequent reprogramming

diagnostic analysis of cochlear implant, age 7 years or older; with programming

diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming

evaluation for prescription of non-speech-generating augmentative and alternative communication device, face-to-face with the patient; first hour

therapeutic service(s) for the use of non-speech-generating device, including programming and modification

evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; first hour

evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; each additional 30 minutes (list separately in addition to code for primary procedure)

therapeutic services for the use of speech-generating device, including programming and modification

motion fluoroscopic evaluation of swallowing function by cine or video recording

flexible endoscopic evaluation of swallowing by cine or video recording

flexible endoscopic evaluation of swallowing by cine or video recording; interpretation and report only

flexible endoscopic evaluation, laryngeal sensory testing by cine or video recording

flexible endoscopic evaluation, laryngeal sensory testing by cine or video recording; interpretation and report only

flexible endoscopic evaluation of swallowing and laryngeal sensory testing by cine or video recording

flexible endoscopic evaluation of swallowing and laryngeal sensory testing by cine or video recording; interpretation and report only

evaluation for prescription of non-speech-generating augmentative and alternative communication device, face-to-face with the patient; each additional 30 minutes (list separately in addition to code for primary procedure)

evaluation of central auditory function, with report; initial 60 minutes

evaluation of central auditory function, with report; each additional 15 minutes (list separately in addition to code for primary procedure)

assessment of tinnitus (includes pitch, loudness matching, and masking)

evaluation of auditory rehabilitation status; each additional 15 minutes (list separately in addition to code for primary procedure)

diagnostic analysis with programming of auditory brainstem implant, per hour

percutaneous transluminal coronary angioplasty; single major coronary artery or branch

percutaneous transluminal coronary angioplasty; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)

percutaneous transluminal coronary atherectomy, with coronary angioplasty when performed; single major coronary artery or branch

percutaneous transluminal coronary atherectomy, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)

percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch

percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)

percutaneous transluminal coronary atherectomy, with intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch

percutaneous transluminal coronary atherectomy, with intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)

percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel

percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)

percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel

percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty; single vessel

percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)

cardioversion, elective, electrical conversion of arrhythmia; external

cardioversion, elective, electrical conversion of arrhythmia; internal (separate procedure)

percutaneous transluminal coronary thrombectomy mechanical (list separately in addition to code for primary procedure)

transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy (list separately in addition to code for primary procedure)

thrombolysis, coronary; by intracoronary infusion, including selective coronary angiography

endoluminal imaging of coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vessel (list separately in addition to code for primary procedure)

endoluminal imaging of coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; each additional vessel (list separately in addition to code for primary procedure)

atrial septectomy or septostomy; transvenous method, balloon (eg, rashkind type) (includes cardiac catheterization)

atrial septectomy or septostomy; blade method (park septostomy) (includes cardiac catheterization)

percutaneous transluminal pulmonary artery balloon angioplasty; single vessel

percutaneous transluminal pulmonary artery balloon angioplasty; each additional vessel (list separately in addition to code for primary procedure)

electrocardiogram, routine ecg with at least 12 leads; with interpretation and report

electrocardiogram, routine ecg with at least 12 leads; tracing only, without interpretation and report

electrocardiogram, routine ecg with at least 12 leads; interpretation and report only

cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; with supervision, interpretation and report

cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report

cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report

cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only

microvolt t-wave alternans for assessment of ventricular arrhythmias

rhythm ecg, 1-3 leads; tracing only without interpretation and report

arterial pressure waveform analysis for assessment of central arterial pressures, includes obtaining waveform(s), digitization and application of nonlinear mathematical transformations to determine central arterial pressures and augmentation index, with interpretation and report, upper extremity artery, non-invasive

external electrocardiographic recording up to 48 hours by continuous rhythm recording and storage; includes recording, scanning analysis with report, review and interpretation by a physician or other qualified health care professional

external electrocardiographic recording up to 48 hours by continuous rhythm recording and storage; recording (includes connection, recording, and disconnection)

external electrocardiographic recording up to 48 hours by continuous rhythm recording and storage; scanning analysis with report

external electrocardiographic recording up to 48 hours by continuous rhythm recording and storage; review and interpretation by a physician or other qualified health care professional

external mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ecg data storage (retrievable with query) with ecg triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; review and interpretation with report by a physician or other qualified health care professional

external mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ecg data storage (retrievable with query) with ecg triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional

programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; implantable subcutaneous lead defibrillator system

interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; implantable subcutaneous lead defibrillator system

external patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; includes transmission, review and interpretation by a physician or other qualified health care professional

external patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; recording (includes connection, recording, and disconnection)

external patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; transmission and analysis

external patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; review and interpretation by a physician or other qualified health care professional

signal-averaged electrocardiography (saecg), with or without ecg

programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; single lead pacemaker system

programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system

programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; multiple lead pacemaker system

programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; single lead transvenous implantable defibrillator system

programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead transvenous implantable defibrillator system

programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; multiple lead transvenous implantable defibrillator system

programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; implantable loop recorder system

peri-procedural device evaluation (in person) and programming of device system parameters before or after a surgery, procedure, or test with analysis, review and report by a physician or other qualified health care professional; single, dual, or multiple lead pacemaker system

peri-procedural device evaluation (in person) and programming of device system parameters before or after a surgery, procedure, or test with analysis, review and report by a physician or other qualified health care professional; single, dual, or multiple lead implantable defibrillator system

interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system

interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead transvenous implantable defibrillator system, including analysis of heart rhythm derived data elements

interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; implantable cardiovascular monitor system, including analysis of 1 or more recorded physiologic cardiovascular data elements from all internal and external sensors

interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; implantable loop recorder system, including heart rhythm derived data analysis

interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; wearable defibrillator system

transtelephonic rhythm strip pacemaker evaluation(s) single, dual, or multiple lead pacemaker system, includes recording with and without magnet application with analysis, review and report(s) by a physician or other qualified health care professional, up to 90 days

interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional

interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional

interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results

interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular monitor system, including analysis of 1 or more recorded physiologic cardiovascular data elements from all internal and external sensors, analysis, review(s) and report(s) by a physician or other qualified health care professional

interrogation device evaluation(s), (remote) up to 30 days; implantable loop recorder system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional

interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular monitor system or implantable loop recorder system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results

transthoracic echocardiography for congenital cardiac anomalies; complete

transthoracic echocardiography for congenital cardiac anomalies; follow-up or limited study

echocardiography, transthoracic, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography

echocardiography, transthoracic, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography

echocardiography, transthoracic, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study

echocardiography, transesophageal, real-time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report

echocardiography, transesophageal, real-time with image documentation (2d) (with or without m-mode recording); placement of transesophageal probe only

echocardiography, transesophageal, real-time with image documentation (2d) (with or without m-mode recording); image acquisition, interpretation and report only

transesophageal echocardiography for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report

transesophageal echocardiography for congenital cardiac anomalies; placement of transesophageal probe only

transesophageal echocardiography for congenital cardiac anomalies; image acquisition, interpretation and report only

echocardiography, transesophageal (tee) for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis

doppler echocardiography, pulsed wave and/or continuous wave with spectral display (list separately in addition to codes for echocardiographic imaging); complete

doppler echocardiography, pulsed wave and/or continuous wave with spectral display (list separately in addition to codes for echocardiographic imaging); follow-up or limited study (list separately in addition to codes for echocardiographic imaging)

doppler echocardiography color flow velocity mapping (list separately in addition to codes for echocardiography)

echocardiography, transthoracic, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report

echocardiography, transthoracic, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional

use of echocardiographic contrast agent during stress echocardiography (list separately in addition to code for primary procedure)

echocardiography, transesophageal (tee) for guidance of a transcatheter intracardiac or great vessel(s) structural intervention(s) (eg,tavr, transcatheter pulmonary valve replacement, mitral valve repair, paravalvular regurgitation repair, left atrial appendage occlusion/closure, ventricular septal defect closure) (peri-and intra-procedural), real-time image acquisition and documentation, guidance with quantitative measurements, probe manipulation, interpretation, and report, including diagnostic transesophageal echocardiography and, when performed, administration of ultrasound contrast, doppler, color flow, and 3d

right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed

left heart catheterization including intraprocedural injection(s) for left ventriculography, imaging supervision and interpretation, when performed

combined right and left heart catheterization including intraprocedural injection(s) for left ventriculography, imaging supervision and interpretation, when performed

catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation

catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography

catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization

catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization

catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed

catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography

catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed

catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography

left heart catheterization by transseptal puncture through intact septum or by transapical puncture (list separately in addition to code for primary procedure)

pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed (list separately in addition to code for primary procedure)

physiologic exercise study (eg, bicycle or arm ergometry) including assessing hemodynamic measurements before and after (list separately in addition to code for primary procedure)

insertion and placement of flow directed catheter (eg, swan-ganz) for monitoring purposes

combined right heart catheterization and retrograde left heart catheterization, for congenital cardiac anomalies

combined right heart catheterization and transseptal left heart catheterization through intact septum with or without retrograde left heart catheterization, for congenital cardiac anomalies

combined right heart catheterization and transseptal left heart catheterization through existing septal opening, with or without retrograde left heart catheterization, for congenital cardiac anomalies

indicator dilution studies such as dye or thermodilution, including arterial and/or venous catheterization; with cardiac output measurement (separate procedure)

indicator dilution studies such as dye or thermodilution, including arterial and/or venous catheterization; subsequent measurement of cardiac output

injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective coronary angiography during congenital heart catheterization (list separately in addition to code for primary procedure)

injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective opacification of aortocoronary venous or arterial bypass graft(s) (eg, aortocoronary saphenous vein, free radial artery, or free mammary artery graft) to one or more coronary arteries and in situ arterial conduits (eg, internal mammary), whether native or used for bypass to one or more coronary arteries during congenital heart catheterization, when performed (list separately in addition to code for primary procedure)

injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective left ventricular or left atrial angiography (list separately in addition to code for primary procedure)

injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective right ventricular or right atrial angiography (list separately in addition to code for primary procedure)

injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for supravalvular aortography (list separately in addition to code for primary procedure)

injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for pulmonary angiography (list separately in addition to code for primary procedure)

intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (list separately in addition to code for primary procedure)

intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; each additional vessel (list separately in addition to code for primary procedure)

percutaneous transcatheter closure of congenital interatrial communication (ie, fontan fenestration, atrial septal defect) with implant

percutaneous transcatheter closure of a congenital ventricular septal defect with implant

percutaneous transcatheter septal reduction therapy (eg, alcohol septal ablation) including temporary pacemaker insertion when performed

percutaneous transcatheter closure of paravalvular leak; initial occlusion device, mitral valve

percutaneous transcatheter closure of paravalvular leak; initial occlusion device, aortic valve

percutaneous transcatheter closure of paravalvular leak; each additional occlusion device (list separately in addition to code for primary procedure)

intraventricular and/or intra-atrial mapping of tachycardia site(s) with catheter manipulation to record from multiple sites to identify origin of tachycardia (list separately in addition to code for primary procedure)

intracardiac electrophysiologic 3-dimensional mapping (list separately in addition to code for primary procedure)

esophageal recording of atrial electrogram with or without ventricular electrogram(s)

esophageal recording of atrial electrogram with or without ventricular electrogram(s); with pacing

comprehensive electrophysiologic evaluation with right atrial pacing and recording, right ventricular pacing and recording, his bundle recording, including insertion and repositioning of multiple electrode catheters, without induction or attempted induction of arrhythmia

comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with right atrial pacing and recording, right ventricular pacing and recording, his bundle recording

comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with left atrial pacing and recording from coronary sinus or left atrium (list separately in addition to code for primary procedure)

comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with left ventricular pacing and recording (list separately in addition to code for primary procedure)

programmed stimulation and pacing after intravenous drug infusion (list separately in addition to code for primary procedure)

electrophysiologic follow-up study with pacing and recording to test effectiveness of therapy, including induction or attempted induction of arrhythmia

intra-operative epicardial and endocardial pacing and mapping to localize the site of tachycardia or zone of slow conduction for surgical correction

electrophysiologic evaluation of single or dual chamber pacing cardioverter-defibrillator leads including defibrillation threshold evaluation (induction of arrhythmia, evaluation of sensing and pacing for arrhythmia termination) at time of initial implantation or replacement

electrophysiologic evaluation of single or dual chamber pacing cardioverter-defibrillator leads including defibrillation threshold evaluation (induction of arrhythmia, evaluation of sensing and pacing for arrhythmia termination) at time of initial implantation or replacement; with testing of single or dual chamber pacing cardioverter-defibrillator pulse generator

electrophysiologic evaluation of single or dual chamber transvenous pacing cardioverter-defibrillator (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing and pacing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters)

electrophysiologic evaluation of subcutaneous implantable defibrillator (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters)

intracardiac catheter ablation of atrioventricular node function, atrioventricular conduction for creation of complete heart block, with or without temporary pacemaker placement

comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of an arrhythmia with right atrial pacing and recording, right ventricular pacing and recording (when necessary), and his bundle recording (when necessary) with intracardiac catheter ablation of arrhythmogenic focus; with treatment of supraventricular tachycardia by ablation of fast or slow atrioventricular pathway, accessory atrioventricular connection, cavo-tricuspid isthmus or other single atrial focus or source of atrial re-entry

comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of an arrhythmia with right atrial pacing and recording, right ventricular pacing and recording (when necessary), and his bundle recording (when necessary) with intracardiac catheter ablation of arrhythmogenic focus; with treatment of ventricular tachycardia or focus of ventricular ectopy including intracardiac electrophysiologic 3d mapping, when performed, and left ventricular pacing and recording, when performed

intracardiac catheter ablation of a discrete mechanism of arrhythmia which is distinct from the primary ablated mechanism, including repeat diagnostic maneuvers, to treat a spontaneous or induced arrhythmia (list separately in addition to code for primary procedure)

comprehensive electrophysiologic evaluation including transseptal catheterizations, insertion and repositioning of multiple electrode catheters with induction or attempted induction of an arrhythmia including left or right atrial pacing/recording when necessary, right ventricular pacing/recording when necessary, and his bundle recording when necessary with intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation

additional linear or focal intracardiac catheter ablation of the left or right atrium for treatment of atrial fibrillation remaining after completion of pulmonary vein isolation (list separately in addition to code for primary procedure)

evaluation of cardiovascular function with tilt table evaluation, with continuous ecg monitoring and intermittent blood pressure monitoring, with or without pharmacological intervention

intracardiac echocardiography during therapeutic/diagnostic intervention, including imaging supervision and interpretation (list separately in addition to code for primary procedure)

bioimpedance spectroscopy (bis), extracellular fluid analysis for lymphedema assessment(s)

electronic analysis of antitachycardia pacemaker system (includes electrocardiographic recording, programming of device, induction and termination of tachycardia via implanted pacemaker, and interpretation of recordings)

initial set-up and programming by a physician or other qualified health care professional of wearable cardioverter-defibrillator includes initial programming of system, establishing baseline electronic ecg, transmission of data to data repository, patient instruction in wearing system and patient reporting of problems or events

interrogation of ventricular assist device (vad), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum status, recovery), with programming, if performed, and report

ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; including recording, scanning analysis, interpretation and report

ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; recording only

ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; scanning analysis with report

ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; review with interpretation and report

patient/caregiver training for initiation of home international normalized ratio (inr) monitoring under the direction of a physician or other qualified health care professional, face-to-face, including use and care of the inr monitor, obtaining blood sample, instructions for reporting home inr test results, and documentation of patient's/caregiver's ability to perform testing and report results

anticoagulant management for a patient taking warfarin, must include review and interpretation of a new home, office, or lab international normalized ratio (inr) test result, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s), when performed

physician or other qualified health care professional services for outpatient cardiac rehabilitation; without continuous ecg monitoring (per session)

physician or other qualified health care professional services for outpatient cardiac rehabilitation; with continuous ecg monitoring (per session)

duplex scan of extracranial arteries; unilateral or limited study

transcranial doppler study of the intracranial arteries; complete study

transcranial doppler study of the intracranial arteries; limited study

transcranial doppler study of the intracranial arteries; vasoreactivity study

transcranial doppler study of the intracranial arteries; emboli detection without intravenous microbubble injection

transcranial doppler study of the intracranial arteries; emboli detection with intravenous microbubble injection

quantitative carotid intima media thickness and carotid atheroma evaluation, bilateral

limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, doppler waveform recording and analysis at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus volume plethysmography at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries with, transcutaneous oxygen tension measurement at 1-2 levels)

complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure measurements with bidirectional doppler waveform recording and analysis, at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental volume plethysmography at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental transcutaneous oxygen tension measurements at 3 or more levels), or single level study with provocative functional maneuvers (eg, measurements with postural provocative tests, or measurements with reactive hyperemia)

noninvasive physiologic studies of lower extremity arteries, at rest and following treadmill stress testing, (ie, bidirectional doppler waveform or volume plethysmography recording and analysis at rest with ankle/brachial indices immediately after and at timed intervals following performance of a standardized protocol on a motorized treadmill plus recording of time of onset of claudication or other symptoms, maximal walking time, and time to recovery) complete bilateral study

duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study

duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study

duplex scan of upper extremity arteries or arterial bypass grafts; complete bilateral study

duplex scan of upper extremity arteries or arterial bypass grafts; unilateral or limited study

duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study

duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study

duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; complete study

duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study

duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; complete study

duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study

duplex scan of arterial inflow and venous outflow of penile vessels; complete study

duplex scan of arterial inflow and venous outflow of penile vessels; follow-up or limited study

duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)

ventilation assist and management, initiation of pressure or volume preset ventilators for assisted or controlled breathing; hospital inpatient/observation, initial day

ventilation assist and management, initiation of pressure or volume preset ventilators for assisted or controlled breathing; hospital inpatient/observation, each subsequent day

ventilation assist and management, initiation of pressure or volume preset ventilators for assisted or controlled breathing; nursing facility, per day

home ventilator management care plan oversight of a patient (patient not present) in home, domiciliary or rest home (eg, assisted living) requiring review of status, review of laboratories and other studies and revision of orders and respiratory care plan (as appropriate), within a calendar month, 30 minutes or more

spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation

measurement of spirometric forced expiratory flows in an infant or child through 2 years of age

measurement of spirometric forced expiratory flows, before and after bronchodilator, in an infant or child through 2 years of age

measurement of lung volumes (ie, functional residual capacity [frc], forced vital capacity [fvc], and expiratory reserve volume [erv]) in an infant or child through 2 years of age

patient-initiated spirometric recording per 30-day period of time; includes reinforced education, transmission of spirometric tracing, data capture, analysis of transmitted data, periodic recalibration and review and interpretation by a physician or other qualified health care professional

patient-initiated spirometric recording per 30-day period of time; recording (includes hook-up, reinforced education, data transmission, data capture, trend analysis, and periodic recalibration)

patient-initiated spirometric recording per 30-day period of time; review and interpretation only by a physician or other qualified health care professional

bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration

bronchospasm provocation evaluation, multiple spirometric determinations as in 94010, with administered agents (eg, antigen[s], cold air, methacholine)

expired gas collection, quantitative, single procedure (separate procedure)

high altitude simulation test (hast), with interpretation and report by a physician or other qualified health care professional

high altitude simulation test (hast), with interpretation and report by a physician or other qualified health care professional; with supplemental oxygen titration

intrapulmonary surfactant administration by a physician or other qualified health care professional through endotracheal tube

exercise test for bronchospasm, including pre- and post-spirometry, electrocardiographic recording(s), and pulse oximetry

pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed

cardiopulmonary exercise testing, including measurements of minute ventilation, co2 production, o2 uptake, and electrocardiographic recordings

pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device

aerosol inhalation of pentamidine for pneumocystis carinii pneumonia treatment or prophylaxis

continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour

continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (list separately in addition to code for primary procedure)

continuous positive airway pressure ventilation (cpap), initiation and management

continuous negative pressure ventilation (cnp), initiation and management

demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or ippb device

manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation

manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; subsequent

mechanical chest wall oscillation to facilitate lung function, per session

oxygen uptake, expired gas analysis; rest and exercise, direct, simple

oxygen uptake, expired gas analysis; including co2 output, percentage oxygen extracted

oxygen uptake, expired gas analysis; rest, indirect (separate procedure)

plethysmography for determination of lung volumes and, when performed, airway resistance

gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes

diffusing capacity (eg, carbon monoxide, membrane) (list separately in addition to code for primary procedure)

pulmonary compliance study (eg, plethysmography, volume and pressure measurements)

noninvasive ear or pulse oximetry for oxygen saturation; single determination

noninvasive ear or pulse oximetry for oxygen saturation; multiple determinations (eg, during exercise)

noninvasive ear or pulse oximetry for oxygen saturation; by continuous overnight monitoring (separate procedure)

circadian respiratory pattern recording (pediatric pneumogram), 12-24 hour continuous recording, infant

pediatric home apnea monitoring event recording including respiratory rate, pattern and heart rate per 30-day period of time; includes monitor attachment, download of data, review, interpretation, and preparation of a report by a physician or other qualified health care professional

pediatric home apnea monitoring event recording including respiratory rate, pattern and heart rate per 30-day period of time; monitor attachment only (includes hook-up, initiation of recording and disconnection)

pediatric home apnea monitoring event recording including respiratory rate, pattern and heart rate per 30-day period of time; monitoring, download of information, receipt of transmission(s) and analyses by computer only

pediatric home apnea monitoring event recording including respiratory rate, pattern and heart rate per 30-day period of time; review, interpretation and preparation of report only by a physician or other qualified health care professional

car seat/bed testing for airway integrity, neonate, with continual nursing observation and continuous recording of pulse oximetry, heart rate and respiratory rate, with interpretation and report; 60 minutes

car seat/bed testing for airway integrity, neonate, with continual nursing observation and continuous recording of pulse oximetry, heart rate and respiratory rate, with interpretation and report; each additional full 30 minutes (list separately in addition to code for primary procedure)

percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests

allergy testing, any combination of percutaneous (scratch, puncture, prick) and intracutaneous (intradermal), sequential and incremental, with venoms, immediate type reaction, including test interpretation and report, specify number of tests

allergy testing, any combination of percutaneous (scratch, puncture, prick) and intracutaneous (intradermal), sequential and incremental, with drugs or biologicals, immediate type reaction, including test interpretation and report, specify number of tests

intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests

intracutaneous (intradermal) tests, sequential and incremental, with allergenic extracts for airborne allergens, immediate type reaction, including test interpretation and report, specify number of tests

intracutaneous (intradermal) tests with allergenic extracts, delayed type reaction, including reading, specify number of tests

inhalation bronchial challenge testing (not including necessary pulmonary function tests); with histamine, methacholine, or similar compounds

inhalation bronchial challenge testing (not including necessary pulmonary function tests); with antigens or gases, specify

ingestion challenge test (sequential and incremental ingestion of test items, eg, food, drug or other substance); initial 120 minutes of testing

ingestion challenge test (sequential and incremental ingestion of test items, eg, food, drug or other substance); each additional 60 minutes of testing (list separately in addition to code for primary procedure)

professional services for allergen immunotherapy not including provision of allergenic extracts; single injection

professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections

professional services for allergen immunotherapy in the office or institution of the prescribing physician or other qualified health care professional, including provision of allergenic extract; single injection

professional services for allergen immunotherapy in the office or institution of the prescribing physician or other qualified health care professional, including provision of allergenic extract; 2 or more injections

professional services for allergen immunotherapy in the office or institution of the prescribing physician or other qualified health care professional, including provision of allergenic extract; single stinging insect venom

professional services for allergen immunotherapy in the office or institution of the prescribing physician or other qualified health care professional, including provision of allergenic extract; 2 stinging insect venoms

professional services for allergen immunotherapy in the office or institution of the prescribing physician or other qualified health care professional, including provision of allergenic extract; 3 stinging insect venoms

professional services for allergen immunotherapy in the office or institution of the prescribing physician or other qualified health care professional, including provision of allergenic extract; 4 stinging insect venoms

professional services for allergen immunotherapy in the office or institution of the prescribing physician or other qualified health care professional, including provision of allergenic extract; 5 stinging insect venoms

professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, single dose vial(s) (specify number of vials)

professional services for the supervision of preparation and provision of antigens for allergen immunotherapy (specify number of doses); single stinging insect venom

professional services for the supervision of preparation and provision of antigens for allergen immunotherapy (specify number of doses); 2 single stinging insect venoms

professional services for the supervision of preparation and provision of antigens for allergen immunotherapy (specify number of doses); 3 single stinging insect venoms

professional services for the supervision of preparation and provision of antigens for allergen immunotherapy (specify number of doses); 4 single stinging insect venoms

professional services for the supervision of preparation and provision of antigens for allergen immunotherapy (specify number of doses); 5 single stinging insect venoms

professional services for the supervision of preparation and provision of antigens for allergen immunotherapy; single or multiple antigens (specify number of doses)

professional services for the supervision of preparation and provision of antigens for allergen immunotherapy; whole body extract of biting insect or other arthropod (specify number of doses)

rapid desensitization procedure, each hour (eg, insulin, penicillin, equine serum)

ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; patient-provided equipment, sensor placement, hook-up, calibration of monitor, patient training, and printout of recording

ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; physician or other qualified health care professional (office) provided equipment, sensor placement, hook-up, calibration of monitor, patient training, removal of sensor, and printout of recording

ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report

polysomnography; younger than 6 years, sleep staging with 4 or more additional parameters of sleep, attended by a technologist

polysomnography; younger than 6 years, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bi-level ventilation, attended by a technologist

sleep study, unattended, simultaneous recording; heart rate, oxygen saturation, respiratory analysis (eg, by airflow or peripheral arterial tone), and sleep time

sleep study, unattended, simultaneous recording; minimum of heart rate, oxygen saturation, and respiratory analysis (eg, by airflow or peripheral arterial tone)

actigraphy testing, recording, analysis, interpretation, and report (minimum of 72 hours to 14 consecutive days of recording)

multiple sleep latency or maintenance of wakefulness testing, recording, analysis and interpretation of physiological measurements of sleep during multiple trials to assess sleepiness

sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement)

sleep study, simultaneous recording of ventilation, respiratory effort, ecg or heart rate, and oxygen saturation, attended by a technologist

polysomnography; any age, sleep staging with 1-3 additional parameters of sleep, attended by a technologist

polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist

polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist

electroencephalogram (eeg) extended monitoring; greater than 1 hour

electroencephalogram (eeg); including recording awake and drowsy

electroencephalogram (eeg); including recording awake and asleep

insertion by physician or other qualified health care professional of sphenoidal electrodes for electroencephalographic (eeg) recording

muscle testing, manual (separate procedure) with report; extremity (excluding hand) or trunk

muscle testing, manual (separate procedure) with report; hand, with or without comparison with normal side

muscle testing, manual (separate procedure) with report; total evaluation of body, excluding hands

muscle testing, manual (separate procedure) with report; total evaluation of body, including hands

range of motion measurements and report (separate procedure); each extremity (excluding hand) or each trunk section (spine)

range of motion measurements and report (separate procedure); hand, with or without comparison with normal side

needle electromyography; 1 extremity with or without related paraspinal areas

needle electromyography; 2 extremities with or without related paraspinal areas

needle electromyography; 3 extremities with or without related paraspinal areas

needle electromyography; 4 extremities with or without related paraspinal areas

needle electromyography; cranial nerve supplied muscle(s), unilateral

needle electromyography; cranial nerve supplied muscles, bilateral

needle electromyography; thoracic paraspinal muscles (excluding t1 or t12)

needle electromyography; limited study of muscles in 1 extremity or non-limb (axial) muscles (unilateral or bilateral), other than thoracic paraspinal, cranial nerve supplied muscles, or sphincters

needle electromyography using single fiber electrode, with quantitative measurement of jitter, blocking and/or fiber density, any/all sites of each muscle studied

electrical stimulation for guidance in conjunction with chemodenervation (list separately in addition to code for primary procedure)

needle electromyography for guidance in conjunction with chemodenervation (list separately in addition to code for primary procedure)

ischemic limb exercise test with serial specimen(s) acquisition for muscle(s) metabolite(s)

needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (list separately in addition to code for primary procedure)

needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; complete, five or more muscles studied, innervated by three or more nerves or four or more spinal levels (list separately in addition to code for primary procedure)

needle electromyography, non-extremity (cranial nerve supplied or axial) muscle(s) done with nerve conduction, amplitude and latency/velocity study (list separately in addition to code for primary procedure)

motor and/or sensory nerve conduction, using preconfigured electrode array(s), amplitude and latency/velocity study, each limb, includes f-wave study when performed, with interpretation and report

testing of autonomic nervous system function; cardiovagal innervation (parasympathetic function), including 2 or more of the following: heart rate response to deep breathing with recorded r-r interval, valsalva ratio, and 30:15 ratio

testing of autonomic nervous system function; vasomotor adrenergic innervation (sympathetic adrenergic function), including beat-to-beat blood pressure and r-r interval changes during valsalva maneuver and at least 5 minutes of passive tilt

testing of autonomic nervous system function; sudomotor, including 1 or more of the following: quantitative sudomotor axon reflex test (qsart), silastic sweat imprint, thermoregulatory sweat test, and changes in sympathetic skin potential

testing of autonomic nervous system function; combined parasympathetic and sympathetic adrenergic function testing with at least 5 minutes of passive tilt

short-latency somatosensory evoked potential study, stimulation of any/all peripheral nerves or skin sites, recording from the central nervous system; in upper limbs

short-latency somatosensory evoked potential study, stimulation of any/all peripheral nerves or skin sites, recording from the central nervous system; in lower limbs

short-latency somatosensory evoked potential study, stimulation of any/all peripheral nerves or skin sites, recording from the central nervous system; in the trunk or head

central motor evoked potential study (transcranial motor stimulation); upper limbs

central motor evoked potential study (transcranial motor stimulation); lower limbs

visual evoked potential (vep) checkerboard or flash testing, central nervous system except glaucoma, with interpretation and report

neuromuscular junction testing (repetitive stimulation, paired stimuli), each nerve, any 1 method

short-latency somatosensory evoked potential study, stimulation of any/all peripheral nerves or skin sites, recording from the central nervous system; in upper and lower limbs

central motor evoked potential study (transcranial motor stimulation); in upper and lower limbs

continuous intraoperative neurophysiology monitoring in the operating room, one on one monitoring requiring personal attendance, each 15 minutes (list separately in addition to code for primary procedure)

continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby) or for monitoring of more than one case while in the operating room, per hour (list separately in addition to code for primary procedure)

simultaneous, independent, quantitative measures of both parasympathetic function and sympathetic function, based on time-frequency analysis of heart rate variability concurrent with time-frequency analysis of continuous respiratory activity, with mean heart rate and blood pressure measures, during rest, paced (deep) breathing, valsalva maneuvers, and head-up postural change

monitoring for identification and lateralization of cerebral seizure focus, electroencephalographic (eg, 8 channel eeg) recording and interpretation, each 24 hours

monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (eeg) and video recording and interpretation (eg, for presurgical localization), each 24 hours

monitoring for localization of cerebral seizure focus by computerized portable 16 or more channel eeg, electroencephalographic (eeg) recording and interpretation, each 24 hours, unattended

pharmacological or physical activation requiring physician or other qualified health care professional attendance during eeg recording of activation phase (eg, thiopental activation test)

electroencephalogram (eeg) during nonintracranial surgery (eg, carotid surgery)

monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, electroencephalographic (eeg) recording and interpretation, each 24 hours, attended by a technologist or nurse

digital analysis of electroencephalogram (eeg) (eg, for epileptic spike analysis)

wada activation test for hemispheric function, including electroencephalographic (eeg) monitoring

functional cortical and subcortical mapping by stimulation and/or recording of electrodes on brain surface, or of depth electrodes, to provoke seizures or identify vital brain structures; initial hour of attendance by a physician or other qualified health care professional

functional cortical and subcortical mapping by stimulation and/or recording of electrodes on brain surface, or of depth electrodes, to provoke seizures or identify vital brain structures; each additional hour of attendance by a physician or other qualified health care professional (list separately in addition to code for primary procedure)

magnetoencephalography (meg), recording and analysis; for spontaneous brain magnetic activity (eg, epileptic cerebral cortex localization)

magnetoencephalography (meg), recording and analysis; for evoked magnetic fields, single modality (eg, sensory, motor, language, or visual cortex localization)

magnetoencephalography (meg), recording and analysis; for evoked magnetic fields, each additional modality (eg, sensory, motor, language, or visual cortex localization) (list separately in addition to code for primary procedure)

electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude, pulse duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient compliance measurements); simple or complex brain, spinal cord, or peripheral (ie, cranial nerve, peripheral nerve, sacral nerve, neuromuscular) neurostimulator pulse generator/transmitter, without reprogramming

electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude, pulse duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient compliance measurements); simple spinal cord, or peripheral (ie, peripheral nerve, sacral nerve, neuromuscular) neurostimulator pulse generator/transmitter, with intraoperative or subsequent programming

electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude, pulse duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient compliance measurements); complex spinal cord, or peripheral (ie, peripheral nerve, sacral nerve, neuromuscular) (except cranial nerve) neurostimulator pulse generator/transmitter, with intraoperative or subsequent programming

electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude, pulse duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient compliance measurements); complex cranial nerve neurostimulator pulse generator/transmitter, with intraoperative or subsequent programming, with or without nerve interface testing, first hour

electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude, pulse duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient compliance measurements); complex cranial nerve neurostimulator pulse generator/transmitter, with intraoperative or subsequent programming, each additional 30 minutes after first hour (list separately in addition to code for primary procedure)

electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude and duration, battery status, electrode selectability and polarity, impedance and patient compliance measurements), complex deep brain neurostimulator pulse generator/transmitter, with initial or subsequent programming; first hour

electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude and duration, battery status, electrode selectability and polarity, impedance and patient compliance measurements), complex deep brain neurostimulator pulse generator/transmitter, with initial or subsequent programming; each additional 30 minutes after first hour (list separately in addition to code for primary procedure)

electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude and duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient measurements) gastric neurostimulator pulse generator/transmitter; intraoperative, with programming

electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude and duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient measurements) gastric neurostimulator pulse generator/transmitter; subsequent, without reprogramming

electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude and duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient measurements) gastric neurostimulator pulse generator/transmitter; subsequent, with reprogramming

refilling and maintenance of implantable pump or reservoir for drug delivery, spinal (intrathecal, epidural) or brain (intraventricular), includes electronic analysis of pump, when performed

refilling and maintenance of implantable pump or reservoir for drug delivery, spinal (intrathecal, epidural) or brain (intraventricular), includes electronic analysis of pump, when performed; requiring skill of a physician or other qualified health care professional

canalith repositioning procedure(s) (eg, epley maneuver, semont maneuver), per day

comprehensive computer-based motion analysis by video-taping and 3d kinematics

comprehensive computer-based motion analysis by video-taping and 3d kinematics; with dynamic plantar pressure measurements during walking

dynamic surface electromyography, during walking or other functional activities, 1-12 muscles

dynamic fine wire electromyography, during walking or other functional activities, 1 muscle

review and interpretation by physician or other qualified health care professional of comprehensive computer-based motion analysis, dynamic plantar pressure measurements, dynamic surface electromyography during walking or other functional activities, and dynamic fine wire electromyography, with written report

neurofunctional testing selection and administration during noninvasive imaging functional brain mapping, with test administered entirely by a physician or other qualified health care professional (ie, psychologist), with review of test results and report

medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family

psychological testing (includes psychodiagnostic assessment of emotionality, intellectual abilities, personality and psychopathology, eg, mmpi, rorschach, wais), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time interpreting these test results and preparing the report

psychological testing (includes psychodiagnostic assessment of emotionality, intellectual abilities, personality and psychopathology, eg, mmpi and wais), with qualified health care professional interpretation and report, administered by technician, per hour of technician time, face-to-face

psychological testing (includes psychodiagnostic assessment of emotionality, intellectual abilities, personality and psychopathology, eg, mmpi), administered by a computer, with qualified health care professional interpretation and report

assessment of aphasia (includes assessment of expressive and receptive speech and language function, language comprehension, speech production ability, reading, spelling, writing, eg, by boston diagnostic aphasia examination) with interpretation and report, per hour

developmental screening (eg, developmental milestone survey, speech and language delay screen), with scoring and documentation, per standardized instrument

developmental testing, (includes assessment of motor, language, social, adaptive, and/or cognitive functioning by standardized developmental instruments) with interpretation and report

neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities), per hour of the psychologist's or physician's time, both face-to-face time with the patient and time interpreting test results and preparing the report

neuropsychological testing (eg, halstead-reitan neuropsychological battery, wechsler memory scales and wisconsin card sorting test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time interpreting these test results and preparing the report

neuropsychological testing (eg, halstead-reitan neuropsychological battery, wechsler memory scales and wisconsin card sorting test), with qualified health care professional interpretation and report, administered by technician, per hour of technician time, face-to-face

neuropsychological testing (eg, wisconsin card sorting test), administered by a computer, with qualified health care professional interpretation and report

standardized cognitive performance testing (eg, ross information processing assessment) per hour of a qualified health care professional's time, both face-to-face time administering tests to the patient and time interpreting these test results and preparing the report

brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [adhd] scale), with scoring and documentation, per standardized instrument

health and behavior assessment (eg, health-focused clinical interview, behavioral observations, psychophysiological monitoring, health-oriented questionnaires), each 15 minutes face-to-face with the patient; initial assessment

health and behavior assessment (eg, health-focused clinical interview, behavioral observations, psychophysiological monitoring, health-oriented questionnaires), each 15 minutes face-to-face with the patient; re-assessment

health and behavior intervention, each 15 minutes, face-to-face; individual

health and behavior intervention, each 15 minutes, face-to-face; group (2 or more patients)

health and behavior intervention, each 15 minutes, face-to-face; family (with the patient present)

health and behavior intervention, each 15 minutes, face-to-face; family (without the patient present)

administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument

administration of caregiver-focused health risk assessment instrument (eg, depression inventory) for the benefit of the patient, with scoring and documentation, per standardized instrument

intravenous infusion, hydration; each additional hour (list separately in addition to code for primary procedure)

intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour

intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (list separately in addition to code for primary procedure)

intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (list separately in addition to code for primary procedure)

intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (list separately in addition to code for primary procedure)

subcutaneous infusion for therapy or prophylaxis (specify substance or drug); initial, up to 1 hour, including pump set-up and establishment of subcutaneous infusion site(s)

subcutaneous infusion for therapy or prophylaxis (specify substance or drug); each additional hour (list separately in addition to code for primary procedure)

subcutaneous infusion for therapy or prophylaxis (specify substance or drug); additional pump set-up with establishment of new subcutaneous infusion site(s) (list separately in addition to code for primary procedure)

therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular

therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intra-arterial

therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug

therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (list separately in addition to code for primary procedure)

therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (list separately in addition to code for primary procedure)

application of on-body injector (includes cannula insertion) for timed subcutaneous injection

unlisted therapeutic, prophylactic, or diagnostic intravenous or intra-arterial injection or infusion

chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic

chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic

chemotherapy administration; intralesional, up to and including 7 lesions

chemotherapy administration; intravenous, push technique, single or initial substance/drug

chemotherapy administration; intravenous, push technique, each additional substance/drug (list separately in addition to code for primary procedure)

chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug

chemotherapy administration, intravenous infusion technique; each additional hour (list separately in addition to code for primary procedure)

chemotherapy administration, intravenous infusion technique; initiation of prolonged chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump

chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (list separately in addition to code for primary procedure)

chemotherapy administration, intra-arterial; infusion technique, up to 1 hour

chemotherapy administration, intra-arterial; infusion technique, each additional hour (list separately in addition to code for primary procedure)

chemotherapy administration, intra-arterial; infusion technique, initiation of prolonged infusion (more than 8 hours), requiring the use of a portable or implantable pump

chemotherapy administration into pleural cavity, requiring and including thoracentesis

chemotherapy administration into the peritoneal cavity via indwelling port or catheter

chemotherapy administration, into cns (eg, intrathecal), requiring and including spinal puncture

refilling and maintenance of implantable pump or reservoir for drug delivery, systemic (eg, intravenous, intra-arterial)

irrigation of implanted venous access device for drug delivery systems

chemotherapy injection, subarachnoid or intraventricular via subcutaneous reservoir, single or multiple agents

photodynamic therapy by external application of light to destroy premalignant lesions of the skin and adjacent mucosa with application and illumination/activation of photosensitive drug(s), per day

photodynamic therapy by endoscopic application of light to ablate abnormal tissue via activation of photosensitive drug(s); first 30 minutes (list separately in addition to code for endoscopy or bronchoscopy procedures of lung and gastrointestinal tract)

photodynamic therapy by endoscopic application of light to ablate abnormal tissue via activation of photosensitive drug(s); each additional 15 minutes (list separately in addition to code for endoscopy or bronchoscopy procedures of lung and gastrointestinal tract)

photodynamic therapy by external application of light to destroy premalignant lesions of the skin and adjacent mucosa with application and illumination/activation of photosensitizing drug(s) provided by a physician or other qualified health care professional, per day

debridement of premalignant hyperkeratotic lesion(s) (ie, targeted curettage, abrasion) followed with photodynamic therapy by external application of light to destroy premalignant lesions of the skin and adjacent mucosa with application and illumination/activation of photosensitizing drug(s) provided by a physician or other qualified health care professional, per day

microscopic examination of hairs plucked or clipped by the examiner (excluding hair collected by the patient) to determine telogen and anagen counts, or structural hair shaft abnormality

whole body integumentary photography, for monitoring of high risk patients with dysplastic nevus syndrome or a history of dysplastic nevi, or patients with a personal or familial history of melanoma

photochemotherapy; tar and ultraviolet b (goeckerman treatment) or petrolatum and ultraviolet b

photochemotherapy (goeckerman and/or puva) for severe photoresponsive dermatoses requiring at least 4-8 hours of care under direct supervision of the physician (includes application of medication and dressings)

laser treatment for inflammatory skin disease (psoriasis); total area less than 250 sq cm

laser treatment for inflammatory skin disease (psoriasis); 250 sq cm to 500 sq cm

laser treatment for inflammatory skin disease (psoriasis); over 500 sq cm

reflectance confocal microscopy (rcm) for cellular and sub-cellular imaging of skin; image acquisition and interpretation and report, first lesion

reflectance confocal microscopy (rcm) for cellular and sub-cellular imaging of skin; image acquisition only, first lesion

reflectance confocal microscopy (rcm) for cellular and sub-cellular imaging of skin; interpretation and report only, first lesion

reflectance confocal microscopy (rcm) for cellular and sub-cellular imaging of skin; image acquisition and interpretation and report, each additional lesion (list separately in addition to code for primary procedure)

reflectance confocal microscopy (rcm) for cellular and sub-cellular imaging of skin; image acquisition only, each additional lesion (list separately in addition to code for primary procedure)

reflectance confocal microscopy (rcm) for cellular and sub-cellular imaging of skin; interpretation and report only, each additional lesion (list separately in addition to code for primary procedure)

application of a modality to 1 or more areas; traction, mechanical

application of a modality to 1 or more areas; electrical stimulation (unattended)

application of a modality to 1 or more areas; vasopneumatic devices

application of a modality to 1 or more areas; diathermy (eg, microwave)

application of a modality to 1 or more areas; electrical stimulation (manual), each 15 minutes

application of a modality to 1 or more areas; iontophoresis, each 15 minutes

application of a modality to 1 or more areas; contrast baths, each 15 minutes

application of a modality to 1 or more areas; ultrasound, each 15 minutes

application of a modality to 1 or more areas; hubbard tank, each 15 minutes

unlisted modality (specify type and time if constant attendance)

therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility

therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities

therapeutic procedure, 1 or more areas, each 15 minutes; aquatic therapy with therapeutic exercises

therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)

therapeutic procedure, 1 or more areas, each 15 minutes; massage, including effleurage, petrissage and/or tapotement (stroking, compression, percussion)

therapeutic interventions that focus on cognitive function (eg, attention, memory, reasoning, executive function, problem solving, and/or pragmatic functioning) and compensatory strategies to manage the performance of an activity (eg, managing time or schedules, initiating, organizing and sequencing tasks), direct (one-on-one) patient contact

manual therapy techniques (eg, mobilization/ manipulation, manual lymphatic drainage, manual traction), 1 or more regions, each 15 minutes

physical therapy evaluation: low complexity, requiring these components: a history with no personal factors and/or comorbidities that impact the plan of care; an examination of body system(s) using standardized tests and measures addressing 1-2 elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; a clinical presentation with stable and/or uncomplicated characteristics; and clinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. typically, 20 minutes are spent face-to-face with the patient and/or family.

physical therapy evaluation: moderate complexity, requiring these components: a history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; an examination of body systems using standardized tests and measures in addressing a total of 3 or more elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; an evolving clinical presentation with changing characteristics; and clinical decision making of moderate complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. typically, 30 minutes are spent face-to-face with the patient and/or family.

physical therapy evaluation: high complexity, requiring these components: a history of present problem with 3 or more personal factors and/or comorbidities that impact the plan of care; an examination of body systems using standardized tests and measures addressing a total of 4 or more elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; a clinical presentation with unstable and unpredictable characteristics; and clinical decision making of high complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. typically, 45 minutes are spent face-to-face with the patient and/or family.

re-evaluation of physical therapy established plan of care, requiring these components: an examination including a review of history and use of standardized tests and measures is required; and revised plan of care using a standardized patient assessment instrument and/or measurable assessment of functional outcome typically, 20 minutes are spent face-to-face with the patient and/or family.

occupational therapy evaluation, low complexity, requiring these components: an occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; an assessment(s) that identifies 1-3 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and clinical decision making of low complexity, which includes an analysis of the occupational profile, analysis of data from problem-focused assessment(s), and consideration of a limited number of treatment options. patient presents with no comorbidities that affect occupational performance. modification of tasks or assistance (eg, physical or verbal) with assessment(s) is not necessary to enable completion of evaluation component. typically, 30 minutes are spent face-to-face with the patient and/or family.

occupational therapy evaluation, moderate complexity, requiring these components: an occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or psychosocial history related to current functional performance; an assessment(s) that identifies 3-5 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and clinical decision making of moderate analytic complexity, which includes an analysis of the occupational profile, analysis of data from detailed assessment(s), and consideration of several treatment options. patient may present with comorbidities that affect occupational performance. minimal to moderate modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component. typically, 45 minutes are spent face-to-face with the patient and/or family.

occupational therapy evaluation, high complexity, requiring these components: an occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psychosocial history related to current functional performance; an assessment(s) that identifies 5 or more performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and clinical decision making of high analytic complexity, which includes an analysis of the patient profile, analysis of data from comprehensive assessment(s), and consideration of multiple treatment options. patient presents with comorbidities that affect occupational performance. significant modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component. typically, 60 minutes are spent face-to-face with the patient and/or family.

re-evaluation of occupational therapy established plan of care, requiring these components: an assessment of changes in patient functional or medical status with revised plan of care; an update to the initial occupational profile to reflect changes in condition or environment that affect future interventions and/or goals; and a revised plan of care. a formal reevaluation is performed when there is a documented change in functional status or a significant change to the plan of care is required. typically, 30 minutes are spent face-to-face with the patient and/or family.

athletic training evaluation, low complexity, requiring these components: a history and physical activity profile with no comorbidities that affect physical activity; an examination of affected body area and other symptomatic or related systems addressing 1-2 elements from any of the following: body structures, physical activity, and/or participation deficiencies; and clinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. typically, 15 minutes are spent face-to-face with the patient and/or family.

athletic training evaluation, moderate complexity, requiring these components: a medical history and physical activity profile with 1-2 comorbidities that affect physical activity; an examination of affected body area and other symptomatic or related systems addressing a total of 3 or more elements from any of the following: body structures, physical activity, and/or participation deficiencies; and clinical decision making of moderate complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. typically, 30 minutes are spent face-to-face with the patient and/or family.

athletic training evaluation, high complexity, requiring these components: a medical history and physical activity profile, with 3 or more comorbidities that affect physical activity; a comprehensive examination of body systems using standardized tests and measures addressing a total of 4 or more elements from any of the following: body structures, physical activity, and/or participation deficiencies; clinical presentation with unstable and unpredictable characteristics; and clinical decision making of high complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. typically, 45 minutes are spent face-to-face with the patient and/or family.

re-evaluation of athletic training established plan of care requiring these components: an assessment of patient's current functional status when there is a documented change; and a revised plan of care using a standardized patient assessment instrument and/or measurable assessment of functional outcome with an update in management options, goals, and interventions. typically, 20 minutes are spent face-to-face with the patient and/or family.

therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes

sensory integrative techniques to enhance sensory processing and promote adaptive responses to environmental demands, direct (one-on-one) patient contact, each 15 minutes

self-care/home management training (eg, activities of daily living (adl) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes

community/work reintegration training (eg, shopping, transportation, money management, avocational activities and/or work environment/modification analysis, work task analysis, use of assistive technology device/adaptive equipment), direct one-on-one contact, each 15 minutes

wheelchair management (eg, assessment, fitting, training), each 15 minutes

work hardening/conditioning; each additional hour (list separately in addition to code for primary procedure)

debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, use of a whirlpool, when performed and instruction(s) for ongoing care, per session, total wound(s) surface area; first 20 sq cm or less

debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, use of a whirlpool, when performed and instruction(s) for ongoing care, per session, total wound(s) surface area; each additional 20 sq cm, or part thereof (list separately in addition to code for primary procedure)

removal of devitalized tissue from wound(s), non-selective debridement, without anesthesia (eg, wet-to-moist dressings, enzymatic, abrasion, larval therapy), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session

negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (dme), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less than or equal to 50 square centimeters

negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (dme), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area greater than 50 square centimeters

negative pressure wound therapy, (eg, vacuum assisted drainage collection), utilizing disposable, non-durable medical equipment including provision of exudate management collection system, topical application(s), wound assessment, and instructions for ongoing care, per session; total wound(s) surface area less than or equal to 50 square centimeters

negative pressure wound therapy, (eg, vacuum assisted drainage collection), utilizing disposable, non-durable medical equipment including provision of exudate management collection system, topical application(s), wound assessment, and instructions for ongoing care, per session; total wound(s) surface area greater than 50 square centimeters

low frequency, non-contact, non-thermal ultrasound, including topical application(s), when performed, wound assessment, and instruction(s) for ongoing care, per day

physical performance test or measurement (eg, musculoskeletal, functional capacity), with written report, each 15 minutes

assistive technology assessment (eg, to restore, augment or compensate for existing function, optimize functional tasks and/or maximize environmental accessibility), direct one-on-one contact, with written report, each 15 minutes

orthotic(s) management and training (including assessment and fitting when not otherwise reported), upper extremity(ies), lower extremity(ies) and/or trunk, initial orthotic(s) encounter, each 15 minutes

prosthetic(s) training, upper and/or lower extremity(ies), initial prosthetic(s) encounter, each 15 minutes

orthotic(s)/prosthetic(s) management and/or training, upper extremity(ies), lower extremity(ies), and/or trunk, subsequent orthotic(s)/prosthetic(s) encounter, each 15 minutes

medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes

medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes

medical nutrition therapy; group (2 or more individual(s)), each 30 minutes

acupuncture, 1 or more needles; without electrical stimulation, initial 15 minutes of personal one-on-one contact with the patient

acupuncture, 1 or more needles; without electrical stimulation, each additional 15 minutes of personal one-on-one contact with the patient, with re-insertion of needle(s) (list separately in addition to code for primary procedure)

acupuncture, 1 or more needles; with electrical stimulation, initial 15 minutes of personal one-on-one contact with the patient

acupuncture, 1 or more needles; with electrical stimulation, each additional 15 minutes of personal one-on-one contact with the patient, with re-insertion of needle(s) (list separately in addition to code for primary procedure)

osteopathic manipulative treatment (omt); 1-2 body regions involved

osteopathic manipulative treatment (omt); 3-4 body regions involved

osteopathic manipulative treatment (omt); 5-6 body regions involved

osteopathic manipulative treatment (omt); 7-8 body regions involved

osteopathic manipulative treatment (omt); 9-10 body regions involved

chiropractic manipulative treatment (cmt); extraspinal, 1 or more regions

education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; individual patient

education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 2-4 patients

education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 5-8 patients

telephone assessment and management service provided by a qualified nonphysician health care professional to an established patient, parent, or guardian not originating from a related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion

telephone assessment and management service provided by a qualified nonphysician health care professional to an established patient, parent, or guardian not originating from a related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion

telephone assessment and management service provided by a qualified nonphysician health care professional to an established patient, parent, or guardian not originating from a related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion

online assessment and management service provided by a qualified nonphysician health care professional to an established patient or guardian, not originating from a related assessment and management service provided within the previous 7 days, using the internet or similar electronic communications network

handling and/or conveyance of specimen for transfer from the office to a laboratory

handling and/or conveyance of specimen for transfer from the patient in other than an office to a laboratory (distance may be indicated)

handling, conveyance, and/or any other service in connection with the implementation of an order involving devices (eg, designing, fitting, packaging, handling, delivery or mailing) when devices such as orthotics, protectives, prosthetics are fabricated by an outside laboratory or shop but which items have been designed, and are to be fitted and adjusted by the attending physician or other qualified health care professional

postoperative follow-up visit, normally included in the surgical package, to indicate that an evaluation and management service was performed during a postoperative period for a reason(s) related to the original procedure

services provided in the office at times other than regularly scheduled office hours, or days when the office is normally closed (eg, holidays, saturday or sunday), in addition to basic service

service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service

service(s) provided between 10:00 pm and 8:00 am at 24-hour facility, in addition to basic service

service(s) typically provided in the office, provided out of the office at request of patient, in addition to basic service

service(s) provided on an emergency basis in the office, which disrupts other scheduled office services, in addition to basic service

service(s) provided on an emergency basis, out of the office, which disrupts other scheduled office services, in addition to basic service

supplies and materials (except spectacles), provided by the physician or other qualified health care professional over and above those usually included with the office visit or other services rendered (list drugs, trays, supplies, or materials provided)

educational supplies, such as books, tapes, and pamphlets, for the patient's education at cost to physician or other qualified health care professional

physician or other qualified health care professional qualified by education, training, licensure/regulation (when applicable) educational services rendered to patients in a group setting (eg, prenatal, obesity, or diabetic instructions)

special reports such as insurance forms, more than the information conveyed in the usual medical communications or standard reporting form

analysis of clinical data stored in computers (eg, ecgs, blood pressures, hematologic data)

collection and interpretation of physiologic data (eg, ecg, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the physician or other qualified health care professional, qualified by education, training, licensure/regulation (when applicable) requiring a minimum of 30 minutes of time

anesthesia for patient of extreme age, younger than 1 year and older than 70 (list separately in addition to code for primary anesthesia procedure)

anesthesia complicated by utilization of total body hypothermia (list separately in addition to code for primary anesthesia procedure)

anesthesia complicated by utilization of controlled hypotension (list separately in addition to code for primary anesthesia procedure)

anesthesia complicated by emergency conditions (specify) (list separately in addition to code for primary anesthesia procedure)

moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient younger than 5 years of age

moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older

moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (list separately in addition to code for primary service)

moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; initial 15 minutes of intraservice time, patient younger than 5 years of age

moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; initial 15 minutes of intraservice time, patient age 5 years or older

moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; each additional 15 minutes intraservice time (list separately in addition to code for primary service)

anogenital examination, magnified, in childhood for suspected trauma, including image recording when performed

visual function screening, automated or semi-automated bilateral quantitative determination of visual acuity, ocular alignment, color vision by pseudoisochromatic plates, and field of vision (may include all or some screening of the determination[s] for contrast sensitivity, vision under glare)

instrument-based ocular screening (eg, photoscreening, automated-refraction), bilateral; with remote analysis and report

ipecac or similar administration for individual emesis and continued observation until stomach adequately emptied of poison

instrument-based ocular screening (eg, photoscreening, automated-refraction), bilateral; with on-site analysis

physician or other qualified health care professional attendance and supervision of hyperbaric oxygen therapy, per session

initiation of selective head or total body hypothermia in the critically ill neonate, includes appropriate patient selection by review of clinical, imaging and laboratory data, confirmation of esophageal temperature probe location, evaluation of amplitude eeg, supervision of controlled hypothermia, and assessment of patient tolerance of cooling

application of topical fluoride varnish by a physician or other qualified health care professional

assembly and operation of pump with oxygenator or heat exchanger (with or without ecg and/or pressure monitoring); each hour

assembly and operation of pump with oxygenator or heat exchanger (with or without ecg and/or pressure monitoring); 45 minutes

assembly and operation of pump with oxygenator or heat exchanger (with or without ecg and/or pressure monitoring); 30 minutes

office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent face-to-face with the patient and/or family.

office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of low to moderate severity. typically, 20 minutes are spent face-to-face with the patient and/or family.

office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate severity. typically, 30 minutes are spent face-to-face with the patient and/or family.

office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent face-to-face with the patient and/or family.

office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent face-to-face with the patient and/or family.

office or other outpatient visit for the evaluation and management of an established patient, that may not require the presence of a physician or other qualified health care professional. usually, the presenting problem(s) are minimal. typically, 5 minutes are spent performing or supervising these services.

office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent face-to-face with the patient and/or family.

office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity. counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of low to moderate severity. typically, 15 minutes are spent face-to-face with the patient and/or family.

office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent face-to-face with the patient and/or family.

office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent face-to-face with the patient and/or family.

observation care discharge day management (this code is to be utilized to report all services provided to a patient on discharge from outpatient hospital "observation status" if the discharge is on other than the initial date of "observation status." to report services to a patient designated as "observation status" or "inpatient status" and discharged on the same date, use the codes for observation or inpatient care services [including admission and discharge services, 99234-99236 as appropriate.])

initial observation care, per day, for the evaluation and management of a patient which requires these 3 key components: a detailed or comprehensive history; a detailed or comprehensive examination; and medical decision making that is straightforward or of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the problem(s) requiring admission to outpatient hospital "observation status" are of low severity. typically, 30 minutes are spent at the bedside and on the patient's hospital floor or unit.

initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the problem(s) requiring admission to outpatient hospital "observation status" are of moderate severity. typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit.

initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the problem(s) requiring admission to outpatient hospital "observation status" are of high severity. typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.

initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: a detailed or comprehensive history; a detailed or comprehensive examination; and medical decision making that is straightforward or of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the problem(s) requiring admission are of low severity. typically, 30 minutes are spent at the bedside and on the patient's hospital floor or unit.

initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the problem(s) requiring admission are of moderate severity. typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit.

initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the problem(s) requiring admission are of high severity. typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.

subsequent observation care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: problem focused interval history; problem focused examination; medical decision making that is straightforward or of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is stable, recovering, or improving. typically, 15 minutes are spent at the bedside and on the patient's hospital floor or unit.

subsequent observation care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: an expanded problem focused interval history; an expanded problem focused examination; medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is responding inadequately to therapy or has developed a minor complication. typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.

subsequent observation care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: a detailed interval history; a detailed examination; medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is unstable or has developed a significant complication or a significant new problem. typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit.

subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: a problem focused interval history; a problem focused examination; medical decision making that is straightforward or of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is stable, recovering or improving. typically, 15 minutes are spent at the bedside and on the patient's hospital floor or unit.

subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: an expanded problem focused interval history; an expanded problem focused examination; medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is responding inadequately to therapy or has developed a minor complication. typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.

subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: a detailed interval history; a detailed examination; medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is unstable or has developed a significant complication or a significant new problem. typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit.

observation or inpatient hospital care, for the evaluation and management of a patient including admission and discharge on the same date, which requires these 3 key components: a detailed or comprehensive history; a detailed or comprehensive examination; and medical decision making that is straightforward or of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually the presenting problem(s) requiring admission are of low severity. typically, 40 minutes are spent at the bedside and on the patient's hospital floor or unit.

observation or inpatient hospital care, for the evaluation and management of a patient including admission and discharge on the same date, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually the presenting problem(s) requiring admission are of moderate severity. typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit.

observation or inpatient hospital care, for the evaluation and management of a patient including admission and discharge on the same date, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually the presenting problem(s) requiring admission are of high severity. typically, 55 minutes are spent at the bedside and on the patient's hospital floor or unit.

office consultation for a new or established patient, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are self limited or minor. typically, 15 minutes are spent face-to-face with the patient and/or family.

office consultation for a new or established patient, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; and straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of low severity. typically, 30 minutes are spent face-to-face with the patient and/or family.

office consultation for a new or established patient, which requires these 3 key components: a detailed history; a detailed examination; and medical decision making of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate severity. typically, 40 minutes are spent face-to-face with the patient and/or family.

office consultation for a new or established patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent face-to-face with the patient and/or family.

office consultation for a new or established patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 80 minutes are spent face-to-face with the patient and/or family.

inpatient consultation for a new or established patient, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are self limited or minor. typically, 20 minutes are spent at the bedside and on the patient's hospital floor or unit.

inpatient consultation for a new or established patient, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; and straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of low severity. typically, 40 minutes are spent at the bedside and on the patient's hospital floor or unit.

inpatient consultation for a new or established patient, which requires these 3 key components: a detailed history; a detailed examination; and medical decision making of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate severity. typically, 55 minutes are spent at the bedside and on the patient's hospital floor or unit.

inpatient consultation for a new or established patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 80 minutes are spent at the bedside and on the patient's hospital floor or unit.

inpatient consultation for a new or established patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 110 minutes are spent at the bedside and on the patient's hospital floor or unit.

emergency department visit for the evaluation and management of a patient, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are self limited or minor.

emergency department visit for the evaluation and management of a patient, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; and medical decision making of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of low to moderate severity.

emergency department visit for the evaluation and management of a patient, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate severity.

emergency department visit for the evaluation and management of a patient, which requires these 3 key components: a detailed history; a detailed examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of high severity, and require urgent evaluation by the physician, or other qualified health care professionals but do not pose an immediate significant threat to life or physiologic function.

emergency department visit for the evaluation and management of a patient, which requires these 3 key components within the constraints imposed by the urgency of the patient's clinical condition and/or mental status: a comprehensive history; a comprehensive examination; and medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of high severity and pose an immediate significant threat to life or physiologic function.

physician or other qualified health care professional direction of emergency medical systems (ems) emergency care, advanced life support

critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes

critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (list separately in addition to code for primary service)

initial nursing facility care, per day, for the evaluation and management of a patient, which requires these 3 key components: a detailed or comprehensive history; a detailed or comprehensive examination; and medical decision making that is straightforward or of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the problem(s) requiring admission are of low severity. typically, 25 minutes are spent at the bedside and on the patient's facility floor or unit.

initial nursing facility care, per day, for the evaluation and management of a patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the problem(s) requiring admission are of moderate severity. typically, 35 minutes are spent at the bedside and on the patient's facility floor or unit.

initial nursing facility care, per day, for the evaluation and management of a patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the problem(s) requiring admission are of high severity. typically, 45 minutes are spent at the bedside and on the patient's facility floor or unit.

subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: a problem focused interval history; a problem focused examination; straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is stable, recovering, or improving. typically, 10 minutes are spent at the bedside and on the patient's facility floor or unit.

subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: an expanded problem focused interval history; an expanded problem focused examination; medical decision making of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is responding inadequately to therapy or has developed a minor complication. typically, 15 minutes are spent at the bedside and on the patient's facility floor or unit.

subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: a detailed interval history; a detailed examination; medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient has developed a significant complication or a significant new problem. typically, 25 minutes are spent at the bedside and on the patient's facility floor or unit.

subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: a comprehensive interval history; a comprehensive examination; medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. the patient may be unstable or may have developed a significant new problem requiring immediate physician attention. typically, 35 minutes are spent at the bedside and on the patient's facility floor or unit.

evaluation and management of a patient involving an annual nursing facility assessment, which requires these 3 key components: a detailed interval history; a comprehensive examination; and medical decision making that is of low to moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is stable, recovering, or improving. typically, 30 minutes are spent at the bedside and on the patient's facility floor or unit.

domiciliary or rest home visit for the evaluation and management of a new patient, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of low severity. typically, 20 minutes are spent with the patient and/or family or caregiver.

domiciliary or rest home visit for the evaluation and management of a new patient, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; and medical decision making of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate severity. typically, 30 minutes are spent with the patient and/or family or caregiver.

domiciliary or rest home visit for the evaluation and management of a new patient, which requires these 3 key components: a detailed history; a detailed examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent with the patient and/or family or caregiver.

domiciliary or rest home visit for the evaluation and management of a new patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of high severity. typically, 60 minutes are spent with the patient and/or family or caregiver.

domiciliary or rest home visit for the evaluation and management of a new patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is unstable or has developed a significant new problem requiring immediate physician attention. typically, 75 minutes are spent with the patient and/or family or caregiver.

domiciliary or rest home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: a problem focused interval history; a problem focused examination; straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are self-limited or minor. typically, 15 minutes are spent with the patient and/or family or caregiver.

domiciliary or rest home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: an expanded problem focused interval history; an expanded problem focused examination; medical decision making of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of low to moderate severity. typically, 25 minutes are spent with the patient and/or family or caregiver.

domiciliary or rest home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: a detailed interval history; a detailed examination; medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent with the patient and/or family or caregiver.

domiciliary or rest home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: a comprehensive interval history; a comprehensive examination; medical decision making of moderate to high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. the patient may be unstable or may have developed a significant new problem requiring immediate physician attention. typically, 60 minutes are spent with the patient and/or family or caregiver.

individual physician supervision of a patient (patient not present) in home, domiciliary or rest home (eg, assisted living facility) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 15-29 minutes

individual physician supervision of a patient (patient not present) in home, domiciliary or rest home (eg, assisted living facility) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 30 minutes or more

home visit for the evaluation and management of a new patient, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of low severity. typically, 20 minutes are spent face-to-face with the patient and/or family.

home visit for the evaluation and management of a new patient, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; and medical decision making of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate severity. typically, 30 minutes are spent face-to-face with the patient and/or family.

home visit for the evaluation and management of a new patient, which requires these 3 key components: a detailed history; a detailed examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent face-to-face with the patient and/or family.

home visit for the evaluation and management of a new patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of high severity. typically, 60 minutes are spent face-to-face with the patient and/or family.

home visit for the evaluation and management of a new patient, which requires these 3 key components: a comprehensive history; a comprehensive examination; and medical decision making of high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the patient is unstable or has developed a significant new problem requiring immediate physician attention. typically, 75 minutes are spent face-to-face with the patient and/or family.

home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: a problem focused interval history; a problem focused examination; straightforward medical decision making. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are self limited or minor. typically, 15 minutes are spent face-to-face with the patient and/or family.

home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: an expanded problem focused interval history; an expanded problem focused examination; medical decision making of low complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of low to moderate severity. typically, 25 minutes are spent face-to-face with the patient and/or family.

home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: a detailed interval history; a detailed examination; medical decision making of moderate complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are moderate to high severity. typically, 40 minutes are spent face-to-face with the patient and/or family.

home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: a comprehensive interval history; a comprehensive examination; medical decision making of moderate to high complexity. counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. usually, the presenting problem(s) are of moderate to high severity. the patient may be unstable or may have developed a significant new problem requiring immediate physician attention. typically, 60 minutes are spent face-to-face with the patient and/or family.

prolonged evaluation and management or psychotherapy service(s) (beyond the typical service time of the primary procedure) in the office or other outpatient setting requiring direct patient contact beyond the usual service; first hour (list separately in addition to code for office or other outpatient evaluation and management or psychotherapy service)

prolonged evaluation and management or psychotherapy service(s) (beyond the typical service time of the primary procedure) in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code for prolonged service)

prolonged service in the inpatient or observation setting, requiring unit/floor time beyond the usual service; first hour (list separately in addition to code for inpatient evaluation and management service)

prolonged service in the inpatient or observation setting, requiring unit/floor time beyond the usual service; each additional 30 minutes (list separately in addition to code for prolonged service)

prolonged evaluation and management service before and/or after direct patient care; first hour

prolonged evaluation and management service before and/or after direct patient care; each additional 30 minutes (list separately in addition to code for prolonged service)

standby service, requiring prolonged attendance, each 30 minutes (eg, operative standby, standby for frozen section, for cesarean/high risk delivery, for monitoring eeg)

medical team conference with interdisciplinary team of health care professionals, face-to-face with patient and/or family, 30 minutes or more, participation by nonphysician qualified health care professional

medical team conference with interdisciplinary team of health care professionals, patient and/or family not present, 30 minutes or more; participation by physician

medical team conference with interdisciplinary team of health care professionals, patient and/or family not present, 30 minutes or more; participation by nonphysician qualified health care professional

supervision of a patient under care of home health agency (patient not present) in home, domiciliary or equivalent environment (eg, alzheimer's facility) requiring complex and multidisciplinary care modalities involving regular development and/or revision of care plans by that individual, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 15-29 minutes

supervision of a patient under care of home health agency (patient not present) in home, domiciliary or equivalent environment (eg, alzheimer's facility) requiring complex and multidisciplinary care modalities involving regular development and/or revision of care plans by that individual, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 30 minutes or more

supervision of a hospice patient (patient not present) requiring complex and multidisciplinary care modalities involving regular development and/or revision of care plans by that individual, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 15-29 minutes

supervision of a hospice patient (patient not present) requiring complex and multidisciplinary care modalities involving regular development and/or revision of care plans by that individual, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 30 minutes or more

supervision of a nursing facility patient (patient not present) requiring complex and multidisciplinary care modalities involving regular development and/or revision of care plans by that individual, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 15-29 minutes

supervision of a nursing facility patient (patient not present) requiring complex and multidisciplinary care modalities involving regular development and/or revision of care plans by that individual, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 30 minutes or more

initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; infant (age younger than 1 year)

initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; early childhood (age 1 through 4 years)

initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; late childhood (age 5 through 11 years)

initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; adolescent (age 12 through 17 years)

initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 18-39 years

initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 40-64 years

initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 65 years and older

periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year)

periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years)

periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years)

periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years)

periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years

periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years

periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 65 years and older

preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes

preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 30 minutes

preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 45 minutes

preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 60 minutes

smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes

smoking and tobacco use cessation counseling visit; intensive, greater than 10 minutes

alcohol and/or substance (other than tobacco) abuse structured screening (eg, audit, dast), and brief intervention (sbi) services; 15 to 30 minutes

alcohol and/or substance (other than tobacco) abuse structured screening (eg, audit, dast), and brief intervention (sbi) services; greater than 30 minutes

preventive medicine counseling and/or risk factor reduction intervention(s) provided to individuals in a group setting (separate procedure); approximately 30 minutes

preventive medicine counseling and/or risk factor reduction intervention(s) provided to individuals in a group setting (separate procedure); approximately 60 minutes

prolonged clinical staff service (the service beyond the typical service time) during an evaluation and management service in the office or outpatient setting, direct patient contact with physician supervision; first hour (list separately in addition to code for outpatient evaluation and management service)

prolonged clinical staff service (the service beyond the typical service time) during an evaluation and management service in the office or outpatient setting, direct patient contact with physician supervision; each additional 30 minutes (list separately in addition to code for prolonged service)

telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion

telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion

telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion

online evaluation and management service provided by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient or guardian, not originating from a related e/m service provided within the previous 7 days, using the internet or similar electronic communications network

interprofessional telephone/internet assessment and management service provided by a consultative physician including a verbal and written report to the patient's treating/requesting physician or other qualified health care professional; 5-10 minutes of medical consultative discussion and review

interprofessional telephone/internet assessment and management service provided by a consultative physician including a verbal and written report to the patient's treating/requesting physician or other qualified health care professional; 11-20 minutes of medical consultative discussion and review

interprofessional telephone/internet assessment and management service provided by a consultative physician including a verbal and written report to the patient's treating/requesting physician or other qualified health care professional; 21-30 minutes of medical consultative discussion and review

interprofessional telephone/internet assessment and management service provided by a consultative physician including a verbal and written report to the patient's treating/requesting physician or other qualified health care professional; 31 minutes or more of medical consultative discussion and review

basic life and/or disability examination that includes: measurement of height, weight, and blood pressure; completion of a medical history following a life insurance pro forma; collection of blood sample and/or urinalysis complying with "chain of custody" protocols; and completion of necessary documentation/certificates.

work related or medical disability examination by the treating physician that includes: completion of a medical history commensurate with the patient's condition; performance of an examination commensurate with the patient's condition; formulation of a diagnosis, assessment of capabilities and stability, and calculation of impairment; development of future medical treatment plan; and completion of necessary documentation/certificates and report.

work related or medical disability examination by other than the treating physician that includes: completion of a medical history commensurate with the patient's condition; performance of an examination commensurate with the patient's condition; formulation of a diagnosis, assessment of capabilities and stability, and calculation of impairment; development of future medical treatment plan; and completion of necessary documentation/certificates and report.

initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant

initial care, per day, for evaluation and management of normal newborn infant seen in other than hospital or birthing center

subsequent hospital care, per day, for evaluation and management of normal newborn

initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant admitted and discharged on the same date

attendance at delivery (when requested by the delivering physician or other qualified health care professional) and initial stabilization of newborn

delivery/birthing room resuscitation, provision of positive pressure ventilation and/or chest compressions in the presence of acute inadequate ventilation and/or cardiac output

critical care face-to-face services, during an interfacility transport of critically ill or critically injured pediatric patient, 24 months of age or younger; first 30-74 minutes of hands-on care during transport

critical care face-to-face services, during an interfacility transport of critically ill or critically injured pediatric patient, 24 months of age or younger; each additional 30 minutes (list separately in addition to code for primary service)

initial inpatient neonatal critical care, per day, for the evaluation and management of a critically ill neonate, 28 days of age or younger

subsequent inpatient neonatal critical care, per day, for the evaluation and management of a critically ill neonate, 28 days of age or younger

initial inpatient pediatric critical care, per day, for the evaluation and management of a critically ill infant or young child, 29 days through 24 months of age

subsequent inpatient pediatric critical care, per day, for the evaluation and management of a critically ill infant or young child, 29 days through 24 months of age

initial inpatient pediatric critical care, per day, for the evaluation and management of a critically ill infant or young child, 2 through 5 years of age

subsequent inpatient pediatric critical care, per day, for the evaluation and management of a critically ill infant or young child, 2 through 5 years of age

initial hospital care, per day, for the evaluation and management of the neonate, 28 days of age or younger, who requires intensive observation, frequent interventions, and other intensive care services

subsequent intensive care, per day, for the evaluation and management of the recovering very low birth weight infant (present body weight less than 1500 grams)

subsequent intensive care, per day, for the evaluation and management of the recovering low birth weight infant (present body weight of 1500-2500 grams)

subsequent intensive care, per day, for the evaluation and management of the recovering infant (present body weight of 2501-5000 grams)

assessment of and care planning for a patient with cognitive impairment, requiring an independent historian, in the office or other outpatient, home or domiciliary or rest home, with all of the following required elements: cognition-focused evaluation including a pertinent history and examination; medical decision making of moderate or high complexity; functional assessment (eg, basic and instrumental activities of daily living), including decision-making capacity; use of standardized instruments for staging of dementia (eg, functional assessment staging test [fast], clinical dementia rating [cdr]); medication reconciliation and review for high-risk medications; evaluation for neuropsychiatric and behavioral symptoms, including depression, including use of standardized screening instrument(s); evaluation of safety (eg, home), including motor vehicle operation; identification of caregiver(s), caregiver knowledge, caregiver needs, social supports, and the willingness of caregiver to take on caregiving tasks; development, updating or revision, or review of an advance care plan; creation of a written care plan, including initial plans to address any neuropsychiatric symptoms, neuro-cognitive symptoms, functional limitations, and referral to community resources as needed (eg, rehabilitation services, adult day programs, support groups) shared with the patient and/or caregiver with initial education and support. typically, 50 minutes are spent face-to-face with the patient and/or family or caregiver.

care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team.

supervision by a control physician of interfacility transport care of the critically ill or critically injured pediatric patient, 24 months of age or younger, includes two-way communication with transport team before transport, at the referring facility and during the transport, including data interpretation and report; first 30 minutes

supervision by a control physician of interfacility transport care of the critically ill or critically injured pediatric patient, 24 months of age or younger, includes two-way communication with transport team before transport, at the referring facility and during the transport, including data interpretation and report; each additional 30 minutes (list separately in addition to code for primary procedure)

complex chronic care management services, with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, establishment or substantial revision of a comprehensive care plan, moderate or high complexity medical decision making; 60 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month.

complex chronic care management services, with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, establishment or substantial revision of a comprehensive care plan, moderate or high complexity medical decision making; 60 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month.; each additional 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure)

chronic care management services, at least 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month, with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient; chronic conditions place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline; comprehensive care plan established, implemented, revised, or monitored.

initial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan; review by the psychiatric consultant with modifications of the plan if recommended; entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies.

subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation; participation in weekly caseload consultation with the psychiatric consultant; ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers; additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant; provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies; monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.

initial or subsequent psychiatric collaborative care management, each additional 30 minutes in a calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure)

transitional care management services with the following required elements: communication (direct contact, telephone, electronic) with the patient and/or caregiver within 2 business days of discharge medical decision making of at least moderate complexity during the service period face-to-face visit, within 14 calendar days of discharge

transitional care management services with the following required elements: communication (direct contact, telephone, electronic) with the patient and/or caregiver within 2 business days of discharge medical decision making of high complexity during the service period face-to-face visit, within 7 calendar days of discharge

advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate

advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; each additional 30 minutes (list separately in addition to code for primary procedure)

home visit for prenatal monitoring and assessment to include fetal heart rate, non-stress test, uterine monitoring, and gestational diabetes monitoring

home visit for respiratory therapy care (eg, bronchodilator, oxygen therapy, respiratory assessment, apnea evaluation)

home visit for stoma care and maintenance including colostomy and cystostomy

home visit for care and maintenance of catheter(s) (eg, urinary, drainage, and enteral)

home visit for assistance with activities of daily living and personal care

home visit for fecal impaction management and enema administration

home infusion/specialty drug administration, per visit (up to 2 hours)

home infusion/specialty drug administration, per visit (up to 2 hours); each additional hour (list separately in addition to code for primary procedure)

medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; initial 15 minutes, new patient

medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; initial 15 minutes, established patient

medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; each additional 15 minutes (list separately in addition to code for primary service)

red blood cell antigen typing, dna, human erythrocyte antigen gene analysis of 35 antigens from 11 blood groups, utilizing whole blood, common rbc alleles reported

oncology (colorectal), quantitative assessment of three urine metabolites (ascorbic acid, succinic acid and carnitine) by liquid chromatography with tandem mass spectrometry (lc-ms/ms) using multiple reaction monitoring acquisition, algorithm reported as likelihood of adenomatous polyps

oncology (ovarian) biochemical assays of five proteins (apolipoprotein a-1, ca 125 ii, follicle stimulating hormone, human epididymis protein 4, transferrin), utilizing serum, algorithm reported as a likelihood score

infectious disease (bacterial), dna, 27 resistance genes, pcr amplification and probe hybridization in microarray format (molecular detection and identification of ampc, carbapenemase and esbl coding genes), bacterial culture colonies, report of genes detected or not detected, per isolate

oncology (prostate) gene expression profile by real-time rt-pcr of 3 genes (erg, pca3, and spdef), urine, algorithm reported as risk score

prescription drug monitoring, 120 or more drugs and substances, definitive tandem mass spectrometry with chromatography, urine, qualitative report of presence (including quantitative levels, when detected) or absence of each drug or substance with description and severity of potential interactions, with identified substances, per date of service

drug test(s), presumptive, with definitive confirmation of positive results, any number of drug classes, urine, includes specimen verification including dna authentication in comparison to buccal dna, per date of service

helicobacter pylori detection and antibiotic resistance, dna, 16s and 23s rrna, gyra, pbp1, rdxa and rpob, next generation sequencing, formalin-fixed paraffin-embedded or fresh tissue, predictive, reported as positive or negative for resistance to clarithromycin, fluoroquinolones, metronidazole, amoxicillin, tetracycline and rifabutin

oncology (breast cancer), erbb2 (her2) copy number by fish, tumor cells from formalin-fixed paraffin-embedded tissue isolated using image-based dielectrophoresis (dep) sorting, reported as erbb2 gene amplified or non-amplified

infectious disease (bacterial), strain typing by whole genome sequencing, phylogenetic-based report of strain relatedness, per submitted isolate

prescription drug monitoring, evaluation of drugs present by lc-ms/ms, using oral fluid, reported as a comparison to an estimated steady-state range, per date of service including all drug compounds and metabolites

germline disorders, gene rearrangement detection by whole genome next-generation sequencing, dna, whole blood, report of specific gene rearrangement(s)

oncology (solid organ neoplasia), gene rearrangement detection by whole genome next-generation sequencing, dna, fresh or frozen tissue or cells, report of specific gene rearrangement(s)

hematology (hematolymphoid neoplasia), gene rearrangement detection by whole genome next-generation sequencing, dna, whole blood or bone marrow, report of specific gene rearrangement(s)

drug metabolism (adverse drug reactions), dna, 22 drug metabolism and transporter genes, real-time pcr, blood or buccal swab, genotype and metabolizer status for therapeutic decision support

oncology (hematolymphoid neoplasia), rna, bcr/abl1 major and minor breakpoint fusion transcripts, quantitative pcr amplification, blood or bone marrow, report of fusion not detected or detected with quantitation

oncology (hematolymphoid neoplasia), jak2 mutation, dna, pcr amplification of exons 12-14 and sequence analysis, blood or bone marrow, report of jak2 mutation not detected or detected

oncology (thyroid), microrna profiling by rt-pcr of 10 microrna sequences, utilizing fine needle aspirate, algorithm reported as a positive or negative result for moderate to high risk of malignancy

oncology, rna, gene expression by whole transcriptome sequencing, formalin-fixed paraffin embedded tissue or fresh frozen tissue, predictive algorithm reported as potential targets for therapeutic agents

drug test(s), presumptive, with definitive confirmation of positive results, any number of drug classes, urine, with specimen verification including dna authentication in comparison to buccal dna, per date of service

oncology (prostate),  detection of 8 autoantibodies (arf 6, nkx3-1, 5’-utr-bmi1, cep 164, 3’-utr-ropporin, desmocollin, aurkaip-1, csnk2a2), multiplexed immunoassay and flow cytometry serum, algorithm reported as risk score

targeted genomic sequence analysis panel, non-small cell lung neoplasia, dna and rna analysis, 23 genes, interrogation for sequence variants and rearrangements, reported as presence/absence of variants and associated therapy(ies) to consider

oncology (acute myelogenous leukemia), dna, genotyping of internal tandem duplication, p.d835, p.i836, using mononuclear cells, reported as detection or non-detection of flt3 mutation and indication for or against the use of midostaurin